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Abstract
12-Metallacrown-3 complexes were formed by self-assembly of organometallic half-
sandwich complexes [(π-ligand)MCl2]2 (M = Ru, Rh, Ir) and 3-hydroxy-2-pyridone lig-
ands in the presence of Cs2CO3 as base. Upon mixing of different macrocycles,
reversible metal fragment exchange occured, resulting in the generation of small
dynamic combinatorial libraries. Investigation of their adaptive behaviour revealed a
strong bias for the amplification of hetero-assemblies, and especially of the member
whose composition reflects the overall composition of the library. As a consequence, it is
not necessarily the thermodynamically most stable member (e.g. the assembly with the
highest affinity to a given target) that is amplified the most. Dynamic exchange proc-
esses of this kind have also been used to synthesise mixed-metal macrocycles by control-
led desymmetrisation of sterically hindered 12-metallacrown-3 complexes.
Using amino-substituted 3-hydroxy-2-pyridone ligands, monomeric O,O’-chelate
complexes were formed in aqueous solution. Self-assembly into trimeric metallamacro-
cycles was observed upon addition of base and in phosphate buffer solution, as evidenced
by NMR spectroscopy and single crystal X-ray analyses. The macrocycles were able to
act as highly selective receptors for lithium ions. The binding constants depend on the
nature of the halfsandwich complex, the ligand, and the pH. With a commercially availa-
ble [(cymene)RuCl2]2 complex and 4-(N-methylpiperazine)-3-hydroxy-2-pyridone, a
receptor with a Li+ binding constant of Ka = (5.8±1.0) × 10
4 M−1 and a Li+ to Na+ selec-
tivity of 10000:1 has been obtained. The fact that the assembly process of the receptor is
pH dependant has been used to detect the presence of lithium ions by a simple pH meas-
urement. Furthermore, it was possible to transduce the binding of Li+ into a change of
color by means of a chemical reaction with FeCl3. This allowed the detection of Li
+ in the
pharmacologically relevant concentration range of 0.5–1.5 mM by the ‘naked eye’. Mod-
ifications of the bridging ligand allowed the design of a potential fluorescent PET sensor
for Li+ ions in water.
7Li/6Li isotope separation was achieved by complexation of LiCl with 12-metalla-
crown-3 complexes having sterically very demanding π-ligands. An enrichment of 7Li of
5.4 % was observed. Using ligands in which two 3-hydroxy-2-pyridone units were con-
nected by a linker, hexanuclear structures of up to 2.8 nm have been obtained. These
assemblies can be regarded as expanded triple-stranded helicates.
Keywords
halfsandwich complexes [(π-ligand)MCl2]2 (M = Ru, Rh, Ir) ? 3-hydroxy-2-pyridone
ligands ? 12-metallacrown-3 complexes ? dynamic combinatorial chemistry ? pH
dependant self-assembly ? lithium ionophores ? 7Li/6Li isotope separation ?
expanded triple stranded helicates

Version Abrégée
Des complexes 12-metallacrown-3 ont été realisés par auto-assemblage de complexes
demi-sandwich [(π-ligand)MCl2]2 (M = Ru, Rh, Ir) et de ligands 3-hydroxy-2-pyridone
en présence de Cs2CO3 agissant comme base. L’échange réversible des sous-unités
métalliques des différents macrocycles a été observé. Ceci a été utilisé pour la formation
de bibliothèques combinatoires dynamiques. L’investigation de leur comportement
adaptatif a révélé que l’amplification des assemblages mixtes est favorisées.
Spécialement le membre qui possède la même composition que la bibliothèque est
amplifiée. En conséquence, le membre le plus stable thermo-dynamiquement (par
example l’assemblage avec l’affinité la plus élévée pour une certaine molécule cible)
n’est pas forcement le plus amplifié. Les processus d’échanges réversibles ont été
exploités pour la synthèse de complexes comportant deux fragments métalliques
différents par la désymmétrisation contrôlée de complexes 12-metallacrown-3
stériquement encombrés
Dans l’eau, des complexes monomériques ont été obtenus en utilisant des ligands
3-hydroxy-2-pyridones auxquelles un groupement amino a été attaché. Les deux atomes
d’oxygène du ligand se coordinant au métal. Dans une solution tampon phosphate ou
après addition de base, l’auto-assemblage de trimers métallamacrocycliques a été
observé. Ceci a été vérifé par spectroscopie RMN et par l’analyse de monocristaux par
rayons X. Les macrocycles obtenus sont des récepteurs sélectifs pour Li+ dans l’eau. La
constante d’association dépend de la nature des complexes demi-sandwich, du ligand et
du pH. En utilisant le complexe commercial [(cymène)RuCl2]2 et le ligand
4-(N-methylpiperazine)-3-hydroxy-2-pyridone, un récepteur avec une constante d’asso-
ciation de Ka = (5.8±1.0) × 10
4 M−1 et une sélectivité de Li+ sur Na+ de 10000:1 a été
obtenu. Grâce à l’auto-assemblage en fonction du pH, la présence du Li+ a pu être
détectée par une simple mesure du pH. La complexation de Li+ a été visualisée par un
changement de la couleur. Ceci a été atteint par réaction chimique du récepteur complexé
avec FeCl3. Il était ainsi possible de détecté le Li
+ dans la gamme pharmacologique
important de 0.5–1.5 mM ‘à l’œil nu’. La modification du ligand pontant a permis de
proposer la structure d’un senseur PET fluorescent pour Li+ dans l’eau.
Les isotopes 6Li et 7Li ont été séparés par complexation de LiCl en utilisant des
complexes 12-metallacrown-3 stériquement très encombrés. Une augmentation de 7Li de
5.4 % a été observée. Si deux unités de 3-hydroxy-2-pyridone sont connectées, des
complexes hexanucléaires avec une longeur maximale de 2.8 nm ont été obtenus. Ils
peuvent être décrits comme des hélicates élargis à trois branches.
Mots Clés
complexes demi-sandwich [(π-ligand)MCl2]2 (M = Ru, Rh, Ir) ? ligands 3-hydroxy-2-
pyridones ? complexes 12-metallacrown-3 ? chimie combinatoire dynamique ? auto-
assemblage en fonction du pH ? ionophores du lithium ? séparation isotopique de 6Li
et 7Li ? hélicates élargis à trois branches

Zusammenfassung
12-Metallakrone-3 Komplexe wurden durch Selbstanordnung von metallorganischen
Halbsandwich Komplexen [(π-Ligand)MCl2]2 (M = Ru, Rh, Ir) und 3-Hydroxy-2-pyri-
don-Liganden in Anwesenheit von Cs2CO3 als Base dargestellt. Beim Mischen ver-
schiedener Makrozyklen wurde der reversible Austausch von Metallfragment-
untereinheiten beobachtet. So konnten kleine dynamische kombinatorische Bibliotheken
erstellt werden. Untersuchung des adaptiven Verhaltens der Bibliotheken zeigte, daß
diese eine starke Neigung zur Bildung von Heteroassoziaten aufwiesen. Vor allem der
Komplex, der die Zusammensetzung der Bibliothek wiederspiegelt, wurde bevorzugt
gebildet. Daraus kann gefolgert werden, daß der thermodynamisch stabilste Komplex (z.
B. der Komplex mit der höchsten Affinität für ein Targetmolekül) nicht zwingenderweise
am stärksten angereichert wird. Dieser dynamische Austauschprozeß ermöglichte die
kontrollierte Aufhebung der Symmetrie von sterisch gehinderten 12-Metallakrone-3
Komplexen. Es wurden gemischte Metallamakrozyklen, d. h., Komplexe die zwei unter-
schiedliche Metallfragmente aufweisen, erhalten.
 Bei der Verwendung von amino substituierten 3-Hydroxy-2-pyridon-Liganden in
wässriger Lösung, bildeten sich einkernige O,O’-Chelatkomplexe. Bei Zugabe von Base
oder in Phosphatpufferlösung fand Selbst-Assoziation in dreikernige Metallamakro-
zyklen statt. Dies wurde durch NMR Spektroskopie und Röntgenstrukturanalyse an
Einzelkristallen gezeigt. Diese Makrozyklen sind hochselektive Rezeptoren für Li+
Ionen. Die Stärke der Li+-Bindungskonstante hing von der Natur des Halbsandwich
Komplexes, des Liganden und des pH-Wertes ab. Die höchste Li+-Affinität zeigte eine
Mischung des kommerziell erhältlichen [(cymol)RuCl2]2 Komplexes und des Liganden
4-(N-Methylpiperazin)-3-hydroxy-2-pyridon. Die Bindungskonstante betrug
Ka = (5.8±1.0) × 10
4 M−1 und der Komplex zeigte eine Li+ Selektivität von 10000:1 im
Vergleich zu Na+. Die pH-Abhängigkeit der Bindungskonstante wurde genutzt, um die
Anwesenheit von Lithium Ionen durch eine Messung des pH-Wertes nachzuweisen. Des-
weiteren konnte der Grad der Li+-Komplexierung durch einen Farbtest visualisiert wer-
den. Dies erlaubte den Nachweis im pharmakologisch relevanten Bereich (0.5–1.5 mM)
durch das bloße Auge. Die Derivatisierung des verbrückenden Liganden erlaubte das
Design eines potentiellen fluoreszierenden PET-Sensor für Li+ Ionen in Wasser.
Eine Trennung der Isotope 6Li und 7Li wurde durch Komplexierung von LiCl mit
12-Metallakrone-3 Komplexen mit sterisch anspruchsvollen π-Liganden erreicht. 7Li
wurde zu 5.4 % angereichert. Sechskernige Metallkomplexe mit einer Länge von bis zu
2.8 nm wurden durch Verbrückung zweier 3-Hydroxy-2-pyridon-Liganden erhalten.
Schlüsselwörter
Halbsandwich Komplexe [(π-Ligand)MCl2]2 (M = Ru, Rh, Ir) ? 3-Hydroxy-2-pyridon-
Liganden ? 12-Metallacrown-3 Komplexe ? Dynamische kombinatorische Chemie ?
pH-abhängige Selbstanordnung ? Lithium-Ionophore ? 7Li/6Li-Isotopentrennung ?
Erweiterte dreisträngige Helikate
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I.I Molecular Architecture
Human beings have always been fascinated by symmetry. This fascination originates
from the paradoxal combination of simplicity and complexity in symmetric objects.
Symmetry is perceived as pure aesthetics, and symmetry is omnipresent.
The highest degree of symmetry is expressed in the sphere. Highly symmetric, convex
polyhedra approximating a spherical shell are the Platonic (Figure I.1) and Archimedean
solids. The faces of the five Platonic solids consist of only one regular polygon, and those
of the 13 Archimedean solids of two or three regular polygons.[1] Spherical shells are
important motifs in nature due to their low surface-to-volume ratios; an illustrative exam-
ple is the icosahedral or dodecahedral shape of the capsids of most viruses.[2]
The imitation of such symmetric objects on the molecular level has always been a spe-
cial challenge in synthetic chemistry. But although classical covalent hydrocarbon chem-
istry has a large collection of reliable reactions at their disposal, the synthesis of such
objects has been proven to be extremely difficult. Nonetheless, three Platonic solids,
tetra(tert-butyl)tetrahedrone,[3] cubane,[4, 5] and dodecahedrane[6, 7] have been synthe-
sised after much effort. The remaining two Platonic solids, the icosahedron and the octa-
hedron, are unlikely to be synthesised by classical organic means: first, because of the
limited number of bonds a carbon atom can form, and second, because of the restriction
to a tetrahedral, trigonal or linear geometry. Two more carbon-based highly symmetric
structures are worthwhile to mention: adamantane,[8–10] which displays a tetrahedral
symmetry, and fullerenes, with its best known member, C60, representing the Archime-
dean solid of a truncated icosahedron (12 pentagonal and 20 hexagonal faces).[11–13]
Figure I.1 The five Platonic solids: the faces of the tetrahedron, octahedron and icosahedron
consist of regular triangles, those of the cube of squares and the faces of the
dodecahedron of pentagons.
Tetrahedron Cube Octahedron
Dodecahedron Icosahedron
I Introduction
4
Especially the restriction to certain angles provoked Fujita and coworkers to incorpo-
rate transition metal fragments into the organic framework. In 1990, they presented the
formation of a metallasupramolecular square.[14–16] Complex E1, readily self-assembles
from [(en)Pd(II)(NO3)2] and 4,4’-bipyridine in aqueous alcoholic solution. The preferred
coordination geometry of the metal centre is square planar, with two coordination sites in
cis position to each other blocked by the chelate ligand, so that the two bridging ligands
can only coordinate by opening an angle of 90°. The strength of the metal–ligand interac-
tion of the monodentate bridging ligand allows replacement of the weakly bound NO3
−
groups, but not of the chelate ligand. The ditopic bridging ligand itself is linear and rigid,
with one coordination group at each side, so that upon coordination of four ligands and
four metal centres only a square planar geometry can be formed. The self-assembly
occurs under thermodynamic control, and results in almost quantitative product forma-
tion. Although metal organic frameworks have been reported before,[17–19] the power of
Fujita’s approach launched a completely new research domain: transition metal based
self-assembly of discrete nanoscopic supramolecular species with predetermined size and
shape such as molecular cycles, boxes and cages, so called molecular architecture.[20]
The general synthetic approach has been extended to the formation of infinite networks
and grids.[21]
Whereas in the beginning most structures were obtained by serendipity or ‘trial and
error’, three different rational synthetic design strategies have been emerged over the last
decade: the directional bonding approach,[22, 23] the symmetry interaction approach[24–
26] and the weak-link approach.[27, 28] All three use metal centres with predetermined
coordination geometry and angles as structural building blocks in combination with
multibranched organic ligands possessing heteroatoms as coordination groups.
Scheme I.1 Self-assembly of a molecular square presented by Fujita.[14]
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A large variety of different topologies has been synthesised up to now. Size, shape and
internal cavity dimensions are now predictable features, but the interest in the field is far
from ceasing. The driving force behind is the ease with which large and complex struc-
tures can be obtained. Nevertheless, the focus turns now from ‘structure to function’, and
the new challenge is to transform aesthetic structures into functional constructs. Envi-
sioned functional properties are cavity-directed synthesis, homo- and heterogeneous
catalysis and photo- and electrochemical sensing. Host-guest chemistry, redox activity
and magnetic behaviour of metallasupramolecular architecture are likewise in the focus
of research.[29–32]
There are some intrinsic difficulties towards this aim. Typically, the metal centres are
coordinatively inert, acting solely as corner stones of the supramolecular assemblies.
Likewise, properties inherent to the ligands are often turned off, due to their proximity to
the metal ions, e.g. quenching of the luminescence of ligands by the nearby metal centres
has been observed.[33, 34] Moreover, chemistry confined to a small space inside supra-
molecular architecture behaves often quite different to what is expected, being at the same
time strain and opportunity.
I Introduction
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I.II Transition Metal Based Self-Assembly
In transition metal based self-assembly the building blocks are held together by metal–
ligand coordinative interactions. The building blocks contain all necessary information
to assemble selectively into discrete complex aggregates. The assembly process occurs
generally under thermodynamic control, and the formed species have unique features
different from their building blocks. Self-correction is an intrinsic feature of the synthetic
strategy.[35]
Non-covalent metal–ligand bonds are considered as ‘weak’, though this assumption is
probably more due to their inherent reversibility than their bond strength. Their bond
strength of 40–120 kJ/bond is in between ‘classical’ non-covalent weak interactions such
as hydrogen bonds, van der Waals, Coulombic and dipole-dipole interactions and cova-
lent bonds. Weak interactions are usually associated with many different reaction path-
ways and poor selectivity. But this ‘lack of control’ turns out to be the intrinsic advantage,
as it is synonymous with ‘error correction’.
Non-covalent interactions are kinetically labile. Typically, a fast thermodynamic equi-
librium exists between the starting materials and all potential products. An ‘improperly’
connected bond can simply ‘go back’ on the reaction pathway to be reconnected in
another fashion. Due to this inherent reversibility, a self-correction process can take
place, leading ideally to the thermodynamically favoured product in high yields. How-
ever, to single out one product, the thermodynamic advantage over all other possible spe-
cies has to be sufficiently large. For many metallasupramolecular systems no clear
thermodynamic preference is given, and several species are in equilibrium with each
other.[29]
In contrast, the often observed formation of cyclic species in metal-directed self-
assembly is no coincidence, but a consequence of thermodynamics. Cyclic structures are
intrinsically favoured over oligomeric structures for the simple reason that the average
number of metal–ligand interactions per building block is higher, thus displaying an
higher relative enthalpic gain. If ligand structure and coordination geometry of the metal
centre are purposely designed for cyclic structures, this behaviour is enhanced. Small
assemblies are preferred over large assemblies due to entropic reasons: less building
blocks are necessary to form the same amount of assemblies. Ercolani [36, 37] has exam-
ined the macrocyclisation process from a theoretical point of view. Cyclic species are in
equilibrium with the monomeric building blocks and polymeric species and exist only in
a certain concentration range. Below the so called lower self-assembly concentration
(lsac), the equilibrium is in favour for the monomeric building blocks, whereas, above the
effective molarity (EM) formation of polymeric species is preferred instead of further
macrocyclisation.
I.II Transition Metal Based Self-Assembly
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In general, enthalpic reasons rule over entropic reasons due to the large gain of energy
upon metal–ligand bond formation,[29] but entropy becomes the decisive factor if the
enthalpies of two or more potential topologies are very close. An example is the compe-
tition between squares and triangles. Rigid linear bridging ligands and metal centres with
square planar geometry should lead to the formation of molecular squares. However,
some deviations from the ideal geometry are tolerated by both building blocks. Whereas
enthalpy favours the formation of squares due to less strained systems, entropy favours
triangles. Typically, both topologies co-exist in an equilibrium with each other. This is the
case even for very rigid ligands such as tetraphenoxy-substituted diazadibenzoperylene
bridging ligands and perfectly preorganised (dppp)PdII or (dppp)PtII units, as shown by
Würthner and coworkers (Scheme I.2).[38]
As a result, bridging ligands are mostly very rigid with structurally predisposed coor-
dination groups. Nitrogen is the most employed heteroatom for coordination to the metal
centre, as the metal–nitrogen bond strength is strong enough to replace weakly bound lig-
ands. The combination of metal ions having a geometric coordination preference and
strongly bound directing ligands is most common. Directing ligands block certain coordi-
nation sites and direct the incoming ligands into a certain angle to each other. Generally,
phosphine-metal bonds are strong enough to guarantee slow exchange kinetics; moreover
chelate ligands are often used. Typical experimental concentrations are in the millimolar
range in order to favour cyclic products over monomeric and polymeric species.
Metal-directed self-assembly targets primarily symmetric topologies.
One has to keep in mind, that metal-directed self-assembly targets primarily symmetric
topologies. It is therefore suited to mimic size and shape of biological entities in order to
Scheme I.2 Equilibrium between square planar and triangular topology.[38]
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obtain similar structural properties, a goal difficult to achieve by organic means. Classical
organic chemistry is specialized to form typically one new bond at the time, revealing a
major drawback: the synthesis of large and complex molecular assemblies. Moreover,
covalent bond formation is usually carried out under kinetic control, and improperly con-
nected bonds are therefore hard to fix.
To summarise: self-assembly has several advantages compared to covalent chemistry
when the synthesis of large and symmetric structures is concerned. The assembly of
building blocks into supramolecular assemblies represents a highly convergent synthetic
protocol with the simultaneous formation of a multitude of interaction. These interactions
establish usually very fast in an almost defect-free fashion due to an inherent error correc-
tion process. Transition metal based self-assembly provides even more advantages as it
combines the benefits of error correction with a certain stability of the metal–ligand
bonds. Furthermore, classical weak interactions are non-directional, whereas transition
metals and heterocycles provide some directionality.[39] Structural versatility is given due
to a large number of transition metal complexes and bridging ligands.
I.III Design Strategies
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I.III Design Strategies
Molecular architecture represents polygons and polyhedra on a molecular basis. Typi-
cally, the metal centres are located on the vertices, whereas the ligands outline the edges.
But polyhedra can also be designed by covering the faces with ligands. This second way
to depict polyhedra, is called molecular panelling and was particularly developed by
Fujita.[16, 40, 41] Three different design strategies based on metal-directed self-assembly
will be discussed. The directional bonding and the symmetry interaction approach target
both the thermodynamic product. Ligands have several coordination groups. The direc-
tional bonding approach employs generally very rigid monodentate ligands, and the sym-
metry interaction approach chelating ligands (but assemblies with monodentate ligands
have also been reported). Despite the availability of several atoms able to coordinate to
metal ions, most often, nitrogen-to-metal coordination is employed. This leads com-
monly to charged assemblies. The main difference between these two methods is how to
control the incoming ligands into their correct coordination position. Whereas the direc-
tional bonding approach makes use of directing ligands, which block certain coordina-
tion sites of the metal centre, the symmetry interaction approach takes advantages of the
preferred coordination geometry of the ‘naked’ metal ion. The weak-link approach is a
relatively new manner to access more flexible assemblies. Often, the kinetic product
instead of the thermodynamic product is obtained. Ligands coordinate with two different
coordination groups of different strength. Typically phosphines and ethers are used.
Molecular architecture was probably most often generated according to the directional
bonding approach. The principle has been elaborated by Fujita[42, 43] since the beginning
of the 90s and then been systematized by Stang in 1997.[22, 23] Since then, reviews have
been appeared on a regular basis.[16, 20, 27, 35, 40, 44] The symmetry interaction model has
extensively been used by Saalfrank,[45, 46] Lehn[47, 48] and Raymond.[24–26] Especially,
definitions introduced by Raymond[25] describing the geometric relationship between the
ligand and the metal centre facilitated the rational design and helped to evolve this rather
complex approach. The symmetry interaction approach has been reviewed several times
by Raymond[24–26] and others.[27, 35, 44] The weak-link approach has been developed in
particular by Mirkin and was first demonstrated in 1998.[49] Two reviews on this topic
have appeared so far.[27, 28] Worthwhile to mention is also a publication outlining the
most important rules of ligand design by Steel.[50]
I.III.1 The Weak-Link Approach
The weak-link approach is not only conceptually different from the directional bonding
and the symmetry interaction approach, but targets also another type of complexes con-
taining more flexible ligands and metal centres with free coordination sites. Therefore,
hemilabile ligands[51, 52] are used, which are in general chelate ligands, but with two
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coordination groups of different affinity towards the metal ion. Upon coordination, one
of the two metal–ligand bonds is much weaker than the other – the so called weak-link –
and can be cleaved selectively while maintaining the overall supramolecular structure. 
The employed hemilabile ligands are the core of the weak-link approach. Typically,
they contain arenes as central bridging units, to which two bidentate coordination sites are
attached. This bidentate coordination site is composed of a phosphine group and a second
coordination group X, typically an ether. The general synthetic scheme of the weak-link
approach is shown in Scheme I.3. Coordination of a hemilabile ligand to a metal ion such
as RhI provides a condensed intermediate B with two metal–ligand bonds of different
strength: a very strong metal–phosphine bond and a much weaker metal–X bond. The tar-
get molecule C, the open and much more flexible macrocyclic structure, is obtained by
selectively cleaving the weak metal–X bond by addition of so called ancillary ligands L,
which show a stronger affinity for the metal ion.
In further contrast to the directional bonding and the symmetry interaction approach,
reactions of the weak-link approach occur under kinetic rather than thermodynamic con-
trol, and there is evidence that the mononuclear complex A is the thermodynamically
favoured product.[53] But once the condensed intermediate B is formed, it seems to be
metastable, and transition into A is hampered by large activation barriers. The kinetic
control displays also the major disadvantage of the weak-link approach, as an error cor-
rection is not longer possible. However, use of flexible ligands and ‘naked’ transition
metals ions allows the access to flexible structures and metal centres with free coordina-
tion sites, which are available for further chemistry. Both features are intrinsic advantages
for the ‘transition from structure to function’.
This strategy was first demonstrated by Mirkin in 1998, using the hemilabile
bis(bidentate) ligand E4 in combination with a RhI starting material in a 1:1 ratio to gen-
erate the condensed intermediate E5, in which both – the phosphine as well as the ether
group – are coordinated to the metal ion. The open 26-membered macrocycle E6 was
obtained by breaking the weak Rh–O bond via coordination of ligands with higher affin-
ity such as CO, CH3CN or both to the metal centre (Scheme I.4).
[49]
Scheme I.3 General synthetic scheme of the weak-link approach.
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Generally, the weak-link consist of a ether-based hemilabile oxygen-metal bond, but
thioethers and amines have also been used. As the strength of the metal–X bond increases
from ethers to amines to thioethers, cleaving requires ancillary ligands with stronger
affinity. RhI is most commonly used as transition metal, but other d8 square planar metals
such as PdII and IrI have likewise been used. Examples exist also for the d10 tetrahedral
metal centre CuI and the d6 octahedral metal centre RuII. Among the most used ancillary
ligands are CO, acetonitrile and isocyanides, but ring opening can also be achieved by
using anions, pyridines or diamines.[27, 28]
I.III.2 The Symmetry Interaction Approach
The symmetry interaction approach is the most sophisticated of the three design strate-
gies, as the coordination geometry of the metal, the ligand orientation and the ligand-
ligand steric interactions have to be considered. Preorganised multibranched chelate lig-
ands in combination with transition or main group metals assemble into supramolecular
structures, mainly driven by the preferred coordination geometry of the metal centre.
Scheme I.4 Synthesis of a flexible macrocyclic structures employing the weak-link
approach.[49]
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Generally, chelate ligands, providing stronger binding of the ligand to the metal,[54] and
‘naked’ metals ions, i.e., metals free of any strongly coordinating blocking ligands, are
used. The first complexes synthesised according to the symmetry interaction approach
have been presented in the mid 80s by Maverick (Figure I.2), even though unintention-
ally and without recognition of the underlying priniples.[18, 19]
Nowadays, numerous examples of discrete structures employing the symmetry inter-
action approach can be found in the literature, especially macrocyclic systems presented
by the groups of Lehn,[47, 48] Saalfrank[45, 55–58] and Raymond.[24–26] But these topolo-
gies were often discovered by serendipity or by systematic variation of the ligand and
metal components.[25, 27, 35] The complexity of the approach is both, its strength and lim-
itation.
The development into a rational synthetic scheme was driven especially by Raymond
and Caulder.[24–26] Their definition of terms which specify the geometrical relationship
between the ligand and the metal centre are now essential for the description of high sym-
metry coordination clusters and facilitate their rational design.
The Coordinate Vector The coordinate vector is defined as the vector directed
from the ligand to the metal centre. Monodentate and bidentate ligands are the two most
important cases to consider. In the first case, the coordinate vector is simply the vector
from the coordinating atom directed to the metal ion. In the second case, the coordinate
vector is the vector which bisects the bidentate chelating group and is headed towards the
metal ion.
The Chelate Plane The chelate plane is a plane orthogonal to the major symmetry
axis of the metal complex. In the case of coordination of bidentate ligands to an octahe-
dral metal centre, the chelate plane is spanned by the coordinate vectors of all coordinated
ligands. Most importantly, any symmetric coordination complex can be described by the
relationship between the chelate planes.
Figure I.2 First metallamacrocyclic structure employing the symmetry interaction approach.
I.III Design Strategies
13
The Approach Angle The approach angle is the angle between the vector con-
necting the two coordinating atoms and the major symmetry axis of the metal centre.
In principle, coordination complexes of any symmetry can be formed. The symmetry
elements of the point group corresponding to the target molecule have to be provided by
the building blocks. Among the most widely reported topologies are helical and tetrahe-
dral structures. These two topologies are an interesting examples of the complexity of the
symmetry interaction approach, as they are both assembled from building blocks with the
same inherent symmetry. But providing the symmetry elements is only a necessary
requirement, the actual topology will be determined by the relative orientation of the
symmetry axes one to another. For example, a M2L3 triple helicate belongs to the point
group D3,
[59] consisting of a C2 and C3 axis. A tetrahedron owns likewise C2 and C3 axes.
Thus, in both cases, one of the building blocks must possess a C2 axis, whereas the other
must have a C3 axis. The three-fold axis can be provided by a metal centre with pseudo-
octahedral coordination, and a two-fold axis by a C2-symmetric bis(bidentate) ligand. If
the symmetry axes span an angle of 90°, a triple helicate is formed, but if they span an
angle of ~55°, a M4L6 adamantoid structure is obtained (Figure I.4).
[26, 45, 55–58, 60, 61]
Figure I.3 Definitions for the symmetry interaction model. a) Coordinate vector for a bidentate
ligand. b) Chelate plane defined by the plane orthogonal to the major metal
symmetry axis. c) Approach angle for bidentate chelator.[24, 25]
Figure I.4 Symmetry determination according to the orientation of the C2 and C3 axes.
Reproduced by permission of The Royal Society of Chemistry from ref. [25].
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I.III.3 The Directional Bonding Approach
The directional bonding approach is probably the most used design strategy for molecu-
lar architecture. First examples in the literature employing this approach are tetranuclear
metal complexes from Verkade[17] and the quantitative synthesis of a molecular square
by Fujita in 1990 (Scheme I.1).[14–16] The underlying principles were formulated for the
first time by Stang in 1997,[22, 23] initially named ‘molecular library approach’.[22] But
this term didn’t gain general acceptance and was replaced four years later with ‘direc-
tional bonding approach’ by Mirkin.[27]
The directional bonding approach employs highly directional metal fragments in com-
bination with multibranched monodentate rigid ligands to gain structural access to poly-
gons and polyhedra. Coordination in a directional fashion is ensured by the rigidity of the
ligands and the coordination geometry of the metal centres in combination with large
blocking ligands. These so called blocking or directing ligands are coordinatively inert,
meaning that their kinetic exchange is so slow compared to those of the incoming bridg-
ing ligands and weakly bound ligands occupying the ‘free’ coordination sites of the metal
that they can be seen as kinetically stable. Consequently, the angle spanned by the two
incoming ligands is given and upon further coordination of metal centres and bridging
ligands a ‘closed’ aggregate of predetermined symmetry will be obtained.[22, 23]
The design principle is illustrated in Scheme I.5 for several two-dimensional struc-
tures. Four metal centres with an 90° angle and four linear ditopic ligands will result in
the formation of a molecular square, whereas a triangular macrocycle would be assem-
bled from three linear ligands in combination with three metal fragments with an 60°
angle.[22, 23]
In more general terms, a polygon or polyhedra is split into two different subunits,
either both angular or into a linear and an angular one. Joined together in the correct ratio,
the building blocks should theoretically assemble only in a predetermined geometrical
form. Although this strategy has been developed for transition metal based self-assembly,
the design principle should be applicable universally, as long as two requirements are ful-
filled: 
1. The building blocks are rigid, have predefined angles between the different
coordination sites and are complementary to each other.
2. The building blocks are mixed in the appropriate ratio.
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However, things are more complicated and often not so straightforward as described
here. The metal centres and the bridging ligands tolerate some deviations from their ideal
geometry, and the self-assembly process itself is governed by more factors than the pre-
determination of building blocks. Thus, unexpected results are often obtained. Fre-
quently, metallasupramolecular self-assembly reactions display no clear thermodynamic
preference and two or more species are found in equilibrium. Many more topologies than
those here presented have been obtained, among those prismatic, anti prismatic and non-
symmetrical structures. Since the first systematic description in 1997,[22, 23] the topic has
been reviewed several times by Stang,[20, 35] Mirkin,[27] Fujita[16, 42, 43] and others.[44]
Whereas most researchers described molecular analogues of symmetric polyhedra, in
which the ligands were located on the edges, Fujita did so by panelling the faces of poly-
hedra.[16, 40, 41] Several reviews with special emphasis on molecular squares[16, 29, 62]
have been appeared and molecular architecture employing nucleobases as ligands has
been intensively studied and reviewed by Navarro and Lippert.[39, 63] Jones paid special
attention at the construction of molecular containers.[64]
Scheme I.5 Design principle of the directional bonding approach for selected two-
dimensional structures.[22, 23, 35]
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The underlying design principles are also the major limitations of the approach. Rigid
ligands favour the formation of supramolecular topologies but flexibility is important for
functional features. The metal centres are coordinatively inert and no free coordination
sites are available. They act solely as building blocks of the structure. Especially the per-
turbation of the physical properties of both, metal centres and ligands, hampers the devel-
opment from structure to function. The largest potential lies probably in their application
as reaction vessels[31] and containers for the stabilisation of guests which are difficult to
study otherwise.[65–68]
I.III.3.a Assembly of Polygons
An overview of different polygons accessible by the combination of typical building
blocks with different geometry is given in Figure I.5. Among these structures, tetranu-
clear molecular squares are most widely reported. Especially the emphasis of Fujita and
Stang pushed molecular squares into a independent topic of metal-directed self-assem-
bly.[22, 23, 35, 43, 62] The formation of squares starting from angular units displaying an
90° angle and linear building blocks is favoured, as the formation of a rectangular shape
is almost strain free. Only few triangles have been reported, maybe due to the fact that
angles of 60° are quite uncommon in transition metal complexes.[23] Nonetheless, trian-
gles are often reported as side products from the formation of molecular squares (see
chapter I.II).
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Four different molecular squares, demonstrating both common and uncommon struc-
tural building blocks and features, are shown in Figure I.6. Cis protected PtII and PdII
complexes acting as angular units and rigid ditopic bridging ligands acting as linear units
are among the most common building blocks; a nice overview of employed building
blocks has been compiled by Mirkin.[27]
Chelating phosphine ligands are most often used as directing ligands, but functionali-
sation with crown ethers, calixarenes[69] or for example ferrocene groups is possible, as
shown by Stang for complex E11.[70] Ligands are in most cases very rigid and linear.
Generally, this is achieved by fused or linked arenes. An interesting example is complex
E12, in which porphyrines have been used as angular units linked by trans-[PdIICl2]
2+
metal centres acting as linear bridging units.[33] Complex E10[71] and E9[72] are excep-
tionally large. Complex E9, for example has a metal–metal diagonal length of 3.4 nm.
This complex is also interesting, as the dipyridylperylene units retain their photophysical
properties. Reversible electrochemistry of the ligand in the final PtII complex give raise to
Figure I.5 Two-dimensional molecular topologies targeted by the directional bonding
approach.[22, 23, 35]
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potential applications as electro- or photochemical sensor for large guest molecules.[72,
73] The ligand has been further functionalised with ferrocene groups towards this aim.[74]
I.III.3.b Assembly of Polyhedra
Assembly of polyhedra can be either edge-directed or face-directed. In the first case, all
building blocks lie on the edges. The shape of the polyhedra can be outlined by simply
replacing the building blocks with strokes. If some or all faces of the target polyhedra are
spanned by the building blocks, the approach is called face-directed. This approach is
less intuitive, and it is sometimes quite difficult to ‘recognize’ the polyhedra. The self-
Figure I.6 Selected molecular squares obtained according to the directional bonding
approach.
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assembly of a molecular cube in edge-directed and face-directed fashion is shown in
Scheme I.6 to illustrate both approaches.[20]
Eight tritopic corners with an 90° angle and twelve linear ditopic subunits are neces-
sary to obtain a molecular cube according to the edge-directed approach. This strategy has
been successful applied by several research groups.[75–78] Face directed self-assembly of
a molecular cube has been demonstrated by Brisbois and coworkers using six tetratopic
planar 90° faces and twelve ditopic 90° angles.[79]
All Platonic solids, as well of most of the Archimedean solids have been synthesised
according to either one or both techniques. Polyhedra which can be obtained by combina-
tion of di- and tritopic building blocks following the edge-directed technique are pre-
sented in Figure I.7.
Scheme I.6 Edge-directed self-assembly (top) and face-directed self-assembly (bottom)
illustrated at the example of a cubic cage.
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Some of the most spectacular assemblies obtained so far are the octahedra E13 and
E14 presented by Fujita[80, 81] and a cuboctahedron E17 presented by Stang
(Figure I.8).[82] Complex E13 was obtained by self-assembly of the commonly used
[(en)Pd]2+ unit and 2,4,6-tris(4-pyridyl)-1,3,5-triazine acting as a tridentate triangular
building block.[80] The metal centres occupy the corners of the octahedron, and four of
the eight faces are occupied by triangular ligands. Alternatively, the hexahedral complex
E14 was obtained when using the hexadentate ligand 1,3,5-tris(3,5-pyrimidyl)ben-
zene.[81] All six faces are occupied by the ligand and connected via 18 [(en)Pd]2+ units,
located this time on the edges of the octahedron instead at the corners. The cuboctahedral
complex E17 was obtained by self-assembly of the eight tridentate ligands E15, repre-
Figure I.7 Polyhedra obtained by combination of ditopic and tritopic building blocks.
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senting the triangular faces of the cuboctahedron, which were linked by twelve angular
units E16.[82]
Complex E13 is outstanding as its simple preparation allows the synthesis on a com-
mercial basis. The complex is well soluble in water and provides a large hydrophobic cav-
ity with diagonal Pd–Pd distances of 2.2 nm. Most important, as only four of the eight
faces are occupied by ligands, the cavity is accessible for large molecules. Applications
using complex E13 as reaction vessel are now starting to emerge.[83–91]
Figure I.8 Selected examples of molecular architecture obtained by employing the directional
bonding approach.
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I.IV Halfsandwich Complexes in Metal-
Directed Self-Assembly
Organometallic complexes of RuII, RhIII and IrIII have likewise been used as building
blocks in transition metal based self-assembly. Dimeric halfsandwich complexes of the
general formula [(π-ligand)MCl2]2 are ideally suited starting materials, as they are either
commercially available or easily accessible. They are soluble in organic solvents as well
as in water. After abstraction of the chloro ligands, three facial coordination sites are
available for neutral or anionic ligands. The metal centre displays a pseudo tetrahedral,
piano stool like geometry. Organometallic halfsandwich complexes used for the assem-
bly of molecular architecture as well as in this work are presented Figure I.9.
Two- and tridentate ligands have mainly been employed to obtain macrocyclic struc-
tures. Using bidentate ligands, such as cyanide,[75, 76, 78, 92–94] cyanamide,[95, 96] diisocy-
ano compounds,[97–99] diamino compounds,[100] or 4,4’-bipyridine ligands[101, 102]
molecular rectangles and cage like structures have been obtained.
Whereas tridentate planar ligands result in the formation of metallamacrocycles of dif-
ferent nuclearity, tridentate non-planar ligands give raise to three-dimensional topologies,
Figure I.9 Selected chloro-bridged organometallic halfsandwich complexes.
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as recently demonstrated by Rauchfuss.[103] Reaction of [Cp*Rh(MeNO2)n]
2+ and
[PhB(CN)3]
− in nitromethane resulted in the formation of a hexagonal prism. The geom-
etry of cyclic assemblies obtained from halfsandwich complexes and tridentate planar lig-
ands depends on the relative arrangement of the donor atoms. The geometric shapes
observed so far and their correlation to the relative orientation of the coordinate vectors
are summarized in Figure I.10.
Most often, polycationic trinuclear species of type A have been reported. They were
first described by Fish in 1992,[104] who studied the self-assembly of [Cp*RhCl2]2 with
adenine derivatives.[104–110] Structurally similar complexes using (arene)RuII, Cp*IrIII,
Cp*RhIII were subsequently investigated by Sheldrick[111–113] and Yamanari.[114, 115]
Recently, formation of trimeric assemblies from of the (9-ane-S3)Ru
II moieties and
9-methyladenine have been reported.[116] Furthermore, trimeric metallamacrocycles
were obtained using amino acids,[117–122] and 9-ethyl-hypoxanthine.[123] Using dianionic
Figure I.10 Different metallamacrocyclic geometries obtained from reactions of halfsandwich
complexes and tridentate ligands.
I Introduction
24
bridging ligands, neutral species were obtained. Neutral trinuclear macrocycles have been
especially developed by Severin and coworkers. They have been obtained with the fol-
lowing ligands: 3-acetamido-2-pyridone,[124] 2,3-dihydroxyquinoline,[125] 2,3-dihy-
droxyquinoxaline,[125] 6-methyl-2,3-dihydroxyphenazine,[125] and 3-hydroxy-2-
pyridone[124, 126, 127] as well as its 5-chloro derivative.[128, 129] Although these ligands
are very diverse, they have a common feature: the similar arrangement of the donor atoms
results in the same orientation of the coordinate vectors.
For the free adenine ligand, a different coordination scheme was observed, resulting in
tetranuclear assemblies of type B.[111, 113] Similar structures were obtained for 6-purine-
thione[130] and 4-imidazolecarboxylic acid,[125] both displaying the same arrangement of
donor atoms as adenine. A hexanuclear macrocycle of type E has been obtained using 9-sub-
stituted 6-purinethione as ligand.[131] As shown, tridentate ligands can also adopt a coor-
dination mode which leads to dinuclear species of type D[132] as well as of type C.[99, 125, 133]
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I.V Metallacrown Complexes
Metallacrown complexes are among the earliest metallamacrocycles described and were
first reported by Pecoraro in 1989.[134–136] Metallacrown complexes are inorganic ana-
logues of crown ethers and obtained by replacing two carbon atoms of the latter with a
metal and a heteroatom (such as nitrogen). In analogy to their organic counterparts, ring
size and the number of oxygen donor atoms are indicated in their name, e.g. 12-metalla-
crown-4 has a total of twelve atoms defining the metallamacrocycle and four oxygen
donor atoms pointing into the central cavity.[137, 138] A comparison of metallacrown
complexes and crown ethers shown in Figure I.11 clearly demonstrate their analogy.[139]
Despite the difference bond lengths of M–O or M–N bonds compared to C–C or C–O
bonds, similar cavity sizes are found for metallacrown complexes and their organic coun-
terparts. Thus, metallacrown complexes are also well suited to act as specific ion recep-
tors. However, their binding affinity is in general increased compared to organic crown
ethers due to the rigidity of their metallamacrocyclic framework and a higher polarization
of the oxygen donor atoms.[134–136, 139–141]
To date, metallacrown complexes of various metals have been reported. The most
commonly used bridging ligands are salicylhydroxamic acid and its derivatives with the
same structural binding motif. Usually, metallacrown complexes are obtained in a single
Figure I.11 Crown ethers and their analogous metallacrown complexes.
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step reaction in good yields.[142–150] Ring sizes from 9[134, 136] to 36 atoms[151] have
been reported, as well as sandwich type metallacrown complexes[152, 153] and double
crown complexes.[154–156] The metallacrown analogy has been expanded to metallacalix-
arenes[157] and metallacryptands.[158] Recently, inverse metallacrowns, i.e. the metal cen-
tres point into the cavity, so that these macrocycles function as anion receptors, have been
presented.[159–163]
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I.VI Neutral 12-Metallacrown-3 Complexes
Neutral trimeric macrocycles complexes using organometallic building blocks and tri-
dentate rigid dianionic oxo-pyridonate ligands have been developed in the Severin
group.[124, 126, 127, 164] The following chapter gives an introduction into the field, which
is the basis of the presented work. 12-Metallacrown-3 complexes self-assemble easily
from organometallic dimeric halfsandwich complexes [(π-ligand)MCl2]2 and
3-hydroxypyridone ligands in the presence of a base such as Cs2CO3. The synthetic
scheme (Scheme I.7) is very versatile, as not only the metal fragment, but also the ligand
can be varied. Reactions perform generally in good yields (>> 60 %).
Scheme I.7 shows the halfsandwich complexes and ligands used so far. Using
3-hydroxy-2-pyridonea L1 as bridging ligand, complexes with various (arene)Ru[124, 126,
Scheme I.7 Synthesis of neutral 12-metallacrown-3 complexes. The relative arrangement of
the donor atoms of the ligands is highlighted in bold.
a. The use of 3-hydroxy-2-pyridone and 2,3-dihydroxypyridine is equivalent, as both compounds are in a tautomeric
equilibrium with each other.
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164, 165] and Cp*M (M =Rh, Ir)[124, 165, 166] metal fragments have been obtained. Trinu-
clear species with different ligands were likewise obtained if the relative arrangement of
the donor atoms was maintained. This is the case for 5-chloro-3-hydroxy-2-pyridone
EL1,[128] 3-acetamido-2-pyridone EL2,[124] 2,3-dihydroxyquinoline EL3 and 2,3-dihy-
droxyquinoxaline EL4.[125] Expanded trinuclear metallamacrocycles have been obtained
for 6-methyl-2,3-dihydroxyphenazine EL5 and [(Me3C6H3)RuCl2]2.
[125] The relative
orientation of the coordinate vectors is maintained, but the donor atoms are further apart,
leading to one of the largest metallamacrocycles based on organometallic halfsandwich
complexes reported so far. However, investigations have mostly focused on assemblies
derived from 3-hydroxy-2-pyridone as they present the most interesting host-guest chem-
istry. Although most of the following discussion is in general also valid for complexes
obtained with alternative bridging ligands, only results from metallamacrocycles
obtained from 3-hydroxy-2-pyridone will be presented.
I.VI.1 Structural Characterization
The self-assembly process is highly diastereoselective. Racemic mixtures of complexes
with MRMRMR or MSMSMS configuration are obtained; their chiral resolution has been
achieved by fractional crystallisation using the optical pure shift reagent [chinchonidin-
ium][D-trisphat].[129] As shown by single crystal X-ray analysis, the structure of all
complexes in the crystal is very similar. All assemblies show a pseudo C3 symmetrical
geometry with three tetrahedral (π-ligand)M corners connected by three dianionic 3-oxo-
2-pyridonate ligands. The tridentate ligands are coordinated via two oxygen atoms to the
metal, forming five-membered chelate rings; the nitrogen atoms of the pyridine rings are
coordinated to the next metal atom. In total, twelve atoms form a metallamacrocylic
framework similar to a crown, which contains three oxygen donor atoms. Thus, these
type of metallamacrocycles can be seen as organometallic analogues of 12-crown-3
ethers (Figure I.14). PGSE studies have revealed an hydrodynamic radius rH of 6.4 Å in
CD2Cl2.
[167] Both the catechol part and the pyridine part of the ligand are coordinated in
a slightly bent fashion to the corresponding metal. Overall, the bond lengths and angles
are very similar, and substitution of the metal fragment has only a very small influence
on the overall structure. Nevertheless, the macrocycles show some flexibility, which is
manifested in the differences of the M–M’ distances, being between 5.32 and 5.46 Å
apart. This is probably due to an increased repulsion between bulkier π-ligands. A simi-
lar lengthening of the M–M’ distances is observed upon binding to sterically demanding
guest molecules, such as NaI, but the changes upon coordination to metal salts of lithium
and sodium remain small. The metallamacrocyclic framework is very rigid and under-
goes only minor changes upon coordination of metal salts (see Table IX.10 on page 227
for a compilation of structural data for all 12-metallacrown-3 complexes and their metal
salt adducts).
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The complex [(benzene)Ru(L1−2 H+)]3 and its LiCl adduct has been chosen as an rep-
resentative example to illustrate the general structure of 12-metallacrown-3 complexes.
Figure I.12 shows the graphic representation of [(benzene)Ru(L1−2 H+)]3 and its LiCl
adduct [(benzene)Ru(L1−2 H+)]3 × LiCl in the crystal. The two pictures at the top show
the view along the pseudo C3 axis and give an insight into the cavity formed by the three
benzene ligands. At the bottom of this cavity three oxygen atoms of the pyridonate lig-
ands come into close proximity to each other with an average O–O’ distance of 3.04 Å
forming the binding site for alkali metal ions. The bound Li+ cation is located in the mid-
dle of the cavity, slightly above the plane defined by the three oxygen atoms. It displays
a pseudo tetrahedral coordination, with the fourth coordination site occupied by the chlo-
Figure I.12 Graphic representation of [(benzene)Ru(L1−2 H+)]3 (left) and its LiCl adduct
[(benzene)Ru(L1−2 H+)]3 × LiCl (right) in the crystal. Both pictures at the top
show the structures along the pseudo C3 axis; the pictures at the bottom visualize
the crown structure. Hydrogen atoms and solvent molecules are omitted for
reasons of clarity; the chloride anion sitting on top of the lithium cation is also
omitted in the top right picture.
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ride anion (see right picture at the bottom of Figure I.12). The average O-Li distance is
1.96 Å and the chloride anion is 2.38 Å apart from the Li+ cation. The images at the bot-
tom visualise the crown like structure of the complex; upon binding only minor changes
of the bond lengths are observed. The space filling representation in Figure I.13 shows
nicely how the Li+ ion is encapsulated by the π-ligands.
I.VI.2 Host-Guest Chemistry
As illustrated above, the π-ligands of the complexes form a half sphere. At the bottom of
this cavity, three oxygen donor atoms are in close proximity to each other, forming a
binding site for small cations. Due to the steric demand of the π-ligands, only small alka-
line ions such as Li+ and Na+ can access the binding site. Bigger alkaline ions such as K+
and Cs+ are effectively blocked. The metal ion is bound to the three adjacent oxygen
atoms. The fourth coordination site is generally occupied by the counter anion
(Figure I.12 and Figure I.14).
Adducts of lithium and sodium salts are easily obtained by mixing the metallamacro-
cycle with the corresponding metal salts in methanol. The coordination of guest mole-
cules to the binding site can be detected using 1H NMR spectroscopy. The signals of the
bridging ligand and of the π-ligands undergo significant shifts downfield. If the lithium or
sodium salt is added in substoichiometric amounts, two sets of signals can be detected,
Figure I.13 Space filling representation of [(benzene)Ru(L1−2 H+)]3 (left) and its LiCl adduct
[(benzene)Ru(L1−2 H+)]3 × LiCl (right) in the crystal. Solvent molecules and the
chloride anion sitting on top of the lithium cation are deleted for reasons of clarity.
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indicating that the exchange is slow compared to the NMR time scale. Thus, stability con-
stants can directly be obtained by integration of suited 1H NMR signals.
I.VI.2.a Binding Affinity
The stability of the host-guest complexes is exceedingly high. The binding affinities in
chloroform are not only significantly higher than those of crown ethers, but comparable
to those of macrobicyclic ionophores such as the 2,2,1-cryptand for NaCl adducts and
2,1,1-cryptand for LiCl adducts. In methanol, lower values, as expected for more polar
solvents, were found. Association constants for the corresponding NaCl adducts are
between Ka = (1.1 ± 0.5) × 10
2 M−1 for (C6H6)Ru complex and
Ka = (3.5 ± 0.5) × 10
3 M−1 for the (cymene)Ru complex. Also, the binding affinity of
sodium adducts has been found to depend on the anion employed: NaI adducts show
lower Ka values than NaCl adducts.
[124, 126] It has to be noted, however, that the binding
constants are no longer in the range of cryptands, but similar to those of 15-crown-5.[140]
This behaviour can be partly attributed to the fact that ion pairs are bound in chloroform
in order to avoid energetically less favoured ‘naked’ halide anions. In methanol, this
advantage seems to be less pronounced, decreasing the binding affinity over proportion.
The Li+ adducts are in general more stable than the corresponding Na+ adducts and dis-
play, even in methanol, binding constants close or higher than 105 M−1.[124, 126]
There are several factors adding up to the high stability of lithium and sodium salt
adducts which also explain why metallamacrocycles, especially 12-metallacrown-3 com-
plexes presented here, display intrinsically higher binding affinities than organic crown
complexes.
1. The metallamacrocyclic framework is very rigid, and the binding site is ideally
preorganised for the binding of small alkaline ions such as Li+ or Na+. Only
Figure I.14 The 12-metallacrown-3 framework and the coordination of lithium and sodium salts
to the binding site.
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very small structural changes occur upon binding as verified by X-ray analy-
sis.[124, 126]
2. There is a maximum of one solvent molecule which fits into the cavity formed
by the π-ligands. The energetic costs for the desolvation of the binding site is
therefore very low.
3. The metal salts are bound as ion pairs, an energetically very favourable feature
in organic solvents such as chloroform.
4. The binding site of metallacrown complexes is highly polarized. Computational
studies have shown that the three oxygen donor atoms display a significant
higher partial negative charge than the oxygen atoms of normal crown
ethers.[128] This is due to the higher electronegativity of the adjacent metal
atoms compared to carbon atoms.
Classical organic crown ethers display none of these advantages.
The high affinity towards Li+ and Na+ allowed the stabilisation of molecular LiF and
LiFHF inside the cavity of the receptor.[168] Likewise, Na2SiF6 could be encapsulated by
two [(cymene)Ru(L1−2 H+)]3 complexes.[169] Both are difficult to achieve, as the high
lattice energy of the salts present a thermodynamic trap.
I.VI.2.b Binding Kinetics
A further difference between crown ether or cryptands and 12-metallacrown-3 com-
plexes are their respective binding kinetics. The exchange kinetics decrease dramatically
from crown ethers over cryptands to 12-metallacrown-3 complexes. The metal is slowly
bound, once it is inside the binding cavity it is more or less trapped and only released
extremely slow. The formation and dissociation rates of Li+ by selected receptors given
in Table I.1 support this statement.b
Table I.1: Formation rate kf and dissociation rate kd of the Li
+ complexation by complex
[Cp*Ir(L1−2 H+)]3a, 2,1,1-cryptanda and 18-crown-6b.
a. Solvent: methanol
b. Solvent: water
Compound kf / M
−1 s−1 kd / s−1 Ka / M−1
[Cp*Ir(L1−2 H+)]3[128] 1.6 × 10−3 < 10−8 > 105
2,1,1-Cryptand[171, 172] 4.8 × 105 4.4 × 10−3 1.1 × 108
18-crown-6[173] 8 × 107 6 × 107 1.3
b. Binding constants and dynamics determined in different solvents should in principle not be compared. However,
the release rate of crown ethers is generally several orders of magnitude higher than that of cryptands.[170]
I.VI Neutral 12-Metallacrown-3 Complexes
33
I.VI.2.c Selectivity
The metallamacrocycles [(π-ligand)M(L1−2 H+)]3 are not only very potent ionophores,
they are also very selective. All complexes form lithium salt adducts, but only complexes
containing the (C6H6)Ru, (cymene)Ru or (C6H5CO2Et)Ru metal fragment are likewise
able to coordinate sodium salts. None of the complexes is able to bind potassium ions.
The pronounced selectivity can be partly explained with an size exclusion effect due to
the size of the π-ligands. They effectively block the binding site for cations bigger than
Na+, such as K+ or Cs+. Furthermore, very bulky ligands such as C6H3Et3, C6Me6 and
Cp* narrow the entrance of the binding site further, so that binding of Na+ is also not
longer possible.
Although the exclusion of certain cations can be explained with the steric size of the
π-ligands, the general preference of the receptors for Li+, which are theoretically able to
bind to both, Li+ and Na+, is less obvious. In this context it should be noted that the ‘hole-
size-relationship’ of crown ethers is also ambiguous.[170] The binding affinity is often
most pronounced if the size of the crown ether’s interior cavity is about the same size as
the cation,[140, 174] but there are also examples in which this is not the case. For a study of
the binding behaviour of simple crown ethers (12-crown-4 to 24-crown-8) using metha-
nol as solvent and metal chlorides as salts, it was found that K+ was bound best for all
crown ethers independent of their ring size. Furthermore, 18-crown-6 showed the highest
binding affinity towards Na+, K+, Ca2+ and NH4
+ of all investigated crown ethers.[175]
Overall, in some cases the binding behaviour can be explained on the basis of the ‘hole-
size- relationship’, but it is not a principle that should be applied universally. Other fac-
tors like the number of  donor atoms as well as the hydration energy and preferred com-
plexation geometry of the metal ions have to be considered too. A similar observation of
enhanced affinity of 12-metallacrown-4 complexes for Li+ over other cations was made
by Pecorao.[137]
The high selectivity of 12-metallacrown-3 complexes for Li+ ions can be illustrated at
the example of complex [(C6H5CO2Et)Ru(L1−2 H+)]3. Even though the receptor is prin-
cipally able to bind Li+ and Na+, a Li+ specific extraction behaviour has been observed. If
an aqueous solution of Li+ containing a large excess of NaCl, KCl, CsCl, MgCl2 and
CaCl2 was shaken with a chloroform solution of this receptor, only Li
+ was extracted.[165]
This behaviour is interesting, as the extraction of LiCl from water is difficult to accom-
plish due to the high enthalpy of hydration of Li+ and Cl−.[176] In addition the enthalpy of
the competing alkaline metal cations is much smaller.
I.VI.3 Sensing
Upon binding to metal ions, the redox potential of the metallamacrocycle changes sub-
stantially. This difference in the oxidation behaviour could be used to design a colori-
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metric test for Li+ in chloroform. After addition of DDQ (2,3-dichloro-5,6-dicyano-1,4-
benzoquinone), solutions containing the free receptor turned immediately dark, whereas
only slight colour changes were observed for the respective Li+ or Na+ complexes. The
steric requirements of large π-ligands were used to design a fluoride specific chemo-
sensor. Only the very small fluoride anion can access the Li+ cation – which serve as bind-
ing site – bound in the cavity of the [Cp*Rh(L1−2 H+)]3 complex. The binding event was
detected by electrochemical means.[166]
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I.VII Aims of the research project
The purpose of this work was to further investigate the supramolecular chemistry of
12-metallacrown-3 complexes with special emphasis on water as solvent.
1. The adaptive behaviour of dynamic combinatorial libraries (DCLs) was investi-
gated theoretically, and the results were confirmed experimentally with small
model DCLs generated through reversible metal fragment exchange between
different 12-metallacrown-3 complexes.
2. Ligands which render 12-metallacrown-3 complexes soluble in water have been
developed. Their coordination behaviour with halfsandwich complexes
[(π-ligand)MCl2]2 in water has been studied. The self-assembly process and
their binding behaviour towards small alkaline ions such as Li+ and Na+ was
investigated. Special attention was paid to methods, which allow to transduce
the binding event into a readable signal in order to generate Li+ specific sensors
in water.
3. The size exclusion effect of bulky π-ligands upon binding to small alkaline ions
has been investigated towards the ability of 6Li/7Li isotope separation.
4. Linking of two 3-hydroxy-2-pyridone units led to a new structural motif:
expanded triple stranded helicates.
5. A prime concern was the development of new bridging ligands in order to mod-
ulate the features of 12-metallacrown-3 complexes.
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II.I Dynamic Combinatorial Chemistry
In classical organic synthesis bond formation is mostly achieved by kinetically control-
led reactions resulting in strong and irreversible covalent bonds.[177] This strategy has
been applied ever since by synthetic chemists and has led to some very efficient synthe-
ses of both, natural and unnatural products. Although reversible reactions under thermo-
dynamic control have been known since a very long time, their application in synthesis
has been sparse compared to kinetically controlled reactions. Their main disadvantage is
their reversibility associated with a mixture of products where one product is desired.
Dynamic combinatorial chemistry (DCC) uses exactly this reversibility as a fundamen-
tally new approach for the discovery of new species that take part in molecular recogni-
tion. Reversibility is no longer a disadvantage but the intrinsic strength of the system.
Thermodynamic vs. Kinetic Control Whereas in kinetically controlled reactions
the relative magnitude of the transition states determines the product distribution, the rel-
ative thermodynamic stabilities of the products are responsible for the product ratio under
thermodynamic control. The product distribution of kinetically controlled reactions can
be influenced by the stabilisation of the transition state, implying a detailed knowledge of
the reaction mechanism. Once the bond formation has taken place, the reaction should be
quenched. The reversibility of thermodynamic controlled reactions requires a sufficiently
long reaction time to shift the product distribution to the thermodynamically favoured
product. This offers the possibility to influence the product ratio either by introducing cer-
tain features into the starting material which will increase the relative thermodynamic sta-
bility of the desired product or by applying the principle of Le Chatelier: Using a
compound in excess or removal of a compound will force the equilibrium into one direc-
tion. A more subtle method of stabilisation is the addition of a template.[178]
II.I.1 Dynamic Covalent Chemistry
Dynamic covalent chemistry focuses on reversible covalent bond formation under ther-
modynamic control. A fundamental alteration of the perception of these reaction has
occurred over the last decade. Whereas reversibility has been associated with vast prod-
uct mixtures in the past, the term reversibility is now associated with the possibility of
going back on the reaction path/coordinate, a feature which is best summarized with key-
words like ‘error checking’ and ‘proof reading’. An extensive review by Rowan covers
this field.[177] But the focus lies exclusively on reversible covalent reactions. Dynamic
combinatorial chemistry includes both, reversible covalent and non-covalent bond for-
mation. Non-covalent interactions such as hydrogen bonds, metal–ligand coordination,
donor-acceptor and electrostatic interactions are naturally reversible and well known
from supramolecular chemistry. The main difference between supramolecular chemistry
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and dynamic covalent chemistry is the velocity of the equilibration process: non-covalent
bonds exchange much faster, even though the equilibration of covalent bonds can be
accelerated by using suited catalysts.
II.I.2 Dynamic Combinatorial Chemistry
A reversible reaction is dynamic, meaning that the equilibrium and thus the product ratio
can be shifted by applying any kind of suited pressure on the system. Starting from a
mixture of compounds, which are all interconnected to each other by dynamic equilibria,
the external stimuli for re-equilibration could be the addition of a target molecule which
can somehow interact with the compounds in the mixtures. Interaction of the target with
a specific compound could lead to a thermodynamic stabilisation. The response of the
system to the new thermodynamic situation would be a re-equilibration of the mixture
resulting in the amplification of the stabilised complex. Such a mixture, in which the
compounds are connected to each other by dynamic equilibria and which is able to adapt
to the environment, is called a dynamic combinatorial library (DCL). DCC combines
self-assembly and molecular recognition under thermodynamic control to pick out the
best suited molecule out of a large potential collection.
This approach is illustrated in Figure II.1.[179] Several subunits assemble to form a
small dynamic combinatorial library. The concentration of each member of the library
depends on the corresponding relative thermodynamic stability, here represented by the
number of small balls in the wells of the free energy landscape of the library. The added
template interacts specifically with one member of the library. The host-guest complex
will be thermodynamically stabilised leading to its amplification and the simultaneous
extinction of the other members.[179–185] A comprehensive review about dynamic com-
binatorial chemistry has been appeared recently.[186]
Figure II.1 A small dynamic combinatorial library and its free energy landscape showing the
effect of adding a template that strongly and selectively binds to one of the
equilibrating species. Reprinted with permission from Elsevier from ref. [179].
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Amplification of the Fittest The paradigm of DCC states that the ratio of a library
member in the mixture is correlated to the relative thermodynamic stability. Thus, the
thermodynamically most stable member should be the species with the highest concentra-
tion in solution. Starting from a DCL without any thermodynamic preference – i.e. from
a statistical distribution of the library members – the thermodynamically most stable
member after templating should also show the highest amplification factorc, leading to
expressions such as ‘amplification of the fittest’ or ‘molecular Darwinism’.[181, 187]
II.I.3 Dynamic Combinatorial Libraries
The term dynamic combinatorial library occurred for the first time in the mid 1990s, with
some seminal publications from Sanders,[188–191] Lehn[192–194] and other research
groups.[195–200] The group of Sanders presented the ‘living’ macrolactonisation of oligo-
cholates and cinchonidine under thermodynamic control. Although, any kind of linear or
cyclic compound could potentially be formed, only trimers were obtained in the case of
cinchonidine,[188] and mixtures of dimers, trimers and tetramers in the case of oligocho-
lates.[189] Lehn presented a metal-based system,[192–194] in which size and shape of the
assemblies depended on the employed anion. A tris-bipyridine ligand was mixed with
metal ions preferring octahedral coordination such as FeII. Thus, a DCL of circular heli-
cates was generated, which could in principle differ in size from squares (four metal
ions), to hexagons (six metal ions) and larger constructs. Using chloride anions as tem-
plate, pentagonal helicates formed in quantitative yield; the use of larger anions resulted
in the formation of hexagons.
A remarkable DCL has been presented recently by Sanders.[201] An acetylcholine tar-
get was shown to amplify a high affinity catenane receptor from a DCL of macrocycles
with hydrazone linkages (Figure II.2). The library consists mostly of cyclic oligomers,
and catenane species are not detectable in the absence of the target. Acetylcholine binds
to a single catenane diastereomer in one specific conformation with an exceptional high
binding constant. This example demonstrate nicely the power of DCC, as a catenane
structure being the best binder was highly unexpected.[201]
Selection experiments with DCLs have been performed by using various target mole-
cules such as alkali metal ions,[202–205] alkaline earth metal ions,[206] alkylammonium
ions,[207–210] anions,[211] N-heterocycles,[212–214] crown ethers,[215] uracil deriva-
tives,[216] halocarbons,[217–219] biphenyl,[220] nucleic acids,[221, 222] small peptides,[223,
224] proteins,[225, 226] protein crystals,[227] and transition state analogues.[228]
c. The amplification factor f is defined as the ratio of the stabilised and the non-stabilised library member.
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Structural Diversity Structural diversity in DCLs can be obtained by covalent and
non-covalent bond formation under thermodynamic control, as well as by reversible
conformational or configurational changes and photochemical equilibria. In a DCL, sev-
eral nearly isoenergetic assembliesd built up from the same reactive building blocks,
define an ensemble of products. The number of products, which may potentially be
formed, depends on the valency of the building blocks. Two fundamental systems can be
distinguished. Whereas in an open system the number of products which may form is infi-
nite, a predetermined number of products is characteristic for closed systems. Open sys-
tems are formed by building blocks with at least two valencies, and closed systems are
formed by building blocks having only one valency. Therefore, a mixture of m amines
and n aldehydes can not form more than m × n imines, but a mixture of n amino-alde-
hydes could form n2 different dimers, n3 trimers, n4 tetramers, and so on. More complex
topologies can be accessed by mixing building blocks with different valencies. The diver-
sity of an open system cannot be fully expressed and is for this reason termed virtual
diversity.[181] In principle every kind of supramolecular or metal-directed self-assembly
employing non-covalent bond formation could be seen as an open virtual system.
Virtual Combinatorial Libraries As pointed out by Lehn,[181] it can be distin-
guished between dynamic and virtual combinatorial libraries. The term dynamic is cor-
rect, but in most cases incomplete as it refers only to the ability of the library constituents
to reversibly convert. However, if all potential combinations should be included in the
description, whether they are present in the mixture or not, the term virtual seems better
as it expresses both, reversibility and entireness of the system. In the following the term
DCL will be used, and the term VCL only in cases where virtual member of the library are
involved.
Figure II.2 Amplification of an interlocked structure as best binder from a DCL.[201]
d. From now on, the notion ‘assembly’ will also include reversible covalent bond formation under thermodynamic
control.
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Casting & Molding The template, which will be added in order to shift the dynamic
equilibrium, can be either a ligand or a receptor. The first case is called molding: the aim
is to find a suited receptor for a certain ligand. The second case is called casting, as a
receptor is employed to find the best suited ligand.[181] The concept of molding and cast-
ing is shown in Figure II.3.
Traditional vs. Dynamic Combinatorial Libraries Traditional combinatorial
libraries (CLs) and DCLs are complementary in their characteristics as well as in their
strengths and weaknesses. The strengths of one are the weaknesses of the other. Tradi-
tional CLs consist of a static and real set of molecular constituents which were synthe-
sised in a systematic fashion in absence of any target. The different parts of the
molecules are connected by covalent, non-reversible bonds. Generation and screening
are two completely separated steps. DCLs on the other hand have a virtual and dynamic
set of molecular or supramolecular constituents; their building blocks are connected to
each other by reversible covalent or non-covalent bonds. There is no systematic synthe-
sis of every single members, but recognition-directed self-assembly in the presence of
the target will reveal certain members of the library as potential hits. There is no longer a
distinct separation of generation and screening of the library. Traditional CLs are a col-
lection of prefabricated discrete molecules, and DCLs only a collection of components.
The library members are expressed as an adaptive response to the environment.[181]
Advantages  There are three main advantages of DCLs over traditional CLs. As the
building blocks are continuously interchanging between the different members of the
DCL, a binding event leads to the amplification of the desired compound(s) at the expense
of the other library members. This facilitates enormously the screening: a simple compar-
Figure II.3 DCLs can be templated by receptor molecules (top) or ligand molecules (bottom).
Reprinted with permission from Elsevier from ref. [183].
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ison of the library distribution before and after templating is sufficient. In some cases
amplification is even efficient enough to enable isolation of the hit directly from the
library, in a preparative scale and in high yield. DCLs still follow the need of structural
variety but with a large decrease in synthetic effort. Complex topologies are a lot easier to
access, as only the building blocks have to be modified in a way to allow assembly of
higher complexity. Ideally preparation, screening and isolation will be achieved in one
step.[183]
Limitations Although the reversible linkage between the building blocks is the intrin-
sic advantage of DCLs, it constitutes also one of the major limitations, as there is only a
very limited number of reversible reactions available. Also, many methods developed in
traditional combinatorial chemistry are not compatible with DCC. Once formed, irrevers-
ible bonds remain fixed and unaffected by subsequent reactions, whereas reversible
bonds do not necessarily. Maybe the most important point is solubility. Each library mem-
ber of a DCL must be soluble enough. If the re-dissolving rate of a precipitate is very
slow, the product, and all the building blocks it is comprised off, will be kinetically
trapped. The sudden decrease of certain building blocks will have a significant influence
on the overall composition of the library and the outcome of the DCL experiment in gen-
eral.[183]
A summary of the comparison between traditional combinatorial libraries and DCLs is
given in Table II.1.[183]
Employed Reversible Reactions Reactions which can be used in DCC should ful-
fil several requirements. The reaction has to be reversible and the exchange process
should be fast. In addition, the reaction should be carried out under mild conditions, show
tolerance towards other functional groups and no interference with the recognition event.
For analytical reasons, the re-equilibration should be possible to switch off. The switch
off of the exchange should neither affect the library composition nor the characteristics of
the library members, such as binding properties etc. Finally, the isolated product should
be stable under the conditions in which it will be used later.
Table II.1: Comparison of traditional combinatorial libraries with DCLs.[183]
Traditional Combinatorial Libraries Dynamic Combinatorial Libraries
Concentrations are unaffected by recognition events Molecular recognition can induce amplification
Selected compounds need to be re-synthesised Selected compounds can be isolated from the library
Complex topologies are difficult to access Complex topologies are easily accessible
Many irreversible reactions available Number of suitable reversible reactions is limited
Insolubility of library members of no consequence All library members need to be soluble
Control over every individual reaction step Limited control due to the reversibility
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These are severe limitations and the choice of possible reactions is narrowed down sig-
nificantly. The remaining reactions can be classified into three different types: reversible
covalent and non-covalent bond formation and reversible intramolecular processes.
Examples of reversible covalent reactions are disulfide formation, Diels-Alder reactions,
Michael reaction, olefin metathesis and reactions of the carbonyl group: imine and
(hemi)acetal formation, transacylation and aldol formation. Non-covalent reversible reac-
tions are hydrogen bonding, metal–ligand coordination, electrostatic and donor acceptor
interactions. As reversible intramolecular processes can be cited configurational iso-
merisations (e.g. cis-trans isomerisations) and conformational changes such as internal
rotations or ring inversions.[181, 229] Among the most commonly used reactions are
hydrogen bonding, metal–ligand coordination, transimination of hydrazones and oximes,
disulfide exchange and olefin metathesis.[183, 230]
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II.II Results and Discussions
II.II.1 Classification of Dynamic Combinatorial Libraries
A DCL can assemble from one or several building blocks and the different members can
have a fixed or variable stoichiometry.e In principle, it has also to be distinguished if the
building blocks or the assemblies formed by them are the main species of the library
(DCL vs. VCL). Furthermore, it makes a difference if each subunit can react with every
other subunit and if each member of the library can be converted into every other mem-
ber of the library (Type A vs. Type B & Type C). These different network topologies
have a major influence on the adaptive behaviour of DCLs and have absolutely be con-
sidered when designing an amplification experiment. Three different main types of
DCLs can be distinguished.f
Type A A DCL of Type A consists of only one building block. Structural diversity is
generated by the number of building blocks which assemble (Scheme II.1). As only one
subunit is employed, there are no restrictions regarding the reactivity of the building
blocks towards each other; it also means that each member of the library can be con-
verted into every other member. Experimental examples of libraries of Type A are by far
the most common in the literature.[188, 192, 193, 204, 207, 208, 210, 215]
Type B Libraries of Type B consist of different building blocks which assemble to
oligomeric species with fixed aggregation number (Scheme II.2). It has to be distin-
guished between libraries in which each building block is able to associate with every
other building block or not. Depending on the type of interaction which is used to link the
subunits, this is not necessarily the case. Two characteristics are worthwhile to mention.
First, the library can collapse into one single member, if this member reflects the overall
composition of the library. Second, an amplification of a member comprised of one
building block will always lead to the concomitant amplification of members comprised
e. The term ‘stoichiometry’ is used simply to indicate the number of subunits of a certain assembly. It is not meant to
characterize the nature of the subunits.
f. In principle, all these types of DCL can be comprised of linear and/or cyclic assemblies – the graphical focus on
cyclic assemblies was chosen for reasons of consistency with the later presented experimental data.
Scheme II.1 DCL of Type A: One building block assembles with variable stoichiometry.
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of the other building blocks leading therefore to the amplification of false positives.
There are few experimental examples of libraries of Type B in the literature.[212, 231]
Type B* A variation of the latter class are DCLs of Type B*, which are obtained by
assembly of different building blocks with uniform aggregation number but all members
of the library have at least one common subunit, for example a common spacer or bridg-
ing ligand (Scheme II.3).
Type C DCLs of Type C are a hybrid of Type A and Type B. Different building blocks
assemble to form species with different aggregation numbers (Scheme II.4). As for
Type B, false positives can be amplified and it has to be distinguished if each subunit can
react with every other subunit. DCLs of Type C have been investigated experimen-
tally.[209, 218, 228, 232]
Compared to the wealth of experimental data there is a surprising lack of theoretical
analyses concerning the adaptive behaviour of DCLs. Simple calculations of the steady-
state concentrations of members of a DCLs as a function of their thermodynamic stabili-
sation to investigate the adaptive behaviour of DCLs have not been presented so far.
Scheme II.2 DCL of Type B: Different subunits assemble with fixed stoichiometry.
Scheme II.3 DCL of Type B*: Different building blocks assemble with fixed stoichiometry; the
assemblies have at least one common building block.
Scheme II.4 DCL of Type C: Different subunits assemble with different stoichiometries.
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II.II.2 Theoretical Investigations
Numerical simulations have been performed to study the effect of thermodynamic differ-
ences on the steady-state concentration of members of a library of Type B. In libraries of
Type B, several structurally diverse building blocks can form assemblies of fixed
stoichiometry; cyclic trimeric assemblies X3 were chosen.
g In the following, it will be
shown that DCLs of Type B and C can display an adaptive behaviour fundamentally dif-
ferent from that of libraries of Type A. It will be demonstrated, that there is no direct cor-
relation between the relative amplification and the thermodynamic stability of the DCL
members in such systems.
Assumptions The calculations are based on the assumption that all assemblies are in
equilibrium with their corresponding building blocks. It is further assumed, that every
building block is able to associate with every other building block. Equimolar amounts of
three different building blocks A, B, and C assemble to form trimeric assemblies X3. For
the present discussion, the focus has been on DCLs, i.e. the equilibrium constants favour
trimeric assemblies and were chosen so high that the concentration of the building blocks
in the solution is neglectable. The association constants was therefore fixed to
KXXX = 1 × 10
5 mM−2. The relative steady-state concentration of the different library
members were calculated using the program Gepasi, version 3.30.[233, 234]
Thermodynamic preferences were introduced by arbitrarily stabilizing certain mem-
bers of the library. Conclusions about the characteristics of the adaptive behaviour of
DCLs could be drawn by comparison of the steady-state concentrations of a library with-
out thermodynamic preference with those having thermodynamic preferences. It has to be
noted, that for the present discussion it is irrelevant whether the thermodynamic differen-
tiation between the DCL members is caused by binding to a guest molecule, by binding to
a receptor, or by arbitrarily introducing them. The underlying model is held purposely
very simple and some extreme situations are presented to demonstrate the peculiar char-
acteristics of these DCLs. The relative steady-state concentrations as a function of the rel-
ative stability of the respective library member are presented in Table II.2.
g. Cyclic trimeric assemblies were chosen for reasons of consistency with the experimental data presented later.
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The data for a statistical mixture without thermodynamic preferences is given in
Entry 1. The following three entries describe the hypotheticalh cases that only one mem-
ber of the library is stabilised (e.g. by selective binding to a suited guest molecule). If the
assembly AAA is stabilised by a factor of 1000, it is amplified relative to the original
equilibrium concentration by a factor of fAAA = 7.6 and subsequently represents the dom-
inant species in solution (Entry 2). Upon selective stabilisation of AAB (Entry 3), a sim-
ilar result is obtained: AAB is clearly the dominant species in solution (47.7%;
fAAB = 4.3). As typical for libraries of type B, in both cases species with a high content of
B and C such as BBC and CCC are likewise amplified to a considerable extent (e.g.
Entry 3: fCCC = 3.6). A rather dramatic effect is observed upon selective stabilisation of
ABC (Entry 4): the whole mixture collapses to give almost exclusively ABC. The steady
state concentrations of a mixture in which both AAA and ABC are stabilised relative to
the other members are given in Entry 5. Remarkably, only ABC is amplified and com-
pletely dominates the mixture (98.6%). The assembly AAA, on the other hand, goes
nearly extinct (0.4%). A more equilibrated situation is described in Entry 6. The incorpo-
ration of the fragment A leads to an additive stabilisation by a factor of 300. In this mix-
ture, three species of moderate stability are dominating having the same amplification
factor: ABB, ACC and ABC (f = 2.1). The most stable assembly AAA, however, is the
Table II.2: Calculated steady-state concentrations of a dynamic mixture of macrocycles with
fixed stoichiometry X3 obtained by assembly of three different building blocks
([A]total = [B]total = [C]total).
Relative Stability
Relative Concentration / %
Entry
1
1
3.7
1
11.1
1
11.1
1
3.7
1
11.1
1
11.1
1
3.7
1
11.1
1
11.1
1
22.2
2
1000
28.1
1
0.5
1
3.4
1
7.2
1
21.5
1
21.5
1
7.2
1
0.5
1
3.4
1
6.8
3
1
0.0
1000
47.7
1
0.5
1
1.9
1
11.1
1
21.2
1
13.5
1
0.1
1
1.9
1
2.0
4
1
0.0
1
0.1
1
0.1
1
0.0
1
0.1
1
0.1
1
0.0
1
0.1
1
0.1
1000
99.6
5
1000
0.4
1
0.0
1
0.1
1
0.1
1
0.3
1
0.3
1
0.1
1
0.0
1
0.1
1000
98.6
6
900
0.1
600
2.1
300
22.8
1
0.5
1
1.6
1
1.6
1
0.5
600
2.1
300
22.8
300
47.7
h. The examples in Table II.2, entries 2–5 describe extreme situations in which only one or two species of the DCL are
stabilised. They were chosen because their results demonstrate the peculiar characteristics of a DCL of Type B. A
more balanced situation with a broader distribution of stability constants is more likely for ‘real’ systems.
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species with the lowest concentration of all members (0.1%). We thus observe the quasi-
extinction of the thermodynamically most stable species in the mixture.
This theoretical analysis demonstrates that a DCL can adapt in a way, which is quite
different from the paradigm ‘amplification of the fittest’.[187] It is not necessarily the most
stable member of the library, which is amplified the most. Quite contrary, it is possible
that the most stable member goes extinct and that members of mediocre or low stability
are amplified. Further analyses of related model systems show that a behaviour of this
kind can also be found for DCLs of non-cyclic assemblies and for libraries of Type C as
is presented in Table II.3 and Table II.4, respectively.
Table II.3 shows the data of a DCL of equimolar amounts of three different building
blocks which can assemble into dimers. It should be noted, that this library can not col-
lapse into one single member, as formation of dimers from three different building blocks
will always leave at least one building ‘unused’ resulting in the concomitant amplification
of dimers comprised of this building block. Absence of any thermodynamical preference
results in a statistical distribution of all DCL members and is given in Entry 1. Stabilisa-
tion of dimer AA or AB results in their amplification by a factor of fAA = fAB = 2.9,
respectively (Entry 2 and 3). Entry 4 shows a competition situation between the dimers
AA and AB. Both are stabilised by a factor of 1000, but only AB is amplified and AA
goes again almost extinct. A 10fold increase of its stabilisation compared to AB (Entry 5)
does not lead to an amplification in its favour. Even when experiments to eliminate the
false positives were carried out, the most stable member of the DCL would again be unde-
tected. In a more equilibrated situation such as presented in Entry 6, the most stable mem-
Table II.3: Calculated steady-state concentrations of a dynamic mixture of dimers obtained by
assembly of different building blocks (KXX >> 1; [A]total = [B]total = [C]total).
Relative Stability
Relative Concentration / %
Entry
1
1
11.1
1
22.2
1
11.1
1
22.2
1
22.2
1
11.1
2
1000
31.9
1
1.4
1
16.3
1
1.4
1
32.6
1
16.3
3
1
0.0
1000
64.6
1
0.0
1
2.0
1
2.0
1
31.3
4
1000
3.0
1000
60.1
1
0.3
1
0.6
1
6.0
1
30
5
10,000
6.5
1000
53.4
1
1.1
1
0.3
1
11.0
1
27.7
6
600
0.2
300
33.1
1
8.4
300
33.1
1
16.8
1
8.4
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ber AA goes also extinct and hetero-assemblies of mediocre stability are amplified the
most. In all cases, the concomitant amplification of dimers comprised of the remaining
building blocks is observed. This shows, that the behaviour of a DCL of linear assemblies
is similar to the behaviour of a DCL comprised of cyclic assemblies.
An investigation of the behaviour of a DCL of Type C is shown in Table II.4. Equimo-
lar amounts of three different building blocks A, B and C (100 mM each) can assemble
into dimers and trimers. Whereas A and B can be linked to only one other building block,
C can be linked to two other building blocks. Thus, a DCL of eight possible assemblies is
generated: four linear dimers AA, AB, BB & CC, two linear trimers ACA & BCB and one
cyclic trimer CCC.
The association constants K1 and K2 were chosen so as to result in a DCL without any
thermodynamic preference in which the presence of each member reflects a statistical dis-
tribution (Entry 1). Stabilisation of a single member of the library by a factor of 1000
results in its amplification as well as in the concomitant amplification of members com-
posed of ‘unused’ building blocks (Entry 2–4). Entry 5 shows a case, where the member
which reflects the overall composition of the library, ACB, is stabilised by a factor of
1000. Similar to a DCL of Type B, the library collapses to give almost exclusively ACB.
Table II.4: Calculated steady-state concentrations of a dynamic mixture of dimers and trimers
obtained by assembly of three different building blocks (K1 = 1 x 10
8 M−1,
K2 = 1 x 10
13 M−2; [A]total = [B]total = [C]total = 100 mM)
Stability Constant
Absolute Concentration / mM
Entry
1
K1
12.5
K1
25.0
K1
12.5
K1
10.0
K2
12.5
K2
25.0
K2
12.5
K2
10.0
2
103×K1
47.7
K1
2.1
K1
22.2
K1
13.2
K2
0.1
K2
2.4
K2
25.6
K2
15.2
3
K1
0.1
103×K1
99.6
K1
0.1
K1
16.9
K2
0.1
K2
0.1
K2
0.1
K2
22.0
4
K1
0.1
K1
2.5
K1
0.3
K1
0.4
103×K2
47.7
K2
2.0
K2
21.3
K2
5.3
5
K1
0.3
K1
0.5
K1
0.3
K1
0.4
K2
0.1
103×K2
98.9
K2
0.1
K2
0.1
6
K1
0.0
K1
0.1
K1
11.1
K1
3.1
105×K2
17.3
103×K2
65.3
K2
6.2
K2
1.7
7
K1
2.8
K1
5.7
K1
2.8
K1
0.0
K2
0.0
103×K2
88.5
K2
0.0
105×K2
3.8
8
600×K1
2.6
300×K1
32.3
K1
2.6
K1
8.0
600×K2
2.4
300×K2
57.8
K2
2.4
K2
7.2
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Also in competition situations, the library behaves analogously. Stabilisation of ACB by
a factor of 1000 and ACA or CCC by a factor of 100000 will still bias the library in favour
of ACB (Entry 6 and 7). The reason for this behaviour can be seen in the fact that the
amplification of a member of mediocre stability, which integrates all building blocks, will
lead to a thermodynamically more stable mixture than the amplification of a member
which integrates only parts of the subunits would do. This is even the case if this member
is clearly the thermodynamically most stable one. The focus has to be on the thermody-
namically most stable mixture and not on the thermodynamically most stable member.
Overall, the theoretical analyses predict that libraries of Type B and C behave in the
same manner, whether the building blocks form linear, cyclic or both assemblies. In gen-
eral, they display the following characteristics:
1. The selection of an assembly with a high content of one subunit will lead to the
concomitant amplification of one or more assemblies comprised of the other
subunit(s). 
2. There is an intrinsic bias for the selection of hetero-assemblies, or more pre-
cisely, for assemblies, the composition of which reflects the overall composition
of the library.i
For libraries of Type A, on the other hand, these ‘restrictions’ do not apply because the
members compete for the same resource: the common building block. The same is true
for DCLs which are based on reversible conformational changes.[198, 235]
II.II.3 Investigation of a synthetic DCL of Type B
To demonstrate that the above mentioned characteristics can indeed be found in synthetic
DCLs, the equilibrium concentrations of dynamic mixtures of metallamacrocycles were
investigated. 12-metallacrown-3 complexes were expected to be ideally suited starting
materials for the generation of DCLs because their framework contains labile metal–
ligand bonds. They consist of three subunits, which represent the building blocks of the
library. In methanol, a fast equilibrium between the subunits and the trimeric assemblies
exists, with the equilibrium far on the side of the assemblies. Mixing of different
12-metallacrown-3 complexes results in a library of Type B: different building blocks
assemble into aggregates with a fixed stoichiometry of three subunits. The metalla-
macrocycles employed are shown in Scheme II.5.[124] In analogy to the presented theo-
retical data, they are named aaa, bbb and ccc, each letter representing a subunit of the
trimeric structure x3.
i. A library of Type B composed of equal amounts of three different building blocks A, B and C, for example, will
show a bias for the selection of the assembly ABC.
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Instead of using a target molecule to induce the selection process, steric effects have
been chosen to introduce thermodynamic differences among the DCL members. As
already mentioned, for the present discussion it is irrelevant whether the thermodynamic
differentiation between the DCL members is caused by binding to a guest molecule, by
binding to a receptor, or by steric effects. For this purpose, the new metallamacrocycle
ccc with sterically demanding π-ligands was synthesised. The structure of this complex
in the crystal shows that the three triisopropylbenzene ligands are in very close proximity
to each other and the space filling representation illustrates nicely the steric overload
(Figure II.4).
As a result of this steric congestion, the Ru–Ru distance of 5.40 Å is increased when
compared to the (benzene)Ru complex aaa (Ru–Ru = 5.32 Å) (see Table IX.10 on
page 227 for more structural data). A similar expansion of the macrocycle was observed
for the (hexamethylbenzene)Ru complex bbb (Ru–Ru = 5.46 Å).[124] These data indicate
that the macrocycles bbb and ccc are less stable than aaa due to steric repulsion of the π-
ligands.
Scheme II.5 Trimeric 12-metallacrown-3 complexes employed for the generation of a DCL of
Type B.
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Figure II.4 Ball and stick (top) and space filling (bottom) representation of complex
[(C6H3
iPr3)Ru(L1−2 H+)]3 (ccc) in the crystal. Solvents molecules are omitted for
clarity; hydrogen atoms are not depicted in the picture at the top.
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N
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N
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Scrambling of the organometallic fragments occurs when a 1:1 mixture of the symmet-
rical complexes aaa and ccc in methanol is heated to 40 °C. The mixed complexes aac
and acc can be observed within several minutes. The steady state concentrations are
reached after twelve hours. The reaction can conveniently be followed by 1H NMR spec-
troscopy if CD3OD is employed (Figure II.5). Since the exchange of the fragments is
slow on the NMR time scale, the relative concentration could be determined by integra-
tion of suited signals. The labelled signals correspond to the C6H6 (δ = 5.5–5.7 ppm) and
to the C6H3
iPr3 protons (δ = 5.0–5.2 ppm) of the π-ligands of a and c. The small signals
between d = 5.5 and 6.8 ppm correspond to the protons of the bridging pyridonate lig-
ands.
The equilibrium concentrations of all possible binary mixtures of aaa, bbb and ccc
are given in Table II.5. For a hypothetical mixture with equally stable members, a statis-
tical distribution of 1:3:3:1 is expected. Concentrations approaching these theoretical
values are found for a mixture of bbb and ccc: all four possible species can be detected
in the mixture with slight preference for the mixed complex bcc (Entry 1). This result
Figure II.5 Aromatic region of the 1H NMR spectrum (CD3OD) of an equimolar mixture of aaa
and ccc before equilibration (top) and after equilibration (middle), and an
equimolar mixture of aaa, bbb and ccc after equilibration (bottom).
5.25.45.65.86.06.26.46.66.8 5.0
 / ppm
aaa
ccc
aac
acc
aac
acc
aac
abc
+
accabb
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δ
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points to the fact that the steric requirements of the large hexamethylbenzene and triiso-
propylbenzene π-ligands are comparable.
As soon as thermodynamic differences are introduced, the relative distribution
changes substantially (Entry 2 and 3). For mixtures with the small (benzene)Ru complex
aaa, the hetero-assemblies are completely dominating after equilibration and only traces
of the homotrimeric complexes can be detected (Figure II.5). Based on the size of the π-
ligands, complexes should become more stable the more a fragments they contain. In
accordance with the theoretical predictions, this leads to the selection of the mixed spe-
cies aab/abb and aac/acc, respectively, and not of the most stable species aaa.
A DCL obtained by mixing all three complexes aaa, bbb, and ccc should display a
behaviour which resembles the theoretical model described in Table II.2, Entry 6, since
only the incorporation of the fragment a will lead to a stabilisation. Consequently, the
complexes abb, acc and abc should be selected. And this is exactly what can be
observed: the 1H NMR spectrum of the equilibrium mixture showed that these three com-
plexes are clearly dominating the mixture (Figure II.5). This result was confirmed by 13C
NMR spectroscopy. Again, it was not the most stable species aaa, aab and aac which
were amplified. Quite contrary, the signals of complex aaa could not be detected. The
competition situation in the described DCL has thus led to the extinction of the most sta-
ble assembly.
II.II.4 Amplification of the Fittest
There are possibilities to circumvent or reduce the ‘problems’, which may be encoun-
tered if DCLs of Type B and C are used for selection processes. First, one can conduct
the experiment in a way that it is possible to separate the target and the bound DCL
Table II.5: Equilibrium concentrations of the four metallamacrocycles obtained by scrambling
of equimolar amounts of two homotrimeric complexes in CD3OD.
a
a. The relative concentration was determined by integration of selected 1H NMR signals. The error is estimated to be 
± 3%.
Entry Starting mixture Equilibrium mixture
1
14% 19% 49% 18%
2
< 3% 45% 55% < 3%
3
< 3% 45% 55% < 3%
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members from the unbound members (e.g. using a target on a solid support or a reaction
which destroys unbound members).[199, 221, 225] This will eliminate the false positives,
which arise from the concomitant amplification of species, which do not bind to the tar-
get. However, this approach does not reduce the intrinsic bias for the selection of hetero-
assemblies. Secondly, the DCL can be designed in a way that without target it has an
equilibrium distribution in which the monomeric building blocks represent the dominat-
ing species and the various aggregates are present in only very small amounts. In this
case, the selective stabilisation of one or several aggregates of this virtual combinatorial
library[181] will give rise to amplification factors which are not only significantly higher,
but which also correspond much closer to the relative thermodynamic stability. Further-
more, there will be no concomitant amplification of assemblies, which do not bind to the
target. Some experiments, which confirm this prediction, have been described
recently.[226, 236–238] A theoretical analysis of a VCL amplification experiment analo-
gous to that of a DCL of Type B is shown in Table II.6.
Three different building blocks A, B and C form trimeric cyclic assemblies; contrary
to a DCL of Type B discussed before, the building blocks are now the main species
present in the library. The assemblies are only virtually present as is shown for a statistical
distribution of the assemblies in Entry 1. Stabilisation of AAA by a factor of 1000 will
lead to an 152fold amplification and is clearly the dominant trimeric species in solution
(Entry 2). Entry 3 shows the stabilisation of the mixed assembly AAB by a factor of 1000
Table II.6: Calculated steady-state concentrations of a virtual combinatorial library with fixed
stoichiometry X3 obtained by the assembly of three different building blocks
(KXXX = 0.1 M
−1; [A]total = [B]total = [C]total = 100 mM).
Relative Stability
Absolute Concentration / mM
Entry
1
1
0.1
1
0.3
1
0.3
1
0.1
1
0.3
1
0.3
1
0.1
1
0.3
1
0.3
1
0.6 97.5 97.5 97.5
2
103
15.2
1
0.1
1
0.2
1
0.1
1
0.3
1
0.3
1
0.1
1
0.1
1
0.2
1
0.3 53.4 98.2 98.2
3
1
0.0
103
30.5
1
0.1
1
0.0
1
0.1
1
0.2
1
0.1
1
0.0
1
0.1
1
0.2 38.5 68.6 98.7
4
1
0.0
1
0.0
1
0.0
1
0.0
1
0.0
1
0.0
1
0.0
1
0.0
1
0.0
103
54.8 45 45 45
5
103
4.5
1
0.0
1
0.0
1
0.0
1
0.0
1
0.0
1
0.0
1
0.0
1
0.0
103
50.9 35.5 48.9 48.9
6
105
18.3
1
0.0
1
0.0
1
0.0
1
0.1
1
0.1
1
0.0
1
0.0
1
0.0
103
32.8 12.2 66.8 66.8
7
900
2.0
600
8.1
300
8.4
1
0.0
1
0.1
1
0.1
1
0.0
600
8.1
300
8.4
300
16.9 27.9 57.9 57.9
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leading to a more than 100fold increase of its concentration. If ABC, the member which
reflects the overall composition of the library, is stabilised, its concentration increases
from 0.6 mM to 54.8 mM corresponding to an 169fold amplification! In all three cases,
no concomitant amplification of other members of the library occurs. If one member of
the library is stabilised, the VCL will adapt in such a way that the stabilised member will
be expressed. The thermodynamically most stable mixture is the mixture in which the
thermodynamically most stable member is amplified the most.
Entry 5 describes the situation where AAA and ABC are both stabilised by a factor of
1000. Even though AAA is amplified by a factor of fAAA = 45, ABC is amplified by a fac-
tor of fABC = 85, reflecting the bias for hetero-assemblies. In the case of Entry 6, where
AAA is stabilised by a factor of 100000, thus 100fold more than ABC, the highest ampli-
fication factor correlates with the thermodynamic most stable member: AAA is amplified
by a factor of fAAA = 183 whereas ABC is only amplified by a factor of fABC = 55. How-
ever, in the potentially more realistic situation of Entry 7, in which each fragment of A
leads to an additional stabilisation by a factor of 300, the bias for hetero-assemblies
becomes again visible. The most stable member AAA is only increased by a factor
fAAA = 20, whereas members with mediocre and low stability will be amplified with a
factor of fAAA = 27. The highest amplification factors has again the member ABC
(fAAA = 28), the one reflecting the overall composition of the library to which the library
is intrinsically biased.
In competition situations, the library composition still does not always reflect the ther-
modynamic stabilities of the respective library member. However, the most stable mem-
ber goes no longer extinct but will also be amplified in solution. Even though the
amplification factor does not always correlate with the thermodynamic stability of the
members, all hits are present in detectable amounts and a further investigation of their
properties will reveal the order of their thermodynamic stabilities.
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II.III Conclusions
DCLs have been classified into different types and the adaptive behaviour of DCLs of
Type B and Type C has been discussed. The presented theoretical and experimental data
are in contradiction with a former paradigm of DCC, i.e. the expression of the thermody-
namically most stable member. As the main conclusion it can be stated that it is not nec-
essarily the strongest binder which will be amplified the most in a DCL experiment.
The herein presented data indicates that DCLs of Type B and C behave similarly,
whether they are generated from cyclic or linear assemblies, but show a behaviour differ-
ent from those of Type A. In competition situations, DCLs of Type B and C show an
intrinsic bias for hetero-assemblies, especially for compounds which reflects the overall
composition of the library. The selection of an assembly with a high content of one sub-
unit involves the concomitant amplification of assemblies comprised of the others sub-
units. The amplification depends also strongly on whether the experiment is carried out in
a virtual fashion or not. If the equilibrium is on the site of the building blocks and not on
the site of the assemblies, the amplification factors correlate more closely with the rela-
tive thermodynamic stability of the members.
Further simulations have confirmed these results. A recent theoretical study of Severin
investigated the adaptive behaviour of simple model DCLs of Type A, B, B* and C as a
function of the binding affinity of the different members, the target and the building block
concentration.[239] It has been found, that DCLs show generally an intrinsic bias for
assemblies with small aggregation numbers and for hetero-assemblies. All examined
DCLs show a region, in which the correlation between binding affinity and amplification
factor breaks down. Noteworthy, at one specific point, no adaption at all occurs after
templating, although the affinities of the DCL members to the target differ substantially.
However, this behaviour seems reasonable, considering the urge of the DCL to maximize
the binding interactions in the entire library. With a fixed amount of building blocks, the
overall stabilisation of a mixture of many small moderate binders is simply higher than
the overall stabilisation of a mixture of a few strong binders.
But theory provides also a hint how to design DCL experiments in which the correla-
tion between binding affinity and amplification is acceptable. In general, the bias for
small and hetero-assemblies is less pronounced for small binding constants. Most impor-
tantly, the thermodynamic gain in stability of a VCL experiment is far more pronounced
for the formation of the thermodynamically most stable member. Now, the overall gain in
energy is not any longer limited by the total number of building blocks, but by the inter-
action with the target. As it is not always possible to redesign a DCL into a VCL experi-
ment, it is important to realise, that a similar situation to a VCL experiment is obtained if
the common building blocks of DCLs of Type B* are used in substoichiometric quanti-
ties.
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A different approach is the variation of the target concentration. Again, the thermody-
namic gain of the DCL is not dictated by the number of the building blocks, but by the
number of the target molecules. Thus, the energetic gain based on a fixed number of target
molecules will be higher if thermodynamically more stable members will be expressed
instead of members of mediocre stability. This behaviour has been confirmed experimen-
tally by the groups of Severin and Sanders.[240, 241] The correlation between binding
strength and amplification in large libraries (between 10 and 106 members) has been
investigated theoretically by Sanders and coworkers.[242] In a systematic variation of the
‘experimental conditions’, they were able to map under which conditions the correlation
is acceptable. They found that a disruption of the correlation can also occur in large librar-
ies, but only under very specific conditions. In general, they advise to keep the template
concentration at about one tenth of the building block concentration in order to have a
high probability that the best binder is among the three most amplified members. For very
low building block concentrations, only the template concentration determines the quality
of the correlation between amplification and binding affinity.
In conclusion, even though the presented theoretical and experimental results chal-
lenged the DCC approach in its generality, it seems apparent that the usefulness of DCL
techniques need not to be restricted. The presented work induced several theoretical[239,
242] and experimental[240, 241, 243] publications addressing the question whether the
amplifications in DCL experiments reflect the binding affinities of the members and if
DCL experiments can be designed in a fashion that they follow the paradigm of ‘amplifi-
cation of the fittest’. The importance of DCC and an enhanced comprehension of the
adaptive behaviour of complex equilibrium systems has been highlighted recently.[244]
However, success of DCC will finally depend on the creativity of researchers to design
the right DCL for a given problem. An excerpt from Sjibren Otto, one of the pioneers of
DCC, clearly states the point: “…, when using dynamic combinatorial chemistry, it is
important to realise that – as with any combinatorial approach – it will only be successful
if the right libraries are designed. Combinatorial chemistry is by no means an excuse to
abandon rational design and ignore chemical intuition – it only reduces the level of struc-
tural detail required at the design stage.”[230] 
Chapter III
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III.I Introduction
As described in the introduction, transition metal-based self-assembly processes have
been used extensively to build macrocyclic compounds with diverse structures and func-
tionalities.[27–29, 32, 35, 44, 245, 246] In the majority of these cases, metal complexes M
with available coordination sites were combined with bridging ligands L to give sym-
metrical macrocycles of the type MnLn. These reactions are typically performed in a sin-
gle step under thermodynamic control. Macrocycles containing two different metal
fragments M and M', however, are generally constructed in a two-step procedure.[76, 247–
261] For mixed-metal squares and rectangles, this is illustrated in Scheme III.1. In a first
step, a ditopic ligand is coordinated to a metal M. The resulting complex ML2 is then
reacted with a metal M’ to give the tetranuclear complex M2M’2L4. Usually, the pre-
formed metal complex ML2 is kinetically inert under the reaction conditions employed
in the second step (Scheme III.1a).[76, 247, 249–252, 254, 256–258, 260] This avoids scram-
bling reactions, which would lead to mixtures of assemblies with variable M–M’ content
and position. Alternatively, the formation of mixed-metal assemblies can be favoured by
the utilization of ligands having two distinct donor sites, each of which with a pro-
nounced selectivity for the respective metal fragment M or M’, respectively
(Scheme III.1b).[248, 253, 255, 259, 261] Additional specificity can be achieved by template
effects. For the latter case, one-step syntheses of heterometallic macrocycles under ther-
modynamic control have been reported.[262, 263]
An alternative way to access complexes with different metal centres is the scrambling of
assemblies with labile metal–ligand bonds. If such a dynamic mixture could be biased
towards one product, mixed-metal complexes in synthetically interesting yields would be
obtained.
Scheme III.1 Stepwise synthesis of tetranuclear macrocycles containing two different metal
fragments M and M’.
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III.II Kinetics of Metal Fragment Exchange
Mixed 12-metallacrown-3 complexes formed upon mixing of homotrimeric complexes
via metal fragment exchange. The driving force of their formation is the intrinsic bias of
dynamic mixtures towards hetero-assemblies as shown in the previous chapter. To obtain
more information about the formation, the kinetics of the metal fragment exchange pro-
cess were studied by 1H NMR spectroscopy. First, the scrambling reaction of
[(C6H3
iPr3)Ru(L1−2 H+)]3 (AAA) and [(cymene)Ru(L1−2 H+)]3 (BBB) has been inves-
tigated. The complexes were mixed in MeOH in a 1:1 ratio, with an initial concentration
of 5.0 mM each. To accelerate the scrambling process, the solution was heated to 40 °C.
The time course is depicted in Figure III.1. 
The beginning of the reaction was marked by the fast decrease of AAA, and a rapid
increase of AAB. The formation of ABB was almost negligible in the first 15 minutes.
During this period, the decrease of AAA was almost twice as fast as the decrease BBB.
After 40 minutes a turning point was reached. The concentration of AAB was at its max-
imum and represented 68 % of the total trimer concentration. Subsequently, a decrease of
AAB and a concomitant increase of ABB was observed. Accordingly, the concentration-
time profile of ABB showed a sigmoidal form. After six hours, the mixture was at equi-
librium and only the two mixed complexes AAB and ABB were found in solution, both
with an approximate concentration of 50 %.
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Figure III.1 Time course of the reaction between AAA (?) and BBB (?) to give the mixed-
metal macrocycles AAB (Δ) and ABB (?) as determined by 1H NMR
spectroscopy. The reaction was performed in CD3OD 40 °C with initial
concentrations of [AAA]0 = [BBB]0 .= 5.0 mM. The total trimer concentration was
[trimer]total = 10 mM.
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For equally stable macrocycles, a statistical mixture of AAA:AAB:ABB :BBB of
1:3:3:1 would be expected. At first glance, the complete dominance of AAB and ABB
after equilibration might suggest a preferential stabilisation of the mixed complexes with
respect to the homotrimers AAA and BBB (Situation a, Figure III.2). But there is another
explanation for such a distribution: the B-rich species ABB and BBB are stabilized and
the homotrimer AAA is significantly destabilised (Situation b, Figure III.2). For
ΔΔG1 = ΔΔG2 = ½ ΔΔG3, the two situations result in the same equilibrium distribution
with equal amounts of heterotrimers being the dominant species in solution.
An energy distribution similar to what is described in situation b of Figure III.2 is more
likely to account for the dynamic mixture described above. Complex AAA has three steri-
cally demanding triisopropylbenzene ligands. The π-ligands approach each other and
destabilise the aggregate. For the mixed trimer AAB, only one unfavourable A–A interac-
tion is found, whereas the aggregates ABB and BBB display no intramolecular A–A con-
tacts at all. The kinetic data support this picture. The sterically encumbered trimer AAA
rapidly reacts with the smaller cymene complex BBB to give AAB. This first reaction is
Figure III.2 For equally stable trimers AAA, AAB, ABB and BBB, a statistical 1:3:3:1
distribution is expected. The energetic situations shown in situation a and b both
result in selective formation of the mixed trimers AAB and ABB.
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followed by a second, much slower reaction, in which AAB is converted into ABB
(Scheme III.2).
An interesting consequence from an asymmetric free energy distribution is the possi-
bility to bias the equilibration process in favour of a certain species. For a dynamic mix-
ture of equally stable trimers AAA, AAB, ABB, and BBB, the relative concentration of the
mixed trimer ABB after equilibration can be increased from 37.5 % to a maximum theo-
retical value of 44.3 % by using two equivalents of BBB and only one equivalent of AAA.
For a system such as the one described in situation b of Figure III.2, the maximum rela-
tive concentration of a mixed trimer after equilibration can be much higher.
To demonstrate this point, the scrambling reaction of AAA and [(C6H6)Ru(L1−2 H+)]3
(CCC) has been investigated (Figure III.3). The small benzene complex CCC was chosen
to further accentuate the difference between the π-ligands. This time, the complexes were
mixed in a 1:2 ratio with initial concentrations of [AAA] = 2.0 mM and [CCC] = 4.1 mM.
The time course of the reaction is shown in Figure III.3. The beginning of the equilibra-
tion process was again marked by the fast formation of the mixed complex AAC com-
prised of two large (C6H3
iPr3)Ru moieties and the simultaneous rapid decrease of AAA.
After 26 minutes, more than 95 % of the initial amount of complex AAA were converted
and the concentration of AAC reached its maximum. Then, its concentration decreased in
favour of ACC. The equilibrium was reached after ten hours. The heterotrimer ACC com-
pletely dominated the mixture (83 %) and only minor amounts of AAC (7 %) and CCC
(10 %) were found in the solution.
Scheme III.2 The equilibration of [(C6H3
iPr3)Ru(L1−2 H+)]3 (AAA) and [(cymene)Ru(L1−
2 H+)]3 (BBB) proceeds in two steps. First, the sterically encumbered AAA is
converted into AAB. This is followed by a second, much slower transformation,
in which ABB is formed.
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Figure III.3 Time course of the reaction between AAA (?) and CCC (?, calculated) to give
the mixed-metal macrocycles AAC (Δ) and ACC (?) as determined by 1H NMR
spectroscopy. The reaction was performed in CD3OD 40 °C with initial
concentrations of [AAA]0 = 1.95 mM and [CCC3]0 = 4.13 mM. The total trimer
concentration was [trimer]total = 6.08 mM.
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Generally, mixtures comprised of two macrocycles, one owning large π-ligands, and
the other one small π-ligands, show an unique kinetic behaviour, which can be described
as follows:
1. Macrocycles with bulky π-ligands react significantly faster than macrocycles
with small π-ligands.
2. Hetero-assemblies comprised of one small and two bulky π-ligands form very
fast at the beginning of the exchange process, the concentration passes through
a maximum and declines until the equilibrium is attained.
3. Hetero-assemblies comprised of two small and one bulky π-ligand form slowly
at the beginning; once the bulky homotrimeric complexes have disappeared,
their formation accelerates.
The main conclusion of the kinetic data is that steric congestion seems to be reduced
stepwise by successive insertion of metal fragments with small π-ligands as shown in the
cartoon of Figure III.2. Although the reaction mechanism can not be deduced from the
data, one possibility can be excluded: a bimolecular mechanism, in which both starting
complexes exchange one metal fragment. In this case, both hetero-assemblies would
show equal concentrations at any moment of the reaction.
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III.III Synthesis of Mixed-Metal Macrocycles
The results described above suggest that equilibration processes with 2:1 stoichiometries
of complexes having significantly different π-ligands can be used for the controlled for-
mation of mixed-metal macrocycles in preparative amounts. The following results show
that this is indeed the case. Solutions comprised of two equivalents of the small benzene
complex [(C6H6)Ru(L1−2 H+)]3 (CCC) in combination with one equivalent of the trimers
[(C6H3
iPr3)Ru(L1−2 H+)]3 (AAA), [(C6Me6)Ru(L1−2 H+)]3 (DDD), or [Cp*Rh(L1−
2 H+)]3 (EEE), all of which have sterically demanding π-ligands, were tempered in meth-
anol at 45 °C over night. Analysis by 1H NMR spectroscopy revealed that the composi-
tion of the reaction mixtures was biased to over 80 % to the mixed-metal complex
comprised of two (benzene)Ru fragments.
For practical reasons, the mixed-metal complexes were synthetised starting from two
equivalents of the halfsandwich complex [(C6H6)RuCl2]2 (1), one equivalent of the half-
sandwich complex [(C6H3
iPr3)RuCl2]2 (5), [(C6Me6)RuCl2]2 (6) or [Cp*RhCl2]2 (9) and
six equivalents of the bridging ligand L1 in the presence of Cs2CO3. The reaction mix-
tures were equlibrated over night in methanol at 45 °C. After removal of the solvent under
reduced pressure and extraction with dichloromethane, the products ACC, DCC, and ECC
were isolated in 60 % yield and over 90 % purity.j It should be noted that exchange proc-
esses were found to be significantly slower in less polar solvents such as benzene and
chloroform as compared to methanol. This allowed the characterization of the mixed
trimers in pure form.
The 1H NMR data of all three products were in agreement with the anticipated struc-
ture: three sets of signals were observed for aromatic protons of the bridging pyridonate
ligands and two singlets were found for the chemically distinct benzene π-ligands. The
complexes DCC and ECC were also characterized by a single crystal X-ray analysis
(Figure III.4 and Figure III.5, respectively).
The bond lengths and angles found for the macrocyclic core of DCC and ECC are com-
parable to what has been observed for the corresponding homotrimeric complexes.[124,
126] Additional structural anisotropy due to the presence of different halfsandwich com-
plexes was not observed. Indirect evidence for the reduced steric strain of the mixed-
metal macrocycles DCC and ECC is the fact that their average metal–metal distances
(DCC: 5.26 Å; ECC: 5.26 Å) are shorter than what has been observed for the homotrim-
ers DDD (5.46 Å) and EEE (5.35 Å). A compilation of the most important structural data
can be found in Table IX.10 on page 227. The importance of the size of the π-ligand for
the stability of the trimeric aggregates is also evident from the space filling representa-
tions of DCC and ECC (Figure III.6).
j. In case of complex ECC a purity of 83 % was obtained.
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Figure III.4 Ball and stick representation of the molecular structure of DCC in the crystal. The
hydrogen atoms and the solvent molecules are omitted for clarity. Selected bond
lengths (Å): Ru1–N1 2.130(6), Ru1–O5 2.086(4), Ru1–O6 2.065(5), Ru2–O1
2.060(5), Ru2–O2 2.069(5), Ru2–N2 2.118(6), Ru3–O3 2.069(5), Ru3–O4
2.073(5), Ru3–N3 2.139(6).
Figure III.5 Ball and stick representation of the molecular structure of ECC in the crystal. The
hydrogen atoms and the solvent molecules are omitted for clarity. Selected bond
lengths (Å): Rh1–O5 2.080(7), Rh1–O6 2.088(8), Rh1–N1 2.122(9), Ru1–O2
2.067(6), Ru1–O1 2.078(7), Ru1–N2 2.106(8), Ru2–O3 2.072(6), Ru2–O4
2.076(7), Ru2–N3 2.104(9).
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Figure III.6 Space filling representation of the molecular structure of DCC (top) and ECC
(bottom) in the crystal. The solvent molecules have been omitted for clarity.
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III.IV Conclusions
12-Metallacrown-3 complexes containing two different metal fragments have been pre-
sented and their formation by metal fragment exchange has been studied. It was found
that the equilibration proceeds in two steps and that the final mixture is completely dom-
inated by the mixed-metal macrocycles. The results are rationalized by assuming unfa-
vourable steric interactions between adjacent bulky (π-ligand)M fragments (M = Ru,
Rh). These steric interactions have been used to bias dynamic exchange processes in
such a way that mixed-metal macrocycles are obtained in over 60 % yield under thermo-
dynamic control. No additional anisotropy of the binding lengths or angles has been
observed and the average metal–metal distances indicate that there is no steric repulsion
between the π-ligands. The results are conceptually related to work on mixed-ligand
metallamacrocycles and cages. Navarro and Romero have shown that scrambling of
symmetrical (en)PdII-based macrocycles with bridging 4,7-phenantroline and 2-pyrimid-
inolate ligands can lead to the dominant formation of a single product given that appro-
priate stoichiometries are employed.[264] Fujita et al.[265, 266] and James at al.[267] have
used steric interactions between ligands to achieve the quantitative formation of macro-
cycles and coordination cages containing two different heterocyclic ligands. It should be
noted that rather small differences in free energy of the various aggregates can be suffi-
cient to bias dynamic mixtures of metallamacrocycles (or cages) towards the formation
of a defined product. For the system described in situation b of Figure III.2, for example,
a difference of ΔΔG2 = ½ ΔΔG3 = 3.0 kcal mol−1 results in an increase of the relative
concentration of mixed product ABB from 44.3 % (statistical) to 91.6 % if the two com-
plexes were mixed in a 2:1 ratio ([AAA]initial = ½ [BBB]initial).
k In view of the fact that
asymmetric metallamacrocycles may display interesting functional differences (host-
guest chemistry etc.) when compared to their symmetrical MnLn counterparts, the strat-
egy discussed above should be regarded as an attractive alternative to step-wise synthetic
procedures.
k. The equilibrium constants were calculated with the program Gepasi, version 3.30.[233, 234]
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IV.I Introduction
“…progress in lithium research has been hampered by the unavailability of a sensitive
and specific Li+ spectroscopic tool.” This statement can be found in the ‘Concluding
Remarks’ of a recent review article about the pharmacological action of lithium
salts.[268] In the following, water soluble Li+-specific organometallic receptors and their
binding properties will be presented. These receptors can be used to design a pH depend-
ant Li+ sensor and a ‘naked eye’ colorimetric test for Li+ in water. Furthermore, it will be
outlined, how simple structural modifications allow the development of a chemosensor
for the selective detection of lithium ions in water using fluorescence spectroscopy.
IV.I.1 The Pharmacology of Lithium Ions
In 1949, John Cade reported that lithium salts have a calming effect on patients with
acute mania.[269] The potential value in psychiatry was subsequently confirmed by many
other studies and since the mid-1960s, lithium salts are among the most frequently used
drugs for patients suffering from bipolar disorder.[270–272] Despite the development of
alternative drugs, lithium ‘remains the treatment of choice’[270] and the ‘gold stand-
ard’[273] for acute episodes and the prevention of relapses. Recent studies suggest that
lithium could also be used for the treatment of Alzheimer's disease[274, 275] and of schiz-
ophrenia and it was speculated whether lithium could become the ‘aspirin of the
brain’.[276] Apart from applications in the field of psychiatry and neurology, lithium salts
have been employed to treat skin diseases, were shown to inhibit the replication of cer-
tain viruses and can affect the immune response.[271]
Unfortunately, the therapeutic range of lithium salts (0.5–1.2 mM) used in the treat-
ment of bipolar disorder is very close to toxic levels (<2.0 mM).[277–279] Establishing the
accurate dose is hence of crucial importance. Measurements are currently carried out
using flame emission spectroscopy, a relative expensive method which give no immediate
reply. But measurements should best taken at the office of the treating physician, i.e. in
blood (buffer solution) in the presence of high concentrations of other small cations such
as Na+ and K+. Tools to rapidly quantify lithium are therefore of prime importance.
Given the pharmacological relevance, it is not surprising that considerable efforts have
been devoted towards the development of sensors for lithium ions.[277–279] From a chem-
ical point of view, the synthesis of specific receptors is of special interest. So far, most
investigations have focused on organic macrocycles, which are generally employed in a
non aqueous environment.[277–294] The design of synthetic receptors, which can be used
directly in water, represents a special challenge. First of all, the host needs to be soluble in
water. This severely limits the type of building blocks, which can be employed to con-
struct the receptor. Secondly, the hydration enthalpy of Li+ is very high (−519 kJmol-
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1).[176] As a consequence, the binding constants of artificial hosts are significantly lower
in water when compared to organic solvents. The Li+ specific ionophore 12-crown-4, for
example, displays a binding constant of logK = 4.25 in acetonitrile whereas in water, no
interaction with Li+ could be detected at all (logK ~ 0).[295] Apart from an innovative
alternative approach using gold nanoparticles,[296] aza-macrobicyclic cage molecules
play a dominant role among the few receptors, which are able to bind Li+ in water with
high affinity.[297–303] One of the highest stability constants was found for the 2,1,1-cryp-
tand (logK = 5.5).[297] This receptor also displays a good selectivity for Li+ over Na+
(200:1). For potential applications, however, aza-macrobicyclic receptors show several
severe disadvantages: the synthesis of these compounds generally requires several steps
and proceeds with modest overall yields.[297–303] Additionally, commercially available
cryptands are in general very expensive, and their purity may be modest, e.g. only 90 %
in the case of the Li+ specific 2,1,1-cryptand.
An ideal sensor should be able to detect Li+ at the millimolar level in the presence of
other alkaline and earth-alkaline cations by colorimetric or fluorescent means. The syn-
thesis of such a sensor should be simple and using easily available starting materials.
IV.I.2 12-Metallacrown-3: Ionophores in Organic Solvents
As presented in chapter I.VI, metallamacrocyclic ionophores for the small alkaline ions
Li+ and Na+ in organic solvents have been developed recently in the Severin group.[124,
126, 127] These macrocyclic hosts self-assemble from halfsandwich complexes [(π-
ligand)MCl2]2 and 3-hydroxy-2-pyridone in the presence of Cs2CO3 (Scheme IV.1). The
metal fragment adopts a piano stool like pseudo tetrahedral geometry and the deproto-
nated 3-hydroxy-2-pyridone acts as tridentate bridging ligand.
Scheme IV.1 Self-assembly of metallamacrocyclic ionophores from [(π-ligand)MCl2]2 and
3-hydroxy-2-pyridone.
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IV.II pH Triggered Self-Assembly of Organo-
metallic Receptor for Li+ Ions in Water
IV.II.1 Employed Ligands and Halfsandwich Complexes
The ligands L2–L5 (Figure IV.1) were chosen for the synthesis of water soluble receptors
because
1. They contain the 3-hydroxy-2-pyridone structural motif, which favours the for-
mation of trinuclear metallamacrocycles.[124–126, 128, 165, 166, 168, 169]
2. They contain a tertiary amino group, which is able to enhance the solubility of
the resulting complexes (formation of ammonium groups) without interfering
with the self-assembly process.
All ligands were easily prepared in a Mannich reaction of 3-hydroxy-2-pyridone, for-
maldehyde and the corresponding secondary amine (Scheme IV.2).[304–307] Attack
occurred first at the more reactive C4-position, and if more than one equivalent was used,
reaction occurred also at the C6-position. However, investigation of the self-assembly of
halfsandwich complexes and bridging ligands bearing two methyleneamino groups did
not result in trinuclear metallamacrocyclic structures.
As the reaction partner, organometallic halfsandwich complexes of ruthenium (1–6),
rhodium (7–9) and iridium (10 and 11) have been employed. Although some of these
complexes are commercially available (1, 3, 9 and 11), all halfsandwich complexes have
been synthesised in the laboratory. Their structures are presented in Figure IV.2.
Figure IV.1 Ligands L2–L5 used for the self-assembly of water soluble metallamacrocycles.
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IV.II.2 Formation of Monomeric Complexes in Water
First, the reaction of the complexes 1–11 with the ligands L2–L5 in plain water was
investigated. When the chloro-bridged halfsandwich complexes were stirred with
2 equiv. of the respective ligand, clear yellow to orange solutions were obtained after
Scheme IV.2 Mannich reaction of 3-hydroxy-2-pyridone, formaldehyde and a secondary
amine to obtain ligands L2–L5.
Figure IV.2 Dimeric halfsandwich complexes [(π-ligand)MCl2]2 employed for the self-assembly
of water soluble metallamacrocycles.
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several minutes. 1H NMR spectroscopic investigation of the resulting mixtures showed
the presence of a single complex. Given the known tendency of hydroxy-pyridone lig-
ands to form O,O'-chelates with halfsandwich complexes,[124, 308, 309] it appeared likely
that mononuclear complexes of type A had formed (Scheme IV.3). This was confirmed
for several examples by single crystal X-ray analysis (see chapter IV.II.4).
The chloro ligands of complexes of type A are expected to be labile because upon
abstraction of the ligand, a cationic complex is formed, which can be described by two
mesomeric forms: one in which the positive charge is located at the metal and another in
which the positive charge is localized on the nitrogen atom of the pyridine ring
(Scheme IV.4).
In a good donor solvent such as water, it is thus expected that the chloro-ligands are
substituted by water. The following experiments suggest that this is indeed the case. An
aqueous solution (D2O) containing the monomeric complex formed from 3 and L2 was
treated with 10 equiv. of AgNO3. A white precipitate of AgCl formed immediately, which
was separated by filtration. The 1H NMR spectrum of the resulting complex was identical
to that of the starting material indicating that the nature of the anion (NO3
− vs. Cl−) has a
minor effect on the ruthenium complex. Similar results were obtained with the rhodium
and iridium complexes obtained from L2 and 9 or 11, respectively.
Scheme IV.3 Formation of mononuclear complexes of type A.
Scheme IV.4 Chloro vs. aqua complexes.
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Table IV.1: Selected 1H NMR signals (ppm) of monomeric halfsandwich complexes obtained
by reaction of the complexes 1–11 with the ligands L2–L5 in D2O.
Entry Complex Ligand H1a H2a H3/4
1 — L2 6.69 6.28 4.05
2 — L3 7.02 6.38 3.73
3 — L4 6.62 6.20 3.98
4 — L5 6.90 6.33 3.70
5 1 L2 6.91 6.53 4.22
6 1 L5 6.91 6.55 3.68
7 2 L2 6.92 6.53 4.23
8 2 L5 6.89 6.54 3.71
9 3 L2 6.88 6.49 4.21
10 3 L3 6.90 6.53 4.33
11 3 L4 6.70 6.50 4.25
12 3 L5 6.88 6.53 3.70
13 4 L2 6.92 6.70 4.23
14 4 L5 6.91 6.55 3.75
15 5 L2 6.86 6.49 4.21
16 5 L5 6.84 6.51 3.70
17 6 L2 6.82 6.46 4.21
18 6 L3 6.81 6.46 4.27
19 6 L4 6.82 6.46 4.27
20 6 L5 6.81 6.49 3.69
21 7 L2 6.92 6.53 4.19
22 7 L5 6.92 6.57 3.70
23 8 L2 6.74 6.38 4.09
24 8 L5 6.84 6.51 3.74
25 9 L2 6.81 6.45 4.18
26 9 L5 6.82 6.49 3.72
27 10 L2 6.89 6.50 4.21
28 10 L5 6.89 6.52 3.78
29 11 L2 6.89 6.49 4.23
30 11 L5 6.86 6.50 3.77
a. The signals appear as doublets with a coupling constant of 3J = 7 Hz.
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The coordination of the metal to the oxygen atoms of the ligand results in a transloca-
tion of a proton from the hydroxy to the amine group. This is reflected by the chemical
shift of the signals for the methylene group next to the nitrogen atom (H3/4, Table IV.1).
While for the free ligands, the signals of these protons appear between δ = 3.70 and
4.05 ppm (Table IV.1, entries 1–4), the corresponding signals for the metal complexes
with L2, L3 and L4 appear between δ = 4.09 and 4.33 ppm in agreement with the presence
of a protonated amine group. For complexes with the ligand L5, on the other hand, the
signals of the methylene protons are only slightly shifted. This indicates that it is predom-
inantly the terminal nitrogen atom of the piperazine group, which is protonated
(Figure IV.3).
 The fact that the MeNR2 nitrogen of ligand L5 is more basic was confirmed in 
1H
NMR titration experiments with DCl. Upon addition of incremental amounts of DCl
(0.0–2.0 equiv.) to a solution of ligand L5, it was first the signals of the NMe (peak 2) pro-
tons, which were shifted. Significant differences in chemical shift for the H3/4 protons
(peak 1) were only observed upon addition of more than 1.0 equiv. of DCl as shown in
Figure IV.4.
Figure IV.3 Proton translocation of monomeric halfsandwich complexes containing the ligands
L2 (left) and L5 (right).
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IV.II.3 pH Triggered Assembly of 12-Metallacrown-3 Com-
plexes
Next, the influence of the pH was investigated using potentiometric titrations. Increasing
amounts of CsOH (0.0–1.0 equiv.) were added to solutions of monomeric complexes of
type A (15.0 mM). In all cases, a pH profile characteristic of a weak acid was obtained.
The data obtained for the ruthenium complexes 1–4 and the ligand L2 are depicted in
Figure IV.5;l the corresponding data for the rhodium and iridium complexes 7–11 are
shown in Figure IV.6.
Figure IV.4 1H NMR spectrum of L5 in D2O (spectrum d) and after addition of increasing
amounts of DCl. First, the NMe group is protonated (spectra b & c), then the NCH2
group (spectrum a). The solvent peak is denoted by an asterisk.
l. The (triisopropylbenzene)Ru complex 5 and the (hexamethylbenzene)Ru complex 6 were not included in this study
because of the low solubility of the resulting complexes in water. However, the corresponding trimers could be syn-
thesised in MeOH in the presence of Cs2CO3.
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Figure IV.5 The pH of solutions containing the ligand L2 (15.0 mM) and the complexes 1 (?),
2 (?), 3 (Δ) and 4 (?) ([Ru] = 15.0 mM) after addition of increasing amounts of
CsOH (0.0–1.0 equiv.).
Figure IV.6 The pH of solutions containing the ligand L2 (15.0 mM) and the complexes 7 (?),
8 (?), 9 (Δ), 10 (?) and 11 (?) ([Rh] = [Ir] = 15.0 mM) after addition of
increasing amounts of CsOH (0.0–1.0 equiv.).
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The ruthenium complexes 1–3 all behave very similar with an inflection point at
pH ~ 5.5. The (C6H5CO2Et)Ru complex 4 having an electron withdrawing ester side
chain, on the other hand, is slightly more acidic with an inflection point at pH = 4.3. The
acidity of the complexes is not only affected by the nature of the π-ligand but also by the
metal ion. This is evidenced by comparing the data of the rhodium complexes 8 and 9
with that of the iridium complexes 10 and 11 (Figure IV.6). Clearly, the iridium com-
plexes are more acidic than the rhodium complexes having the same type of π-ligands (8
vs. 10 and 9 vs. 11).
When combined with the (cymene)Ru complex 3, the pyridone ligands L2, L3 and L4
gave rise to very similar pH profiles with pKa = 5.4. For the piperazine ligand L5, on the
other hand, the inflection point was found at slightly higher pH (pKa = 6.9). Tables com-
piling the inflection points are given in the Appendix (Table IX.6 and Table IX.7 on
page 216).
For some metal–ligand combinations, precipitation occurred after addition of 1.5–
2.0 equiv. of CsOH (pH ~ 9.0–10.5, [metal] = 15 mM). This indicates that the fully
deprotonated complexes display a lower solubility in water. There are various metal–
ligand mixtures, however, for which no precipitation was observed after addition of
2 equiv. of CsOH. In particular, complexes with (C6H6)Ru (1), (C6H5Me)Ru (2), CpRh
(7) and (C5HMe4)Ru (8) metal fragments show a relatively high solubility (> 5 mM),
Table IV.2: The pH of solutions containing the complex 3 ([Ru] = 15.0 mM) and the ligands L2
(Δ), L3 (?), L4(?) and L5 (?) (15.0 mM) after addition of increasing amounts of
CsOH (0.0–1.0 equiv.).
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even in the fully deprotonated form. The solubility was not only influenced by the metal
fragment, but also by the ligand. In general, the solubility increased in the following
order: L2 < L3 ~ L4 < L5. The equivalents of CsOH after which precipitation of 12-
metallacrown-3 complexes occured are compiled in Table IX.4 on page 215.
In order to obtain more information about the complexes which are formed at different
pH, 1H NMR titration experiments for selected metal–ligand combinations have been
performed. Part of the 1H NMR spectra obtained for a mixture of the (cymene)Ru com-
plex 3 and the ligand L2 upon addition of CsOH (0.0–1.0 equiv.) is shown in Figure IV.7.
For the monomeric complex obtained in plain D2O (spectrum e), one can observe a sin-
glet for the NCH2 group at 4.21 ppm, two doublets between 5.5 and 6.0 ppm for the aro-
matic CH protons of the cymene π-ligand and two doublets between 6.5 and 7.0 ppm for
pyridone CH protons. Upon addition of CsOH, the signals of a second complex can be
detected. The latter is completely dominating the solution after addition of one equivalent
of CsOH.
The signals of the new complex can be assigned to a trimeric macrocycle of type B
(Scheme IV.5). An important difference between the spectra of the monomeric and the
trimeric complex is the multiplicity of the aromatic CH protons of the cymene π-ligand
and of the NCH2 protons. Although the metals represent stereogenic centres in both com-
plexes, only the rigid metallamacrocycle is conformationally stable on the NMR time
scale. As a consequence, we can observe two doublets for the diastereotopic NCH2 pro-
tons at ~ 4 ppm and four doublets for the cymene CH protons between 5.2 and 6.2 ppm
(spectrum ‘a’ of Figure IV.7).
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 NMR titration experiments using the iridium complex 10 and the ligand L2 gave sim-
ilar results: upon addition of CsOH, one could observe the signals of a second complex
(Figure IV.8). With one equivalent of CsOH, this complex is the dominant species in solu-
tion (> 95 %). The two doublets for the NCH2 protons confirm the presence of a chiral
complex, which is conformationally stable on the NMR time scale.
Figure IV.7 Part of the 1H NMR spectrum (D2O) of a solution containing [(cymene)RuCl2]2 (3)
(7.5 mM) and the ligand L2 (15.0 mM) after addition of different amounts of CsOH:
a) 1.00 equiv. b) 0.75 equiv. c) 0.50 equiv. d) 0.25 equiv. e) 0.00 equiv.. The
spectrum ‘a’ corresponds to the trimer B and the spectrum ‘e’ corresponds to the
monomer A. The solvent peak is denoted by an asterisk.
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The 1H NMR data described above are in agreement with a pH dependant self-assem-
bly process as shown in Scheme IV.5. After deprotonation of the pyridone, the ring nitro-
gen is able to coordinate to a metal, thereby replacing a weakly bound water ligand. The
pH at which 50 % of the monomer A is converted to the trimer B varies substantially
(Figure IV.5 and Figure IV.6). It is plausible that steric effects influence the aggregation
but electronic effects also seem to be of importance as evidenced by the unusual behav-
iour of the ester substituted ruthenium complex 4.
Figure IV.8 Part of the 1H NMR spectrum (D2O) of a solution containing [(C5Me4H)IrCl2]2 (10)
(7.5 mM) and the ligand L2 (15.0 mM) after addition of different amounts of CsOH:
a) 1.00 equiv. b) 0.75 equiv. c) 0.50 equiv. d) 0.25 equiv. e) 0.00 equiv.. The
spectrum ‘a’ corresponds to the trimer B and the spectrum ‘e’ corresponds to the
monomer A. The solvent peak is denoted by an asterix.
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Additional evidence for the presence of trimeric macrocycles was obtained by ESI
mass spectroscopy; spectra of solutions containing ligand L2 and metal complexes 3 or
11 in phosphate buffer solution (PBS) at pH 8 showed isotopically resolved peaks for the
monoprotonated trimers.
NMR titration experiments with mixtures, which display a pKa > 6, gave slightly dif-
ferent results since more than one equivalent of CsOH with respect to the ligand was
needed to complete the assembly process. The amount of CsOH that was required to gen-
erate the metallamacrocycle was found to depend on the nature of the metal complex and
the ligand. Whereas for a combination of the ligand L5 with the (cymene)Ru complex 3,
the addition of 1.25 equiv. of CsOH was sufficient to obtain over 95 % of the respective
trimer, for the (C5Me4H)Rh complex 8 almost 2 equiv. were needed (Figure IV.9). For
some other mixtures such as the Cp*Rh complex 9 and the ligand L5, precipitation was
observed before completion of macrocyclisation.m
Scheme IV.5 pH dependant self-assembly of trinuclear metallamacrocycles of type B.
m. The pH dependant assembly of Cp*Rh complexes using nucleobase ligands has been investigated extensively by
the Fish’s group.[108, 110]
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For the above mentioned cases, the pyridone proton has a comparable acidity as the
ammonium side-chain. Accordingly, we observe the partial deprotonation of the side-
chain before the deprotonation of the pyridone. Since macrocyclisation necessitates the
deprotonation of the pyridone NH proton, more than one equivalent of CsOH is needed.
Figure IV.9 Part of the 1H NMR spectrum (D2O) of a solution containing [(C5Me4H)RhCl2]2
(7.5 mM) and the ligand L5 (15.0 mM) after addition of different amounts of CsOH:
a) 2.00 equiv. b) 1.75 equiv. c) 1.50 equiv. d) 1.25 equiv. e) 1.00 equiv. f)
0.75 equiv. g) 0.50 equiv. h) 0.25 equiv. i) 0.00 equiv.. The spectrum ‘a’
corresponds to the trimer B and the spectrum ‘i’ corresponds to the monomer A.
The solvent peak is denoted by an asterisk.
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For the extreme case of complex [(C5HMe4)RhCl2]2 8 and ligand L5, this situation is
illustrated in Scheme IV.6. When the chloro-bridged complex 8 is dissolved with two
equivalents of the ligand L5, the monomeric complex [(C5HMe4)Rh(L5)(H2O)]
2+ is
formed. Addition of base initially leads to a deprotonation of the side chain. The assembly
process to generate the macrocycle [(C5HMe4)Rh(L5−2 H+)]3 therefore requires 2 equiv.
of base (with respect to the ligand).
Self-assembly occured not only after addition of base, but also in buffer solution.[310]
When a mixture of [(π-ligand)MCl2]2 and 2 equiv. of ligand L2 was stirred in a phosphate
buffer solution in D2O (100 mM) at pH 7.0, clear orange solutions were obtained. As pre-
sented above, the self-assembly process is pH dependant. Thus, pronounced differences
were observed for the various metal complexes. Whereas 1H NMR spectroscopy indi-
cated the formation of a trimeric structure for [(C6H6)RuCl2]2, [(C6H5Me)RuCl2]2,
[(cymene)RuCl2]2, [(C6H5CO2Et)MCl2]2 and [Cp*IrCl2]2, a monomeric structure was
observed for [Cp*RhCl2]2 (Figure IV.10). This is in agreement with the more basic
inflection point of rhodium complexes compared to iridium complexes. It should be
noted, that the observed differences are caused only by the electronical differences of rho-
dium and iridium. If the pH was raised, the partial formation of a macrocyclic complex
Scheme IV.6 pH dependant self-assembly of trinuclear metallamacrocycles of type B requiring
more than 1.0 equiv. of CsOH.
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was likewise observed. The spectra of trinuclear complexes in phosphate buffer solution
were identical to those obtained after addition of CsOH.
IV.II.4 Structural Investigations.
In order to obtain structural information about monomeric complexes of type A, the reac-
tion products of various metal–ligand combinations without the addition of base have
been crystallised. Suited single crystals were obtained for reactions of the hexamethyl-
benzene ruthenium complex [(C6Me6)RuCl2]2 (6) with the ligands L2, L3, and L4. The
molecular structures of one enantiomer of the resulting complexes in the crystal are
depicted in Figure IV.11.
Overall, the molecular structures are very similar. The ligands are coordinated to the
Ru atoms via the two pyridone O-atoms forming five-membered chelate rings. As sug-
gested by NMR data, the ligands are in a zwitterionic form with a deprotonated 3-hydroxy
group and an ammonium side-chain. In case of the ruthenium complexes, the NH proton
of the ammonium group displays a hydrogen bond to the chloride counter ion. A second
hydrogen bond can be observed between the chloride counter ion and the pyridone NH
proton of an adjacent, symmetry-related complex. As a result, we observe the dimeriza-
tion of the two enantiomeric ruthenium complexes present in the crystal via hydrogen
bonding to two chloride anions (Figure IV.12). This arrangement seems to be energeti-
cally quite stable because it is observed for all three complexes. Since the crystals were
obtained from organic solvents, the second chloride is coordinated to the metal and not
Figure IV.10 Part of the 1H NMR spectra in phosphate buffer solution (D2O) at pH 7.0 of the
products obtained in reactions of ligand L2 with [Cp*RhCl2]2 (bottom) and
[Cp*IrCl2]2 (top). Two doublets for diastereotopic NCH2 protons at δ ~ 4 ppm are
observed only for [Cp*IrCl2]2. The solvent peak is denoted by an asterisk.
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replaced by an aqua ligand. A summary of selected bond length and angles for the three
complexes is given in Table IV.3.
Crystals were also obtained for the intermediate between monomeric form A and
trimeric form B. As shown in Figure IV.11 (bottom right), the complex [Cp*Rh(L3−
H+)Cl] show a similar structure to the monomeric complexes presented above, but the
Figure IV.11 Graphic representations of the molecular structures of the monomeric complexes
[(C6Me6)Ru(L2)Cl]Cl (top left), [(C6Me6)Ru(L3)Cl]Cl (top right),
[(C6Me6)Ru(L4)Cl]Cl (bottom left) and [Cp*Rh(L3−1 H+)Cl] (bottom right) in the
crystal. The complexes were obtained in reactions of the complex 6 or 9 with two
equivalents of the ligands L2, L3 or L4, respectively. Solvent molecules are not
shown for clarity.
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side chain is deprotonated and the counterion is missing. Selected bond length and angles
are given together with the monomeric complexes of type A in Table IV.3.
Cationic complexes of type B were found to be difficult to crystallise, presumably due
to the presence of three chloride counter ions. We thus focused on the neutral, completely
deprotonated complexes. They were obtained by reaction of the respective chloro-
bridged complexes with two equivalents of the pyridone ligands and an excess of base
(Cs2CO3) in methanol (Scheme IV.7). After evaporation of the solvent, the products were
separated from the salts by extraction with CH2Cl2 or hexane. A table with all synthesised
Figure IV.12 In the crystal, two cationic complexes [(C6Me6)Ru(L2)Cl]
+ are connected via
hydrogen bonding to the chloride counter ions. A similar arrangement is found for
the complexes (C6Me6)Ru(L3)Cl]Cl and [(C6Me6)Ru(L4)Cl]Cl.
Table IV.3: Selected bond lengths (Å) and angles (°) of the monomeric complexes
[(C6Me6)Ru(L2)Cl]Cl, [(C6Me6)Ru(L3)Cl]Cl, [(C6Me6)Ru(L4)Cl]Cl and
[Cp*Rh(L3−H+)Cl].
Complex M–Cl M–O1 M–O2
O1–M–
O2
O1–M–
Cl1
M–O1–
C1–C2
N2–Cl2 N1–Cl2
[(C6Me6)Ru(L2)Cl]Cl 2.42 2.15 2.09 78.6 83.3 14.23 3.08 3.14
[(C6Me6)Ru(L3)Cl]Cl 2.43 2.17 2.07 78.4 84.5 11.24 3.07 3.17
[(C6Me6)Ru(L4)Cl]Cl 2.43 2.14 2.08 78.3 85.2 13.79 3.02 3.14
[Cp*Rh(L2−H+]Cl 2.42 2.14 2.13 78.3 86.9 7.52 — —
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complexes can be found in the Appendix (Table IX.3 on page 214). Suited single crystals
for X-ray analysis were obtained for the complexes [(cymene)Ru(L2−2 H+)]3,
[(cymene)Ru(L3−2 H+)]3, [(cymene)Ru(L5−2 H+)]3, [(C5HMe4)Rh(L5−2 H+)]3,
[Cp*Rh(L5−2 H+)]3 and [Cp*Ir(L3−2 H+)]3. Graphic representations of the molecular
structures in the crystal are depicted in Figure IV.14 and Figure IV.13.
Scheme IV.7 Synthesis of deprotonated trinuclear metallamacrocycles in MeOH in the
presence of CsOH.
Figure IV.13 Graphic representations of the molecular structures of the trimeric complexes
[Cp*Rh(L5−2 H+)]3 (left) and [Cp*Ir(L3−2 H+)]3 (right), in the crystal. Hydrogen
atoms and solvent molecules are omitted for clarity.
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All six complexes show the expected trinuclear metallamacrocyclic structure with the
metal centres being bridged by the two adjacent O-atoms and the N-atom of the pyrido-
nate ligand. A comparison of important structural parameter shows that the substitution of
the (cymene)Ru fragment with a Cp*Rh or a Cp*Ir fragment has only a small influence
on the macrocyclic framework (Table IV.4).
Figure IV.14 Graphic representations of the molecular structures of the trimeric complexes
[(cymene)Ru(L2−2 H+)]3 (top left), [(cymene)Ru(L3−2 H+)]3 (top right),
[(cymene)Ru(L5−2 H+)]3 (bottom left) and [(C5HMe4)Rh(L5−2 H+)]3 (bottom
right) in the crystal. Hydrogen atoms and solvent molecules are omitted for clarity.
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A difference between the crystal structures of the Cp*M complexes on one side and
the (cymene)Ru and (C5HMe4)Rh complexes on the other side, is that the for the latter, a
Table IV.4: Selected bond lengths (Å) and angles (°) for 12-metallacrown-3 complexes of
3-hydroxy-2-pyridone ligands with diverse metal fragments.
Complex M–N M–O1 M–O2
O1–M–
O2
M–O–
C1–C2
M–N–
C1–C2
O–O’ M–M’
[(cymene)Ru(L2−2 H+)]3a 2.14 2.08 2.07 79.6 11.7 7.0 3.10 5.43
[(cymene)Ru(L3−2 H+)]3a 2.14 2.09 2.06 79.1 13.4 9.7 3.13 5.37
[(cymene)Ru(L5−2 H+)]3a 2.14 2.08 2.05 79.5 12.8 8.7 3.10 5.34
[(C5HMe4)Rh(L5−2 H+)]3 2.12 2.08 2.09 78.0 9.9 16.2 3.15 5.32
[Cp*Rh(L5−2 H+)]3 2.13 2.09 2.05 80.1 12.4 7.4 3.11 5.35
[Cp*Ir(L3−2 H+)]3 2.13 2.12 2.09 78.6 8.8 5.8 3.04 5.37
a. Averaged values are given.
Figure IV.15 View along the pseudo C3 symmetry axis of the (cymene)Ru complex
[(cymene)Ru(L3−2 H+)]3 highlighting the hydrogen bonded water molecules
within the cavity of the macrocycle. Distances (Å): O1–O10 = 2.942(5); O4–
O10 = 2.895(5); O7–O10 = 2.980(5).
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water molecule can be found in the macrocyclic cavity.n These water molecules are
within hydrogen bond distance to the bridging O-atoms (Figure IV.15). This is of special
interest, since the O-atoms represent the binding site for alkali metal ions (see chapter
IV.II.5).
IV.II.5 Host-Guest Chemistry.
Macrocyclic complexes of type B (Scheme IV.5) can be regarded as organometallic ana-
logues of 12-crown-3.[137, 138] Similar to their organic counterparts,[311, 312] they are
able to bind lithium ions although with a much higher affinity and selectivity
(Scheme IV.8).
A central point of the present study was to investigate, how the affinity of these self-
assembled receptors is influenced by structural modifications of the ligand and/or the
metal fragment. The Li+ binding constants for several complexes of type B using the
metal/ligand combinations specified in Table IV.5 have been therefore determined. The
assembly process was induced in situ using CsOH. For all complexes, the binding con-
stant was determined by 1H NMR spectroscopy. The complexation of Li+ results in pro-
nounced differences in chemical shifts and the exchange of Li+ is slow compared to the
NMR time scale (for a representative example see Figure IV.16). This allows calculating
Ka directly by integration of suited signals.
First, the influence of the different metal fragments was investigated using the ligand
L2 (entry 1–3, 7, 8, & 10–13). For the ruthenium complexes 1–4, the data suggest a cor-
n. The hydrogen atoms could not be localised, presumably due to a rotational disorder along the pseudo C3 symmetry
axis.
Scheme IV.8 Binding of Li+ to trinuclear metallamacrocyclic receptors.
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relation between the electronic properties of the arene π-ligand and the association con-
stant Ka. The lowest value of Ka = (28 ± 6) M
−1 is found for the (C6H5CO2Et)Ru
complex 4 having an electron-withdrawing ester substituent (entry 7). For the (arene)Ru
complexes 1–3, the binding constants increase with number of the electron donating alkyl
groups from Ka = (7.5 ± 0.6) × 10
2 M−1 to Ka = (2.1 ± 0.6) × 103 M−1 (entry 1–3). Simi-
larly, the (C5HMe4)Rh complex 8 displays a higher affinity for Li
+
(Ka = (1.3 ± 0.2) × 10
4 M−1) than the CpRh complex 7 (Ka = (2.9 ± 0.5)× 103 M−1,
entry 9 and entry 10). For the Cp*Rh complex 9, on the other hand, a relatively low bind-
ing constant of Ka = (1.3 ± 0.4) × 10
1 M−1 was observed (entry 11). Here, the negative
effect of the sterically demanding Cp* π-ligands, which block the binding site, dominates
over the positive electronic effect of the five methyl groups on the cyclopentadienyl
ligand.
The nature of the metal ion is a second important factor influencing the binding con-
stants. Rhodium complexes were found to display higher binding constants than their
analogous iridium complexes (entry 10 vs. 12; entry 11 vs. 13). It is known that the polar-
ity of the metal-oxygen bond is a crucial factor for the binding affinity of metallacrown
Figure IV.16 Part of the 1H NMR spectrum (D2O) of a solution containing the receptor
[(cymene)Ru(L5−2 H+)]3 (5.0 mM) and a) Na2SO4 (125 mM), b) LiCl (10.0 mM)
and c) no alkali metal salt. The addition of LiCl results in quantitative adduct
formation whereas for Na2SO4, a mixture between the free and the complexed
receptor can be observed. The solvent peak is denoted by an asterisk.
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complexes[128] and the observed difference between rhodium and iridium can possibly be
attributed to a less polar binding site (oxygen atoms) in the case of iridium receptors.
Table IV.5: Binding constants Ka for the complexation of Li
+ and Na+ of selected trinuclear
metallamacrocycles.a
a. Binding constants were determined by 1H NMR spectroscopy at receptor concentrations of 1.0 or 5.0 mM for Li+ 
and Na+, respectively.
Entry Complex Ligand
equiv.
of CsOHb
b. Equivalents with respect to the amount of ligand.
equiv.
of MXc
c. Equivalents with respect to the amount of formed receptor.
Ka / M
−1
1 1 L2 1.0 2.0 LiCl 7.5 ± 0.6 × 102
2 2 L2 1.0 2.0 (4.0) LiCld
d. Two different MX concentrations were employed to determine Ka.
1.2 ± 0.6 × 103
3 3 L2 1.0 2.0 LiCl 2.1 ± 0.6 × 103
4 3 L2 1.0 1.0 Li2SO4 2.2 ± 0.6 × 10
3
4 3 L2 1.0 2.0 LiNO3 2.3 ± 0.6 × 10
3
6 3 L2 1.0 50 LiOAc 2.2 ± 0.6 × 103
7 4 L2 1.0 2.0 (6.0) LiCl 2.8 ± 0.6 × 101
8 7 L2 1.0 2.0 (4.0) LiCl 2.9 ± 0.5 × 102
9 7 L2 1.5 2.0 LiCl 1.6 ± 0.5 × 103
10 8 L2 1.5 2.0 LiCl 1.3 ± 0.2 × 104
11 9 L2 1.3 50 Li2SO4 1.3 ± 0.4 × 10
1
12 10 L2 1.0 2.0 (4.0) LiCl 2.6 ± 0.5 × 102
13 11 L2 1.0 50 Li2SO4 9.0 ± 2.0 × 10
−2
14 3 L3 1.0 2.0 LiCl 2.3 ± 0.6 × 103
15 3 L4 1.0 2.0 LiCl 2.4 ± 0.6 × 103
16 1 L5 1.0 2.0 LiCl 4.0 ± 0.6 × 103
17 2 L5 1.0 2.0 LiCl 5.4 ± 0.5 × 103
18 2 L5 1.5 2.0 LiCl 1.3 ± 0.5 × 104
19 2 L5 2.0 2.0 LiCl 3.0 ± 0.6 × 104
20 3 L5 2.0 2.0 LiCl 5.8 ± 1.0 × 104
21 7 L5 2.0 2.0 LiCl 2.7 ± 0.6 × 103
22 8 L5 2.0 2.0 LiCl 5.6 ± 2.1 × 104
23 10 L5 1.0 2.0 LiCl 1.2 ± 0.6 × 103
24 3 L2 1.0 50 Na2SO4 5.0 ± 1.0 × 10
−1
25 8 L2 1.5 50 Na2SO4 1.3 ± 0.3
26 3 L3 1.0 50 Na2SO4 6.0 ± 1.0 × 10
−1
27 3 L4 1.0 50 Na2SO4 6.0 ± 1.0 × 10
−1
28 3 L5 2.0 15 (25) Na2SO4 5.0 ± 1.0
29 8 L5 2.0 15 (25) Na2SO4 7.0 ± 1.0
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Macrocycles containing the ligands L2, L3 and L4 showed very similar affinities for
Li+ (entry 3, 14 and 15). Receptors based on ligand L5, on the other hand, displayed
higher binding constants (entry 1 vs. 16; entry 2 vs. 17; entry 12 vs. 23). As described
above, a unique feature of ligand L5 is that the protons are located on the terminal methyl-
amino groups and not on the amino group adjacent to the pyridone. This means that the
protons – and thus the positive charges – are located further away from the Li+ binding
site, which increases the affinity.
The importance of the charges raised the question which influence the change of the
pH would have on the binding constants. The addition of more than one equivalent of
CsOH with respect to the ligand was expected to lead to a deprotonation of the amino side
chains and therefore to a higher affinity for Li+. This was indeed the case: if one equiva-
lent of CsOH was added to a mixture of the (C6H5Me)Ru complex 2 and ligand L5, a
binding constant of Ka = (5.4 ± 0.5) × 10
3 M−1 was determinedo. This value increased to
Ka = (1.3 ± 0.5) × 10
4 M−1 and finally to Ka = (3.0 ± 0.6) × 104 M−1 upon addition of 1.5
or 2.0 equiv. of CsOH, respectively (entry 17–19). A similar trend was observed for the
CpRh complex 7 in combination with L2 (entry 8 and 9). These studies were restricted to
metal–ligand combinations for which complete deprotonation did not result in precipita-
tion.
Overall, the best Li+ receptors were the macrocycles obtained from a combination of
the ligand L5 with the (cymene)Ru complex 3 (Ka = (5.8 ± 1.0) × 10
4 M−1) or the
(C5Me4H)Rh complex 8 (Ka = (5.6 ± 2.1) × 10
4 M−1) with two equivalents of CsOH
(entry 20 and 22). It should be noted that these values are amongst the highest ever
reported for Li+ complexation in water.[277–279] For potential applications, the
(cymene)Ru complex is particularly appealing because the starting material 3 is commer-
cially available. The corresponding receptor [(cymene)Ru(L5−2 H+)]3 can either be pre-
pared in situ by base induced self-assembly or be synthesised prior to binding studies as
outlined in Scheme IV.7. The Li+ binding constant was found to be identical.
In organic solvents, 12-metallacrown-3 complexes were found to bind lithium and
sodium salts as ion pairs.[127] Consequently, the binding constants depend on the nature
of the anion. For the water soluble receptors presented above, a dependence of this kind
was not observed: the binding constants for the complexation of LiCl, Li2SO4, LiNO3
and LiOAc were – within the limits of accuracy – all the same (entry 3–6).
A remarkable feature of the new receptors is their extremely high selectivity for Li+
over Na+. For most metal–ligand combinations, it was not possible to observe a complex-
ation of Na+ under the conditions employed ([receptor] = 5.0 mM, [Na+] = 500 mM).
Only for the high affinity receptors formed from 3 and 8 it was possible to observe Na+
o. With only 1.0 equiv. of CsOH, the macrocyclisation was not quantitative, and 10 % of a monomeric complex of
type A was observed. For the calculation of the binding constant, the concentrations were adjusted accordingly.
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adducts by 1H NMR spectroscopy and thus to calculate the binding constants. As listed in
Table IV.5, the values for the complexation of Na+ are approximately four orders of mag-
nitude lower than the values determined for Li+ (entry 24–29).
In order to obtain more information about the differences of the high affinity host
[(cymene)Ru(L5−2 H+)]3 and the cationic host obtained from 3, L2 and 1.0 equiv. of
CsOH (entry 3), we have investigated the kinetics of the Li+ complexation. A stock solu-
tion of LiCl ([Li+]final = 9.8 mM) was added to a solution of the respective receptor in
D2O (4.9 mM). The time course of adduct formation was then determined by 
1H NMR
spectroscopy. The results are depicted in Figure IV.17. Fitting of the experimental data to
a simple bimolecular reaction model with the help of the program Gepasi[233, 234] (ver-
sion 3.30, using a preinstalled Levenberg-Marquart algorithm) showed that the complex-
ation rates kon for both receptors are very similar: for the combination of 3 and L2 a value
of (2.72 ± 0.02) × 10−4 mM−1 s−1 was determined whereas for [(cymene)Ru(L5−2 H+)]3,
a value of (2.94 ± 0.03) × 10−4 mM−1 s−1 was found. The difference in affinity can there-
fore be attributed to a difference in the decomplexation rates koff of the two hosts. For 3/
L2/1.0 equiv. CsOH, a value of koff = (1.17 ± 0.05) × 10
−4 s−1 was determined. The
resulting calculated binding constant of Ka = kon/koff = 2.3 × 10
−3 M−1 corresponds well
to what was determined by 1H NMR spectroscopy under equilibrium conditions
(Table IV.5, entry 3). For the high affinity receptor [(cymene)Ru(L5−2 H+)]3, a meaning-
ful decomplexation rate could not be deduced from the kinetic data, because the quantita-
tive formation of the Li+ adduct was observed by 1H NMR under the employed
conditions. Using the value for the binding constant determined at a lower receptor con-
centration of 1.0 mM (Table IV.5, entry 20), however, a decomplexation rate
koff = 5 × 10
−6 s−1 can be estimated.
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Figure IV.17 Time course of Li+ adduct formation of the receptor obtained from 3, L2 and
1.0 equiv. of CsOH (?) and of receptor [(cymene)Ru(L5−2 H+)]3 (?) as
determined by 1H NMR spectroscopy (D2O; [Li
+] = 9.8 mM; [receptor] = 4.9 mM).
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IV.III From Receptors to Sensors
IV.III.1 A pH Sensor for Li+ Ions 
The base induced macrocyclisation of 3 and L5 to give receptor [(cymene)Ru(L5−
2 H+)]3 was found to be a reversible process: when 6 equiv. of DCl were added to solu-
tion of [(cymene)Ru(L5−2 H+)]3 in D2O, the spectrum of the monomeric complex
[(cymene)Ru(L5)(H2O)]
+ was observed by 1H NMR spectroscopy (Scheme IV.9).
Accordingly, a potentiometric titration of [(cymene)Ru(L5−2 H+)]3 with HCl gave a
curve, which was nearly identical with what was found for 3, L5 and CsOH
(Figure IV.18).p 
Scheme IV.9 Design of a pH dependant sensor for Li+ ions in water.
p. Small deviations with respect to the reverse titration curve with CsOH were observed in the final part of the curve
(5–6 equiv. of HCl). They could be reduced if the titrations were performed very slowly.
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In the presence of LiCl, however, a different behaviour was observed. Addition of HCl
to a solution of [(cymene)Ru(L5−2 H+)]3 containing lithium ions resulted in the immedi-
ate protonation of the amine side chains but not in the cleavage of the macrocycle
(Scheme IV.9). This is reflected by the titration curves with HCl: the first part is identical
for titrations with and without Li+ but after addition of three equivalents of HCl, a sharp
drop in pH was observed for solutions containing Li+ because the acid is not consumed to
form monomeric complexes (Figure IV.18). 
The different behaviour of receptor [(cymene)Ru(L5−2 H+)]3 in the presence and
absence of lithium ions offers the possibility to detect Li+ in water by a simple pH meas-
urement. Various amounts of Li+ (0.0–1.5 equiv. with respect to the receptor) were added
to a solution of receptor [(cymene)Ru(L5−2 H+)]3 (5.0 mM). After equilibration,
4.5 equiv. of HCl (with respect to the receptor) were added and the pH was determined
(Figure IV.19). Between 0.0 and 1.0 equiv. of Li+, the resulting pH differs by more than
two units. This difference is sufficient to allow a semiquantitative determination of Li+ in
the low millimolar concentration range using commercially available pH strips (accuracy:
0.5 pH units).
Figure IV.18 pH of solutions containing receptor [(cymene)Ru(L5−2 H+)]3 (5.0 mM) after
addition of increasing amounts of HCl (equivalents with respect to the trimeric
receptor). The titrations were performed in the presence of 1.0 equiv. LiCl (?), 0.5
equiv. LiCl (Δ) and without LiCl (?).
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IV.III.2 A Colorimetric Test for Li+ Ions in Water
From the reactions with HCl it was apparent that the kinetic and thermodynamic stability
of receptor [(cymene)Ru(L5−2 H+)]3 was enhanced in the presence of lithium ions. This
raised the question whether a difference between the free receptor [(cymene)Ru(L5−
2 H+)]3 and the host-guest complex [(cymene)Ru(L5−2 H+)]3 × Li+ can also be observed
for other chemical reactions. Screening of a number of different reagents revealed that
simple Fe(III) salts are ideally suited: when an excess of FeCl3 was added to an aqueous
solution of [(cymene)Ru(L5−2 H+)]3, the receptor immediately decomposed to give a
dark brown solution from which a brown powder slowly precipitated.q In the presence of
lithium ions, this reaction was kinetically inhibited and addition of FeCl3 lead to no
immediate colour change.r This difference in reactivity can be used for the ‘naked eye’
detection of Li+ in water in the pharmacologically relevant concentration range of 0.5–
1.2 mM.[277–279] An example is shown in Figure IV.20. Nine solutions with three differ-
ent receptor concentrations (0.5, 1.0 and 1.6 mM) and three different Li+ concentrations
(0.1, 1.0 and 1.6 mM) were prepared. Upon addition of an excess of FeCl3 (~ 3 equiv.
Figure IV.19 pH of solutions containing the receptor [(cymene)Ru(L5−2 H+)]3 (5.0 mM) in the
presence of various amounts of LiCl (0.0–1.5 equiv.) after addition of HCl
(4.5 equiv. with respect to the receptor).
q. Attempts to identify the product of the reaction were not successful.
r. After 15 min., a dark precipitate was also observed in the presence of lithium ions.
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with respect to [(cymene)Ru(L5−2 H+)]3), a colour change was only observed for solu-
tions in which the receptor was not saturated with Li+. A 3 × 3 assay of this kind can thus
be used to determine whether the Li+ concentration is in the range 0.0–0.5 mM, 0.5–
1.0 mM, 1.0–1.5 mM or above 1.5 mM. It remains to be seen whether a colorimetric test
of this kind can be used to determine Li+ in more complicated matrixes, such as body
fluids. From previous studies, it is known that peptides may show a high affinity to half-
sandwich complexes of RhII and RhIII.[313–315] It therefore seems likely that peptides
would have to be removed from samples prior to testing.
IV.III.3 Functionalisation of the Bridging Ligand
Two building blocks were used to generate 12-metallacrown-3 receptors: the 3-hydroxy-
2-pyridone ligands and the dimeric halfsandwich complexes [(π-ligand)MCl2]2. For the
development of Li+ specific sensors on the basis of these metallamacrocyclic receptors,
further modifications are necessary. As these modifications should not interfere with the
self-assembly process or with the binding properties of the receptor, it seemed best to
concentrate on further modifications at the C4-position of the hydroxy-pyridone ligand.
Although the Mannich reaction proofed to be quite useful for the modification of the
bridging ligands, it is limited to the use of secondary amines. A tailored functionalisation
such as attaching a fluorophore is thus not possible. Given the importance of further
modifications of the bridging ligand, a convenient way to access structural diversity had
to be found.
Ligand L6 was prepared from 3-hydroxy-2-pyridone, formaldehyde and dibenzyl-
amine in 28 % yield. It should be noted that 2 equiv. of dibenzylamine had to be
employed in order to obtain a pure product. The use of only 1 equiv. resulted in the for-
Figure IV.20 Photos of aqueous solutions containing different concentrations of host
[(cymene)Ru(L5−2 H+)]3 (0.5, 1.0 and 1.6 mM) and different concentrations of Li+
(0.1, 1.0 and 1.6 mM) after addition of an excess of FeCl3 (3 equiv. with respect to
the receptor). A brown colour is observed for solutions in which the receptor
[(cymene)Ru(L5−2 H+)]3 is not saturated with Li+. The photos were recorded one
minute after addition of FeCl3.
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mation of a mixture of the ligands L1 and L6 in a ratio 1:1. Purification in this case was
achieved by extraction of L1 with water from a solution of the product mixture in chloro-
form.
Subsequent cleaving of the benzyl groups by hydrogenation in the presence of Pd/C as
catalyst led to ligand L7. Unfortunately, Pd/C is not only able to cleave the benzyl groups,
but also to reduce the aromatic ring in considerable amounts, leading to compound L8 as
side product. Optimization of the reaction conditions by stringent control of the reaction
time, the substrate and the catalyst concentration allowed to increase the yield of the
hydrogenation step to 50 %. An alternative approach to circumvent the problem of side
product formation is a slight decrease of the catalyst activity. Thus, no side product was
observed if Pd/Al2O3 was employed. However, the decrease of the catalyst activity
resulted in a multifold increase of the reaction time.
Overall, ligand L7 can be obtained in high purity from commercially available and
cheap starting materials in two steps. Attaching an primary amino group to the pyridone
ligand resulted in a versatile precursor giving access to a variety of functionalised
3-hydroxy-2-pyridones. Examples for its versatility are the synthesis of ligands to which
a fluorescent unit is attached (see chapter IV.III.4) and the synthesis of bridged 3-
hydroxy-2-pyridone units such as EL6 and EL7 (Figure IV.22), the latter one carried out
by a postdoctoral coworker. These molecules are in so far interesting, as they give poten-
Figure IV.21 Synthesis of precursor 4-aminomethylene-3-hydroxy-2-pyridone L7.
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tial access to hexanuclear complexes with a helical like structure similar to those pre-
sented later on (see chapter VI). Three 3-hydroxy-2-pyridone units attached together,
such as molecule EL8 could give access to structurally very complex cage compounds.
IV.III.4 A Fluorescence Sensor for Li+ Ions in Water
Due to its sensitivity, fluorescence spectroscopy is one of the most important analytical
tools in chemistry. Generally, a chemosensors displays a fluorescent unit attached either
with or without spacer to a binding unit. Upon binding of the analyte, the fluorescent
behaviour changes. Two different design principles of fluorescent chemosensors can be
distinguished: photoinduced electron transfer (PET) and photoinduced charge transfer
(PCT).[316]
In the case of a fluorescent PET cation sensor, the fluorescence is quenched until a
binding event occurs. Thus, fluorescence turns ‘on’ in the present of analyte. The princi-
ple is depicted in Figure IV.23 (bottom). The fluorophore acts as an acceptor, whereas the
receptor has to be a potential electron donor. If the fluorescent unit is excited, an electron
is promoted from the highest occupied molecular orbital HOMO to the lowest unoccupied
molecular orbital LUMO. The HOMO of the free receptor unit is energetically higher
than the HOMO of the fluorescent unit and photoinduced electron transfer (PET) occurs,
causing constant fluorescence quenching. Upon binding, the redox potential of the
receptor increases, leading to a decrease in energy of the HOMO of the donor group of the
receptor. Hence, PET is not longer possible and fluorescence quenching is suppressed.
Figure IV.22 Bridged 3-hydroxy-2-pyridone ligands.
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Most often the receptor units contains amines which act as donor groups, but the use of
transition metals to quench the fluorescence is also known.[317, 318] Generally, very sim-
ple fluorescent units such as naphthalene or anthracene have been employed and fluores-
cent PET chemosensors for cations based on crown units, cryptands, podands, calixarene
and chelating units have been realised.[316] The first fluorescent PET chemosensor for Li+
ions in organic solvents has been presented by Gunnlaugson in 2004[290, 294] but no Li+-
specific fluorescent chemosensors, which are operational in water are known so far.
The design of a potential Li+ fluorescent sensor in water is presented in Figure IV.23.
A fluorescent unit is attached via an amine group to the 12-metallacrown-3 complex.
Water solubility is achieved via protonation of the three amine groups and electron trans-
fer from the transition metal to the fluorophore will partially quench fluorescence. In the
presence of lithium ions, the metal ions are more difficult to oxidize and quenching is
reduced. The difference of the redox potential is expected to be around 300 mV.[124]
However, one intrinsic problems has to be mentioned: any change in the pH of the solu-
tion leads automatically to a change in the protonation degree of the amine groups which
will cause a fluorescence change. Thus, in order to keep the pH constant, meausurements
have to be carried out in buffer solution. For potential applications of Li+ sensing in blood
this is an intrinsic advantage, because blood itself is buffered.
Figure IV.23 Basic principle of a fluorescent photoinduced electron transfer (PET) cation
sensor. In the absence of analyte, PET occurs from the HOMO of the metal centre
to the HOMO of the fluorophore causing quenching of the fluorescence (left). In
the presence of Li+, the redox potential is increased and the energetic level of the
HOMO of the metal centre decreased. PET is not any longer possible, and the
fluorescence turns on.
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Pyrene and anthracene units have been chosen to act as fluorescent units. Coupling to
the 3-hydroxy-2-pyridone structural motif was achieved by reaction of ligand L7 with
1-pyrenecarboxaldehyde or 9-anthraldehyde. The Schiff base was subsequently reduced
with NaBH4 to give ligand L10 and L12, respectively (Scheme IV.10).
Preliminary measurements indicate indeed an increase of the fluorescence in the pres-
ence of lithium ions, but the results have still to be confirmed.
Scheme IV.10 Synthesis of 3-hydroxy-2-pyridones functionalised with a fluorescent unit.
IV.IV Conclusions
113
IV.IV Conclusions
The utilization of assembly processes to build artificial receptors[319–322] or chemosen-
sors[323–325] is conceptually very appealing, given that the building blocks are easily
accessible. Potent receptors for the pharmacologically interesting lithium ion have been
obtained by base-induced assembly of halfsandwich complexes with simple 3-hydroxy-
2-pyridone derivatives. Due to the inherent flexibility of this approach, it was possible to
investigate the host-guest chemistry of a large variety of receptors in relatively short
time. Of all receptors tested, the ruthenium complex [(cymene)Ru(L5−2 H+)]3 displayed
the most interesting characteristics. In water, it shows a Li+ binding constant of
Ka = (5.8 ± 1.0) × 10
4 M−1. This value is among the highest ever reported for Li+ com-
plexation in water[277–279] and it is sufficient for the quantitative complexation of Li+ in
the pharmacologically relevant concentration range of ~ 1 mM. The selectivity of
[(cymene)Ru(L5−2 H+)]3 is extremely high: the complexation of K+ or Cs+ could not be
detected at all and its affinity for Na+ is four orders of magnitude lower than for Li+. In
order to use receptor [(cymene)Ru(L5−2 H+)]3 for sensing, three methods to transduce
the binding event into a signal output were developed. The first is based on the Li+
induced stabilisation of [(cymene)Ru(L5−2 H+)]3 against de-aggregation by acid and
allows to detect low millimolar concentrations of Li+ by a change of pH. The second is
based on the different reactivity of [(cymene)Ru(L5−2 H+)]3 and its lithium adduct
towards FeCl3. Since this reaction is accompanied by strong a change of colour, it is pos-
sible to detect Li+ at concentrations of ~ 1 mM by the ‘naked eye’. For potential applica-
tions it is of importance that the receptor can be synthesised in situ by self-assembly,
using the commercially available complex [(cymene)RuCl2]2 and the pyridone ligand
L5, which is accessible in a one-step procedure. The third method uses an increase of flu-
orescence to indicate the presence of lithium.

Chapter V
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V.I Introduction
Lithium does not occur free in nature, but in form of over 150 different minerals. Two
stable isotopes are known: 6Li and 7Li. Their natural abundance is 92.41 % and 7.59 %,
respectively, but these values underlie fluctuations of up to several percent depending on
the geological location. A large interest in the isotopic separation is given due to the fact
that 6Li is used in form of 6LiD or 6Li2DT in the hydrogen bombe, and that 
6Li is a pre-
cursor for 3H for future fusion reactors.
The ionic radii of the 7Li isotope and the 6Li isotopes are slightly different. The tabu-
lated value of the crystal radius of hexacoordinated Li+ is 0.90 Å[326] and the difference
between the two isotopes was crystallographically determined to be 0.04 pm
(0.0004 Å)[327] with 7Li+ being the smaller isotope.s This value correlates well with the
theoretical value of 0.05 pm calculated by Knyazev.[328] Note, that the separation of the
Li+ ion from the Na+ ion – whose ionic radii differ by 40 pm (0.4 Å)t – is already a diffi-
cult task. 
Generally, isotopic separation is achieved by using a biphasic system in which one iso-
tope is enriched in one of the two phases, either by kinetic or thermodynamic means. The
degree of separation is expressed by the isotopic separation factor α, which is defined by
the equilibrium constant of both isotopes between two phases P1 and P2 (Figure V.1).
The equilibrium constant K for this system is shown in Equation V.1. Usually, the iso-
topic separation factor α is given as shown in Equation V.2. The elementary isotopic frac-
tionation effect δ is defined as α−1 (Equation V.3). A separation factor greater than 1
means that 7Li was enriched in phase P2, wheras a separation factor less than 1 means
thas 7Li has been enriched in phase P1.
Eq. V.1
s. The radius depends on various parameters such as coordination number, counter ion, etc. and values differ from ref-
erence to reference, as well as from the method of determination.
t. Considered was the crystal radius of tetracoordinated metal ions based on r(VIF−) = 1.19Å (0.73 pm and 1.13 pm
for Li+ and Na+, respectively).[326]
Figure V.1 Equilibrium of 6Li and 7Li between two phases
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Eq. V.2
Eq. V.3
All crown ethers and cryptands show some degree of isotopic recognition, although
small in most cases.[329] Since they exhibit typically fast exchange kinetics,[140, 174] only
the intrinsic difference of the free energy between the two complexes has to be consid-
ered. In the case of 12-crown-4, for example, an enthalpic difference of −0.78 kJ/mol and
an entropic difference of −2.4 J/mol K is responsible for a separation factors of 1.057.[330]
Meanwhile, separation has been achieved by using inorganic ion exchanger,[331–333] res-
ins to which crown ethers have been attached[334–337] and liquid-liquid amalgan based
equilibration systems.[338] Interestingly, it seems that inorganic ion exchanger and poly-
ethers prefer to take up the larger 6Li isotope.[330, 333]
α K≡
Li
7[ ]P2
Li6[ ]P2
----------------⎠⎟
⎞
⎝⎜
⎛
Li
7[ ]P1
Li
6[ ]P1
----------------⎠⎟
⎞
⎝⎜
⎛
----------------------
Li
7[ ]
Li6[ ]
----------- ⎠⎟
⎞
P2
⎝⎜
⎛
Li
7[ ]
Li
6[ ]
----------- ⎠⎟
⎞
P1
⎝⎜
⎛
----------------------==
δ α 1–=
V.II Structural Investigations
119
V.II Structural Investigations
12-Metallacrown-3 complexes are potent ionophores for small alkaline cations such as
Li+ or Na+. Selectivity is achieved via a size exclusion effect. The binding site is
shielded by three π-ligands, which effectively block bigger cations such as K+ or Cs+. If
bulky π-ligands are employed, even the access of Na+ to the binding site is prevented.
Noteworthy, not the binding cavity itself is too small to accomodate the Na+ ion, but only
the entrance is too narrow to pass through. This blocking effect was anticipated to distin-
guish even very small differences in size as the ones of the two lithium isotopes. The
access to the binding site should be easier for the smaller 7Li isotope. Compared to
crown ethers and cryptands, the lithium complexation and dissociation by 12-metalla-
crown-3 complexes is slow. Once the lithium is bound, the dissociation kinetics are to
slow to allow equilibration on a reasonable time scale in favour for the thermodynami-
cally more stable lithium adduct. Any initial isotopic separation should be preserved
through the experiment. Thus, any isotopic enrichment should be due to a kinetic isotope
effect.
Four 12-metallacrown-3 complexes have been investigated in order to demonstrate the
ability of 6Li and 7Li isotope separation (Figure V.2). The C6H5Me ligands of the
[(C6H5Me)Ru(L1−2 H+)]3 complex are the smallest ligands employed and the complex
displays thus the largest entrance to the binding site. There is no special hindrance to
access the binding site and no separation effect is expected. The other three ligands
C6H3
iPr3, C6Me6 and Cp* are much bulkier and the smaller 
7Li isotope should be prefer-
entially complexed by the corresponding receptors.
As described in chapter I.VI, the complexes self-assemble from [(π-ligand)MCl2]2 and
3-hydroxy-2-pyridone in MeOH in the presence of Cs2CO3. The structure in the crystal of
Figure V.2 12-Metallacrown-3 complexes investigated concerning their ability of 6Li and 7Li
isotope separation.
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the new complexes [(C6H5Me)Ru(L1−2 H+)]3 and [(C6H3iPr3)Ru(L1−2 H+)]3u and their
LiCl adducts are shown in Figure V.3 and Figure V.4. As expected, trinuclear assemblies
had formed. The oxygen atoms of the bridging ligands are coordinated to one metal centre
and the ring nitrogen atom to the next metal centre, thus connecting the metal fragments.
The ligands are bound in a slightly bent fashion. A comparison of the most relevant struc-
tural data (Table V.1) reveals similar M–O and M–N bond lengths for all complexes. The
M–M’ distances can be considered as a measure of the steric congestion of the π-ligands
in the complex. Clearly, the complex [(C6H5Me)Ru(L1−2 H+)]3 displays the smallest M–
M’ distance. The steric congestion increases from the Cp* ligand to the C6H3
iPr3 ligand
and is most pronounced for the C6Me6 ligand. A space filling representation along the
pseudo C3 axis showing the size of the opening of all four complexes is depicted in
Figure V.5. The M–M’ and O–O’ distances are assumed to represent the size of the
entrance to the binding site. Therefore, an isotopic enrichment should be most pro-
nounced for the [(C6Me6)Ru(L1−2 H+)]3 complex. Upon binding of LiCl, the overall
structure undergoes only minor changes. Most notably, the M–M’ distances increase,
probably due to the additional steric repulsion between the π-ligand and the chloride
anion, coordinated on top of the Li+ ion and in between the π-ligands.
u. Complex [(C6H3
iPr3)Ru(L1−2 H+)]3 has already been discussed in chapter II.II.3.
Table V.1: Selected bond lengths (Å) and angles (°) for 12-metallacrown-3 complexes of 3-
hydroxy-2-pyridone ligands with diverse metal fragments.
12-Metallacrown-3 M–N M–O1 M–O2
O1–M–
O2
M–O–
C1–C2
M–N–
C1–C2
O–O’ M–M’
[(C6H5Me)Ru(L1−2 H+)]3 2.14 2.09 2.08 79.5 4.5 7.4 3.04 5.37
[(C6H5Me)Ru(L1−2 H+)]3 × LiCl 2.14 2.12 2.08 79.5 8.7 5.8 2.96 5.40
[(C6H3
iPr3)Ru(L1−2 H+)]3 2.14 2.09 2.06 79.5 13.5 8.7 3.15 5.39
[(C6H3
iPr3)Ru(L1−2 H+)]3 × LiCl 2.14 212 2.03 79.5 11.7 11.8 3.07 5.48
[(C6Me6)Ru(L1−2 H+)]3[124] 2.14 2.12 2.05 78.6 15.1 9.8 3.21 5.46
[Cp*Rh(L1−2 H+)]3[124] 2.13 2.09 2.06 80.1 11.2 5.8 3.10 5.35
[Cp*Rh(L1−2 H+)]3 × LiCl[124] 2.12 2.14 2.06 79.2 10.8 9.1 3.07 5.47
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Figure V.3 Graphic representation of the structure of the complex [(C6H5Me)Ru(L1−2 H+)]3
(left) and its LiCl adduct [(C6H5Me)Ru(L1−2 H+)]3 × LiCl (right) in the crystal.
Solvent molecules and hydrogen atoms were omitted for clarity.
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Figure V.4 Graphic representation of the structure of the complex [(C6H3
iPr3)Ru(L1−2 H+)]3
(top) and its LiCl adduct [(C6H3
iPr3)Ru(L1−2 H+)]3 × LiCl (bottom) in the crystal.
Solvent molecules and hydrogen atoms were omitted for clarity.
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Figure V.5 Comparison of the entrance to the binding cavity of the complexes
[(C6H5Me)Ru(L1−2 H+)]3 (top left), [(C6H3iPr3)Ru(L1−2 H+)]3, (top right)
[(C6Me6)Ru(L1−2 H+)]3 (bottom left) and [(Cp*)Rh(L1−2 H+)]3 (bottom right).
Solvent molecules and hydrogen atoms were omitted for clarity.
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V.III Extraction Experiments
The isotopic separation behaviour has been investigated by complexation of LiCl in
MeOH. The different 12-metallacrown-3 complexes were solubilized in MeOH contain-
ing 100 equiv. of LiCl. The solution was stirred for one hour, the solvent removed and
the macrocycle separated from the salt by extraction with CHCl3. 
1H NMR spectroscopy
of the isolated product revealed the presence of a single product: the receptor complexed
with LiCl. The separation factor α was defined as the quotient of the 7Li/6Li ratio in
phase P2 and phase P1 (Equation V.2) Phase P2 is represented by the 12-metallacrown-3
complex, whereas MeOH is representing phase P1. Thus, the separation factor α is
equivalent to the 7Li/6Li ratio in the receptor divided by the ratio of the lithium ions
remaining in solution (Equation V.4). A factor greater than 1 means that 7Li has been
enriched in the macrocycle, whereas a value less than 1 indicates an enrichment of 6Li.
As 100 equiv. of LiCl with respect to the receptor were used, the 7Li/6Li ratio in solution
can be set as constant and equal to the isotopic ratio of the LiCl salt employed
(Equation V.5). Therefore, the isotopic ratio of the Li+ complexed in the macrocycle has
been compared to the isotopic ratio of the used LiCl salt (Equation V.6). The enrichment
of 7Li in the macrocycle is expressed as δ(7Li) in % (Equation V.7) A positive value
indicates the enrichment of 7Li and a negative value the enrichment of 6Li.
Eq. V.4
Eq. V.5
Eq. V.6
Eq. V.7
Measurements of the initial 7Li/6Li isotopic ratio of the employed LiCl salt by laser
atomic absorption spectroscopy revealed a value of 17.08 ± 0.46. This corresponds to
94.47 % 7Li and 5.57 % 6Li. The 7Li percentage is significantly higher than the natural
abundance given in the literature. However, such a strong deviation in favour for 7Li in
chemical reagents has been reported before.[339] The average 7Li enhancement was found
to be 5.4 % for the complex [(C6Me6)Ru(L1−2 H+)]3. The value of the enhancement dif-
fers depending on how the experimental data were treated. A value of (4.4 ± 1.0) % was
obtained when the peak height of the signals or the surface between 30 % of the peak
height and the maximum peak height were evaluated. A slightly higher value of
(5.8 ± 1.0) % was obtained when the surface between 10 % of the peak height and the
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maximum peak height was considered. Integration of the total surface beneath the signals
led to a value of 7Li enrichment of (7.0 ± 2.8) %. In the latter case the standard deviation
was increased due to a more pronounced uncertainty when placing the base line. As
expected, no effect was observed for the complex [(C6H5Me)Ru(L1−2 H+)]3, but neither
complex [(C6H3
iPr3)Ru(L1−2 H+)]3 nor complex [(Cp*)Rh(L1−2 H+)]3 showed any
enhancement either (Table V.2). This is surprising, because the M–M’ distances indicate
in both cases a pronounced sterical congestion (Table V.1). Given that the separation
effect is expected to be of kinetic nature, the complexation kinetics have been investi-
gated by 1H NMR spectroscopy. The slower, both complexation as well as dissociation
rate, the more distinct should be a kinetic isotopic effect.
The dissociation rate itself could not be determined directly because the binding con-
stants in MeOH were too high. The focus has thus been directed on the complexation
rates. The time t1/2, after which half of the receptor had bound Li
+ was determined. By far
the slowest Li+ complexation was observed for complex [(C6Me6)Ru(L1−2 H+)]3. After
35 hours, not even half of the macrocycle in solution had bound Li+. Although complex
[(C6H3
iPr3)Ru(L1−2 H+)]3 showed likewise a relatively slow complexation (t1/2 =9.5 h)
of Li+, no separation effect were observed. The macrocycle  [(C6H5Me)Ru(L1−2 H+)]3
was fully complexed in less than five minutes. The fast complexation of Li+ is in aggree-
ment with a sterically not hindered binding site. Interestingly, receptor [(Cp*)Rh(L1−
2 H+)]3 also displayed a relatively fast complexation kinetic with a half-time of complex-
ation of 45 minutes. Apparently, the complexation rate depends not only on the size of the
π-ligands, but also on the nature of the metal centre.
The reason why no isotopic separation is observed in the case of complex
[(C6H3
iPr3)Ru(L1−2 H+)]3 and complex [(Cp*)Rh(L1−2 H+)]3 can only be guessed. In the
latter case the complexation rate might be too fast. Another explanation might be that the
steric congestion is simply not pronounced enough. In case of all receptors, however, it is
estimated that the dissociation rates are too slow to allow the establishment of a thermo-
dynamic equilibrium.
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The kinetic investigation of the half-time of complexation revealed another interesting
point: the LiCl complexation was carried out by stirring the corresponding macrocycle in
a LiCl solution in MeOH for one hour. After this time, only a very small part of receptor
is actually complexed. However, only the complexed receptor has been detected by 1H
NMR spectroscopy after extraction. This means that the major part of the complexation
happened during the 15 minute period, in which the solvent was removed under reduced
pressure. The solubility of LiCl in MeOH is rather high (10 M[340]), so that its concentra-
tion can increase up to 20fold during the removal of the solvant. This probably forces the
Li+ ion into the cavity of the receptor. Better separation factors can thus be expected with
increased complexation time. Removal of the solvent by lyophilisation may have also an
effect, in any case it should allow a time resolved study of the isotope separation.
V.IV Conclusions
Four 12-metallacrown-3 complexes have been investigated regarding their ability to sep-
arate the 7Li/6Li isotopes. The average enrichment of 7Li has been found  to be 5.4 % for
complex [(C6Me6)Ru(L1−2 H+)]3. No isotopic separation effect has been detected for the
complexes [(C6Me6)Ru(L1−2 H+)]3, [(C6H3iPr3)Ru(L1−2 H+)]3 and [(Cp*)Rh(L1−2 H+)]3.
Table V.2: 7Li isotope enrichement and half-time of Li+ complexation of 12-metallacrown-3
complexes.a
δ (7Li)
Complex t1/2 peak height 10 % p. h.
b 30 % p. h.b total surface
[(C6H5Me)Ru(L1−2 H+)]3 << 5 min (−0.1 ± 2.2) % (−1.9 ± 2.9) % n.d. (−1.2 ± 3.0) %
[(C6H3
iPr3)Ru(L1−2 H+)]3 9.5 h (1.3 ± 0.7) % (−0.1 ± 1.0) % n.d. (−2.9 ± 3.3) %
[(C6Me6)Ru(L1−2 H+)]3c >> 35 h (4.4 ± 1.0) % (5.8 ± 1.0) % (4.4 ± 0.9) % (7.0 ± 2.8) %
[(Cp*)Rh(L1−2 H+)]3 45 min (0.2 ± 1.3) % (0.1 ± 4.7) % n.d. (−0.3 ± 2.9) %
a. n.d.: not determined
b. Enrichment obtained when evaluating the signal surface at the specified percentage of the peak height (p. h.).
c. The standard deviation of the mean is given as error.
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VI.I Bridged Dihydroxypyridine Ligands for 
the Synthesis of Expanded Helicates
Ligands, in which two catechol groups are connected by a spacer, have been used exten-
sively as building blocks in supramolecular chemistry. Various architectures have been
realized including metallamacrocycles,[341–345] heterometallic clusters,[346–349] tetrahe-
dral coordination cages,[24, 26, 30] and most notably triple-stranded helicates.[24, 59, 61,
350] In the following, it will be demonstrated, that the exchange of the catechol group
with a dihydroxypyridine group allows the access to a new structural motif, which can be
described as an expanded triple-stranded helicate. In these complexes, the two chiral
ML3 units are replaced by likewise chiral M3L3 units (Scheme VI.1). Structural evidence
is presented that expanded helicates with a length of 2.8 nm can be obtained.
As presented in chapter IV.II.1, the Mannich reaction of 3-hydroxy-2-pyridonev with
formaldehyde and secondary amines is known to give 4-aminomethyl-substituted prod-
ucts.[304–307] In a similar fashion, diamines have been used to obtain a new type of multi-
functional ligands: bridged dihydroxypyridines. Mannich reaction of 3-hydroxy-2-
pyridone, formaldehyde and the commercially available diamines piperazine, N,N'-
dimethylethylenediamine, and 1,3-di(4-piperidyl)propane gave the corresponding lig-
ands L13, L14 and L15 (Scheme VI.2).
Scheme VI.1 The metal-based self-assembly of bridged catechol or dihydroxypyridine ligands
can lead to the formation of a) helicates or b) expanded helicates.
v. The use of 3-hydroxy-2-pyridone and 2,3-dihydroxypyridine is equivalent, as both compounds are in a tautomeric
equilibrium with each other
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Subsequently, the reaction of these three ligands with the dimeric half sandwich com-
plexes [(π-ligand)MCl2]2 have been examined. When an aqueous solution of complex
[(C6H6)RuCl2]2 (1) or [(C6H5Me)RuCl2]2 (2) and equivalent amounts of ligand L13 or
L14 was carefully layered with NEt3, the complexes [{(C6H6)Ru}2(L13−4 H+)]3 (12),
[{(C6H5Me)Ru}2(L13−4 H+)]3 (13) and [{(C6H5Me)Ru}2(L14−4 H+)]3 (14) were obtained
in the form of orange crystals in 58 %, 60 % and 41 % yield, respectively. A similar reac-
tion with ligand L15 did not provide a crystalline material.w However, using the dimer
[(C5HMe4)RhCl2]2, complex [{(C5HMe4)Rh}2(L15−4 H+)]3 (15) was isolated in 37 %
yield. The complexes were characterized by NMR spectroscopy and single crystal X-ray
analysis.
Scheme VI.2 Synthesis of the ligands L13, L14 and L15 by Mannich reaction of 3-hydroxy-2-
pyridone, formaldehyde and the commercially available diamines piperidine,
N,N'-dimethylethylenediamine, or 1,3-di(4-piperidyl)propane.
w. Since NMR spectroscopy is not suited to distinguish between trinuclear and hexanuclear complexes, only com-
plexes which have been obtained in crystalline form have been focused.
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The 1H NMR spectra of the Ru complexes 13 and 14 in CDCl3 showed a single set of
signals for the toluene and the hydroxypyridine ligand, which was indicative of a highly
symmetrical structure (Figure VI.2, spectra a and b). Five distinct signals were observed
for the aromatic protons of the π-ligand and two doublets were found for the methylene
protons adjacent to the pyridine ring. This was a clear sign for the presence of stereogenic
centres. The 1H NMR spectrum of the rhodium complex 15 showed likewise a single set
of signals (Figure VI.2, spectrum c). Four singlets were observed for the CH3 groups of
the tetramethylcyclopentadienyl ligand and well resolved diastereotopic methylene pro-
tons were found for the NCH2 group next to the heterocycle. The only signal indicating
stereogenic centres in the case of complex 12 are the two doublets of the NCH2 groups.
Due to some flexibility, the CH2 signals of the diamines are very broad.
Figure VI.1 Synthesis of hexanuclear extended triple-stranded helicates.
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The NMR data for the complexes in solution were in agreement with the structures
observed in the solid state (Figure VI.3 and Figure VI.4). All four complexes are com-
prised of six (π-ligand)M fragments, which are connected by three deprotonated ligands.
Two pairs of 12-membered metallamacrocycles are observed for each complex, with the
metals coordinated to the two O atoms and the N atom of the dihydroxypyridine group.
The diamine linker connects the two macrocycles to form a cylindrical structure. The
lengths of these cylinders (maximum H-to-H distance) are 2.0 nm for complex 12, 2.1 nm
for complex 13, 1.9 nm for complex 14 and 2.8 nm for complex 15.
Figure VI.2 1H NMR spectra of the expanded helicates 13 (a), 14 (b) and 15 (c) in CDCl3. The
presence of five distinct aromatic signals or four singlets for the CH3 groups of the
C5HMe4 ligands, as well as two doublets for the NCH2 protons indicate the
presence of stereogenic centres. Water is denoted by an asterisk and NEt3 by a
rhomb.
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Figure VI.3 Graphic representation of the molecular structures of the complexes 12 and 13 in
the crystal. The lengths of the cylinders are 2.0 and 2.1 nm, respectively.
Hydrogen atoms and the co-crystallised solvent molecules are not shown for
clarity.
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Complex 15 is not only remarkable because of its length of nearly 3 nm. The macro-
cycles formed between two opposite metals have a ring size of 44 atoms containing a total
Figure VI.4 Graphic representation of the molecular structures of the complexes 14 and 15 in
the crystal. The lengths of the cylinders are 1.9 and 2.8 nm, respectively.
Hydrogen atoms and the co-crystallised solvent molecules are not shown for
clarity.
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of 18 CH2 groups, only eight of which are part of the semi-rigid piperidine units. Com-
plex 15 is thus a rare example of a discrete, multinuclear complex, which was obtained by
metal-based self-assembly with a highly flexible ligand.[351–358]
The Ru complexes 12, 13 and 14 display pseudo D3 symmetry, with all six metal cen-
tres having the same configuration. The Rh complex 15, on the other hand, has a
crystallographic C3 axis and an idealized overall C3h symmetry. The metal centres at one
end of the molecule have thus the opposite configuration to the metal centres at the other
end. Interestingly, this parallels what has been observed for catecholate-based triple-
stranded helicates: ligands with an even number of methylene groups in the spacer were
found to form chiral helicates, whereas ligands with an odd number of methylene groups
in the spacer gave rise to achiral meso-helicates, in which the metal centres have the
opposite configuration.[59, 61, 350, 359–361]
Preliminary attempts to study the self-assembly process in situ by 1H NMR spectros-
copy have been carried out. Mixing of equimolar amounts of halfsandwich complexes
[(π-ligand)MCl2]2 and ligands L13, L14 and L15 in D2O resulted in clear orange solu-
tions. In each case, 1H NMR data indicated the formation of a monomeric complex, in
which two (π-ligand)M fragments were bridged via the bis(dihydroxypyridone) ligand
leading to dinuclear complexes of type C. Addition of incremental amounts of CsOH
induced the self-assembly process into hexanuclear complexes of type D (Scheme VI.3).
Coordination of the ligand to the metal fragments results most probably in the translo-
cation of a proton from the hydroxy to the amine group. Due to the low solubility of the
ligands, a study of the chemical shifts of the NCH2 protons upon coordination was not
possible. Theoretically, 2.0 equiv. of basex are necessary to induce trimerisation into pro-
tonated, hexanuclear complexes of type D, in which two trimers are bridged together. Sol-
ubility in water is facilitated by the protonation of the six amino groups. These complexes
represent the protonated forms of the corresponding expanded triple-stranded helicates
and further addition of base leads to the generation of the latter one.
x. Equivalents with respect to the amount of ligand.
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However, the illustration of the base induced self-assembly is simplified. In the case of
the short ligands L13 and L14 the six positive charges are in very close proximity to each
other. Thus, it is not clear to which degree the amine groups are protonated. This is sup-
ported by the observation that precipitation often occurred before the self-assembly pro-
cess was completed as for example the base induced self-assembly of [(C6H5Me)RuCl2]2
and the TFA salt of L14. For the study of the self-assembly process in water, the TFA salts
of ligands purified by HPLC have been used. Therefore, two additional equivalents of
CsOH were necessary to neutralise the acid and to generate the free ligand. Part of the 1H
NMR spectra of solutions containing [(C5HMe4)RhCl2]2 & the TFA salt of L15 or
[(C6H5Me)RuCl2]2 & the TFA salt of L13 are shown in Figure VI.5 and Figure VI.6,
respectively.
Scheme VI.3 Base-induced formation of hexanuclear expanded triple-stranded helicates.
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After addition of 2.0 equiv. of CsOH (0.0–2.0 equiv.) to a solution containing
[(C5HMe4)RhCl2]2 and the TFA salt of L15, a single set of signals was observed. The
appearance of the NCH2 protons as singlet, as well as the observation of only two singlets
for the CH3 groups of the (C5HMe4)Rh fragments are in agreement with the formation of
a dinuclear complex of type C. Upon addition of more CsOH (2.0–4.0 equiv.), the gener-
ation of a second species was observed. The second species completely dominated the
Figure VI.5 Part of the 1H NMR spectrum (D2O) of solutions containing [(C5HMe4)RhCl2]2
(5.4 mM) and the TFA salt of ligand L15 (5.4 mM) after addition of different
amounts of CsOH: a) 4.0, b) 3.5, c) 3.0, d) 2.5 and e) 2.0 equiv.. Spectrum ‘a’
corresponds to the protonated form of the hexanuclear complex 15 and spectrum
‘e’ represents the dinuclear complex [{(C5HMe4)Rh}2(L15)(H2O)2]
2+; note that two
equiv. of CsOH are necessary to neutralise the trifluoric acid. The solvent peak is
denoted by an asterisk.
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solution after addition of 4.0 equiv. of base. The appearance of two doublets for the NCH2
protons and four singlets for the CH3 protons of the C5HMe4 ligands, as well as the typi-
cal high field shift of one of the pyridone signals, supported strongly the formation of
hexanuclear complexes of type D.
A similar situation was found for a mixture of [(C6H5Me)RuCl2]2 and the TFA salt of
L13. Upon addition of 2.5 equiv. of CsOH, the 1H NMR data indicated the formation of a
dinuclear complex, and further addition of CsOH resulted in the appearance of a second
species. This second complex totally dominated the solution after addition of 4.7 equiv. of
Figure VI.6 Part of the 1H NMR spectrum (D2O) of solutions containing [(C6H5Me)RuCl2]2
(7.5 mM) and the TFA salt of ligand L13 (7.5 mM) after addition of different
amounts of CsOH: a) 4.7, b) 4.0, c) 3.5, d) 3.0 and e) 2.5 equiv.. Spectrum ‘a’
corresponds to the protonated form of the hexanuclear complex 13 and spectrum
‘e’ represents the dinuclear complex [{(C6H5Me)Ru}2(L13)(H2O)2]
2+; note that at
least two equiv. of CsOH are necessary to neutralise the trifluoric acid. The solvent
peak is denoted by an asterisk.
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base. In contrast to the above presented self-assembly process, more than stoichiometrical
amounts of base were necessary to completely generate the dinuclear as well as the hexa-
nuclear complex. The reason for this behaviour was probably a contamination of ligand
L13 with trifluoric acid. A similar behaviour was not observed for the ligands L14 and
L15.
Overall, the spectra of expanded helicates and their corresponding protonated forms
are very similar (spectrum ‘a’ of Figure VI.5 vs. spectrum ‘c’ of Figure VI.2 and spec-
trum ‘a’ of Figure VI.6 vs. spectrum ‘a’ of Figure VI.2). However, in the case of the
investigated complexes, 1H NMR spectroscopy is not suited to distinguish whether the
meso or the chiral form was obtained. In the case of complexes with an even number of
methylene groups in the spacer, such as 15, the meso and the chiral form can in principle
be distinguished by 1H NMR spectroscopy because the multiplicity of the central CH2
groups of the linker is different. Unfortunately, these signals were not well resolved. Also,
it is presently not clear whether the respective isomer had formed under thermodynamic
or kinetic control. Prolonged heating of the complexes, either in CDCl3 or D2O, led
unfortunately to partial decomposition of the complexes.
As shown in chapter IV.II, trinuclear organometallic macrocycles based on 3-hydroxy-
2-pyridones are configurationally stable on the NMR time scale, even in polar solvents
such as water. Epimerisation processes at the metal centres of the hexanuclear complexes
12–15 were likewise expected to be slow. The NMR data of the self-assembly processes
therefore suggested that the same diastereomer is obtained in solution as was found in the
solid state. This led to the conclusion that the ligands – despite their flexibility – are able
to control the stereochemistry of all six metal centres.
VI Expanded Triple-Stranded Helicates
140
VI.II Conclusions
In summary, the syntheses and the structures of four hexanuclear complexes have been
described. They were obtained by base-induced assembly of organometallic halfsand-
wich complexes with bis(dihydroxypyridine) ligands. The complexes display a unique
structural motif: two chiral [(π-ligand)M]3L3 fragments were connected by three flexible
linkers. They can thus be described as expanded triple-stranded helicates. The synthetic
concept appears to be quite flexible because the bridging ligand as well as the metal frag-
ment can be varied. Complexes of this kind are expected to display an interesting host-
guest chemistry because they contain 12-metallacrown-3 sites, which should be suited
for the complexation of small metal ions (see chapter IV.II.5),[127, 165, 310, 362] as well as
a flexible cavity decorated by amine groups.
Chapter VII
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VII.I General Conclusions
12-Metallacrown-3 complexes are macrocycles composed of three metal fragment sub-
units. They self-assemble from halfsandwich complexes [(π-ligand)MCl2]2 (M = Ru,
Rh, Ir) and 3-hydroxy-2-pyridone ligands in the presence of base. When macrocycles
with different metal fragments were mixed, reversible metal fragment exchange
occurred. This allowed the generation of small dynamic combinatorial libraries (DCLs).
DCLs were classified into different types and their adaptive behaviour was investigated
theoretically. Two main characteristics were predicted: i) the selection of an assembly
with a high content of one subunit will lead to the concomitant amplification of one or
more assemblies comprised of the other subunit(s) and ii) there is an intrinsic bias for the
selection of hetero-assemblies, especially for the member whose composition reflects the
overall composition of the library. For example, a library composed of equal amounts of
three different building blocks A, B and C will show a strong bias for the selection of the
assembly ABC. These predictions were confirmed experimentally by introducing ther-
modynamic differences among the library members of DCLs obtained from 12-metalla-
crown-3 complexes.[363] This means that it is not necessarily the most stable member of
the library which will be amplified the most. The presented theoretical and experimental
results are in contradiction with a former paradigm of dynamic combinatorial chemistry,
i.e. the amplification of the thermodynamically most stable member. In the meantime,
these results were confirmed and have been generally accepted.[186, 239, 240, 242, 244] A
possibility to obtain a better correlation between thermodynamic stability and amplifica-
tion of the library members is to conduct the experiment in a virtual fashion.[239, 363]
The kinetics of the metal fragment exchange of 12-metallacrown-3 complexes were
investigated. The equilibration proceeds in two steps with successive decrease of steric
constraint. It was found that the composition of the dynamic mixture can be further biased
towards one hetero-assembly if the starting materials were mixed in a 2:1 ratio. Thus,
mixed-metal complexes comprised of two small (benzene)Ru fragments and one large
(C6Me6)Ru, (C6H3
iPr3)Ru or Cp*Rh fragment could be synthesised in over 60 %
yield.[364]
12-Metallacrown-3 complexes are potent and selective ionophores for Li+ ions. The
use of modified 3-hydroxy-2-pyridone bridging ligands rendered these complexes solu-
ble in water. Monomeric O,O’-chelate complexes were formed upon mixing of [(π-
ligand)MCl2]2 and 3-hydroxy-2-pyridone ligands substituted with amino groups. Addi-
tion of base induced the self-assembly process into trimeric assemblies. The investigation
of the host-guest chemistry of a large variety of different water soluble 12-metalla-
crown-3 complexes revealed two receptors with outstanding high affinity and selectivity
for Li+ ions in water: the complexes [(cymene)Ru(L5−2 H+)]3 and [(C5HMe4)Rh(L5−
2 H+)]3. Their binding constants are as high as Ka = 6 × 10
4 M−1 and their Li+ over Na+
selectivity is 10000:1. These values are among the highest ever reported for Li+ com-
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plexation in water.[277–279] Thus, the quantitative complexation of Li+ in the pharmaco-
logically relevant concentration range of ~ 1 mM is possible. The complexation of Li+
has been visualised by colorimetric, fluorescent and potentiometric means.[362]
The size exclusion effect of 12-metallacrown-3 complexes with sterically very
demanding π-ligands was used to separate the two stable lithium isotopes 6Li and 7Li. In
extraction experiments with complex [(C6Me6)Ru(L1−2 H+)]3, an enrichment of 7Li of
5.4 % was observed. The separation effect is of kinetic nature, as the dissociation rate is
assumed to be too slow to allow the establishment of a thermodynamic equilibrium.
Two 3-hydroxy-2-pyridone units were connected by Mannich reaction of the latter
with diamines and formaldehyde. Base-induced self-assembly of these bis(dihydroxypy-
ridine) ligands with halfsandwich complexes in water gave hexanuclear complexes. Two
chiral trimeric macrocycles [(π-ligand)M]3L3 fragments were connected by three flexi-
ble linkers. The complexes can be regarded as expanded triple stranded helicates and dis-
play a length up to 2.8 nm. The metal centres at one end of the molecule can have either
the same or the opposite configuration to the metal centres at the other end. In the first
case, the complex is chiral and enantiomers are formed, whereas in the second case an
achiral meso compound is obtained. If a ligand with an even number of chain links was
used, chiral helicates were obtained. The use of a ligand with an odd number of chain
links resulted in the formation of achiral meso-helicates.[365]
In summary, the supramolecular chemistry of 12-metallacrown-3 complexes in both,
organic and aqueous media has been investigated. Special emphasis has been paid on the
reversible metal fragment exchange, the pH dependant self-assembly process and the
host-guest chemistry as well as the synthesis and characterisation of new complexes.
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VIII.I General & Instrumentation
VIII.I.1 General
All reactions were carried out under an atmosphere of dry dinitrogen using standard
Schlenk techniques unless specified otherwise. It should be noted, however, that most of
the organometallic complexes are not very air sensitive; aqueous solutions could be han-
dled in air for a few hours without significant decomposition.
Solvents (analytical grade purity) were degassed and stored under a dinitrogen atmos-
phere. They were used without further purification. Benzene, hexane, chloroform, dichlo-
romethane and diethyl ether were dried and degassed by chromatography if not specified
otherwise.
The weight of the compounds given in the detailed synthesis procedures is impurity
corrected.
VIII.I.2 Instrumentation
NMR Spectroscopy The 1H, 13C and 7Li NMR spectra were recorded on a Bruker
Advance DPX 400 MHz spectrometer. The residual solvent signals were used as internal
reference. Routine 1H NMR spectra in D2O were referenced to the residual HDO signal,
but 13C NMR spectra in D2O, as well as 
1H and 13C NMR spectra in 0.1 M DCl in D2O
were calibrated using dioxane (3.75 ppm). LiCl in D2O was used as external reference for
7Li NMR spectra. All spectra were recorded at room temperature (22  °C).  
Mass Spectroscopy ESI mass spectra were measured with a MicroMass Q-Tof
Ultima spectrometer.
UV/VIS UV/VIS spectra were measured on a Perkin-Elmer Lambda 40 or Perkin-
Elmer Lambda 35 spectrometer.
HPLC Purifications by reversed phase HPLC were carried out using a Waters system
consisting of a Waters 600 controler unit, a Water Delta 600 pump and a Waters 2487 dual
wavelength absorbance detector. A Sunfire preparative C18 coloumn (5 μm, 10×250 mm)
was used as stationary phase, and millipore water and acetonitrile (HPLC grade purity)
with 0.1 % (v/v) trifluoroacetic acid as mobile phase.
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Titrations      Potentiometric titrations and pH measurements were performed using a
Metrohm Titrino 716 DMS instrument. A combined LL pH glass electrode (Metrohm
Ecotrode) was used; and in cases of very small volumes, a combined LL micro pH glass
electrode (Metrohm Biotrode).
Elemental Analysis Elemental Analysis was performed on a EA 1110 CHN or a
EA 1108 CHNS-O Carlo Erba instrument.
ICP Measurements Inductively coupled plasma (ICP) measurements were per-
fomed on a Perkin-Elmer ICP-OES 2000 DV instrument.
Crystallographic Investigations Diffraction data were collected using MoKa
radiation on different equipments and at different temperatures: a 4-circle kappa goniom-
eter equipped with an Oxford Diffraction KM4 Sapphire CCD, a mar345 IPDS or a
Bruker APEX II CCD. Cell refinement and data reduction was performed with CrysAlis
RED 1.7.1. All structures were refined using the full-matrix least-squares on F2 with all
non-H atoms anisotropically defined. The hydrogen atoms were placed in calculated posi-
tions using the ‘riding model’. Structure refinement and geometrical calculations were
carried out with SHELXL-97.[366, 367] All graphic representations were generated with
Diamond 3.1a from the corresponding cif files.
VIII.I.3 Purchase of Compounds
Cs2CO3 (99.9 %), 1,2,3,4-tetramethyl-1,3-cyclopentadiene (technical, 85 %), 1,3-di(4-
piperidyl)propane (97 %) and NaBH4 (98 %) were purchased at Sigma-Aldrich. 3-
hydroxy-2-pyridone (practical, 97 %), paraformaldehyde (95 %), piperidine (98 %),
N,N'-dimethylethylenediamine (>98 %), sodium (metallic), 1,3,5-triisopropylbenzene
(97 %), 1,2,3,4,5-pentamethylcyclopentadiene (95 %), DCl (38 % in D2O), LiCl (anhy-
drous, >98 %), K2HPO4 (>99.5 %, TraceSelect) and 9-anthracenecarboxaldehyde
(>97 %,) were purchased at Fluka. Formaldehyde (37 % in water, stabilized with 10–
15 % MeOH), α-terpinene (technical, 85 %), 1,4-cyclohexadiene 97 %), dicyclopentadi-
ene (95 %), piperazine (anhydrous, 99 %), morpholine (99+ %), dimethylamine (40 % in
H2O), N-methylpiperazine (99+ %), CsOH · H2O (99.5 %) and Pd/C (unreduced, 10 %)
were purchased at Acros. Pd on alumina (5 %), dibenzylamine (98 %), 1-methyl-1,3-
cyclohexadiene (technical, 90 %), and 1-pyrenecarboxaldehyde (99 %) were purchased
at Alfa Aesar. The hydrated salts RuCl3 ·x H2O, RhCl3 ·3 H2O and IrCl3 ·3 H2O were
purchased from Precious Metals Online. Trifluoroacetic acid (99.9 %) for HPLC was
purchased from SDS.
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VIII.II Synthesis
VIII.II.1 π-Ligands
The complexes [(C6H6)RuCl2]2 (1),
[368, 369] [(C6H5Me)RuCl2]2 (2),
[369]
[(cymene)RuCl2]2 (3),
[369, 370] [(C6H5CO2Et)RuCl2]2 (4),
[371] [(C6Me6)RuCl2]2
(6),[370] [(C6H3
iPr3)RuCl2]2 (5),
[372] [(C5H5)RhCl2]2 (7),
[373] [(C5Me4H)RhCl2]2
(8),[374] [Cp*RhCl2]2 (9)
[375] and [Cp*IrCl2]2 (11)
[375] were synthesised according to
literature procedures. In general, the synthesis of the dimeric halfsandwich complexes
was well described. However, modifications and a typical procedure will be given.
All complexes were soluble in water and in PBS. Whereas in water generally two sets
of signals were observed, one species formed in most cases in PBS, probably a phosphato
complex. The solubility in PBS was enhanced compared to water. In general, RhIII com-
plexes showed the highest solubility, whereas the IrIII complexes showed a very low sol-
ubility. The solubility of the ruthenium(II) complexes depend on the type of the π-ligand:
complexes bearing very unpolar π-ligands such as hexamethylbenzene and triisopropyl-
benzene were much less soluble than complexes bearing more polar π-ligands.
VIII.II.1.1 [(C6H6)RuCl2]2
[368, 369]
Yields close to the literature (>90 %) were obtained by using
only 4.0 equiv. of 1,4-cyclohexadiene instead of 14 equiv..
Representative synthetic procedure: RuCl3 ·x H2O (39 %
Ru, 3.1 g, 12.0 mmol) and 1.4-cyclohexadiene (4.6 mL,
47.3 mmol, 3.9 equiv.) were heated in EtOH (150 mL) to
reflux for 4 h. An orange-brown precipitate was filtered off, washed with cold EtOH
(2×5 mL) and dried in vacuo. The product was obtained in 92 % yield (2.76 g,
5.52 mmol). MeOH can be used alternatively to EtOH. The 1H NMR spectrum showed
always a small impurity of about 5 % at 6.52 ppm. 
1H NMR (400 MHz, DMSO): δ (ppm) = 5.97 (s, 12 H, C6H6).
VIII.II.1.2 [(C6H5Me)RuCl2]2
[369]
Although the complex was mentioned in the literature, nei-
ther a detailed synthesis procedure nor a yield was given.
Representative synthetic procedureRepresentative synthetic
procedure: RuCl3 ·x H2O (39 % Ru, 3.0 g, 11.6 mmol) and
1-methyl-1,4-cyclohexadiene (6.0 mL, 53.1 mmol,
4.6 equiv.) were heated in EtOH (150 mL) to reflux for 16 h.
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The reaction was left to cool down to room temperature and then placed in the freezer
over night to ensure complete crystallisation. Dark red microcrystals were filtered off,
washed with cold EtOH (2×5 mL) and dried in vacuo. The product was obtained in 93 %
yield (2.84 g, 5.37 mmol). It happened that the product was contaminated with small
traces of metallic ruthenium. In this case, the crystals were solubilized in CHCl3 and the
ruthenium was filtered off (air sensitive!). The solution was concentrated and the product
crystallised upon addition of hexane.
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.22 (s, 6 H, Me), 5.35 (d, 3J = 6 Hz, 4 H,
C6H5), 5.57 (t, 
3J = 6 Hz, 2 H, C6H5), 5.66 (t, 
3J = 6 Hz, 4 H, C6H5).
VIII.II.1.3 [(Cymene)RuCl2]2
[369, 370]
α-Terpinene was used instead of α-phellandrene. Again,
the use of 6.0 equiv. of α-terpinene were completely suffi-
cient to ensure yields between 80 and 90 %. The reaction
could be scaled up to 5 g of starting material, using 200
mL of solvent (either EtOH or MeOH). Best yields were
obtained by placing the reaction mixture in the freezer
over night to crystallise. The product crystallised in large dark red crystals; a microcrys-
talline, orange precipitate was obtained after addition of Et2O to the reaction mixturer.
Representative synthetic procedure: RuCl3 ·x H2O (39 % Ru, 5.0 g, 19.3 mmol) and α-
terpinene (21 mL, 116 mmol, 6.0 equiv.) were heated in EtOH (150 mL) to reflux for 4 h.
The reaction was left to cool down to room temperature and placed in the freezer over
night for complete crystallisation. Dark red crystals were filtered off, washed with cold
EtOH (2×5 mL) and dried in vacuo. The complex was obtained in 92 % yield (5.43 g,
8.86 mmol). MeOH can be used instead of EtOH.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.28 (d, 3J = 7 Hz, 12 H, CH3CH), 2.16 (s, 6 H,
CH3CH(CH3)2), 2.92 (sept, 
3J = 7 Hz, 2 H, CH(CH3)2), 5.34 (d, 
3J = 6 Hz, 4 H,
MeC6H4
iPr), 5.47 (d, 3J = 6 Hz, 4 H, MeC6H4
iPr).
VIII.II.1.4 [(C6H5CO2Et)RuCl2]2
[371]
Representative synthetic procedure: RuCl3 ·x H2O
(39% Ru, 3.5 g, 13.5 mmol) and ethyl-1,4-
cyclohexadiene-3-carboxylate (8.2 g, 54.0 mmol,
4.0 equiv., crude product from Birch reduction of
benzyl acetate) were heated in EtOH (100 mL) to
reflux for 5 h. The reaction was left to cool down to room temperature and placed in the
freezer over night for complete crystallisation. The orange-brown precipitate was filtered
off, washed with cold EtOH (2×5 mL) and dried in vacuo. The crude product was
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obtained in 91% yield (3.96 g, 6.15 mmol). Purification was achieved by Soxhlet extrac-
tion with ethanol; a brown residue remained on the fritte.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.42 (t, 3J = 7 Hz, 6 H, CH3CH2), 4.47 (q,
3J = 7 Hz, 4 H, CH3CH2), 5.78 (t, 
3J = 6 Hz, 4 H, C6H5), 5.98 (t, 
3J = 6 Hz, 2 H, C6H5),
6.47 (d, 3J = 6 Hz, 4 H, C6H5).
VIII.II.1.5 [(C6H3
iPr3)RuCl2]2
[372]
Contrary to the literature procedure, [(cymene)RuCl2]2
has to be heated about 4 hours in triisopropylbenzene
to guarantee complete exchange of the arene. Triiso-
propylbenzene was generally reused, either without
purification when stored under a dinitrogen atmos-
phere or after distillation. Representative synthetic
procedure: [(cymene)RuCl2]2 (3) (1.5 g, 2.45 mmol)
was heated in triisopropylbenzene (50 mL, excess) to 200 °C for 4 h under vigourous
stirring. The [(cymene)RuCl2]2 complex was completely solubilized. The reaction mix-
ture was allowed to cool down to room temperature and placed in the fridge over night.
Dark red crystals were filtered off and the crude product washed with CH2Cl2 through a
fritte (air sensitive!) in order to remove traces of metallic ruthenium. The complex pre-
cipitated after concentration of the solution under reduced pressure and addition of hex-
ane. A red microcrystalline product was obtained in 63% yield (1.16 g, 1.54 mmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.27 (d, 3J = 7 Hz, 36 H, (CH3)2CH), 3.05
(sept, 3J = 7 Hz, 6 H, (CH3)2CH), 5.13 (s, 
6 H, C6H3).
VIII.II.1.6 [(C6Me6)RuCl2]2
[370]
The reaction was best carried out in an 500 mL round bot-
tom flask equipped with an air cooled condenser. An inert
dinitrogen atmosphere is not necessary and not advisable,
as the sublimating hexamethylbenzene has to be scraped
periodically from the walls of the flask. To avoid a very
hard solidified melt, hexane was added when the melt was
still hot and liquid (careful!). In case of difficulties to remove the hexamethylbenzene,
purification was best achieved by sublimation under reduced pressure. Representative
synthetic procedure: [(cymene)RuCl2]2 (3) (2.0 g, 3.27 mmol) and hexamethylbenzene
(15 g, excess) were heated to 200 °C for 4 h under stirring of the melt. The flask was
taken out of the oil bath and hexane (300 mL) was added. The orange precipitate was fil-
tered off and washed with hexane until the hexamethylbenzene was completely removed.
The complex was obtained as an orange powder in 77% yield (1.68 g, 2.52 mmol).
VIII Experimental Part
152
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.02 (s, 36 H, C6Me6).
VIII.II.1.7 [(C5H5)RhCl2]2
[373]
General procedure: RhCl3 ·3 H2O (3.0 g, 11.4 mmol) and
freshly distilled cyclopentadiene (3.8 mL, 45.6 mmol,
4.0 equiv.) were heated in MeOH (100 mL) to reflux for
48 h. The reaction mixture was cooled down to room tem-
perature and placed in the freezer over night. The precipitate
was filtered off, washed with MeOH (2×5 mL) and dried in vacuo. An orange powder
was obtained in 41 % yield (1.12 g, 2.34 mmol).
1H NMR (400 MHz, D2O): δ (ppm) = 6.09 (s, 10 H, Cp).
VIII.II.1.8 [(C5HMe4)RhCl2]2
[374]
Neither a detailed reaction procedure, yield or spectroscopic
data were given in the literature. Although the reaction was
carried out as refered to, considerable amounts of an insolu-
ble byproduct have been formed. General sample procedure:
RhCl3 ·3 H2O (3.0 g, 11.4 mmol) and 1,2,3,4-tetramethyl-
1,3-cyclopentadiene (4.0 mL, 22.8 mmol, 2.0 equiv.) were heated in MeOH (100 mL) to
reflux for 48 h. The reaction mixture was cooled down to room temperature and placed
in the freezer over night. An orange precipitate was filtered off, washed with Et2O
(2×10 mL) and was then washed through a fritte with CH2Cl2 (N2). The solvent was
removed under reduced pressure and the product dried in vacuo. A brown-orange pow-
der (electrostatic) was obtained in 37 % yield (1.25 g, 2.12 mmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.64 (s, 12 H, CH3), 1.70 (s, 12 H, CH3), 5.01
(s, 2 H, C5HMe4).
VIII.II.1.9 [Cp*RhCl2]2
[375]
Representative synthetic procedure: RhCl3 ·3 H2O (3.0 g,
11.4 mmol) and pentamethylcyclopentadiene (2.0 mL,
12.5 mmol, 1.1 equiv.) were heated in MeOH (100 mL) to
reflux for 48 h. The reaction mixture was cooled down to
room temperature and placed in the freezer over night. Dark
red microcrystals were filtered off, washed with cold MeOH (2×5 mL) and dried in
vacuo. The complex was obtained in 82 % yield (2.89 g, 4.67 mmol).
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1H NMR (400 MHz, CDCl3): δ (ppm) = 1.62 (s, 30 H, Cp*).
VIII.II.1.10 [(C5HMe4)IrCl2]2
Contrary to what was reported by Werner,[376] the complex
could be obtained by reaction of IrCl3 ·3 H2O and 1,2,3,4-
tetramethyl-1,3-cyclopentadiene. General sample procedure:
IrCl3 ·3 H2O (1.0 g, 2.83 mmol) and 1,2,3,4-tetramethyl-1,3-
cyclopentadiene (1.0 mL, 5.66 mmol, 2.0 equiv.) were
heated in MeOH (100 mL) to reflux for 48 h. The reaction mixture was cooled down to
room temperature and placed in the freezer over night. Orange crystals were filtered off,
and washed with Et2O (2×10 mL) and dried in vacuo. The product was obtained in 41 %
yield (447 mg, 1.16 mmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.63 (s, 12 H, CH3), 1.68 (s, 12 H, CH3), 5.26
(s, 2 H, C5HMe4).
VIII.II.1.11 [Cp*IrCl2]2
[375]
The yields obtained routinely in the laboratory were consid-
erably lower than those given in the literature. The complex
was used without recrystallisation from chloroform/hexane.
General procedure: IrCl3 ·3 H2O (1.0 g, 2.84 mmol) and pen-
tamethylcyclopentadiene (0.5 mL, 3.12 mmol, 1.1 equiv.)
were heated in MeOH (50 mL) to reflux for 48 h. The reaction mixture was cooled down
to room temperature and placed in the freezer over night. An orange precipitate was fil-
tered off, washed with MeOH (2×5 mL) and dried in vacuo. The complex was obtained in
54 % yield (0.613 g, 0.77 mmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.59 (s, 30 H, Cp*).
VIII.II.2 Bridging Ligands
The Ligands L2, L3 and L4 were synthesised by a Mannich reaction of 3-hydroxy-2-
pyridone, formaldehyde and the corresponding secondary amine according to modified
literature procedures.[304–306] The ligands L5, L6, L13, L14 and L15 were synthesised in
a similar manner. Ligands L2, L4 and L5 were obtained in high purity and were used
without further purification. Generally, impurities could be removed by recrystallisation
from CHCl3 and acetone. 3-Hydroxy-2-pyridone present in ligand L6 was also removed
by extraction with water from a solution of the ligand in CHCl3. Ligands L13, L14 and
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L15 showed extrem low solubilities in water and organic solvents. Purification was
achieved by reversed phase HPLC from TFA solutions.
VIII.II.2.1 L2[304–306]
3-Hydroxy-2-pyridone (2.00 , 17.5 mmol, 1.0 equiv.), formaldehyde
(1.31 mL, 37 wt% in H2O, 17.5 mmol, 1.0 equiv.) and piperidine
(1.72 mL, 17.5 mmol, 1.0 equiv.) were heated in MeOH (75 mL) to
reflux for 7 h and then stirred at room temperature for 5 h. The cream
colored precipitate was filtered off and washed with acetone. The filtrate
was concentrated to less than 10 mL and acetone was added. A second
crop of ligand was filtered off. Both fractions were dried in vacuo. The
product was obtained in 73 % yield (2.65 g, 12.7 mmol).
1H NMR (400 MHz, D2O): δ (ppm) = 1.62 (m, br, 2 H, CH2), 1.78 (m, br, 4 H, CH2),
3.14 (m, br, 4 H, NCH2), 4.05 (s, 2 H, NCH2), 6.28 (d, 
3J = 6 Hz, 1 H, pyridone), 6.69
(d, 3J = 7 Hz, 1 H, pyridone).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.49 (m, br, 2 H, CH2), 1.65 (m, 4 H, CH2),
2.53 (m, br, 4 H, NCH2), 3.55 (s, 2 H, NCH2), 5.92 (d, 
3J = 7 Hz, 1 H, pyridone), 6.87
(d, J = 7 Hz, 1 H, pyridone), 13.03 (s, br, 1 H, NH).
VIII.II.2.2 L3[304–306]
3-Hydroxy-2-pyridone (2.00 , 17.5 mmol, 1.0 equiv.), formaldehyde
(1.31 mL, 37 wt% in H2O, 17.5 mmol, 1.0 equiv.) and morpholine
(1.53 mL, 17.5 mmol, 1.0 equiv.) were heated in MeOH (75 mL) to
reflux for 5 h and then stirred at room temperature for 5 h. The cream
colored precipitate was filtered off, washed with acetone and dried in
vacuo. The product was obtained in 45 % yield (1.65 g, 7.84 mmol).
About 7 % 3-hydroxy-2-pyridone remained as an impurity, which could
not be removed by recrystallisation from CHCl3 and acetone.
1H NMR (400 MHz, D2O): δ (ppm) = 2.72 (m, br, 4 H, NCH2), 3.73 (s, 2 H, NCH2),
3.80 (m, 4 H, OCH2), 6.38 (d, 
3J = 7 Hz, 1 H, pyridone), 7.02 (d, 3J = 7 Hz, 1 H, pyri-
done).
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.59 (m, br, 4 H, NCH2), 3.59 (s, 2 H, NCH2),
3.76 (m, 4 H, OCH2), 6.05 (d, 
3J = 7 Hz, 1 H, pyridone), 6.90 (d, 3J = 7 Hz, 1 H, pyri-
done) 10.18 (s, br, 1 H, OH), 12.56 (s, br, 1 H, NH).
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VIII.II.2.3 L4[304–306]
Formaldehyde (1.31 mL, 37 wt% in H2O, 17.5 mmol, 1.0 equiv.) and
dimethylamine (40 % in H2O, 2.12 mL, 17.5 mmol, 1.0 equiv.) were
stirred in 10 mL MeOH for 0.5 h, and then added to 3-hydroxy-2-pyri-
done (2.00 , 17.5 mmol, 1.0 equiv.) in MeOH (75 mL). The reaction mix-
tures was refluxed for 2 h and then stirred at room temperature over
night. The cream colored precipitate was filtered off, washed with ace-
tone and dried in vacuo. The product was obtained in 41 % yield (1.21 g, 7.17 mmol).
1H NMR (400 MHz, D2O): δ (ppm) = 2.79 (s, 6 H, NMe2), 4.07 (s, 2 H, NCH2), 6.29 (d,
3J = 7 Hz, 1 H, pyridone), 6.71 (d, 3J = 7 Hz, 1 H, pyridone).
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.35 (s, 6 H, NMe2), 3.52 (s, 2 H, NCH2), 5.97
(d, 3J = 7 Hz, 1 H, pyridone), 6.90 (d, 3J = 7 Hz, 1 H, pyridone), 13.38 (s, br, 1 H, NH).
VIII.II.2.4 L5
3-Hydroxy-2-pyridone (2.00 , 17.5 mmol, 1.0 equiv.), formaldehyde
(1.31 mL, 37 wt% in H2O, 17.5 mmol, 1.0 equiv.) and 1-methylpipera-
zine (1.95 g, 17.5 mmol, 1.0 equiv.) were heated in MeOH (75 mL) to
reflux for 7 h and then stirred for 5 h. The slightly brown solution was
concentrated to less than 25 mL and acetone was added. The cream
colored precipitate was filtered off, washed with acetone and was dried in
vacuo. The product was obtained in 45 % yield (1.76 g, 7.88 mmol).
1H NMR (400 MHz, D2O, 1.5 mM Dioxane): δ (ppm) = 2.36 (s, 3 H, NMe), 2.73 (m, br,
8 H, NCH2, piperazine), 3.73 (s, 2 H, NCH2), 6.36 (d, 
3J = 7 Hz, 1 H, pyridone), 6.93 (d,
3J = 7 Hz, 1 H, pyridone).
13C NMR (101 MHz, D2O, 1.5 mM Dioxane): δ (ppm) = 44.56,  51.66, 53.50, 57.08
(NMe, NCH2), 111.45, 122.18, 126.76, 149.37, 160.51 (pyridone).
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.30 (s, 3 H, NMe), 2.35–2.80 (m, br, 8 H,
NCH2, piperazine), 3.59 (s, 2 H, NCH2), 5.99 (d, 
3J = 6 Hz, 1 H, pyridone), 6.91 (d,
3J = 7 Hz, 1 H, pyridone), 12.93 (s, br, 1 H, NH).
13C NMR (101 MHz, CDCl3): δ (ppm) = 46.02,  52.88, 54.96, 59.58 (NMe, NCH2),
107.68, 123.81, 125.39, 146.78, 159.75 (pyridone).
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VIII.II.2.5 L6
3-Hydroxy-2-pyridone (5.00 g, 43.6 mmol, 1.0 equiv.), formalde-
hyde (3.54 mL, 37 wt% in H2O, 43.65 mmol, 2.0 equiv.) and
dibenzylamine (16.7 mL; 87.2 mmol, 2.0 equiv.) were heated to
reflux for three days in EtOH (400 mL). After a couple of hours, a
precipitate formed in the reaction mixture. The reaction was com-
plete when this precipitate had completely disappeared. It has also
to be noted, that dibenzylamine has to be used in excess; the use of
less than 2 equiv. resulted in the formation of a 1:1 mixture of
ligand L6 and 3-hydroxy-2-pyridone. The slightly brown solution was filtered and the fil-
trate concentrated under reduced pressure to 75 mL. The cream coloured precipitate was
filtered off and dried in vacuo. The crude product was dissolved in CHCl3 (200 mL), fil-
tered over celite and the solution concentrated to 75 mL. After addition of acetone a white
product precipitated which was filtered off and dried in vacuo. The product was obtained
in 28 % (3.92 g, 12.2 mmol) yield.
1H NMR (400 MHz, CDCl3): δ (ppm) = 3.60 (s, 2 H, NCH2), 3.62 (s, 4 H, NCH2), 6.14
(d, 3J = 7 Hz, 2 H, pyridone), 6.92 (d, 3J = 7 Hz, 2 H, pyridone), 7.24–7.36 (m, 10 H,
phenyl), 10.07 (s, br, 1 H, OH), 13.13 (s, br, 1 H, NH).
13C NMR (101 MHz, 0.1 M DCl in D2O, 1.5 mM Dioxane): δ (ppm) = 54.06, 58.38
(NCH2), 108.06, 123.73, 127.00, 127.78, 128.76, 129.54, 137.20, 146.08, 159.56 (pyri-
done & phenyl).
Elemental analysis (%) calcd (found) for C20H20N2O2: C 74.68 (74.98); H 6.24 (6.29);
N 8.92 (8.74).
VIII.II.2.6 L7
The ligand can be synthesised either by using Pd/C or Pd/Al2O3 as catalyst.
In the first case, partial hydrogenation of the pyridine ring is observed; the
best reaction time was found to be 8 h. If the reaction was scaled up, or less
solvent was used, a decrease of yield and purity was observed.
L6 (1.00 g, 3.12 mmol) was solubilized in MeOH (200 mL) in a 500 mL
round bottom schlenk and the solution was degassed. Pd/Al2O3 (0.664 g, 0.312 mmol,
10 mol%) was added under a gentle flux of N2. The nitrogen atmosphere was replaced by
an hydrogen atmosphere and the reaction mixture was stirred for 6 days. The progress of
the reaction was monitored observing the disappearance of the L6 TLC spot (Eluent:
CHCl3:EtOH 8.5:1.5,). The reaction mixture was filtered over celite and the solvent was
removed under reduced pressure. A small amount of MeOH (about 10 mL) was added to
the residue, the resulting crystalline solid was filtered off and dried in vacuo. The product
was obtained in 30 % yield (131 mmol, 0.94 mmol). Remark: The crude product showed
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only small amounts of starting material and use without further purification should be
possible. MeOH was found in the 1H NMR spectra, even after prolonged drying of the
product in vacuo.
1H NMR (400 MHz, D2O): δ (ppm) = 4.00 (s, 2 H, NH2), 6.33 (d, 3J = 7 Hz, 2 H, pyri-
done), 6.71 (d, 3J = 7 Hz, 2 H, pyridone).
13C NMR (101 MHz, D2O): δ (ppm) = 40.55 (NCH2), 111.35, 117.931, 123.44, 155.82,
163.19 (pyridone).
VIII.II.2.7 L9
L7 (200 mg, 1.43 mmol) and 1-pyrenecarboxaldehyde (329 mg,
1.43 mmol) were stirred in dry MeOH (75 mL) for 2 h. The result-
ing faint ocher precipitate was filtered off, washed with MeOH
(2 × 5 mL) and dried in vacuo. The product was obtained in 74 %
yield (372 mg, 1.06 mmol).
1H NMR (400 MHz, DMSO): δ (ppm) = 4.89 (s, 2 H, NCH2), 6.30
(d, 3J = 7 Hz, 1 H, pyridone), 6.90 (d, 3J = 7 Hz, 1 H, pyridone),
8.13 (t, 3J = 8 Hz, 1 H, pyrene), 8.23 (d, 3J = 9 Hz, 1 H, pyrene),
8.29 (d, 3J = 9 Hz, 1 H, pyrene), 8.31–8.41 (m, 4 H, pyrene), 8.59
(d, 3J = 8 Hz, 1 H, pyrene), 9.13 (d, 3J = 10 Hz, 1 H, pyrene), 9.55 (s, 1 H, CHN).
13C NMR (101 MHz, DMSO): δ (ppm) = 58.19 (NCH2), 106.57, 123.01, 123.20,
123.80, 124.08, 125.11, 125.91, 126.21, 126.49, 126.66, 127.30, 127.48, 128.43, 128.75,
128.84, 129.42, 130.17, 130.85, 132.46, 143.56 (pyrene, pyridone, CHN), 157.96,
161.99 (pyridone).
VIII.II.2.8 L10
A suspension of L9 (250 mg, 0.71 mmol) and NaBH4 (96 mg,
2.48 mmol, 3.5 equiv.) was stirred in dry MeOH (50 mL) for 2 h.
The color of the precipitate changed from orange to white. The
solid was filtered off, washed with MeOH (2 × 5 mL) and dried in
vacuo. A white microcrystaline product in 64 % yield (161 mg,
0.45 mmol) was obtained.
1H NMR (400 MHz, DMSO): δ (ppm) = 3.76 (s, 2 H, NCH2), 4.40
(s, 2 H, NCH2), 6.30 (d, 
3J = 7 Hz, 1 H, pyridone), 6.86 (d,
3J = 7 Hz, 1 H, pyridone), 8.07 (t, 3J = 8 Hz, 1 H, pyrene), 8.10 (d,
3J = 8 Hz, 1 H, pyrene), 8.15 (m, 2 H, pyrene), 8.21 (d, 3J = 9 Hz, 1 H, pyrene),  8.26 (d,
3J = 8 Hz, 1 H, pyrene),  8.28 (d, 3J = 8 Hz, 1 H, pyrene),  8.29 (d, 3J = 8 Hz, 1 H,
pyrene), 8.44 (d, 3J = 9 Hz, 1 H, pyrene), 11.57 (s, br, 1 H, NH).
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13C NMR (101 MHz, DMSO): δ (ppm) = 46.44, 50.18 (NCH2), 106.37, 122.96, 123.70,
124.00, 124.10, 124.66, 125.01, 125.08, 126.18, 126.87, 127.21, 127.44, 127.87, 128.62,
129.97, 130.37, 130.81, 134.21, 144.25, 157.86 (pyrene, pyridone).
VIII.II.2.9 L11
L7 (200 mg, 1.43 mmol) and 9-anthraldehyde (303 mg, 1.43 mmol)
were stirred in dry MeOH (60 mL) for 2 h. The resulting yellow pre-
cipitate was filtered off, washed with MeOH (2 × 5 mL) and dried in
vacuo. The product was obtained in 71 % yield (334 mg, 1.02 mmol)
as a yellow powder.
1H NMR (400 MHz, DMSO): δ (ppm) = 4.94 (s, 2H, NCH2), 6.29 (d,
3J = 7 Hz, 1 H, pyridone), 6.90 (d, 3J = 6 Hz, 1 H, pyridone), 7.59 (m,
4 H, anthracene), 8.14 (d, 3J = 9 Hz, 2 H, anthracene), 8.61 (d,
3J = 8 Hz, 2 H, anthracene), 8.72 (s, 1 H, anthracene), 9.13 (s, br, 1 H,
OH), 9.63 (s, 1 H, CHN), 11.67 (s, br, 1 H, NH).
13C NMR (101 MHz, DMSO): δ (ppm) = 58.99 (NCH2), 106.80, 123.24, 124.94,
125.50, 126.64, 126.89, 127.99, 128.79, 129.27, 129.43, 130.81 (anthracene & pyridone,
CHN), 144.08, 158.12, 162.13 (pyridone).
VIII.II.2.10 L12
A suspension of L11 (200 mg, 0.61 mmol) and NaBH4 (82 mg,
2.14 mmol, 3.5 equiv.) was stirred in dry EtOH (50 mL) for 2 h. The
color of the precipitate changed from yellow to faint yellow. The reac-
tion mixture was placed in the fridge over night, the solid filtered off
and washed with MeOH (2 × 5 mL). The faint yellow solid was dried
in vacuo. The product was obtained in 60 % yield (101 mg,
0.31 mmol). All peaks except those of the pyridone ring of the 1H
NMR spectra recorded in 0.1 M DCl in D2O were very susceptible to
minor changes of the concentration. A 13C NMR spectrum could not
be recorded because of crystallisation of the compound. Deuterated
DMSO was not suited as solvent because the peaks were broad.
1H NMR (400 MHz, 0.1 M DCl in D2O): δ (ppm) = 4.14 (s, 2H, NCH2), 4.14 (s, 2H,
NCH2), 5.92 (d, 
3J = 7 Hz, 1 H, pyridone), 6.83 (d, 3J = 6 Hz, 1 H, pyridone), 7.48 (m,
4 H, anthracene), 7.76 (d, 3J = 9 Hz, 1 H, anthracene), 7.92 (d, 3J = 8 Hz, 1 H, anthra-
cene), 8.33 (s, 1 H, anthracene).
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VIII.II.2.11 L13
Piperazine (0.50 g, 5.75 mmol, 1.0 equiv.), 3-
hydroxy-2-pyridone, (1.61 g, 13.8 mmol,
2.4 equiv.) and formaldehyde (1.0 mL, 37 wt% in
H2O, 13.8 mmol, 2.4 equiv.) were heated for 24 h in
EtOH (130 mL). A cream colored precipitate
formed, which was isolated and dried in vacuo. The crude product was obtained in 85 %
purity and 90 % yield (1.72 g, 5.17 mmol).  The product was purified by reversed phase
HPLC (H2O/CH3CN + 0.1 % TFA, gradient: 98:2 to 96:4 in 9 min, λmax = 305 nm, sam-
ple: 2 mL, 10 mM in 0.2 % TFA, Rf = 6.0 min).
1H NMR (400 MHz, 0.1 M DCl in D2O): δ (ppm) = 3.76 (s, br, 8 H, NCH2, piperazine),
4.47 (s, 4 H, NCH2), 6.47 (d, 
3J = 7 Hz, 2 H, pyridone), 7.13 (d, 3J = 7 Hz, 2 H, pyri-
done).
13C NMR (101 MHz, 0.1 M DCl in D2O, 1.5 mM Dioxane): δ (ppm) = 49.00 (NCH2,
piperazine), 54.36 (NCH2), 110.62, 119.28, 125.40, 147.58, 159.25 (pyridone).
VIII.II.2.12 L14
N,N'-Dimethylethylenediamine (0.55 mL, 5.00 mmol,
1.0 equiv.), 3-hydroxy-2-pyridone, (1.40 g; 12.0 mmol,
2.40 equiv.) and formaldehyde (1.0 mL, 37 wt% in H2O,
12.0 mmol, 2.4 equiv.) were heated for 24 h in ethylene glycol
dimethyl ether (130 mL). A cream colored precipitate formed,
which was isolated and dried in vacuo. The crude product was
obtained in about 90 % purity and 71 % yield (1.19 g,
3.56 mmol). The product was purified by reversed phase HPLC
(H2O/CH3CN + 0.1 % TFA, gradient: 98:2 to 97.3:2.7 in 9 min,
λmax = 305 nm, sample: 2 mL, 40 mM in 0.8 % TFA,
Rf = 5.4 min).
1H NMR (400 MHz, 0.1 M DCl in D2O): δ (ppm) = 2.98 (s, 6 H, NCH3), 3.79 (s, 4 H,
NCH2, ethylenediamine), 4.41 (s, 4 H, NCH2), 6.46 (d, 
3J = 7 Hz, 2 H, pyridone), 7.13
(d, 3J = 7 Hz, 2 H, pyridone).
13C NMR (101 MHz, 0.1 M DCl in D2O, 1.5 mM Dioxane): δ (ppm) = 41.72 (NCH3),
50.11, 55.11 (NCH2) 110.45 (pyridone), 116.82 (q, 
1J(C,F) = 292 Hz, TFA), 120.27,
125.58, 147.19, 159.15 (pyridone), 163.39 (q, 1J(C,F) = 36 Hz, TFA).
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VIII.II.2.13 L15
1,3-Di(4-piperidyl)propane (1.17 g,
5.00 mmol, 1.0 equiv.), 3-hydroxy-2-
pyridone (1.15 g; 10.0 mmol,
2.0 equiv.) and formaldehyde
(0.75 mL, 37 wt% in H2O, 10.0 mmol, 2.0 equiv.) were heated for 24 h in EtOH
(130 mL). A cream colored precipitate formed, which was filtered off and dried in vac-
uum. The crude product was obtained in about 85 % purity and 80 % yield (1.18 g,
3.55 mmol). The product was purified by reversed phase HPLC (H2O/CH3CN + 0.1 %
TFA, gradient: 98:2 to 92:8 in 14 min, λmax = 305 nm, sample: 1 mL, 20 mM in 1.0 %
TFA, Rf = 22.6 min).
1H NMR (400 MHz, 0.1 M DCl in D2O): δ (ppm) = 1.20–1.40 (m, 10 H, CH2), 1.55 (m,
br, 2 H, CH), 1.97 (m, 4 H, CH2), 3.05 (m, 4 H, NCH2), 3.55 (m, 4 H, NCH2), 4.23 (s,
4 H, NCH2), 6.45 (d, 
3J = 7 Hz, 2 H, pyridone), 7.11 (d, 3J = 7 Hz, 2 H, pyridone).
13C NMR (101 MHz, 0.1 M DCl in D2O, 1.5 mM Dioxane): δ (ppm) = 23.09, 29.74,
33.24, 35.40 (CH & CH2), 53.95, 54.71 (NCH2) 111.02 (pyridone), 116.96 (q,
1J(C,F) = 293 Hz, TFA), 121.00, 125.10, 147.04, 159.28 (pyridone) 163.56 (q,
1J(C,F) = 36 Hz, TFA).
VIII.II.3 Monomeric Complexes in Water
Monomeric complexes of composed of half-sandwich complexes [(π-ligand)MCl2]2 and
ligands L2, L3, L4 and L5 are described. Monomeric complexes were characterized by
1H NMR spectroscopy, except for cases in which single crystals suited for X-ray crystal-
lography were obtained. The 1H NMR spectra were calibrated to the internal HDO sig-
nal. The methylpiperazine CH2 signals are often very broad, especially when the
monomer was formed in situ; however, the signals could be much more distinct when
crystals were solubilized in deuterated water.
General procedure for the formation of monomeric complexes in water: A mixture of
halfsandwich complex [(π-ligand)MCl2]2 (37.5 μmol) and ligand (75.0 μmol) were
stirred in water (5.00 mL) until a clear solution (15 mM) was obtained.
General procedure for the formation of monomeric complexes in CHCl3: A mixture of
halfsandwich complex [(π-ligand)MCl2]2 (37.5 μmol) and ligand (75.0 μmol) were
stirred in CHCl3 (5.00 mL) until a clear solution (15 mM) was obtained. The solvent was
removed under reduced pressure and the product obtained in quanitative yield.
General procedure for the synthesis of monomeric complexes by crystallisation: A
mixture of [(π-ligand)MCl2]2 (75.0 μmol) and ligand L2, L3 or L4 (150 μmol) was stirred
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in chloroform or dichloromethane (20 mL) until a clear solution was obtained (about
15 minutes). The solution was divided into five test tubes and crystals were obtained by
layering carefully Et2O or pentane over the monomer solution. It was not possible to
obtain any crystals for complexes containing ligand L5.
VIII.II.3.1 [(C6H6)Ru(L2)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.40–2.05 (m,  6 H,
CH2, piperidine), 3.00 (mc, 2 H, CH2, piperidine), 3.48
(mc, 2 H, CH2, piperidine), 4.22 (s, 2 H, NCH2), 5.59 (s,
6 H, C6H6), 6.53 (d, 
3J = 7 Hz, 1 H, pyridone), 6.91 (d,
3J = 7 Hz, 1 H, pyridone).
VIII.II.3.2 [(C6H6)Ru(L5)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 2.60 (m, br,  2 H,
CH2, piperazine), 2.85 (s, 3 H, NCH3), 3.09 (m, br,  4 H,
CH2, piperazine), 3.46 (m, br,  2 H, CH2, piperazine),
3.68 (s, 2 H, NCH2), 5.87 (s, 6 H, C6H6), 6.55 (d,
3J = 7 Hz, 1 H, pyridone), 6.91 (d, 3J = 6 Hz, 1 H, pyri-
done).
VIII.II.3.3 [(C6H5Me)Ru(L2)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.35–2.05 (m, 6 H,
CH2, piperidine), 2.26 (s, 3 H, CH3C6H5), 3.03 (mc, 2 H,
CH2, piperidine), 3.51 (mc, 2 H, CH2, piperidine), 4.23 (s,
2 H, NCH2), 5.59 (d, 
3J = 6 Hz, 2 H, C6H5Me), 5.74 (t,
3J = 6 Hz, 1 H, C6H5Me), 5.95 (t, 
3J = 6 Hz, 2 H, C6H5Me),
6.53 (d, 3J = 7 Hz, 1 H, pyridone), 6.92 (d, 3J = 6 Hz, 1 H,
pyridone).
VIII.II.3.4 [(C6H5Me)Ru(L5)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 2.22 (s, 3 H,
CH3C6H5), 2.45–3.65 (m, 8 H, CH2, piperazine), 2.85 (s,
3 H, NCH3), 3.71 (s, 2 H, NCH2), 5.54 (d, 
3J = 6 Hz, 2 H,
C6H5Me), 5.69 (t, 
3J = 6 Hz, 1 H, C6H5Me), 5.91 (t,
3J = 6 Hz, 2 H, C6H5Me), 6.54 (d, 
3J = 7 Hz, 1 H, pyri-
done), 6.89 (d, 3J = 7 Hz, 1 H, pyridone).
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VIII.II.3.5 [(cymene)Ru(L2)Cl]Cl
Crystalsy were obtained by slow diffusion of Et2O into a
mixture of 3 and L2 (ratio 1:2) in CHCl3.
1H NMR (400 MHz, D2O): δ (ppm) =1.28 (d, 3J = 7 Hz,
6 H, CH(CH3)2), 1.35–2.05 (m, 6 H, CH2, piperidine), 2.23
(s, 2 H, CH3C6H4
iPr), 2.82 (sept, 3J = 7 Hz, 1 H,
CH(CH3)2), 2.00 (mc, 2 H, CH2, piperidine), 3.48 (mc, 2 H,
CH2, piperidine), 4.21 (s, 2 H, NCH2), 5.56 (d, 
3J = 6 Hz,
2 H, MeC6H4
iPr), 5.81 (d, 3J = 6 Hz, 2 H, MeC6H4
iPr), 6.50 (d, 3J = 7 Hz, 1 H, pyri-
done), 6.88 (d, 3J = 7 Hz, 1 H, pyridone).
Elemental analysis (%) calcd (found) for C21H30Cl2N2O2Ru × 2 CHCl3: C 36.68
(37.64), H 4.28 (5.03), N 3.72 (3.94).
VIII.II.3.6 [(cymene)Ru(L3)Cl]Cl
Crystalsy were obtained by slow diffusion of n-pentane into
a mixture of 3 and L3 (ratio 1:2) in CHCl3.
1H NMR (400 MHz, D2O): δ (ppm) = 1.30 (d, 3J = 7 Hz,
6 H, CH(CH3)2), 2.25 (s, 2 H, CH3C6H4
iPr), 2.84 (sept,
3J = 7 Hz, 1 H, CH(CH3)2), 3.29 (m, br, 2 H, CH2, morpho-
line), 3.47 (m, br, 2 H, CH2, morpholine), 3.80 (m, br, 2 H,
CH2, morpholine), 4.12 (m, br, 2 H, CH2, morpholine), 4.33
(s, 2 H, NCH2), 5.59 (d, 
3J = 6 Hz, 2 H, MeC6H4
iPr), 5.83 (d, 3J = 6 Hz, 2 H,
MeC6H4
iPr), 6.53 (d, 3J = 7 Hz, 1 H, pyridone), 6.90 (d, 3J = 6 Hz, 1 H, pyridone).
Elemental analysis (%) calcd (found) for C20H28Cl2N2O3Ru × 1/6 CHCl3: C 45.16
(45.34), H 5.29 (5.24), N 5.22 (5.15).
VIII.II.3.7 [(cymene)Ru(L4)Cl]Cl
Crystalsy were obtained by slow diffusion of Et2O into a mix-
ture of 3 and L4 (ratio 1:2) in CHCl3.
1H NMR (400 MHz, D2O): δ (ppm) = 1.26 (d, 3J = 7 Hz, 6 H,
CH(CH3)2), 2.22 (s, 2 H, CH3C6H4
iPr), 2.83 (sept, 3J = 7 Hz,
1 H, CH(CH3)2), 2.89 (s, 6 H, NCH3), 4.25 (s, 2 H, NCH2),
5.56 (d, 3J = 5 Hz, 2 H, MeC6H4
iPr), 5.81 (d, 3J = 6 Hz, 2 H,
y. Although crystals were obtained, these were not suited for single crystal X-ray analysis.
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MeC6H4
iPr), 6.50 (d, 3J = 6 Hz, 1 H, pyridone), 6.88 (d, 3J = 6 Hz, 1 H, pyridone).
Elemental analysis (%) calcd (found) for C18H26Cl2N2O2Ru × 0.5 CHCl3: C 41.60
(41.76), H 5.00 (5.28), N 5.25 (4.57).
VIII.II.3.8 [(cymene)Ru(L5)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.25 (d, 3J = 7 Hz,
6 H, CH(CH3)2), 2.23 (s, 2 H, CH3C6H4
iPr), 2.65 (m, br,
2 H, CH2, piperazine), 2.80 (sept, 
3J = 7 Hz, 1 H,
CH(CH3)2), 2.84 (s, 3 H, NCH3), 3.10 (m, br, 4 H, CH2,
piperazine), 3.45 (m, br, 2 H, CH2, piperazine), 3.70 (s,
2 H, NCH2), 5.56 (d, 
3J = 6 Hz, 2 H, MeC6H4
iPr), 5.79
(d, 3J = 6 Hz, 2 H, MeC6H4
iPr), 6.53 (d, 3J = 7 Hz, 1 H,
pyridone), 6.88 (d, 3J = 7 Hz, 1 H, pyridone).
VIII.II.3.9 [(C6H5CO2Et)Ru(L2)Cl]Cl
The complex trimerised already in significant amounts in
absence of any base. The 1H NMR data indicated, also the
presence of free ligand and a π-ligand-aqua species in
addition to the monomeric and trimeric complexes. The
peaks were broad, but became well defined with
increased trimerisation.
1H NMR (400 MHz, D2O): δ (ppm) = 1.25 (t, 3J = 7 Hz,
3 H, CO2CH2CH3), 1.30–2.05 (m, 6 H, CH2, piperidine), 2.99 (mc, 2 H, CH2, piperid-
ine), 3.46 (m, br, 2 H, CH2, piperidine), 4.23 (s, 2 H, NCH2), 4.39 (q, 
3J = 7 Hz, 2 H,
CO2CH2CH3), 5.99 (m, br, 2 H, C6H5CO2Et), 6.37 (m, br, 1 H, C6H5CO2Et), 6.54 (m,
br, 1 H, pyridone), 6.70 (d, 3J = 5 Hz, 2 H, C6H5CO2Et), 6.92 (m, br, 1 H, pyridone).
VIII.II.3.10 [(C6H5CO2Et)Ru(L5)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.21 (t,
3J = 7 Hz, 3 H, CO2CH2CH3), 2.45–3.65 (m, br, 8 H,
CH2, piperazine), 2.88 (s, 3 H, NCH3), 3.75 (s, 2 H,
NCH2), 4.36 (q, 
3J = 7 Hz, 2 H, CO2CH2CH3), 5.98
(m, br, 2 H, C6H5CO2Et), 6.25 (m, br, 1 H,
C6H5CO2Et), 6.55 (d, 
3J = 6 Hz, 1 H, pyridone), 6.68
(d, 3J = 6 Hz, 2 H, C6H5CO2Et), 6.91 (d, 
3J = 6 Hz,
1 H, pyridone).
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VIII.II.3.11 [(C6H3
iPr3)Ru(L2)Cl]Cl
The monomeric complex was difficult to obtain by direct
mixing of 5 and L2 in water. However, crystalsy  were
obtained by slow diffusion of Et2O into a mixture of 5
and L2 (ratio 1:2) in CHCl3. The crystals were soluble in
water and chloroform. Alternatively, extended stirring of
a less concentrated mixture (3 mM) also gave the mono-
meric complex.
1H NMR (400 MHz, D2O): δ (ppm) = 1.32 (d, 3J = 7 Hz,
18 H, CH(CH3)2), 1.45–2.05 (m, br, 6 H, CH2, piperidine), 2.86 (sept, 
3J = 7 Hz, 1 H,
CH(CH3)2), 3.00 (m, br, 2 H, CH2, piperidine), 3.46 (m, br, 2 H, CH2, piperidine), 4.21
(s, 2 H, NCH2), 5.61 (s, 3 H, C6H3
iPr3), 6.49 (d, 
3J = 6 Hz, 1 H, pyridone), 6.86 (d,
3J = 7 Hz, 1 H, pyridone).
VIII.II.3.12 [(C6H3
iPr3)Ru(L5)Cl]Cl
Extended stirring of a less concentrated mixture
(3 mM) gave access to the monomeric complex.
1H NMR (400 MHz, D2O): δ (ppm) = 1.31 (d,
3J = 7 Hz, 18 H, CH(CH3)2), 2.83 (s, 3 H, NCH3),
2.65 (m, br, 2 H, CH2, piperazine), 2.87 (sept,
3J = 7 Hz, 1 H, CH(CH3)2), 3.10 (m, br, br, 4 H, CH2,
piperazine), 3.45 (m, br, 2 H, CH2, piperazine), 3.70 (s,
2 H, NCH2), 5.56 (s, 3 H, C6H3
iPr3), 6.51 (d,
3J = 7 Hz, 1 H, pyridone), 6.84 (d, 3J = 6 Hz, 1 H, pyridone).
VIII.II.3.13 [(C6Me6)Ru(L2)Cl]Cl
Crystals suited for singe crystal X-ray analysis were
obtained by slow diffusion of Et2O into a mixture of 6 and
L2 (ratio 1:2) in dichloromethane.
1H NMR (400 MHz, D2O): δ (ppm) = 1.30–2.30 (m, br, 6 H,
CH2, piperidine), 2.14 (s, 18 H, C6Me6), 3.04 (m, br, 2 H,
NCH2, piperidine), 3.50 (m, br, 2 H, NCH2, piperidine), 4.21
(s, 2 H, NCH2), 6.46 (d, 
3J = 7 Hz, 1 H, pyridone), 6.82 (d,
3J = 7 Hz, 1 H, pyridone). 
13C NMR (101 MHz, D2O): δ (ppm) = 17.86 (CH3, C6Me6), 23.92, 25.80, (CH2, piperi-
dine), 56.15, 57.42 (NCH2), 91.79 (C6Me6), 117.02, 121.56, 123.48, 161.41, 167.58
(pyridone).
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Elemental analysis (%) calcd (found) for C23H34Cl2N2O2Ru × 0.5 CH2Cl2: C 48.25
(48.88), H 6.03 (6.09), N 4.79 (4.42).
VIII.II.3.14 [(C6Me6)Ru(L3)Cl]Cl
Crystals suited for singe crystal X-ray analysis were
obtained by slow diffusion of pentane into a mixture of 6 and
L3 (ratio 1:2) in chloroform.
1H NMR (400 MHz, D2O): δ (ppm) = 2.13 (s, 18 H,
C6Me6), 3.34 (m, br, 4 H, NCH2, morpholine), 3.93 (m, br,
4 H, OCH2, morpholine), 4.27 (s, 2 H, NCH2), 6.46 (d,
3J = 7 Hz, 1 H, pyridone), 6.81 (d, 3J = 7 Hz, 1 H, pyridone).
13C NMR (101 MHz, D2O): δ (ppm) = 17.87 (CH3, C6Me6), 54.54, 57.50, 66.77 (NCH2,
OCH2), 91.81 (C6Me6), 116.99, 121.39, 128.55, 161.73, 167.68 (pyridone).
Elemental analysis (%) calcd (found) for C22H32Cl2N2O6Ru × 0.5 CHCl3: C 44.73
(44.43), H 5.42 (5.29), N 4.64 (4.44).
VIII.II.3.15 [(C6Me6)Ru(L4)Cl]Cl
Crystals suited for singe crystal X-ray analysis were obtained
by slow diffusion of pentane into a mixture of 6 and L4 (ratio
1:2) in chloroform.
1H NMR (400 MHz, D2O): δ (ppm) = 2.14 (s, 18 H, C6Me6),
2.90 (s, 6 H, NMe2), 4.27 (s, 2 H, NCH2), 6.46 (d, 
3J = 7 Hz,
1 H, pyridone), 6.82 (d, 3J = 7 Hz, 1 H, pyridone).
13C NMR (101 MHz, D2O): δ (ppm) = 17.84 (CH3, C6Me6), 45.49, 58.54 (NMe2,
NCH2), 91.83 (C6Me6), 116.44, 121.46, 123.59, 161.45, 167.61 (pyridone).
Elemental analysis (%) calcd (found) for C20H29Cl2N2O2Ru × 0.5 CHCl3: C 43.96
(44.43), H 5.13 (5.73), N 5.00 (5.22).
VIII.II.3.16 [(C6Me6)Ru(L5)Cl]Cl
Extended stirring of a less concentrated mixture gave
access to the monomeric complex (3 mM). The quality of
the obtained spectrum was inferior compared to other
spectra of monomeric complexes.
1H NMR (400 MHz, D2O): δ (ppm) = 2.12 (s, 18 H,
C6Me6), 2.60 (m, br,  2 H, CH2, piperazine), 2.86 (s, 3 H,
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NCH3), 3.15 (m, br,  4 H, CH2, piperazine), 3.47 (m, br,  2 H, CH2, piperazine), 3.69 (s,
2 H, NCH2), 6.49 (d, 
3J = 7 Hz, 1 H, pyridone), 6.81 (d, 3J = 7 Hz, 1 H, pyridone).
VIII.II.3.17 [CpRh(L2)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.30–2.05 (m, 6 H,
CH2, piperidine), 2.98 (mc, 2 H, CH2, piperidine), 3.47 (mc,
2 H, CH2, piperidine), 4.19 (s, 2 H, NCH2), 5.90 (s, 5 H,
Cp), 6.53 (d, 3J = 6 Hz, 1 H, pyridone), 6.92 (d, 3J = 7 Hz,
1 H, pyridone).
VIII.II.3.18 [CpRh(L5)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 2.45–3.65 (m, 8 H,
CH2, piperazine), 2.84 (s, 3 H, NCH3), 3.70 (s, 2 H,
NCH2), 5.88 (s, 5 H, Cp), 6.57 (d, 
3J = 7 Hz, 1 H, pyri-
done), 6.92 (d, 3J = 7 Hz, 1 H, pyridone).
VIII.II.3.19 [(C5HMe4)Rh(L2)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.30–2.05 (m, 6 H,
CH2, piperidine), 1.67 (s, 6 H, (CH3)4C5H), 1.74 (s, 6 H,
(CH3)4C5H), 3.01 (mc, 2 H, CH2, piperidine), 3.51 (mc, 2 H,
CH2, piperidine), 4.20 (s, 2 H, NCH2), 5.34 (s, 1 H,
C5HMe4), 6.48 (d, 
3J = 7 Hz, 1 H, pyridone), 6.85 (d,
3J = 7 Hz, 1 H, pyridone).
VIII.II.3.20 [(C5HMe4)Rh(L5)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.66 (s, 6 H,
(CH3)4C5H), 1.72 (s, 6 H, (CH3)4C5H), 2.45–3.65 (m,
8 H, CH2, piperazine), 2.81 (s, 3 H, NCH3), 3.74 (s, 2 H,
NCH2), 5.31 (s, 1 H, C5HMe4), 6.51 (d, 
3J = 7 Hz, 1 H,
pyridone), 6.84 (d, 3J = 6 Hz, 1 H, pyridone).
VIII.II Synthesis
167
VIII.II.3.21 [Cp*Rh(L2)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.35–2.05 (m, 6 H,
CH2, piperidine), 1.67 (s, 15 H, Cp*), 3.00 (mc, 2 H, NCH2,
piperidine), 3.50 (m, br, 2 H, NCH2, piperidine), 4.18 (s,
2 H, NCH2), 6.45 (d, 
3J = 7 Hz, 1 H, pyridone), 6.81 (d,
3J = 7 Hz, 1 H, pyridone).
VIII.II.3.22 [Cp*Rh(L5)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.66 (s, 15 H,
Cp*), 2.35–3.60 (m, br,  8 H, CH2, piperazine), 2.79 (s,
3 H, NCH3), 3.72 (s, 2 H, NCH2), 6.49 (d, 
3J = 7 Hz, 1 H,
pyridone), 6.82 (d, 3J = 7 Hz, 1 H, pyridone).
VIII.II.3.23 [(C5HMe4)Ir(L2)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.30–2.05 (m, 6 H,
CH2, piperidine), 1.63 (s, 6 H, (CH3)4C5H), 1.72 (s, 6 H,
(CH3)4C5H), 3.00 (mc, 2 H, CH2, piperidine), 3.51 (mc, 2 H,
CH2, piperidine), 4.21 (s, 2 H, NCH2), 5.48 (s, 1 H,
C5HMe4), 6.50 (d, 
3J = 7 Hz, 1 H, pyridone), 6.89 (d,
3J = 7 Hz, 1 H, pyridone).
VIII.II.3.24 [(C5HMe4)Ir(L5)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.62 (s, 6 H,
(CH3)4C5H), 1.72 (s, 6 H, (CH3)4C5H), 2.45–3.65 (m,
8 H, CH2, piperazine), 2.83 (s, 3 H, NCH3), 3.78 (s, 2 H,
NCH2), 5.46 (s, 1 H, C5HMe4), 6.52 (d, 
3J = 7 Hz, 1 H,
pyridone), 6.89 (d, 3J = 7 Hz, 1 H, pyridone).
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VIII.II.3.25 [Cp*Ir(L2)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.35–2.05 (m, 6 H,
CH2, piperidine), 1.68 (s, 15 H, Cp*), 3.02 (mc, 2 H, NCH2,
piperidine), 3.52 (m, br, 2 H, NCH2, piperidine), 4.23 (s,
2 H, NCH2), 6.49 (d, 
3J = 7 Hz, 1 H, pyridone), 6.89 (d,
3J = 6 Hz, 1 H, pyridone).
VIII.II.3.26 [Cp*Ir(L5)Cl]Cl
1H NMR (400 MHz, D2O): δ (ppm) = 1.62 (s, 15 H,
Cp*), 2.45–3.65 (m, br,  8 H, CH2, piperazine), 2.81 (s,
3 H, NCH3), 3.77 (s, 2 H, NCH2), 6.50 (d, 
3J = 7 Hz, 1 H,
pyridone), 6.86 (d, 3J = 7 Hz, 1 H, pyridone).
VIII.II.4 Trimeric Complexes and their LiCl Adducts in Water
Trimeric metallamacrocycles composed of halfsandwich complexes [(π-ligand)MCl2]2
and ligands L2, L3, L4 and L5 and their LiCl adducts are described. All complexes were
characterized by 1H NMR spectroscopy. The 1H NMR spectra were calibrated to the
internal HDO signal. Trimerisation could be induced by mixing [(π-ligand)MCl2]2 and
ligand in phosphate buffer solutionz (100 mM, pH 7.0) or by using a CsOH solution in
D2O as base. In both cases, the 
1H NMR signals of the π-ligand were identical. The
NCH2 signals which are more sensitive to the pH did vary slightly in some cases and the
piperidine, morpholine and methylpiperazine CH2 signals were broader when using
CsOH solution than in phosphate buffer solution.
General procedure for the formation of trimeric complexes in PBS: A mixture of half-
sandwich complex [(π-ligand)MCl2]2 (37.5 μmol) and ligand (75.0 μmol) were stirred in
phosphate buffer solution (5.00 mL, 100 mM) until a clear solution of trimer (5.0 mM)
was obtained. Trimerisation was found to be pH dependant and did vary for different
metal fragments.z
General procedure for the formation of trimeric complexes in water: A mixture of half-
sandwich complex [(π-ligand)MCl2]2 (37.5 μmol) and ligand (75.0 μmol) were stirred in
z. For complexes with a basic pKa, a higher pH is necessary for trimerisation, e.g. for the mixture of [Cp*RhCl2]2 and
L2 no trimerisation was observed at pH 7.0.
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water (4.50 mL) until a clear solution of the monomer (16.7 mM) was obtained. A CsOH
solution in water (0.15 M) was added to the monomer solution. If not specified otherwise,
1.0 equiv. of CsOH (based on the mmol of ligand, 0.5 mL, 75 μmol) was used to form the
trimeric complex in quantitative yield. Due to their low solubility, the trimeric macrocy-
cles with 5 and 6 as metal fragments were not investigated.
VIII.II.4.1 [(C6H6)Ru(L2−H+)]33+
[(C6H6)Ru(L2−H+)]33+: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.45–1.85 (m, br, 18 H, CH2, piperidine), 2.88 (m,
br, 12 H, NCH2, piperidine), 3.79 (d, 
2J = 13 Hz, 3 H,
NCH2), 4.01 (d, 
2J = 13 Hz, 3 H, NCH2), 5.78 (s, 18 H,
C6H6), 5.82 (d, 
3J = 7 Hz, 3 H, pyridone), 6.77 (d, 3J = 7 Hz,
3 H, pyridone).
[(C6H6)Ru(L2−H+)]33+ × LiCl: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.45–1.85 (m, br, 18 H, CH2, piperidine), 2.83 (m,
br, 12 H, NCH2, piperidine), 3.91 (d, 
2J = 13 Hz, 3 H,
NCH2), 4.03 (d, 
2J = 13 Hz, 3 H, NCH2), 5.90 (s, 18 H, C6H6), 6.08 (d, 
3J = 6 Hz, 3 H,
pyridone), 6.92 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.35.
VIII.II.4.2 [(C6H6)Ru(L5−H+)]33+
[(C6H6)Ru(L5−H+)]33+: 1H NMR (400 MHz, D2O):
δ (ppm) = 2.45–3.45 (m, br, 24 H, CH2, piperazine), 2.60 (s,
9 H, NCH3), 3.33 (d, 
2J = 13 Hz, 3 H, NCH2), 3.60 (d,
2J = 13 Hz, 3 H, NCH2), 5.73 (s, 18 H, C6H6), 5.78 (d,
3J = 6 Hz, 3 H, pyridone), 6.69 (d, 3J = 6 Hz, 3 H, pyridone).
[(C6H6)Ru(L5−H+)]33+ × LiCl: 1H NMR (400 MHz, D2O):
δ (ppm) = 2.50 (m, br, 6 H, CH2, piperazine), 2.64 (s, 9 H,
NCH3), 2.80–3.30 (m, br, 18 H, CH2, piperazine),  3.37 (d,
2J = 13 Hz, 3 H, NCH2), 3.60 (d, 
2J = 14 Hz, 3 H, NCH2),
5.85 (s, 18 H, C6H6), 6.03 (d, 
3J = 6 Hz, 3 H, pyridone), 6.69
(d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.36.
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VIII.II.4.3 [(C6H5Me)Ru(L2−H+)]33+
[(C6H5Me)Ru(L2−H+)]33+: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.35–1.95 (m, br, 18 H, CH2, piperidine), 2.00 (s,
9 H, CH3C6H5), 2.60–3.60 (m, br, 12 H, NCH2, piperidine),
3.83 (d, 2J = 13 Hz, 3 H, NCH2), 4.03 (d, 
2J = 13 Hz, 3 H,
NCH2), 5.24 (d, 
3J = 6 Hz, 3 H, C6H5Me), 5.49 (t, 
3J = 6 Hz,
3 H, C6H5Me), 5.56 (d, 
3J = 6 Hz, 3 H, C6H5Me), 5.83 (m,
6 H,C6H5Me and pyridone), 6.08 (t, 
3J = 6 Hz, 3 H,
C6H5Me), 6.75 (d, 
3J = 6 Hz, 3 H, pyridone).
[(C6H5Me)Ru(L2−H+)]33+ × LiCl: 1H NMR (400 MHz,
D2O): δ (ppm) = 1.35–1.95 (m, br, 18 H, CH2, piperidine), 1.88 (s, 9 H, CH3C6H5),
2.60–3.60 (m, br, 12 H, NCH2, piperidine), 3.97 (d, 
2J = 13 Hz, 3 H, NCH2), 4.10 (d,
2J = 13 Hz, 3 H, NCH2), 5.26 (d, 
3J = 6 Hz, 3 H, C6H5Me), 5.68 (m, 6 H, C6H5Me),
6.11 (m, 6 H, C6H5Me and pyridone), 6.23 (t, 
3J = 6 Hz, 3 H, C6H5Me), 6.92 (d,
3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.37.
VIII.II.4.4 [(C6H5Me)Ru(L5−H+)]33+
[(C6H5Me)Ru(L5−H+)]33+: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.93 (s, 9 H, CH3C6H5), 2.50–3.35 (m, 24 H,
CH2, piperazine), 2.64 (s, 9 H, NCH3), 3.39 (d, 
2J = 13 Hz,
3 H, NCH2), 3.65 (d, 
2J = 10 Hz, 3 H, NCH2), 5.15 (d,
3J = 6 Hz, 3 H, C6H5Me), 5.44 (t, 
3J = 6 Hz, 3 H, C6H5Me),
5.54 (d, 3J = 6 Hz, 3 H, C6H5Me), 5.81 (m, 6 H, C6H5Me
and pyridone), 6.12 (t, 3J = 6 Hz, 3 H, C6H5Me), 6.68 (d,
3J = 7 Hz, 3 H, pyridone).
[(C6H5Me)Ru(L5−H+)]33+ × LiCl: 1H NMR (400 MHz,
D2O): δ (ppm) =1.78 (s, 9 H, CH3C6H5), 2.35–3.55 (m,
24 H, CH2, piperazine), 2.72 (s, 9 H, NCH3), 3.42 (d, 
2J = 13 Hz, 3 H, NCH2), 3.65 (d,
2J = 13 Hz, 3 H, NCH2), 5.15 (d, 
3J = 6 Hz, 3 H, C6H5Me), 5.61 (t, 
3J = 6 Hz, 3 H,
C6H5Me), 5.66 (d, 
3J = 6 Hz, 3 H, C6H5Me), 6.06 (m, 6 H, C6H5Me and pyridone), 6.29
(t, 3J = 6 Hz, 3 H, C6H5Me), 6.82 (d, 
3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.37.
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VIII.II.4.5 [(cymene)Ru(L2−H+)]33+
[(cymene)Ru(L2−H+)]33+: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.26 (d, 3J = 7 Hz, 9 H, CH(CH3)2), 1.28 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 1.40–2.05 (m, br, 18 H, CH2,
piperidine), 1.84 (s, 9 H, CH3C6H4
iPr), 2.81 (sept,
3J = 7 Hz, 3 H, CH(CH3)2), 2.98 (m, br, 12 H, NCH2,
piperidine), 3.77 (d, 2J = 13 Hz, 3 H, NCH2), 4.07 (d,
2J = 13 Hz, 3 H, NCH2), 5.27 (d, 
3J = 6 Hz, 3 H,
MeC6H4
iPr), 5.52 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 5.80
(d, 3J = 5 Hz, 3 H, MeC6H4
iPr), 5.81 (d, 3J = 6 Hz, 3 H,
pyridone), 6.04 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 6.69 (d,
3J = 6 Hz, 3 H, pyridone).
[(cymene)Ru(L2−H+)]33+ × LiCl: 1H NMR (400 MHz, D2O): δ (ppm) = 1.24 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 1.27 (d, 
3J = 3J = 7 Hz, 9 H, CH(CH3)2), 1.35–2.10 (m, br,
18 H, CH2, piperidine), 1.78 (s, 9 H, CH3C6H4
iPr), 2.79 (sept, 3J = 7 Hz, 3 H,
CH(CH3)2), 2.99 (m, br, 12 H, NCH2, piperidine), 3.90 (d, 
2J = 13 Hz, 3 H, NCH2), 4.12
(d, 2J = 13 Hz, 3 H, NCH2), 5.29 (d, 
3J = 5 Hz, 3 H, MeC6H4
iPr), 5.73 (d, 3J = 6 Hz,
3 H, MeC6H4
iPr), 6.03 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 6.09 (d, 3J = 6 Hz, 3 H, pyri-
done), 6.19 (d, 3J = 5 Hz, 3 H, MeC6H4
iPr), 6.86 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.40.
VIII.II.4.6 [(cymene)Ru(L3−H+)]33+
[(cymene)Ru(L3−H+)]33+ (1.0 equiv. CsOH): 1H NMR
(400 MHz, D2O): δ (ppm) = 1.26 (d, 3J = 7 Hz, 9 H,
CH(CH3)2), 1.29 (d, 
3J = 7 Hz, 9 H, CH(CH3)2), 1.83 (s,
9 H, CH3C6H4
iPr), 2.81 (sept, 3J = 7 Hz, 3 H,
CH(CH3)2), 3.03 (m, br, 12 H, NCH2, morpholine), 3.76
(d, 2J = 13 Hz, 3 H, NCH2), 3.85 (m, br, 12 H, OCH2,
morpholine), 4.11 (d, 2J = 13 Hz, 3 H, NCH2), 5.27 (d,
3J = 6 Hz, 3 H, MeC6H4
iPr), 5.51 (d, 3J = 6 Hz, 3 H,
MeC6H4
iPr), 5.80 (d, 3J = 7 Hz, 3 H, pyridone), 5.82 (d,
3J = 7 Hz, 3 H, MeC6H4
iPr), 6.05 (d, 3J = 6 Hz, 3 H,
MeC6H4
iPr), 6.70 (d, 3J = 6 Hz, 3 H, pyridone).
[(cymene)Ru(L3−H+)]33+ × LiCl: 1H NMR (400 MHz, D2O): δ (ppm) = 1.24 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 1.27 (d, 
3J = 7 Hz, 9 H, CH(CH3)2), 1.77 (s, 9 H,
CH3C6H4
iPr), 2.79 (sept, 3J = 7 Hz, 3 H, CH(CH3)2), 3.03 (m, br, 12 H, NCH2, morpho-
line), 3.85 (m, br, 15 H, OCH2, morpholine and NCH2), 4.13 (d, 
2J = 15 Hz, 3 H,
NCH2), 5.28 (d, 
3J = 7 Hz, 3 H, MeC6H4
iPr), 5.72 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 6.04
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(d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 6.09 (d, 3J = 6 Hz, 3 H, pyridone), 6.19 (d, 3J = 5 Hz,
3 H, MeC6H4
iPr), 6.86 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.40.
VIII.II.4.7 [(cymene)Ru(L4−H+)]33+
[(cymene)Ru(L4−H+)]33+: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.26 (d, 3J = 7 Hz, 9 H, CH(CH3)2), 1.28 (d,
3J = 8 Hz, 9 H, CH(CH3)2), 1.82 (s, 9 H, CH3C6H4
iPr), 2.69
(s, 18 H, NMe2), 2.82 (sept, 
3J = 7 Hz, 3 H, CH(CH3)2),
3.86 (d, 2J = 13 Hz, 3 H, NCH2), 4.18 (d, 
2J = 13 Hz, 3 H,
NCH2), 5.26 (d, 
3J = 6 Hz, 3 H, MeC6H4
iPr), 5.51 (d,
3J = 6 Hz, 3 H, MeC6H4
iPr), 5.79 (d, 3J = 7 Hz, 3 H, pyri-
done), 5.81 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 6.05 (d,
3J = 6 Hz, 3 H, MeC6H4
iPr), 6.72 (d, 3J = 6 Hz, 3 H, pyri-
done).
[(cymene)Ru(L4−H+)]33+ × LiCl: 1H NMR (400 MHz, D2O): δ (ppm) = 1.23 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 1.27 (d, 
3J = 7 Hz, 9 H, CH(CH3)2), 1.78 (s, 9 H,
CH3C6H4
iPr), 2.70 (s, 18 H, NMe2), 2.79 (sept, 
3J = 7 Hz, 3 H, CH(CH3)2), 3.97 (d,
2J = 13 Hz, 3 H, NCH2), 4.14 (d, 
2J = 13 Hz, 3 H, NCH2), 5.29 (d, 
3J = 5 Hz, 3 H,
MeC6H4
iPr), 5.72 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 6.05 (d, 3J = 6 Hz, 6 H, MeC6H4
iPr
and pyridone), 6.17 (d, 3J = 5 Hz, 3 H, MeC6H4
iPr), 6.89 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.40.
VIII.II.4.8 [(cymene)Ru(L5−2 H+)]3
The complex [(cymene)Ru(L5−2 H+)]3 is special in so
far, as it was soluble even if completely deprotonated.
Starting from a monomer solution, the trimerisation was
complete after addition of 1.25 equiv. of CsOH. The bind-
ing constant towards Li+ increases with further deproto-
nation. This behaviour is in agreement with the fact that
three positive charges (the protonated amine groups)
close to the binding site decreases the affinity towards
cations. Whereas the pyridone and all cymene (CH3, 
iPr,
as well as the aromatic MeC6H4
iPr) peaks undergo no
further shift when increasing the amount of CsOH, the
NCH2 and NCH3 peaks of the ligand are more susceptible to the pH. For both peaks, an
high field shift (towards lower ppm) is observed. In general, the complex obtained from
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the self-assembly of 3 and L5 in MeOH in the presence of Cs2CO3 was used for any kind
of experiment. Its 1H NMR spectrum is identical to the spectrum obtained after addition
of 2.0 equiv. of CsOH. The 1H NMR spectrum given beneath is the spectrum obtained by
dissolving the synthesised complex in water. The same complex was used for the binding
study.
[(Cymene)Ru(L5−2 H+)]3: 1H NMR (400 MHz, D2O): δ (ppm) = 1.22 (d, 3J = 7 Hz,
9 H, CH(CH3)2), 1.28 (d, 
3J = 7 Hz, 9 H, CH(CH3)2), 1.77 (s, 9 H, CH3C6H4
iPr), 1.85–
2.95 (m, br, 24 H, CH2, piperazine), 2.18 (s, 9 H, NCH3), 2.76 (sept, 
3J = 7 Hz, 3 H,
CH(CH3)2), 3.20 (d, 
2J = 13 Hz, 3 H, NCH2), 3.37 (d, 
2J = 13 Hz, 3 H, NCH2), 5.22 (d,
3J = 6 Hz, 3 H, MeC6H4
iPr), 5.41 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 5.71 (d, 3J = 6 Hz,
3 H, MeC6H4
iPr), 5.74 (d, 3J = 7 Hz, 3 H, pyridone), 5.98 (d, 3J = 6 Hz, 3 H,
MeC6H4
iPr), 6.62 (d, 3J = 7 Hz, 3 H, pyridone).
[(Cymene)Ru(L5−2 H+)]3 × LiCl: 1H NMR (400 MHz, D2O): δ (ppm) = 1.23 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 1.25 (d, 
3J = 7 Hz, 9 H, CH(CH3)2), 1.73 (s, 9 H,
CH3C6H4
iPr), 1.80–2.95 (m, br, 24 H, CH2, piperazine), 2.21 (s, 9 H, NCH3), 2.75 (sept,
3J = 7 Hz, 3 H, CH(CH3)2), 3.29 (d, 
2J = 13 Hz, 3 H, NCH2), 3.45 (d, 
2J = 13 Hz, 3 H,
NCH2), 5.23 (m, br, 3 H, MeC6H4
iPr), 5.66 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 5.97 (d,
3J = 6 Hz, 3 H, MeC6H4
iPr), 6.00 (d, 3J = 6 Hz, 3 H, pyridone), 6.13 (m, br, 3 H,
MeC6H4
iPr), 6.77 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.43.
[(Cymene)Ru(L5−2 H+)]3 × Na+: 1H NMR (400 MHz, D2O): δ (ppm) = 1.27 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 1.30 (d, 
3J = 7 Hz, 9 H, CH(CH3)2), 1.81 (s, 9 H,
CH3C6H4
iPr), 1.90–2.90 (m, br, 24 H, CH2, piperazine), 2.23 (s, 9 H, NCH3), 2.79 (sept,
3J = 7 Hz, 3 H, CH(CH3)2), 3.30(d, 
2J = 13 Hz, 3 H, NCH2), 3.46 (d, 
2J = 14 Hz, 3 H,
NCH2), 5.37 (d, 
3J = 6 Hz, 3 H, MeC6H4
iPr), 5.62 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 5.95
(m, 6 H, MeC6H4
iPr), 6.12 (d, 3J = 6 Hz, 3 H, pyridone), 6.75 (d, 3J = 6 Hz, 3 H,
MeC6H4
iPr), 6.77 (d, 3J = 6 Hz, 3 H, pyridone).
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VIII.II.4.9 [(C6H5CO2Et)Ru(L2−H+)]33+
[(C6H5CO2Et)Ru(L2−H+)]33: 1H NMR (400 MHz,
D2O): δ (ppm) = 1.23 (t, 3J = 7 Hz, 9 H,
CO2CH2CH3), 1.35–2.05 (m, br, 18 H, CH2, piperid-
ine), 2.55–3.55 (m, 12 H, NCH2, piperidine), 3.85 (d,
2J = 13 Hz, 3 H, NCH2), 4.02 (d, 
2J = 13 Hz, 3 H,
NCH2), 4.26 (q, 
3J = 7 Hz, 6 H, CO2CH2CH3), 5.84
(d, 3J = 7 Hz, 3 H, C5H5CO2Et), 5.98 (m, 6 H,
C5H5CO2Et), 6.16 (t, 
3J = 6 Hz, 3 H, C5H5CO2Et),
6.56 (m, 6 H, C5H5CO2Et and pyridone), 6.77 (d,
3J = 6 Hz, 3 H, pyridone).
[(C6H5CO2Et)Ru(L2−H+)]33 × LiCl: 1H NMR (400 MHz, D2O): δ (ppm) = 1.25 (t,
3J = 7 Hz, 9 H, CO2CH2CH3), 1.35–2.05 (m, br, 18 H, CH2, piperidine), 2.60–3.60 (m,
12 H, NCH2, piperidine), 3.97 (d, 
2J = 13 Hz, 3 H, NCH2), 4.12 (d, 
2J = 13 Hz, 3 H,
NCH2), 4.30 (q, 
3J = 7, Hz, 6 H, CO2CH2CH3), 6.10–6.30 (m, 12 H, C5H5CO2Et), 6.72
(d, 3J = 6 Hz, 3 H, C5H5CO2Et or pyridone), 6.77 (d, 
3J = 6 Hz, 3 H, C5H5CO2Et or
pyridone), 6.87 (d, 3J = 5 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.45.
VIII.II.4.10 [(C6H5CO2Et)Ru(L5−H+)]33+
[(C6H5CO2Et)Ru(L5−H+)]33+: 1H NMR (400 MHz,
D2O): δ (ppm) = 1.22 (t, 3J = 7 Hz, 9 H,
CO2CH2CH3), 2.35–3.45 (m, br, 24 H, CH2, pipera-
zine), 2.64 (s, 9 H, NCH3), 3.35 (d, 
2J = 13 Hz, 3 H,
NCH2), 3.57 (d, 
2J = 13 Hz, 3 H, NCH2), 4.22 (q,
3J = 7, Hz, 6 H, CO2CH2CH3), 5.79 (d, 
3J = 6 Hz, 3 H,
C5H5CO2Et), 5.95 (m, 6 H, C5H5CO2Et), 6.11 (t,
3J = 6 Hz, 3 H, C5H5CO2Et), 6.51 (m, 6 H,
C5H5CO2Et and pyridone), 6.73 (d, 
3J = 6 Hz, 3 H,
pyridone).
[(C6H5CO2Et)Ru(L5−H+)]33+ × LiCl: 1H NMR
(400 MHz, D2O): δ (ppm) = 1.22 (t, 3J = 7 Hz, 9 H, CO2CH2CH3), 2.35–3.45 (m, br,
24 H, CH2, piperazine), 2.64 (s, 9 H, NCH3), 3.35 (d, 
2J = 13 Hz, 3 H, NCH2), 3.57 (d,
2J = 13 Hz, 3 H, NCH2), 4.22 (q, 
3J = 7 Hz, 6 H, CO2CH2CH3), 5.79 (d, 
3J = 6 Hz, 3 H,
C5H5CO2Et), 5.95 (m, 6 H, C5H5CO2Et), 6.11 (t, 
3J = 6 Hz, 3 H, C5H5CO2Et), 6.51 (m,
6 H, C5H5CO2Et and pyridone), 6.73 (d, 
3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.46.
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VIII.II.4.11 [CpRh(L2−H+)]33+
[CpRh(L2−H+)]33+: 1H NMR (400 MHz, D2O): δ (ppm) =
1.45–1.85 (m, br, 18 H, CH2, piperidine), 2.95 (m, br, 12 H,
NCH2, piperidine), 3.92 (d, 
2J = 13 Hz, 3 H, NCH2), 4.07 (d,
2J = 13 Hz, 3 H, NCH2), 5.77 (s, 15 H, Cp), 5.98 (d,
3J = 6 Hz, 3 H, pyridone), 6.92 (d, 3J = 6 Hz, 3 H, pyridone).
[CpRh(L2-H+)]3
3+ × LiCl: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.35–1.90 (m, br, 18 H, CH2, piperidine), 2.92 (m,
br, 12 H, NCH2, piperidine), 4.04 (d, 
2J = 13 Hz, 3 H,
NCH2), 4.10 (d, 
2J = 13 Hz, 3 H, NCH2), 5.90 (s, 15 H, Cp),
6.23 (d, 3J = 6 Hz, 3 H, pyridone), 7.05 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.05.
VIII.II.4.12 [CpRh(L5−H+)]33+
[(Cp)Rh(L5−H+)]33+: 1H NMR (400 MHz, D2O): δ (ppm) =
2.45–3.30 (m, br, 24 H, CH2, piperazine), 2.65 (s, 9 H,
NCH3), 3.41 (d, 
2J = 13 Hz, 3 H, NCH2), 3.62 (d,
2J = 13 Hz, 3 H, NCH2), 5.72 (s, 15 H, Cp), 5.94 (d,
3J = 6 Hz, 3 H, pyridone), 6.85 (d, 3J = 6 Hz, 3 H, pyridone).
[(Cp)Rh(L5-H+)]3
3+ × LiCl: 1H NMR (400 MHz, D2O):
δ (ppm) =  2.45–3.30 (m, br, 24 H, CH2, piperazine), 2.69 (s,
9 H, NCH3), 3.45 (d, 
2J = 13 Hz, 3 H, NCH2), 3.61 (d,
2J = 13 Hz, 3 H, NCH2), 5.84 (s, 15 H, Cp), 6.18 (d,
3J = 6 Hz, 3 H, pyridone), 6.97 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.08.
VIII.II.4.13 [(C5HMe4)Rh(L2−H+)]33+
[(C5HMe4)Rh(L2−H+)]33+: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.35–2.00 (m, br, 18 H, CH2, piperidine), 1.45 (s,
9 H, CH3), 1.59 (s, 9 H, CH3), 1.70 (s, 9 H, CH3), 1.86 (s,
9 H, CH3), 2.70–3.55 (m, br, 12 H, NCH2, piperidine), 3.86
(d, 2J = 13 Hz, 3 H, NCH2), 4.09 (d, 
2J = 13 Hz, 3 H,
NCH2), 5.29 (s, 3 H, C5Me4H), 5.87 (d, 
3J = 6 Hz, 3 H, pyri-
done), 6.75 (d, 3J = 6 Hz, 3 H, pyridone).
[(C5HMe4)Rh(L2−H+)]33+ × LiCl: 1H NMR (400 MHz,
D2O): δ (ppm) = 1.25–2.10 (m, br, 18 H, CH2, piperidine),
VIII Experimental Part
176
1.35 (s, 9 H, CH3), 1.52 (s, 9 H, CH3), 1.73 (s, 9 H, CH3), 1.88 (s, 9 H, CH3), 2.60–3.60
(m, br, 12 H, NCH2, piperidine), 4.00 (d, 
2J = 13 Hz, 3 H, NCH2), 4.15 (d, 
2J = 13 Hz,
3 H, NCH2), 5.64 (s, 3 H, C5Me4H), 6.15 (d, 
3J = 6 Hz, 3 H, pyridone), 6.85 (d,
3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = 0.08.
VIII.II.4.14 [(C5HMe4)Rh(L5−2 H+)]3
Similar to complex [(cymene)Ru(L5−2 H+)]3, the complex
[(C5HMe4)Rh(L5−H+)]33+ was soluble in water even after
complete deprotonation of the amine groups. However, the
difference lies in the fact the 2.0 eqiv. of CsOH were neces-
sary to ensure complete trimerisation. The complex obtained
from the self-assembly of 8 and L5 in MeOH in the presence
of Cs2CO3 was used for any kind of experiment.
[(C5HMe4)Rh(L5−2 H+)]3: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.47 (s, 9 H, CH3), 1.60 (s, 9 H, CH3), 1.74 (s,
9 H, CH3), 1.88 (s, 9 H, CH3), 2.05–3.10 (m, br, 24 H, CH2,
piperazine), 2.24 (s, 9 H, NCH3, piperazine), 3.35 (d, 
2J = 13 Hz, 3 H, NCH2), 3.44 (d,
2J = 13 Hz, 3 H, NCH2), 5.31 (s, 3 H, C5Me4H), 5.83 (d, 
3J = 6 Hz, 3 H, pyridone), 6.79
(d, 3J = 7 Hz, 3 H, pyridone).
[(C5HMe4)Rh(L5−2 H+)]3 × LiCl: 1H NMR (400 MHz, D2O): δ (ppm) = 1.32 (s, 9 H,
CH3), 1.47 (s, 9 H, CH3), 1.76 (s, 9 H, CH3), 1.91 (s, 9 H, CH3), 2.05–3.05 (m, br, 24 H,
CH2, piperazine), 2.21 (s, 9 H, NCH3, piperazine), 3.41 (d, 
2J = 14 Hz, 3 H, NCH2), 3.49
(d, 2J = 14 Hz, 3 H, NCH2), 5.63 (s, 3 H, C5Me4H), 6.07 (d, 
3J = 6 Hz, 3 H, pyridone),
6.86 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = 0.03.
[(C5HMe4)Rh(L5−2 H+)]3 × Na+: 1H NMR (400 MHz, D2O): δ (ppm) = 1.38 (s, 9 H,
CH3), 1.52 (s, 9 H, CH3), 1.71 (s, 9 H, CH3), 1.85 (s, 9 H, CH3), 1.90–3.05 (m, br, 24 H,
CH2, piperazine), 2.21 (s, 9 H, NCH3, piperazine), 3.38 (d, 
2J = 13 Hz, 3 H, NCH2), 3.45
(d, 2J = 14 Hz, 3 H, NCH2), 5.39 (s, 3 H, C5Me4H), 6.98 (d, 
3J = 6 Hz, 3 H, pyridone),
6.82 (d, 3J = 6 Hz, 3 H, pyridone).
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VIII.II.4.15 [Cp*Rh(L2−H+)]33+
[Cp*Rh(L2−H+)]33+: 1H NMR (400 MHz, D2O): δ (ppm) =
1H NMR (400 MHz, D2O): δ (ppm) = 1.40–1.90 (m, br,
18 H, CH2, piperidine), 1.72 (s, 45 H, Cp*), 2.80–3.35 (m,
br, 12 H, CH2, piperidine), 3.85 (d, 
2J = 13 Hz, 3 H, NCH2),
4.00 (d, 2J = 13 Hz, 3 H, NCH2), 5.76 (d, 
3J = 7 Hz, 3 H,
pyridone), 6.70 (d, 3J = 7 Hz, 3 H, pyridone).
[Cp*Rh(L2−H+)]33+ × LiCl: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.35–1.95 (m, br, 18 H, CH2, piperidine), 1.70 (s,
45 H, Cp*), 2.75–3.25 (m, br, 12 H, CH2, piperidine), 3.92
(d, 2J = 14 Hz, 3 H, NCH2), 4.01 (d, 
2J = 13 Hz, 3 H, NCH2), 6.19 (d, 
3J = 6 Hz, 3 H,
pyridone), 685 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = 0.07.
VIII.II.4.16 [Cp*Rh(L5−H+)]33+
More than 1.0 equiv of CsOH was necessary to induce com-
plete trimerisation in water. Unfortunately, the complex pre-
cipitated when adding more than 1.0 equiv. of CsOH,
rendering the investiagation of its binding properties impos-
sible. However, the synthesis of the deprotonated complex
[Cp*Rh(L5−2 H+)]3 starting from 9 and L5 in MeOH in the
presence of Cs2CO3 was achieved. The detailed synthesis
and characterisation of the complex is described in the next
section.
VIII.II.4.17 [(C5HMe4)Ir(L2−H+)]33+
[(C5HMe4)Ir(L2−H+)]33+: 1H NMR (400 MHz, D2O):
δ (ppm) = 1H NMR (400 MHz, D2O): δ (ppm) = 1.35–2.05
(m, br, 18 H, CH2, piperidine), 1.50 (s, 9 H, CH3), 1.53 (s,
9 H, CH3), 1.65 (s, 9 H, CH3), 1.81 (s, 9 H, CH3), 2.70–3.50
(m, br, 12 H, NCH2, piperidine), 3.92 (d, 
2J = 13 Hz, 3 H,
NCH2), 4.16 (d, 
2J = 13 Hz, 3 H, NCH2), 5.40 (s, 3 H,
C5HMe4), 5.89 (d, 
3J = 7 Hz, 3 H, pyridone), 6.83 (d,
3J = 7 Hz, 3 H, pyridone).
[(C5HMe4)Ir(L2−H+)]33+ × LiCl: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.35 (s, 9 H, CH3), 1.40 (s, 9 H, CH3), 1.45–1.95 (m, br, 18 H, CH2, piperid-
ine), 1.69 (s, 9 H, CH3), 1.85 (s, 9 H, CH3), 3.03 (m, br, 12 H, NCH2, piperidine), 4.00
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(d, 2J = 13 Hz, 3 H, NCH2), 4.19 (d, 
2J = 13 Hz, 3 H, NCH2), 5.77 (s, 3 H, C5HMe4),
6.18 (d, 3J = 6 Hz, 3 H, pyridone), 6.91 (d, 3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.55.
VIII.II.4.18 [(C5HMe4)Ir(L5−H+)]33+
[(C5HMe4)Ir(L5−H+)]33+: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.48 (s, 9 H, CH3), 1.52 (s, 9 H, CH3), 1.66 (s,
9 H, CH3), 1.79 (s, 9 H, CH3), 2.45–3.40 (m, br, 24 H, CH2,
piperazine), 2.59 (s, 9 H, NCH3), 3.54 (d, 
2J = 13 Hz, 3 H,
NCH2), 3.85 (d, 
2J = 13 Hz, 3 H, NCH2), 5.37 (s, 3 H,
C5HMe4), 5.85 (d, 
3J = 6 Hz, 3 H, pyridone), 6.81 (d,
3J = 7 Hz, 3 H, pyridone).
[(C5HMe4)Ir(L5−H+)]33+ × LiCl: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.33 (s, 9 H, CH3), 1.38 (s, 9 H, CH3), 1.70 (s,
9 H, CH3), 1.85 (s, 9 H, CH3), 2.45–3.45 (m, br, 24 H, CH2,
piperazine), 2.66 (s, 9 H, NCH3), 3.54 (d, 
2J = 13 Hz, 3 H, NCH2), 3.84 (d, 
2J = 13 Hz,
3 H, NCH2), 5.74 (s, 3 H, C5HMe4), 6.11 (d, 
3J = 6 Hz, 3 H, pyridone), 6.90 (d,
3J = 6 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.60.
VIII.II.4.19 [Cp*Ir(L2−H+)]33+
[Cp*Ir(L2−H+)]33+: 1H NMR (400 MHz, D2O): δ (ppm) = 1H
NMR (400 MHz, D2O): δ (ppm) = 1.45–1.95 (m, br, 18 H,
CH2, piperidine), 1.67 (s, 45 H, Cp*), 3.04 (m, br, 12 H,
NCH2, piperidine), 3.90 (d, 
2J = 13 Hz, 3 H, NCH2), 4.09 (d,
2J = 13 Hz, 3 H, NCH2), 5.81 (d, 
3J = 7 Hz, 3 H, pyridone),
6.78 (d, 3J = 7 Hz, 3 H, pyridone).
[Cp*Ir(L2−H+)]33+ × LiCl: 1H NMR (400 MHz, D2O):
δ (ppm) = 1.35–2.05 (m, br, 18 H, CH2, piperidine), 1.64 (s,
45 H, Cp*), 3.03 (m, br, 12 H, NCH2, piperidine), 3.96 (d,
2J = 13 Hz, 3 H, NCH2), 4.17 (d, 
2J = 13 Hz, 3 H, NCH2),
6.22 (d, 3J = 6 Hz, 3 H, pyridone), 6.91 (d, 3J = 6 Hz, 3 H, pyridone).
The binding affinity towards Li+ was so low, that a 7Li NMR spectrum in reasonable
quality could not be obtained.
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VIII.II.4.20 [Cp*Ir(L5−H+)]33+
[Cp*Ir(L5−H+)]33+: 1H NMR (400 MHz, D2O): δ (ppm) =
1.65 (s, 45 H, Cp*), 2.35–3.45 (m, br, 24 H, CH2, pipera-
zine), 2.58 (s, 9 H, NCH3), 3.56 (d, 
2J = 13 Hz, 3 H, NCH2),
3.87 (d, 2J = 11 Hz, 3 H, NCH2), 5.76 (d, 
3J = 7 Hz, 3 H,
pyridone), 6.75 (d, 3J = 6 Hz, 3 H, pyridone).
[Cp*Ir(L5−H+)]33+ × LiCl: Although the complex did form,
the quality of the obtained 1H NMR spectrum was not suffi-
cient to present any data. Especially the NCH2 peaks were so
broad, that no fine structure was visible. In addition, the
pyridone and Cp* peaks indicated that a third species beside
[Cp*Ir(L5−H+)]33+ and its LiCl adduct was present.
VIII.II.5 Neutral 12-Metallacrown-3 Complexes
General synthesis for trimeric metallamacrocycles: A suspension of halfsandwich
complex [(π-ligand)MCl2]2 (0.50 mmol), ligand (L1, L2, L3, L4 or L5) (1.00 mmol) and
Cs2CO3 (815 mg, 2.50 mmol) was stirred for 2 h in degassed methanol (20 mL) at room
temperature. After evaporation of the solvent under reduced pressure, the product was
extracted with dichloromethane (40 mL). Twice the volume of hexane (80 mL) was
added and the solution was concentrated to 10 mL. In general, most of the trimeric
metallamacrocycles precipitated. The precipitate was filtered and dried in vacuo. The
average yield is about 60 %.
General method for the synthesis of LiCl adducts: A double Schlenk with integrated
fritte and equipped with teflon stoppers was used in order to avoid any contamination of
the product with grease. CHCl3 was dried using by chromatography and MeOH was dis-
tilled over Mg. A mixture of the trimeric metallamacrocycle (0.50 mmol) and an 100fold
excess of LiCl (10 mL, 50 mmol, 0.5 M solution in dry MeOH) were stirred at room tem-
perature. After removal of the solvant under reduced pressure, the LiCl adducts were
extracted with CHCl3.
VIII.II.5.a Trimers Obtained from [(π-ligand)MCl2]2 and Ligand L1
The trimers [(C6H6)Ru(L1−2 H+)]3, [(C6Me6)Ru(L1−2 H+)]3, [Cp*Rh(L1−2 H+)]3  and
their corresponding LiCl adducts were synthesised according to literature proce-
dures.[124]
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VIII.II.5.1 [(C6H6)Ru(L1−2 H+)]3[124]
The synthetic procedure described in the literature used water as
solvent. Unfortunately, the complex seems to be very air sensitive
in the presence of water. A green-brown instead of an orange prod-
uct indicated that the synthesis failed. Alternatively, the complex
can be self-assembled in MeOH. Representative synthetic proce-
dure: A suspension of 1 (250 mg, 0.50 mmol) and L1 (115 mg,
1.00 mmol) and Cs2CO3 (815 mg, 2.5 mmol) was stirred in
degassed MeOH (20 mL) for 2 h at room temperature. The reaction mixture became a
clear orange solution. After evaporation of the solvent under reduced pressure, the prod-
uct was extracted with CH2Cl2 (100 mL). Hexane (100 mL) was added and the volume
reduced to about 25 mL. The product precipitated, was filtered off and dried in vacuo.
The trimer was obtained as an orange powder in 69 % yield (200 mg, 0.23 mmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 5.56 (s, 18 H, C6H6), 5.72 (dd, 3J = 7 Hz,
3J = 6 Hz, 3 H, pyridone), 6.22 (dd, 3J = 7 Hz, 4J = 2 Hz, 3 H, pyridone), 6.72 (dd,
3J = 6 Hz, 4J = 2 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 81.92 (C6H6), 110.79, 115.82, 133.06. 156.11,
170.87 (pyridone).
1H NMR (400 MHz, MeOD): δ (ppm) = 5.58 (s, 18 H, C6H6), 5.67 (dd, 3J = 7 Hz,
3J = 6 Hz, 3 H, pyridone), 6.11 (dd, 3J = 7 Hz, 4J = 2 Hz, 3 H, pyridone), 6.65 (dd,
3J = 6 Hz, 4J = 2 Hz, 3 H, pyridone).
13C NMR (101 MHz, MeOD): δ (ppm) = 83.00 (C6H6), 110.51, 116.05, 134.19. 156.05,
172.30 (pyridone).
VIII.II.5.2 [(C6H5Me)Ru(L1−2 H+)]3
A suspension of 2 (264 mg, 0.50 mmol) and L1 (115 mg,
1.00 mmol) and Cs2CO3 (815 mg, 2.5 mmol) was stirred in
degassed MeOH (20 mL) for 2 h at room temperature. The
reaction mixture became a clear orange solution. After evapora-
tion of the solvent under reduced pressure, the product was
extracted with CH2Cl2 (40 mL). Hexane (50 mL) was added
and the volume reduced to about 15 mL. The product precipi-
tated, was filtered off and dried in vacuo. The trimer was obtained as an orange powder
in 75 % yield (228 mg, 0.25 mmol). Crystals were obtained from CHCl3 layered with
pentane.
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.20 (s, 9 H, CH3C6H5), 5.16 (d, 3J = 6 Hz,
3 H, C6H5Me), 5.21 (t, 
3J = 5 Hz, 3 H, C6H5Me), 5.25 (d, 
3J = 6 Hz, 3 H, C6H5Me),
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5.56 (t, 3J = 6 Hz, 3 H, C6H5Me), 5.69 (t, 
3J = 6 Hz, 3 H, C6H5Me), 5.71 (dd, 
3J = 7 Hz,
3J = 6 Hz, 3 H, pyridone), 6.18 (dd, 3J = 7 Hz, 4J = 1 Hz, 3 H, pyridone), 6.67 (dd,
3J = 6 Hz, 4J = 2 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 18.98 (CH3), 75.60, 77.53, 79.19, 85.22, 85.62,
98.16 (C6H5), 110.489, 115.19, 132.522, 156.62, 171.00 (pyridone).
VIII.II.5.3 [(C6H5Me)Ru(L1−2 H+)]3 × LiCl
[(C6H5Me)Ru(L1−2 H+)]3 (45 mg, 50 μmol) was stirred in a
LiCl solution in MeOH (10 mL, 0.5 M) for 5 min at room tem-
perature using a double Schlenk with integrated fritte. After
evaporation of the solvent under reduced pressure, the LiCl
adduct was extracted with CHCl3 (20 mL). The orange solution
was concentrated to dryness and the product dried in vacuo. An
orange powder was obtained in 40 % yield (19 mg, 20 μmol).
Crystals suited for single crystal X-ray analysis were obtained by slow diffusion of Et2O
into CHCl3.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.91 (s, 9 H, CH3C6H5), 5.10 (d, 3J = 6 Hz,
3 H, C6H5Me), 5.58 (t, 
3J = 5 Hz, 3 H, C6H5Me), 5.89 (d, 
3J = 6 Hz, 3 H, C6H5Me),
5.93 (dd, 3J = 8 Hz, 3J = 6 Hz, 3 H, pyridone), 6.11 (t, 3J = 6 Hz, 3 H, C6H5Me), 6.38
(dd, 3J = 7 Hz, 4J = 1 Hz, 3 H, pyridone), 6.53 (t, 3J = 6 Hz, 3 H, C6H5Me), 6.76 (dd,
3J = 6 Hz, 4J = 1 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 18.72 (CH3), 75.21, 75.56, 78.61, 87.46, 81.81,
100.95 (C6H5), 113.11, 117.88, 133.00, 156.06, 167.90 (pyridone).
7Li NMR (156 MHz, CDCl3): δ (ppm) = − 0.10.
VIII.II.5.4 [(C6H3
iPr3)Ru(L1−2 H+)]3
A suspension of 5 (300 mg, 0.40 mmol), 3-hydroxy-2-pyri-
done (88 mg, 0.80 mmol) and Cs2CO3 (650 mg, 2.00 mmol)
in degassed MeOH (20 mL) was stirred for 2 h at room tem-
perature.  After evaporation of the solvent under reduced
pressure, the product was extracted with  CH2Cl2 (40 mL).
Evaporation of the solvent under reduced pressure gave an
orange powder. The product was recrystallised from hot hex-
ane. Red crystals suited for single crystal X-ray analysis in
69 % yield (239 mg, 0.18 mmol) were obtained.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.24 (d, 3J = 7 Hz, 27 H, CH(CH3)2), 1.35 (d,
3J = 7 Hz, 27 H, CH(CH3)2), 3.09 (sept, 
3J = 7 Hz, 9 H, CH(CH3)2), 4.84 (s, 9 H,
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C6H3
iPr3), 5.53 (t, 
3J = 7 Hz, 3 H, pyridone), 5.96 (dd, 3J = 7 Hz, 4J = 2 Hz, 3 H, pyri-
done), 6.61 (dd, 3J = 6 Hz, 4J = 2 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 21.85, 23.74 (CH3), 30.84 (CH(CH3)2), 68.45
(C6H3
iPr3), 108.85, 109.21, 113.63, 133.23, 157.91, 172.34 (C6H3
iPr3 & pyridone).
1H NMR (400 MHz, MeOD): δ (ppm) = 1.27 (d, 3J = 7 Hz, 27 H, CH(CH3)2), 1.38 (d,
3J = 7 Hz, 27 H, CH(CH3)2), 3.14 (sept, 
3J = 7 Hz, 9 H, CH(CH3)2), 5.00 (s, 9 H,
C6H3
iPr3), 5.54 (t, 
3J = 7 Hz, 3 H, pyridone), 6.00 (dd, 3J = 7 Hz, 4J = 2 Hz, 3 H, pyri-
done), 6.69 (dd, 3J = 6 Hz, 4J = 2 Hz, 3 H, pyridone).
13C NMR (101 MHz, MeOD): δ (ppm) = 22.26, 23.99 (CH3), 32.02 (CH(CH3)2), 69.57
(C6H3
iPr3), 109.96, 110.69, 115.52, 135.36, 157.76, 173.43 (C6H3
iPr3 & pyridone).
Elemental analysis (%) calcd (found) for C60H81N3O6Ru3 × 0.5 C6H14 × H2O: C 58.00
(58.13), H 6.95 (6.92), N 3.22  (3.24).
VIII.II.5.5 [(C6H3
iPr3)Ru(L1−2 H+)]3 × LiCl
[(C6H3
iPr3)Ru(L1−2 H+)]3 (62 mg, 50 μmol) was stirred in a
LiCl solution in MeOH (10 mL, 0.5 M) for 1 h at room tem-
perature using a double Schlenk with integrated fritte. After
evaporation of the solvent under reduced pressure, the LiCl
adduct was extracted with dry CHCl3 (20 mL). The orange
solution was concentrated to dryness and the product dried in
vacuo. An orange powder was obtained in 22 % yield
(14 mg, 11 μmol). Crystals suited for single crystal X-ray
analysis were obtained by recrystallisation from hot hexane.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.13 (d, 3J = 6 Hz, 27 H, CH(CH3)2), 1.27 (d,
3J = 7 Hz, 27 H, CH(CH3)2), 3.53 (sept, br, 
3J = 6 Hz, 9 H, CH(CH3)2), 5.57 (s, 9 H,
C6H3
iPr3), 5.71 (t, 
3J = 7 Hz, 3 H, pyridone), 6.14 (dd, 3J = 7 Hz, 4J = 1 Hz, 3 H, pyri-
done), 6.63 (dd, 3J = 6 Hz, 4J = 1 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 22.60, 23.43 (CH3), 30.00 (CH(CH3)2), 70.38
(C6H3
iPr3), 109.10, 111.72, 116.57, 133.20, 157.50, 170.15 (C6H3
iPr3 & pyridone).
7Li NMR (156 MHz, CDCl3): δ (ppm) = − 0.18.
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VIII.II.5.6 [(C6Me6)Ru(L1−2 H+)]3[124]
Alternatively to the synthesis described in the literature, the
complex can be isolated by extraction with dichloromethane.
Representative synthetic procedure: A suspension of 6 (334 mg,
0.50 mmol) and L1 (115 mg, 1.00 mmol) and Cs2CO3 (815 mg,
2.5 mmol) was stirred in degassed MeOH (20 mL) for 2 h at
room temperature. The reaction mixture became a clear orange
solution. After evaporation of the solvent under reduced pres-
sure, the product was extracted with CH2Cl2 (40 mL). Hexane (40 mL) was added and
the volume reduced to about 15 mL. The product precipitated, was filtered off and dried
in vacuo. The trimer was obtained as an orange powder in 76 % yield (289 mg,
0.26 mmol).
 1H NMR (400 MHz, CDCl3): δ (ppm) = 2.10 (s, 18 H, C6Me6), 5.53 (d, 3J = 7 Hz, 3 H,
pyridone), 5.96 (d, 3J = 9 Hz, 3 H, pyridone), 6.34 (dd, 3J = 6 Hz, 3 H, pyridone).
1H NMR (400 MHz, MeOD): δ (ppm) = 2.19 (s, 18 H, C6Me6), 5.53 (d, 3J = 7 Hz, 3 H,
pyridone), 6.02 (d, 3J = 7 Hz, 3 H, pyridone), 6.44 (dd, 3J = 6 Hz, 3 H, pyridone).
13C NMR (101 MHz, MeOD): δ (ppm) = 16.73 (CH3), 90.46 (C6Me6), 110.15, 114.51,
134.04, 157.94, 173.16 (pyridone).
VIII.II.5.7 [(C6Me6)Ru(L1−2 H+)]3 × LiCl[124]
[(C6Me6)Ru(L1−2 H+)]3 (49 mg, 44 μmol) was stirred in a LiCl
solution in MeOH (9 mL, 0.5 M) for 1 h at room temperature
using a double Schlenk with integrated fritte. After evaporation
of the solvent under reduced pressure, the LiCl adduct was
extracted with dry CHCl3 (20 mL). The orange solution was
concentrated to dryness and the product dried in vacuo. A red
powder was obtained in 51 % yield (26 mg, 23 μmol). Remark:
The solubility of the trimer is rather low. The reaction mixture is best described as suspen-
sion instead of a solution.
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.16 (s, 18 H, C6Me6), 5.91 (dd, 3J = 7 Hz,
3J = 6 Hz, 3 H, pyridone), 6.32 (dd, 3J = 8 Hz, 4J = 2 Hz, 3 H, pyridone), 6.37 (dd,
3J = 6 Hz, 4J = 2 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 16.39 (CH3), 90.21 (C6Me6), 114.41, 118.18,
131.89, 156.71, 167.48 (pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = − 0.58 (br).
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VIII.II.5.8 [(C5HMe4)Rh(L1−2 H+)]3
A suspension of 8 (300 mg, 0.40 mmol), 3-hydroxy-2-pyridone
(88 mg, 0.80 mmol) and Cs2CO3 (650 mg, 2.00 mmol) in
degassed MeOH (20 mL) was stirred for 2 h at room tempera-
ture.  After evaporation of the solvent under reduced pressure,
the product was extracted with  CH2Cl3 (40 mL). The solvent
was evaporated to dryness and the product dried in vacuo. A
red-brown powder in 64 % yield (173 mg, 0.17 mmol) were
obtained. Crystals were obtained from Et2O.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.48 (s, 9 H, CH3), 1.58 (s, 9 H, CH3), 1.74 (s,
9 H, CH3), 1.89 (s, 9 H, CH3), 5.12 (s, 3 H, C5HMe4), 5.79 (dd, 
3J = 7 Hz, 3J = 6 Hz,
3 H, pyridone), 6.21 (dd, 3J = 7 Hz, 4J = 2 Hz, 3 H, pyridone), 6.73 (dd, 3J = 6 Hz,
4J = 2 Hz, 3 H, pyridone).
VIII.II.5.9 [(C5HMe4)Rh(L1−2 H+)]3 × LiCl
Crystals were obtained by vapour diffusion of pentane into a
solution of the complex in toluene.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.33 (s, 9 H,
(CH3)4C5H), 1.47 (s, 9 H, (CH3)4C5H), 1.75 (s, 9 H,
(CH3)4C5H), 2.05 (s, 9 H, (CH3)4C5H), 5.99 (dd, 
3J = 7 Hz,
3J = 6 Hz, 3 H, pyridone), 6.40 (dd, 3J = 7 Hz, 4J = 2 Hz, 3 H,
pyridone), 6.78 (dd, 3J = 6 Hz, 4J = 1 Hz, 3 H, pyridone), 6.90
(s, 3 H, C5HMe4).
VIII.II.5.10 [Cp*Ru(L1−2 H+)]3[124]
Representative synthetic procedure: A suspension of 9 (309 mg,
0.50 mmol), 3-hydroxy-2-pyridone (115 mg, 1.00 mmol) and
Cs2CO3 (815 mg, 2.50 mmol) in degassed MeOH (20 mL) was
stirred for 2 h at room temperature.  After evaporation of the
solvent under reduced pressure, the product was extracted with
CH2Cl2 (40 mL). Hexane (40 mL) was added and the volume
reduced to about 15 mL. The product precipitated, was filtered
off and dried in vacuo. The trimer was obtained as an red-brown
powder in 89 % yield (309 mg, 0.30 mmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.73 (s, 15 H, Cp*), 5.72 (t, 3J = 7 Hz, 3 H,
pyridone), 6.14 (dd, 3J = 7 Hz, 4J = 2 Hz, 3 H, pyridone), 6.71 (dd, 3J = 6 Hz, 4J = 1 Hz,
3 H, pyridone).
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VIII.II.5.11 [Cp*Ru(L1−2 H+)]3 × LiCl[124]
[Cp*Ru(L1−2 H+)]3 (52 mg, 50 μmol) was stirred in a LiCl
solution in MeOH (10 mL, 0.5 M) for 1 h at room temperature
using a double Schlenk with integrated fritte. After evaporation
of the solvent under reduced pressure, the LiCl adduct was
extracted with dry CHCl3 (20 mL). The solution was concen-
trated to dryness and the product dried in vacuo. An red-brown
powder was obtained in 35 % yield (19 mg, 18 μmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.74 (s, 15 H, Cp*),
6.02 (dd, 3J = 8 Hz, 3J = 6 Hz, 3 H, pyridone), 6.40 (dd, 3J = 8 Hz, 4J = 2 Hz, 3 H, pyri-
done), 6.74 (dd, 3J = 6 Hz, 4J = 1 Hz, 3 H, pyridone).
7Li NMR (156 MHz, D2O): δ (ppm) = 009.
VIII.II.5.b Mixed-Metal Complexes
VIII.II.5.1 [{(C6H6)Ru(L1−2 H+)}2{(C6H3iPr3)Ru(L1−2 H+)}]
A suspension of 5 (62 mg, 0.10 mmol, 1.0 equiv.), 1 (110 mg,
0.22 mmol, 2.2 equiv.), 3-hydroxy-2-pyridone (69 mg,
0.60 mmol) and Cs2CO3 (489 mg, 1.50 mmol) in degassed
MeOH (20 mL) was stirred over night at 45 °C.  After evapora-
tion of the solvent under reduced pressure, the product was
extracted with  CH2Cl2 (30 mL). A small amount of precipitate
was observed after addition of hexane (60 mL), which was
removed by filtration. The clear solution was concentrated to
15 mL, the resulting precipitate filtered off and dried in vacuo. The mixed trimer was
obtained as an orange powder in 64 % yield (126 mg, 0.13 mmol) and 96 % purity.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.40 (d, 3J = 7 Hz, 9 H, CH(CH3)2), 1.44 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 2.81 (sept, br, 
3J = 7 Hz, 3 H, CH(CH3)2), 4.97 (s, 3 H,
C6H3
iPr3), 5.44 (s, 6 H, C6H6), 5.45 (s, 6 H, C6H6), 5.62–5.69 (m, 3 H, pyridone), 6.08
(dd, 3J = 7 Hz, 4J = 2 Hz, 1 H, pyridone), 6.12 (dd, 3J = 7 Hz, 4J = 2 Hz, 1 H, pyridone),
6.16 (dd, 3J = 7 Hz, 4J = 1 Hz, 1 H, pyridone), 6.60 (dd, 3J = 6 Hz, 4J = 1 Hz, 1 H, pyri-
done), 6.63 (dd, 3J = 6 Hz, 4J = 2 Hz, 1 H, pyridone), 6.67 (dd, 3J = 6 Hz, 4J = 1 Hz,
1 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 22.60, 23.28 (CH3), 31.51 (CH), 71.09 (C6H3),
81.60, 81.66 (C6H6), 107.10 (C6H3), 109.99, 110.24, 110.30, 114.82, 115.09, 115.33,
132.11, 132.81, 133.11, 156.05, 156.28, 157.43, 171.06, 171.07, 171.62 (pyridone).
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VIII.II.5.2 [{(C6H6)Ru(L1−2 H+)}2{(C6Me6)Ru(L1−2 H+)}]
A suspension of 6 (67 mg, 0.10 mmol, 1.0 equiv.), 1 (110 mg,
0.22 mmol, 2.2 equiv.), 3-hydroxy-2-pyridone (69 mg,
0.60 mmol) and Cs2CO3 (489 mg, 1.50 mmol) in degassed
MeOH (20 mL) was stirred over night at 45 °C.  After evapora-
tion of the solvent under reduced pressure, the product was
extracted with  CH2Cl2 (30 mL). A small amount of precipitate
was observed after addition of hexane (60 mL), which was
removed by filtration. The clear solution was concentrated to
15 mL, the resulting precipitate filtered off and dried in vacuo. The mixed trimer was
obtained as an orange powder in 60 % yield (113 mg, 0.12 mmol) and 92 % purity. The
complex was crystallised from CHCl3/pentane.
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.16 (s, 18 H, C6Me6), 5.46 (s, 6 H, C6H6), 5.48
(s, 6 H, C6H6), 5.60 (dd, 
3J = 7 Hz, 3J = 6 Hz, 1 H, pyridone), 5.67 (t, 3J = 7 Hz, 1 H,
pyridone), 5.71 (dd, 3J = 7 Hz, 3J = 6 Hz, 1 H, pyridone), 6.03 (dd, 3J = 7 Hz, 4J = 1 Hz,
1 H, pyridone), 6.16 (dd, 3J = 7 Hz, 4J = 1 Hz, 1 H, pyridone), 6.17 (dd, 3J = 7 Hz,
4J = 2 Hz, 1 H, pyridone), 6.47 (dd, 3J = 6 Hz, 4J = 2 Hz, 1 H, pyridone), 6.60 (dd,
3J = 6 Hz, 4J = 2 Hz, 1 H, pyridone), 6.60 (dd, 3J = 6 Hz, 4J = 2 Hz, 1 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 15.71 (CH3), 81.47, 81.62 (C6H6), 89.11
(C6Me6), 109.51, 110.14, 110.53, 113.38, 114.73, 115.05, 131.36, 132.23, 132.21,
156.10, 156.13, 158.39, 170.28, 171.19, 171.76 (pyridone).
VIII.II.5.3 [{(C6H6)Ru(L1−2 H+)}2{Cp*Rh(L1−2 H+)}]
A suspension of 9 (62 mg, 0.10 mmol, 1.0 equiv.), 1 (150 mg,
0.30 mmol, 3.0 equiv.), 3-hydroxy-2-pyridone (69 mg,
0.60 mmol) and Cs2CO3 (489 mg, 1.50 mmol) in degassed
MeOH (20 mL) was stirred over night at 45 °C.  After evapora-
tion of the solvent under reduced pressure, the product was
extracted with  CH2Cl2 (30 mL). A small amount of precipitate
was observed after addition of hexane (60 mL), which was
removed by filtration. The clear solution was concentrated to
15 mL, the resulting precipitate filtered off and dried in vacuo. The mixed trimer was
obtained as brown-red powder in 62 % yield (114 mg, 0.12 mmol) and 83 % purity. The
complex was crystallised from benzene/pentane.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.77 (s, 18 H, Cp*), 5.45 (s, 6 H, C6H6), 5.46 (s,
6 H, C6H6), 5.65 (t, 
3J = 7 Hz, 1 H, pyridone), 5.69 (t, 3J = 7 Hz, 1 H, pyridone), 5.79 (t,
3J = 7 Hz, 1 H, pyridone), 6.10 (dd, 3J = 7 Hz, 4J = 1 Hz, 1 H, pyridone), 6.19 (dd,
3J = 7 Hz, 4J = 1 Hz, 1 H, pyridone), 6.23 (dd, 3J = 7 Hz, 4J = 1 Hz, 1 H, pyridone), 6.62
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(dd, 3J = 6 Hz, 4J = 1 Hz, 1 H, pyridone), 6.64 (dd, 3J = 6 Hz, 4J = 1 Hz, 1 H, pyridone),
6.73 (dd, 3J = 6 Hz, 4J = 1 Hz, 1 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 14.26 (CH3), 81.57, 81.77 (C6H6), 90.32 (d,
1J(C,Rh) = 8 Hz, C, Cp*), 109.72, 110.24, 110.96, 113.99, 115.12, 115.21, 131.76,
131.84, 132.38, 156.25, 156.63, 157.93, 169.95, 171.22, 171.88 (pyridone).
VIII.II.5.c Trimers obtained from [(π-ligand)MCl2]2 and Ligands L2–L5
VIII.II.5.1 [(cymene)Ru(L2−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.26 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 1.34 (d, 
3J = 7 Hz, 9 H,
CH(CH3)2), 1.41 (m, br, 18 H, CH2, piperidine), 2.05 (s,
9 H, CH3C6H4
iPr), 2.16 (m, br, 12 H, NCH2, piperid-
ine), 2.74 (sept, 3J = 7 Hz, 3 H, CH(CH3)2), 3.23 (d,
2J = 14 Hz, 3 H, NCH2), 3.33 (d, 
2J = 14 Hz, 3 H,
NCH2), 5.09 (d, 
3J = 6 Hz, 3 H, MeC6H4
iPr), 5.22 (d,
3J = 5 Hz, 3 H, MeC6H4
iPr), 5.33 (d, 3J = 5 Hz, 3 H,
MeC6H4
iPr), 5.58 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 5.69
(d, 3J = 6 Hz, 3 H, pyridone), 6.50 (d, 3J = 6 Hz, 3 H,
pyridone).
VIII.II.5.2 [(cymene)Ru(L3−2 H+)]3
A suspension of complex 3 (306 mg, 0.50 mmol), ligand
L3 (210 mg, 1.00 mmol) and Cs2CO3 (815 mg,
2.50 mmol) in degassed methanol (20 mL) was stirred
for 2 h at room temperature. After evaporation of the
solvent under reduced pressure, the product was
extracted with dichloromethane (40 mL). Twice the vol-
ume of hexane (80 mL) was added and the solution was
concentrated to 10 mL. The precipitate was filtered and
dried in vacuo. The product was obtained as an orange
powder in 62 %yield (305 mg, 0.21 mmol). Orange
crystals were obtained either by slow diffusion of pentane into a solution of
[(cymene)Ru(L3−2 H+)]3 in benzene.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.28 (d, 3J = 7 Hz, 9 H, CH(CH3)2), 1.37 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 2.12 (s, 9 H, CH3C6H4
iPr), 2.22 (m, br, 12 H, CH2, morpho-
line), 2.75 (sept, 3J = 7 z, 3 H, CH(CH3)2), 3.35 (d, 
2J = 14 Hz, 3 H, NCH2), 3.33 (d,
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2J = 14 Hz, 3 H, NCH2), 2.55 (m, br, 12 H, CH2, morpholine), 5.08 (d, 
3J = 6 Hz, 3 H,
MeC6H4
iPr), 5.20 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 5.29 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr),
5.52 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 5.68 (d, 3J = 6 Hz, 3 H, pyridone), 6.49 (d,
3J = 6 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 18.60, 22.93, 23.20 (CH3, MeC6H4iPr), 31.37
(CH, CH(CH3)2), 54.08, 55.71, 67.28 (NCH2, OCH2, morpholine), 77.36, 79.93, 81.49,
82.03 (CH, MeC6H4
iPr), 95.80, 98.07 (C, MeC6H4
iPr), 110.25, 123.11, 131.22, 155.32,
170.83 (pyridone).
Elemental analysis (%) calcd (found) for C60H78N6O9Ru3: C 54.16 (54.45), H 5.91
(5.98), N 6.32 (6.24).
VIII.II.5.3 [(cymene)Ru(L4−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.26 (d, 3J = 7 Hz,
9 H, CH(CH3)2), 1.34 (d, 
3J = 7 Hz, 9 H, CH(CH3)2), 1.93 (s,
9 H, CH3C6H4
iPr), 1.99 (s, 18 H, N(CH3)2), 2.78 (sept,
3J = 7 Hz, 3 H, CH(CH3)2), 3.09 (d, 
2J = 13 Hz, 3 H, NCH2),
3.35 (d, 2J = 13 Hz, 3 H, NCH2), 5.05 (d, 
3J = 6 Hz, 3 H,
MeC6H4
iPr), 5.28 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 5.45 (d,
3J = 6 Hz, 3 H, MeC6H4
iPr), 5.75 (d, 3J = 6 Hz, 3 H, pyri-
done), 5.58 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 6.56 (d,
3J = 6 Hz, 3 H, pyridone).
VIII.II.5.4 [(cymene)Ru(L5−2 H+)]3
A suspension of complex 3 (612 mg, 1.00 mmol),
ligand L5 (447 mg, 2.00 mmol) and Cs2CO3 (1.60 g,
5.00 mmol) in degassed methanol (40 mL) was stirred
for 2 h at room temperature. After evaporation of the
solvent under reduced pressure the product was
extracted with hot hexane (1 × 300 mL and
3 × 125 mL). The solution was concentrated (15 mL)
and cooled down to − 18 °C for 1 h. The precipitate
was filtered and dried in vauco. The product was
obtained as an orange powder in 54 % yield (502 mg,
0.36 mmol). Red crystals were obtained by slow diffusion of pentane into a solution of
[(cymene)Ru(L5−2 H+)]3 in benzene.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.26 (d, 3J = 7 Hz, 9 H, CH(CH3)2), 1.34 (d,
3J = 7 Hz, 9 H, CH(CH3)2), 2.09 (s, 9 H, CH3C6H4
iPr), 2.22 (s, 9 H, NCH3, piperazine),
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1.75–2.65 (m, br, 24 H, NCH2, piperazine), 2.73 (sept, 
3J = 7 Hz, 3 H, CH(CH3)2), 3.28
(d, 2J = 13 Hz, 3 H, NCH2), 3.33 (d, 
2J = 13 Hz, 3 H, NCH2), 5.09 (d, 
3J = 5 Hz, 3 H,
MeC6H4
iPr), 5.21 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr), 5.30 (d, 3J = 6 Hz, 3 H, MeC6H4
iPr),
5.56 (d, 3J = 5 Hz, 3 H, MeC6H4
iPr), 5.69 (d, 3J = 6 Hz, 3 H, pyridone), 6.49 (d,
3J = 6 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 18.86, 22.87, 23.19 (CH3, MeC6H4iPr), 31.26
(CH, CH(CH3)2), 46.27 (NCH3), 53.48, 55.27, 55.54 (NCH2, piperazine), 77.32, 79.89,
81.53, 82.15 (CH, MeC6H4
iPr), 95.97, 98.01 (C, MeC6H4
iPr), 110.35, 123.96, 131.20,
154.99, 170.67 (pyridone).
Elemental analysis (%) calcd (found) for C63H87N9O6Ru3 × H2O: C 54.53 (54.48),
H 6.46 (6.79), N 9.08 (9.22).
VIII.II.5.5 [(C6H3
iPr3)Ru(L2−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.19 (d,
3J = 7 Hz, 27 H, CH(CH3)2), 1.37 (d, 
3J = 7 Hz, 27 H,
CH(CH3)2), 1.90 (m, br, 18 H, CH2, piperidine), 2.30 (m,
br, 12 H, CH2, piperidine), 2.85 (d, 
2J = 13 Hz, 3 H,
NCH2), 3.10 (sept, 
3J = 7 Hz, 3 H, CH(CH3)2), 3.47 (d,
2J = 12 Hz, 3 H, NCH2), 4.77 (s, 9 H, C6H3
iPr3), 5.46 (d,
3J = 6 Hz, 3 H, pyridone), 6.44 (d, 3J = 6 Hz, 3 H, pyri-
done).
VIII.II.5.6 [(C6H3
iPr3)Ru(L3−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.20 (d,
3J = 7 Hz, 27 H, CH(CH3)2), 1.37 (d, 
3J = 7 Hz, 27 H,
CH(CH3)2), 2.32 (m, br, 12 H, CH2, morpholine), 3.01
(d, 2J = 13 Hz, 3 H, NCH2), 3.07 (sept, 
3J = 7 Hz, 3 H,
CH(CH3)2), 3.39 (d, 
2J = 13 Hz, 3 H, NCH2), 3.63 (m,
br, 12 H, CH2, morpholine), 4.77 (s, 9 H, C6H3
iPr3), 5.49
(d, 3J = 6 Hz, 3 H, pyridone), 6.47 (d, 3J = 6 Hz, 3 H,
pyridone).
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VIII.II.5.7 [(C6H3
iPr3)Ru(L4−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.20 (d, 3J = 7 Hz,
27 H, CH(CH3)2), 1.36 (d, 
3J = 7 Hz, 27 H, CH(CH3)2),
2.10 (s, 18 H, N(CH3)2), 2.88 (d, 
2J = 12 Hz, 3 H, NCH2),
3.08 (sept, 3J = 7 Hz, 3 H, CH(CH3)2), 3.37 (d, 
2J = 12 Hz,
3 H, NCH2), 4.77 (s, 9 H, C6H3
iPr3), 5.48 (d, 
3J = 6 Hz, 3 H,
pyridone), 6.47 (d, 3J = 6 Hz, 3 H, pyridone).
VIII.II.5.8 [(C6H3
iPr3)Ru(L5−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.19 (d,
3J = 7 Hz, 27 H, CH(CH3)2), 1.35 (d, 
3J = 7 Hz, 27 H,
CH(CH3)2), 2.25 (s, 9 H, NCH3), 2.35 (m, br, 24 H,
CH2, piperazine), 2.96 (d, 
2J = 12 Hz, 3 H, NCH2),
3.08 (sept, 3J = 7 Hz, 3 H, CH(CH3)2), 3.39 (d,
2J = 12 Hz, 3 H, NCH2), 4.77 (s, 9 H, C6H3
iPr3), 5.49
(d, 3J = 6 Hz, 3 H, pyridone), 6.46 (d, 3J = 6 Hz, 3 H,
pyridone).
VIII.II.5.9 [(C6Me6)Ru(L2−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.85–2.45 (m,
br, 30 H, CH2, piperidine), 2.10 (s, 54 H, C6Me6), 3.06
(d, 2J = 13 Hz, 3 H, NCH2), 3.48 (d, 
2J = 12 Hz, 3 H,
NCH2), 5.50 (m, br, 3 H, pyridone), 6.16 (d, 
3J = 6 Hz,
3 H, pyridone).
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VIII.II.5.10 [(C6Me6)Ru(L3−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.10 (s, 54 H,
C6Me6), 2.41 (m, br, 12 H, CH2, morpholine), 3.13 (d,
2J = 13 Hz, 3 H, NCH2), 3.47 (d, 
2J = 13 Hz, 3 H,
NCH2), 3.65 (m, br, 12 H, CH2, morpholine), 5.50 (m, br,
3 H, pyridone), 6.17 (d, 3J = 6 Hz, 3 H, pyridone).
VIII.II.5.11 [(C6Me6)Ru(L4−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.10 (s, 54 H,
C6Me6), 2.18 (s, 18 H, N(CH3)2), 3.03 (d, br, 
2J = 10 Hz,
3 H, NCH2), 3.43 (d, br, 
2J = 10 Hz, 3 H, NCH2), 5.51 (m, br,
3 H, pyridone), 6.17 (d, 3J = 6 Hz, 3 H, pyridone).
VIII.II.5.12 [(C6Me6)Ru(L5−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 2.09 (s, 54 H,
C6Me6), 2.26 (s, 9 H, NCH3), 2.15–2.65 (m, br, 24 H,
piperazine), 3.10 (d, 2J = 13 Hz, 3 H, NCH2), 3.46 (d,
2J = 12 Hz, 3 H, NCH2), 5.49 (d, 
3J = 6 Hz, 3 H, pyri-
done), 6.16 (d, 3J = 6 Hz, 3 H, pyridone).
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VIII.II.5.13 [(C5HMe4)Rh(L5−2 H+)]3
A suspension of complex 8 (295 mg, 0.50 mmol),
ligand L5 (223 mg, 1.00 mmol) and Cs2CO3 (815 mg,
2.50 mmol) in degassed methanol (30 mL) was stirred
for 2 h at room temperature. After evaporation of the
solvent under reduced pressure, the product was
extracted with dichloromethane (40 mL). Addition of
hexane (60 mL) and concentration of the solvent gave
a red-brown powder which was dried in vacuo. The
product was obtained in 64 % yield (348 mg,
0.21 mmol). Red crystals were obtained from water.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.44 (s, 9 H, CH3), 1.53 (s, 9 H, CH3), 1.67 (s,
9 H, CH3), 1.86 (s, 9 H, CH3), 2.00–2.75 (m, br, 24 H, CH2, piperazine), 2.25 (s, 9 H,
NCH3, piperazine), 3.24 (d, 
2J = 13 Hz, 3 H, NCH2), 3.43 (d, 
2J = 13 Hz, 3 H, NCH2),
5.04 (s, 3 H, C5HMe4), 5.75 (d, 
3J = 6 Hz, 3 H, pyridone), 6.57 (d, 3J = 6 Hz, 3 H, pyri-
done). 
13C NMR (101 MHz, CDCl3): δ (ppm) = 11.21, 11.43, 13.20, 13.37 (CH3, C5HMe4),
49.07 (NCH3), 56.20, 58.30, 58.63 (NCH2, piperazine), 76.80 (d, 
1J(C,Rh) = 8 Hz, CH,
C5HMe4), 97.34 (d, 
1J(C,Rh) = 6 Hz, C, C5HMe4), 102.68 (d, 
1J(C,Rh) = 6 Hz, C,
C5HMe4), 115.40, 125.34, 132.54, 159.38, 172.85 (pyridone).  
Elemental analysis (%) calcd (found) for C60H84N9O6Rh3 × 2 H2O × 3 CH2Cl2:
C 46.51 (46.46), H 5.82 (5.97), N 7.75 (7.71).
During the NMR experiments with receptor [(C5HMe4)Rh(L5−2 H+)]3, it was
observed that the 1H NMR signals of the methyl groups of the π-ligand gradually lost
intensity. A likely explanation for this observation is a selective H/D exchange. An
exchange of this kind has been observed for aqueous solutions of Cp*Rh[377] as well as
Cp*Ru[378] complexes. A more detailed analysis revealed that the H/D exchange is
slightly inhibited if the receptor is bound to a Li+ guest: in the presence of two equivalents
of LiCl, 7 % of the methyl protons were exchanged after 24 hours whereas without lith-
ium ions 20 % were exchanged.
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VIII.II.5.14 [Cp*Rh(L2−2 H+)]3
The complex was obtained as a dark red powder in 75 %
yield (255 mg, 0.25 mmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.25–1.55 (m,
br, 18 H, CH2, piperidine), 1.70 (s, 45 H, Cp*), 2.29 (m,
br, 12 H, CH2, piperidine), 3.28 (d, 
2J = 13 Hz, 3 H,
NCH2), 3.34 (d, 
2J = 13 Hz, 3 H, NCH2), 5.67 (m, br,
3 H, pyridone), 6.56 (d, 3J = 6 Hz, 3 H, pyridone).
VIII.II.5.15 [Cp*Rh(L3−2 H+)]3
The complex was obtained as a dark red powder in 75 %
yield (318 mg, 0.24 mmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.70 (s, 45 H,
Cp*), 2.35 (m, br, 12 H, CH2, morpholine), 3.27 (d,
2J = 12 Hz, 3 H, NCH2), 3.35 (d, 
2J = 13 Hz, 3 H,
NCH2), 3.63 (m, br, 12 H, CH2, morpholine), 5.65 (d,
3J = 6 Hz, 3 H, pyridone), 6.55 (d, 3J = 6 Hz, 3 H, pyri-
done).
VIII.II.5.16 [Cp*Rh(L4−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.69 (s, 45 H, Cp*),
2.10 (s, 18 H, N(CH3)2), 3.19 (d, 
2J = 13 Hz, 3 H, NCH2),
3.36 (d, 2J = 12 Hz, 3 H, NCH2), 5.66 (d, 
3J = 6 Hz, 3 H,
pyridone), 6.56 (d, 3J = 6 Hz, 3 H, pyridone).
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VIII.II.5.17 [Cp*Rh(L5−2 H+)]3
A suspension of complex 9 (309 mg, 0.50 mmol),
ligand L5 (223 mg, 1.00 mmol) and Cs2CO3 (815 mg,
2.50 mmol) in degassed methanol (40 mL) was stirred
for 2 h at room temperature. After evaporation of the
solvent under reduced pressure the product was
extracted with dichloromethane (40 mL). The solvent
was removed to dryness under reduced pressure and
the red-brown powder dried in vacuo. The product was
obtained in 55 % yield (325 mg, 0.18 mmol). Crystals
were obtained by slow diffusion of pentane into a solu-
tion of [Cp*Rh(L5−2 H+)]3 in benzene.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.68 (s, 45 H, CH3, Cp*), 2.05–2.75 (m, br,
24 H, NCH2, piperazine), 2.25 (s, 9 H, NCH3, piperazine), 3.27 (d, 
2J = 13 Hz, 3 H,
NCH2), 3.37 (d, 
2J = 13 Hz, 3 H, NCH2), 5.66 (d, 
3J = 6 Hz, 3 H, pyridone), 6.54 (d,
3J = 6 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 9.31 (CH3, Cp*), 46.30 (NCH3), 53.43, 55.56,
55.92 (NCH2, piperazine), 89.83 (d, 
1J(C,Rh) = 8 Hz, C, Cp*), 111.45, 121.36, 130.11,
157.24, 170.53 (pyridone).
Elemental analysis (%) calcd (found) for C63H87N9O6Ru3 × 1.5 CH2Cl2: C 51.46
(51.26), H 6.23 (6.24), N 8.37 (8.31).
VIII.II.5.18 [Cp*Ir(L2−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.25–1.55 (m,
br, 18 H, CH2, piperidine), 1.66 (s, 45 H, Cp*), 2.31 (m,
br, 12 H, CH2, piperidine), 3.25 (d, 
2J = 13 Hz, 3 H,
NCH2), 3.40 (d, 
2J = 13 Hz, 3 H, NCH2), 5.67 (d,
3J = 6 Hz, 3 H, pyridone), 6.60 (d, 3J = 6 Hz, 3 H, pyri-
done).
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VIII.II.5.19 [Cp*Ir(L3−2 H+)]3
A suspension of complex 11 (398 mg, 0.50 mmol),
ligand L3 (210 mg, 1.00 mmol) and Cs2CO3 (815 mg,
2.50 mmol) in degassed methanol (40 mL) was stirred
for 2 h at room temperature. After evaporation of the
solvent under reduced pressure the product was
extracted with dichloromethane (40 mL). Evaporation of
the solvent gave an orange powder, which was dried in
vacuo. The product was obtained in 59 % yield (321 mg,
0.20 mmol). Crystals were obtained by slow diffusion of
pentane into a solution of [Cp*Ir(L3−2 H+)]3 in dichlo-
romethane.
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.65 (s, 45 H, CH3, Cp*), 2.35 (m, br, 12 H,
CH2, morpholine), 3.34 (d, 
2J = 3 Hz, 3 H, NCH2), 3.39 (d, 
2J = 13 Hz, 3 H, NCH2),
3.63 (m, br, 12 H, CH2, morpholine), 5.67 (d, 
3J = 6 Hz, 3 H, pyridone), 6.59 (d,
3J = 6 Hz, 3 H, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 9.54 (CH3, Cp*), 54.02, 56.07, 67.38 (CH2,
morpholine), 80.94 (C, Cp*), 111.59, 122.10, 130.51, 158.24, 172.55 (pyridone).
Elemental analysis (%) calcd (found) for C60H81N6O9Ir3 × 2 H2O: C 43.86 (43.55),
H 5.21 (5.14), N 5.12 (4.74).
VIII.II.5.20 [Cp*Ir(L4−2 H+)]3
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.66 (s, 45 H, Cp*),
2.12 (s, 18 H, N(CH3)2), 3.16 (d, 
2J = 13 Hz, 3 H, NCH2),
3.40 (d, 2J = 12 Hz, 3 H, NCH2), 5.68 (d, 
3J = 6 Hz, 3 H,
pyridone), 6.61 (d, 3J = 6 Hz, 3 H, pyridone).
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VIII.II.5.21 [Cp*Ir(L5−2 H+)]3
The complex could be obtained as yellow powder in
96 % yield (329 mg, 0.32 mmol).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.64 (s, 45 H,
Cp*), 2.25–2.65 (m, br, 24 H, piperazine), 2.25 (s, 9 H,
NCH3), 3.32 (d, 
2J = 13 Hz, 3 H, NCH2), 3.41 (d,
2J = 13 Hz, 3 H, NCH2), 5.68 (d, 
3J = 6 Hz, 3 H, pyri-
done), 6.58 (d, 3J = 6 Hz, 3 H, pyridone).
VIII.II.6 Expanded Triple-Stranded Helicates
Complexes from the self-assembly of 1, 2 and 8 and the ligands bearing two dihydroxy-
pyridine units L13, L14 and L15 are presented. They were crystallised from a monomer
solution in the presence of NEt3. The solubilized complexes were sensitive towards acid
and CDCl3 used for the NMR spectra was stored over basic Al2O3 in order to remove
any traces of acid.
General procedure for the synthesis of expanded trinuclear helicates by crystallisation
from water: A mixture of halfandwich complex [(π-ligand)MCl2]2 (30 μmol) and the
ligand (30.0 μmol) was stirred in water (10 mL) until a clear solution of the dinuclear
monomeric complex (3.0 mM) was obtained. NEt3 was added by either layering it care-
fully over the aqueous solution or by vapor diffusion. Both methods gave similar yields.
Non-crystalline precipitate was separated from the crystals by repeated addition of water
and decantation. The crystals were filtered isolated and dried in air. The ligands can be
used either without further purification or after purification by HPLC as TFA salts. In the
latter case, the yields of the complexes are higher. The purity of the complexes deter-
mined by 1H NMR spectroscopy was similar for both methods. If ligands were used with-
out further purification, the crystals had to be separated from a fluffy precipitate by
repeated addition of water and decantation.
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VIII.II.6.1 [{(C6H6)Ru}2(L13−4 H+)]3
A suspension of halfsandwich  complex 1 (15.0 mg,
30.0 μmol) and the TFA salt of ligand L13 (16.8 mg,
30.0 mmol) was stirred in water (10 mL) until a clear solu-
tion of monomer (3 mM) was obtained. The solution was
carefully layered with NEt3. Orange crystals in 52 % yield
(14.5 mg, 5.21 μmol) were obtained. Vapour diffusion of
NEt3 into a monomer solution in water showed slightly bet-
ter yields (16.0 mg, 5.75 μmol, 58 %).
1H NMR (400 MHz, C2DCl2): δ (ppm) = 1.42 (m, br, 6 H,
NCH2), 1.85 (m, br, 6 H, NCH2), 2.27 (m, br, 6 H, NCH2),
2.59 (m, br, 6 H, NCH2), 3.12 (d, 
2J = 16 Hz, 6 H, NCH2), 3.21 (d, 
2J = 16 Hz, 6 H,
NCH2), 5.59 (s, 36 H, C6H6), 5.67 (d, 
3J = 6 Hz, pyridone), 6.56 (d, 3J = 6 Hz, pyri-
done).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.47 (m, br, 6 H, NCH2), 1.88 (m, br, 6 H,
NCH2), 2.47 (m, br, 6 H, NCH2), 2.69 (m, br, 6 H, NCH2), 3.24 (d, 
2J = 17 Hz, 6 H,
NCH2), 3.40 (d, 
2J = 17 Hz, 6 H, NCH2), 5.52 (s, 36 H, C6H6), 5.77 (d, 
3J = 6 Hz, pyri-
done), 6.65 (d, 3J = 6 Hz, pyridone).
VIII.II.6.2 [{(C6H5Me)Ru}2(L13−4 H+)]3
A suspension of complex 2 (15.9 mg, 30.0 μmol) and the
TFA salt of ligand L13 (16.8 mg, 30.0 mmol) was stirred in
water (10 mL) until a clear solution of monomer (3 mM) was
obtained. The solution was carefully layered with NEt3.
Orange crystals in 60 % yield (14.4 mg, 6.01 μmol) were
obtained. Vapour diffusion of NEt3 into a monomer solution
in water showed similar yields (13.0 mg, 5.42 μmol, 54 %).
1H NMR (400 MHz, C2DCl2): δ (ppm) = 1.40 (m, br, 6 H,
NCH2), 1.85 (m, br, 6 H, NCH2), 2.24 (s, 18 H, CH3), 2.35
(m, br, 6 H, NCH2), 2.60 (m, br, 6 H, NCH2), 3.13 (d,
2J = 17 Hz, 6 H, NCH2), 3.20 (d, 
2J = 16 Hz, 6 H, NCH2), 5.16 (m, 18 H, C6H5Me),
5.39 (t, 3J = 6 Hz, C6H5Me), 5.57 (t, 
3J = 5 Hz, C6H5Me), 5.64 (d, 
3J = 6 Hz, pyridone),
6.51 (d, 3J = 6 Hz, pyridone).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.50 (m, br, 6 H, NCH2), 1.95 (m, br, 6 H,
NCH2), 2.12 (s, 18 H, CH3), 2.47 (m, br, 6 H, NCH2), 2.68 (m, br, 6 H, NCH2), 3.25 (d,
2J = 17 Hz, 6 H, NCH2), 3.39 (d, 
2J = 17 Hz, 6 H, NCH2), 5.13 (d, 
3J = 6 Hz, C6H5Me),
5.19 (d, 3J = 6 Hz, C6H5Me), 5.21 (t, 
3J = 6 Hz, C6H5Me), 5.54 (t, 
3J = 5 Hz, C6H5Me),
5.75 (t, 3J = 6 Hz, C6H5Me), 5.75 (d, 
3J = 6 Hz, pyridone), 6.61 (d, 3J = 6 Hz, pyridone).
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13C NMR (101 MHz, CDCl3): δ (ppm) = 18.83 (Me), 52.00, 55.50 (br, NCH2, pipera-
zine), 56.36 (NCH2), 75.65, 76.84, 79.08, 85.28, 85.71, 98.28 (C6H5), 108.06, 126.31,
131.76, 153.52, 169.72 (pyridone).
Elemental analysis (%) calcd (found) for C90H96N12O12Ru6 × 14 H2O: C 45.11 (45.23),
H 5.22, (4.98), N 7.01 (7.29).
VIII.II.6.3 [{(C6H5Me)Ru}2(L14−4 H+)]3
A suspension of complex 2 (39.6 mg, 75.0 μmol) and
the unpurified ligand L14 (25.1 mg, 75.0 mmol) was
stirred in water (20 mL) until a clear solution of mono-
mer (7.5 mM) was obtained. The solution was evenly
distributed on two test tubes which were placed in a
Schlenk containing NEt3. Red crystals in 38 % yield
(450 mg, 19.0 μmol) were obtained. Slow diffusion of
NEt3 into a monomer solution in water showed similar
yields (48.8 mg, 20.6 μmol, 41 %).
1H NMR (400 MHz, CDCl3): δ (ppm) = 1.83 (s, 18 H, CH3), 2.14 (s, 18 H, NCH3), 3.32
(d, 2J = 15 Hz, 6 H, NCH2), 3.49 (d, 
2J = 15 Hz, 6 H, NCH2), 5.12 (d, 
3J = 6 Hz,
C6H5Me), 5.14 (d, 
3J = 6 Hz, C6H5Me), 5.24 (t, 
3J = 6 Hz, C6H5Me), 5.57 (t, 
3J = 5 Hz,
C6H5Me), 5.69 (t, 
3J = 6 Hz, C6H5Me), 5.85 (d, 
3J = 6 Hz, pyridone), 6.55 (d, 3J = 6 Hz,
pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 18.79 (Me), 42.90 (NMe), 55.78, 56.16
(NCH2), 75.57, 77.09, 78.733, 85.45, 85.84, 98.24 (C6H5), 109.95, 126.40, 131,66,
154.11, 170.02 (pyridone).
Elemental analysis (%) calcd (found) for C90H102N12O12Ru6 × 12 H2O: C 45.68
(45.45), H 5.37 (5.05), N 7.10 (7.15).
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VIII.II.6.4 [{(C5HMe4)Rh}2(L15−4 H+)]3
A mixture of half-sandwich complex [(C5HMe4)RhCl2]2
(17.7 mg, 30.0 μmol) and the TFA salt of ligand L15 (20.5 mg,
30.0 μmol) was stirred in water (10 mL) until a clear solution of
monomer (3.0 mM) was obtained. The solution was carefully lay-
ered with NEt3. Red-brown crystals in 30 % yield (9.4 mg,
2.97 μmol) were obtained. Vapour diffusion of NEt3 into a mono-
mer solution in water showed slightly better  yields (11.8 mg,
3.72 μmol, 37 %).
1H NMR (400 MHz, CDCl3): δ (ppm) = 0.84 (m, br, 6 H, CH2),
1.12 (m, br, 24 H, CH2), 1.35–1.95 (m, br, 30 H, CH & CH2),
1.50 (s, 18 H, CH3), 1.56 (s, 18 H, CH3), 1.67 (s, 18 H, CH3),
1.86 (s, 18 H, CH3),  2.38 (mc, 6 H, CH2), 2.67 (mc, 6 H, CH2),
3.03 (d, 2J = 14 Hz, 6 H, NCH2), 3.74 (d, 
2J = 14 Hz, 6 H,
NCH2), 5.09 (s, 6 H, C5HMe4), 5.77 (d, 
3J = 6 Hz, pyridone),
6.68 (d, 3J = 6 Hz, pyridone).
13C NMR (101 MHz, CDCl3): δ (ppm) = 8.39, 8.68, 10.41, 10.75 (Me), 23.99, 32.65,
33.76, 35.64, 37.69 (CH, CH2), 53.71, 54.09, 56.29 (NCH2), 74.38, 81.78, 93.73, 96.98,
100.66 (C5HMe4), 111.98, 123.67, 130.68, 155.85, 169.79 (pyridone). The fine structure
of the C5HMe4 peaks was not resolved enough to determine the 
1J(Rh,C) coupling con-
stants.
Elemental analysis (%) calcd (found) for C129H174N12O12Rh6 ×15 H2O: C 52.12
(52.08), H 6.92 (6.73), N 5.65 (5.83).
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VIII.III Measurements
VIII.III.1 Kinetic Measurements
VIII.III.1.a Metal Fragment Exchange Kinetics
Metal fragment exchange between [(cymene)Ru(L2−H+)]3 and [(C6H3iPr3)Ru(L2−
H+)]3: [(cymene)Ru(L2−H+)]3 (3.1 mg, 3.03 μmol) and [(C6H3iPr3)Ru(L2−H+)]3
(3.7 mg, 3.01 μmol) were dissolved in MeOD (0.6 mL). After heating the mixture to
40 °C, 1H NMR measurements were started immediately. The concentration of the sym-
metric and mixed receptors was determined by integration of suited 1H NMR signals. he
total concentration of trimers was 10.1 mM.
Metal fragment exchange between [(C6H6)Ru(L2−H+)]3 and [(C6H3iPr3)Ru(L2−H+)]3:
[(C6H6)Ru(L2−H+)]3 (2.5 mg, 2.9 μmol) and [(C6H3iPr3)Ru(L2−H+)]3 (1.7 mg, 1.4 μmol)
were dissolved in MeOD (0.7 mL). After heating the mixture to 40 °C, 1H NMR meas-
urements were started immediately. The concentration of the symmetric and mixed com-
plexes was determined by integration of suited 1H NMR signals. The total concentration
of trimers was 6.08 mM.
VIII.III.1.b Li+ Complexation Kinetics
A solution of LiCl in D2O (12μL, 0.5 M, 2.0 equiv.) was added to a solution of complex
[(cymene)Ru(L5−2 H+)]3 or [(cymene)Ru(L2−H+)]3 in D2O (0.6 mL, 5.0 mM) in an
NMR tube (final concentratios: [receptor] = 4.9 mM, [Li+] = 9.8 mM). The mixture was
shaken vigorously and the 1H NMR measurements were started immediately. The con-
centration of the free receptor and its Li+ adduct was determined by integration of suited
1H NMR signals.
VIII.III.2 Binding Constants Ka
General procedure for the determination of the binding constant Ka: In a typical experi-
ment, a mixture of the halfsandwich complex [(π-ligand)MCl2]2 (37.5 μmol) and the
respective ligand (75.0 μmol) was stirred in water (4.25 mL) until a clear solution was
obtained. CsOH solution (250 μL, 0.3 M) was added to induce the assembly process.
The solution was divided in five equal parts (900 μL, 5.56 mM) and stock solutions of
various alkali metal salts were added: LiCl (100 μL, 0.10 M, 2.0 equiv.), Na2SO4
(125 μL, 2.0 M, 100 equiv.), KOAc (125 μL, 4.0 M, 100 equiv.), CsOAc (125 μL,
4.0 M, 100 equiv.). The mixtures were equilibrated for 24 hours at room temperature.
The binding constants Ka were determined by integration of suited 
1H NMR signals of
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the free and complexed receptor. In most cases, several baseline-separated signals were
available and averaged values were employed. The concentration of the receptor in such
an experiment was 5.0 mM and the concentration of Li+ 10.0 mM (2.0 equiv.). For
experiments with lower receptor concentration (1.00 mM for [(C5HMe4)Rh(L5−2 H+)]3
and [(cymene)Ru(L5−2 H+)]3) or higher Li+ concentrations, the amounts were varied
accordingly. No binding was observed for potassium or cesium acetate.
The binding constant was calculated as follows. Assumed was the reaction in equilib-
rium of one molecule trimer (Δ) with one cation Li+ to give one [ΔLi+] complex. The
association constant Ka is:
Eq. VIII.1
The total trimer concentration [Δ]tot and the total Li+ concentration [Li+]tot are the sum
of the trimer concentration [Δ] or the Li+ concentration in equilibrium [Li+], respectively
and the concentration of the complexed receptor [ΔLi+]:
Eq. VIII.2
Eq. VIII.3
Experimentally, the ratio I of the free and the complexed receptor is accessible:
Eq. VIII.4
The equilibrium constant can thus be expressed as:
Eq. VIII.5
The Li+ concentration in equilibrium [Li+] can be calculated by using the ratio of  the
free and the complexed receptor I and the total trimer and Li+ concentrations. First, the
total trimer concentration [Δ]tot is divided by the trimer concentration in equilibrium [Δ]:
Eq. VIII.6
Eq. VIII.7
Thus, the trimer concentration in equilibrium [Δ] can be expressed as:
Eq. VIII.8
Ka
ΔLi+[ ]
Δ[ ] Li+[ ]⋅
-------------------------=
Δ[ ]tot Δ[ ] ΔLi+[ ]+=
Li+[ ]tot Li+[ ] ΔLi+[ ]+=
I
ΔLi+[ ]
Δ[ ]----------------=
Ka I
1
Li+[ ]
------------⋅=
Δ[ ]tot
Δ[ ]-------------
Δ[ ]
Δ[ ]-------
ΔLi+[ ]
Δ[ ]----------------+=
ΔLi+[ ]
Δ[ ]---------------- I=
Δ[ ]tot
Δ[ ]------------- 1–=
Δ[ ] Δ[ ]tot
1 I+
-------------=
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This expression is combined with the expression of the total trimer concentration
[Δ]tot:
Eq. VIII.9
The bound receptor concentration [ΔLi+] can now be expressed as a function of the
ratio of free and complexed receptor I:
Eq. VIII.10
Combined with the expression of the total Li+ concentration [Li+]tot, the Li
+ concen-
tration in equilibrium [Li+] is now available:
Eq. VIII.11
Eq. VIII.12
Finally, the binding constant Ka can be calculated as a function of the ratio of the free
and complexed receptor I:
Eq. VIII.13
VIII.III.3 Colorimetric Test for Lithium Ions
A stock solution of receptor [(cymene)Ru(L5−2 H+)]3 (5.0 mM) was prepared by adding
CsOH solution (3.12 mL, 96.0 mM) to a solution of complex 3 (45.9 mg, 75.0 μmol) and
ligand L5 (31.2 mg, 150 μmol) in water (6.88 mL). The nine different samples shown in
Figure IV.20 were made by mixing the trimer stock solution (5.0 mM) and a LiCl solu-
tion (10.0 mM) with water in the right amounts to obtain the given concentrations. The
total volume of each sample amounts to 2.0 mL. After equilibration for 3 h, a solution of
FeCl3 in water was added (0.1 M, final Fe3
+ conc.: 1.7, 3.3 and 5.0 mM). The color
changes occurred instantly.
Δ[ ]tot
Δ[ ]tot
1 I+
------------- ΔLi+[ ]+=
ΔLi+[ ] Δ[ ]tot
Δ[ ]tot
1 I+
-------------–=
Li+[ ] Li+[ ]tot Δ[ ]tot
Δ[ ]tot
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Δ[ ]tot
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VIII.III.4 Titrations
VIII.III.4.a Potentiometric Titrations
General procedure for the potentiometric titration of monomeric complexes with CsOH:
A mixture of the halfsandwich complex [(π-ligand)MCl2]2 (75.0 μmol) and the respec-
tive ligand (150 μmol) was stirred in water (10 mL) until a clear solution was obtained.
The pH was measured after adding a CsOH stock solution in steps of 0.05 equiv. (78 μL,
96 mM). The reaction mixture was allowed to equilibrate for five minutes after each
addition of base. The concentration of the monomeric complex at the beginning of the
titration was 15.0 mM. All titration curves are given in chapter IX.V of the Appendix.
General procedure for the potentiometric titration of trimeric complexes with HCl: A
solution of the trimeric complex (5.0 mM) was generated in situ: A mixture of the half-
sandwich complex [(π-ligand)MCl2]2 (75.0 μmol) and the respective ligand (150 μmol)
was stirred in water (v(H2O) = 10 mL − x mL CsOH solution) until a clear solution was
obtained. The trimeric macrocycle formed after addition of 1.0 equiv.aa of CsOH
(1.56 mL, 96 mM). In case of [(cymene)Ru(L5−2 H+)]3 and [(C5HMe4)Rh(L5−2 H+)]3,
2.0 equiv.aa of CsOH were added (3.12 mL). HCl was added in steps of 0.05 equiv.aa
(76 μL, 0.1 M Titrisol) and the pH measured five minutes after addition. All titration
curves with HCl are given in chapter IX.V of the Appendix.
Titrations of [(cymene)Ru(L5−2 H+)]3 in the presence of LiCl were performed in a
similar manner. The LiCl adduct of the complex was generated in situ by mixing
[(cymene)RuCl2]2 (45.9 mg, 75.0 μmol) and ligand L5 (33.5 mg, 150 μmol) in water
(v(H2O) = 6.88 mL − x mL LiCl solution) until a clear solution was obtained. Then,
CsOH solution (3.12 mL, 96 mM, 2.0 equiv.aa) and various amounts of a Li+ stock solu-
tion (0.25 equiv.: 125 μL, 0.50 equiv.: 250 μL, 0.75 equiv.: 325 μL, 1.00 equiv.: 500 μL,
[LiCl] = 0.1 M; 20 equiv.: 2.0 mL, [LiCl] = 0.5 M). The reaction mixture was equili-
brated for three hours. Then, HCl solution was added in steps of 0.05 equiv.aa (76μL,
0.1 M Titrisol) and the pH was measured after 500s. The concentration of the
[(cymene)Ru(L5−2 H+)]3 × Li+ complex at the beginning was 5.0 mM. The titration
curves in the presence of the different amounts of LiCl are given in chapter IX.V of the
Appendix.
The calibration of curve of the pH as a function of the LiCl concentration
(Figure IV.19 on page 107) was obtained as follows: A mixture of [(cymene)RuCl2]2
(206.7 mg, 337.5 μmol) and ligand L5 (150.7 mg, 675 μmol) was stirred in water
(26.44 mL) until a clear orange solution was obtained. After addition of CsOH
(14.06 mL, 96 mM, 2.0 equiv.aa), a stock solution of the free receptor [(cymene)Ru(L5−
aa. Equivalents with respect to the ligand / metal fragments.
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2 H+)]3 (5.56 mM) was obtained. Various amounts of a LiCl stock solution (0.0–
2.0 equiv., 0.1 M, 0.1 equiv: 15 μL) were added to samples of 2.7 mL. The sample vol-
ume was then completed to 3.0 mL in order to obtain a receptor concentration of 5.0 mM.
The reaction mixture was equilibrated for three hours. After addition of 4.5 equiv.ab of
HCl (150 μL, 0.1 M), the solutions were allowed to equilibrate for five minutes before
measuring the pH.
VIII.III.4.b 1H NMR Titrations
A mixture of the halfsandwich complex [(π-ligand)MCl2]2 (37.5 μmol) and the respec-
tive ligand (75 μmol) was stirred in D2O (4.5 mL) until a clear solution of the corre-
sponding monomer (16.7) was obtained. Incremental amounts of 0.25 equiv. of CsOH in
D2O (25 μL, 0.15 M, 0.25 equiv.) were added to 900 μL monomer solution; the sample
solution was completed to 1.0 mL. In case of the mixture of [(cymene)RuCl2]2 or
[(C5HMe4)RhCl2]2 with ligand L5, a 0.3 M CsOH solution (12.5μL, 0.3 M, 0.25 equiv.)
was employed. The solution was stirred for two minutes before measuring the 1H NMR
spectra.
VIII.III.5 Measurement of the 7Li/6Li Isotopic ratio
The 7Li/6Li isotopic ratios were measured by isotope selective laser graphite furnace
atomic absorption spectroscopy in cooperation with Dr. H. D. Wizemann from the Uni-
versity of Hohenheim, Germany. The method will be decribed only briefly and for more
details it is referred to the literature.[379–381]
 The instrumentation used two diode lasers as radiation sources for the simultaneous
isotope selective excitation. The LiCl adduct of the corresponding 12-metallacrown-3
complex (7.2 μmol) was solubilized in MeOH (0.5 mL) and diluted with HNO3 solution
(0.1 M, 500 mL). Special care had to be taken not to contaminate the sample with traces
of lithium. The concentration of the macrocycle in solution was 14.4 μM which corre-
ponds to a lithium concentration of 100 ng/mL. A small sample volume (10–50 μL) was
then given into the sealed graphite furnace. After drying and ashing steps the furnace was
evacuated to a noble gas pressure of a few hPa and then heated up to approximately 1500–
2000 K where free analyte isotopes are generated. In order to suppress the contribution of
light radiated by the hot surface of the tube wall or other ambient radiation, the radiation
of each diode laser was modulated either by use of a chopper or by sinusoidal wavelength
modulation. Wavelength modulation provides a better signal-to-noise ratio and is pre-
ferred for small absorbances. The entire transmitted laser intensity was recorded by a pho-
todiode and finally processed by one lock-in amplifier for each laser beam (i.e. for each
ab.Equivalents with respect to the receptor concentration.
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isotope). This lock-in amplifier is referenced to the respective modulation frequency or a
higher harmonic thereof. For each atomization cycle a transient signal of a few seconds
duration was obtained for each isotope.
To avoid lithium carbide formation, the lithium solutions were atomized from a tanta-
lum foil which was placed on the bottom of the graphite tube. For this configuration, the
atomization temperature was determined out of the line width to be 1900 K. We measured
the Li isotope signals simultaneously by use of two laser diodes. The laser diode used for
7Li detection had to be tuned to match the 7Li D2 (670.962 nm) resonance transition
while the other laser diode used for 6Li detection had to be tuned to 6Li D1
(670.994 nm).[379] The two laser beams were collimated and merged by a mirror and a
beam splitter. The absorption of 6Li was expected to be only about a few percent of the
absorption of 7Li because the isotope abundance of the samples should be in the range of
the natural abundance (7Li/6Li = 12.18)[382] and the transition probability of D1 amounts
to only one half of the D2 transition probability. Thus, for 6Li detection 2f-wavelength
modulation[380] (3.8 kHz) was applied while the light used for 7Li excitation was modu-
lated by a chopper (10 kHz). The introduction of 10 μL of aqueous solutions with a Li
content of 100 ng/mL provided approximately 25% 7Li absorption. A part of the emission
of each laser was directed through a hot pipe oven which contained a constant amount of
Li vapor. This provided permanent signals suitable to control the frequency stability of
the diode lasers.
For the determination of the 7Li enrichment, the 7Li/6Li signal intensity ratio measured
for the LiCl solution was compared with the corresponding ratio found for the Li bound
in the corresponding metallamacrocyle. For each macrocycle, the investigation encom-
passed ten cycles of the following measurement sequence: LiCl solution, blank solution,
12-metallacrown-3 LiCl adduct solution. The measurements of the blank solution was
carried out in order to verify the absence of memory effects. When the solution of the
macrocycle and the LiCl solution contained the same quantity of Li, it was found that the
signals obtained by introduction of solutions of the metallamacrocycles were reduced to
approximately 2/3 compared with the signal of the LiCl solution. This observation is
referred to a matrix effect.[383] Since both isotopes are affected by a matrix effect in the
same way, it will have no influence on the measured isotope signal ratio. The 7Li/6Li peak
height ratio as well as the ratio for the peak area was determined for the simultaneously
measured 7Li and 6Li signals. The ratio obtained for area evaluation was always a little bit
larger than the peak height ratio. This is caused by the faster diffusion of  6Li out of the
region of interaction due to its lower mass.[379] The standard deviation of the 7Li/6Li ratio
mean value for ten measurements was below 1.5%.
According to the usual definition of isotope enrichment[384] the enrichment of the 7Li
isotope in the macrocycle is given by Equation V.7 of chapter V.III.
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IX.I Abbreviatons
br broad
CL Combinatorial Library
COT Cyclooctatriene
d dublett
DCC Dynamic Combinatorial Chemistry
DCL Dynamic Combinatorial Library
DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone
e.g. exempli gratia
EM Effective Molarity
equiv. equivalent
ESI Electrospray Ionisation
et al. et altera (and others)
HOMO Highest Occupied Molecular Orbital
ICP Inductively Coupled Plasma
i.e. id est
LUMO Lowest Unoccupied Molecular Orbital
lsac Lower Self-Assembly Concentration
MeOH Methanol
PBS Phosphate Buffer Solution
q quartuplett
s singulett
sept septuplett
t triplett
PCT Photoinduced Electron Transfer
PET Photoinduced Charge Transfer
ppm parts per million
δ Chemical shift (ppm)
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IX.II List of Complexes
Figure IX.1 Halfsandwich Complexes [(π-ligand)MCl2]2.
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Figure IX.2 Bridging ligands based on the structural 3-hydroxy-2-pyridone motif.
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Figure IX.3 General structure of monomers formed by [(π-ligand)MCl2]2 and 2.0 equiv. of the
ligands L2, L3, L4 or L5.
Figure IX.4 General structure of water soluble trinuclear 12-metallacrown-3 complexes formed
by self-assembly of [(π-ligand)MCl2]2, 2.0 equiv. of the ligands L2, L3, L4 or L5
and 1.0 equiv. CsOH.
Figure IX.5 General structure of trinuclear 12-metallacrown-3 complexes formed by self-
assembly of [(π-ligand)MCl2]2 and 2.0 equiv. of the ligands L1, L2, L3, L4 or L5 in
MeOH in the presence of and Cs2CO3. Use of the ligands L6, L7, L10 or L12 are
expected to assemble into similar structures.
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IX.III Available 1H NMR Data
Table IX.1: Available 1H NMR data of monomeric complexes [(π-ligand)M(H2O)]2+ in D2O
composed of the respective metal fragment and ligand.a
a. n.d.: not determined
Metal Fragment L2 L3 L4 L5
(C6H6)Ru ? n.d. n.d. ?
(C6H5Me)Ru ? n.d. n.d. ?
(cymene)Ru ?b ?b ?b ?
(C6H5CO2Et)Ru ? n.d. n.d. ?
(C6H3
iPr3)Ru ?b
b. Crystals (not suited for single crystal X-ray analysis) were obtained from CHCl3 or CH2Cl2 and pentane or Et2O.
n.d. n.d. ?
(C6Me6)Ru ?c
c. Crystals suited for single crystal X-ray analysis were obtained from CHCl3 or CH2Cl2 and pentane or Et2O.
?c ?c ?
CpRh ? n.d. n.d. ?
(C5HMe4)Rh ? n.d. n.d. ?
Cp*Rh ? n.d. n.d. ?
(C5HMe4)Ir ? n.d. n.d. ?
Cp*Ir ? n.d. n.d. ?
Table IX.2: Available 1H NMR data of trimeric complexes [(π-ligand)M(ligand−H+)]3 and their
LiCl adductsa in D2O, obtained from [(π-ligand)MCl2]2, ligands L2, L3, L4 or L5
and 1.0 equiv. CsOH.b
a. For LiCl adducts, also 7Li NMR data is available.
b. n.d.: not determined
Metal Fragment L2 L3 L4 L5
(C6H6)Ru ?c
c. Trimerisation was observed also in phosphate buffer solution (100 mM, pH 7.0).
n.d. n.d. ?
(C6H5Me)Ru ?c n.d. n.d. ?
(cymene)Ru ?c ?c ?c ?c,d
d. 2.0 equiv. of CsOH were used.
(C6H5CO2Et)Ru ?c n.d. n.d. ?
(C6H3
iPr3)Ru No 1H NMR data available due to the low solublity of the resulting complexes 
in water.(C6Me6)Ru
CpRh ? n.d. n.d. ?
(C5HMe4)Rh ? n.d. n.d. ?d
Cp*Rh ?e
e. Trimerisation in phosphate buffer solution (100 mM, pH 7.0) was not observed.
n.d. n.d. ?
(C5HMe4)Ir ? n.d. n.d. ?
Cp*Ir ?c n.d. n.d. ?
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Table IX.3: Available 1H NMR data of trimeric complexes [(π-ligand)M(ligand−2 H+)]3 in CDCl3
synthesised from [(π-ligand)MCl2]2 and ligands L1, L2, L3, L4 or L5 in the
presence of Cs2CO3.
a
Metal Fragment L1 L2 L3 L4 L5
(C6H6)Ru Ref. [124]
b,c n.d. n.d. n.d. n.d.
(C6H5Me)Ru ?b,c n.d. n.d. n.d. n.d.
(cymene)Ru Ref. [126]b,c,d ?b ?b ? ?b
(C6H5CO2Et)Ru Ref. [165]
b,c,d n.d. n.d. n.d. n.d.
(C6H3
iPr3)Ru ?b,c ? ? ? ?
(C6Me6)Ru Ref. [124]
b ? ? ? ?
CpRh n.d. ? n.d. n.d. ?
(C5HMe4)Rh ?b,c n.d. n.d. n.d. n.d.b
Cp*Rh Ref. [124]b,c ? ? ? ?b
(C5HMe4)Ir n.d. n.d. n.d. n.d. n.d.
Cp*Ir Ref. [166] ? ?b ? ?
a. n.d.: not determined
b. Crystals suited for single crystal X-ray analysis were obtained.
c. The LiCl adduct was crystallised too.
d. The NaCl adduct was crystallised too.
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IX.IV.1 Water Solubility of 12-Metallacrown-3 Complexes
IX.IV.2 Li+ Binding Constants in Water
Table IX.4: Equivalents of CsOHa after which precipitation of mixtures containing the
respective metal fragment and ligand occured.b
a. Equivalents with respect to the ligand.
b. n.d.: not determined; soluble means that no precipitation was observed after addition of 2.0 equiv. of CsOH
Metal Fragment L2 L3 L4 L5
(C6H6)Ru 1.85 soluble soluble soluble
(C6H5Me)Ru 1.85 soluble soluble soluble
(cymene)Ru 1.25 1.55 1.65 soluble
(C6H5CO2Et)Ru 1.50 n.d. n.d. soluble
CpRh soluble soluble soluble soluble
(C5HMe4)Rh 1.55 soluble soluble soluble
Cp*Rh 1.40 n.d. n.d. 1.50
(C5HMe4)Ir 1.25 n.d. n.d. 1.60
Cp*Ir 1.15 1.25 1.50 1.30
Table IX.5: Binding constants Ka for the complexation of Li
+ of trimeric 12-metallacrown-3
complexes [(π-ligand)M(ligand−H+)]3 in M−1a.
a. Binding constants were determined by 1H NMR spectroscopy at receptor concentrations of  5.0 mM. The trimeric 
complexes were generated in situ from mixtures of [(π-ligand)MCl2]2, 2.0 equiv. of the corresponding ligand and 
1.0 equiv. of CsOH.
Metal Fragment L2 L3 L4 L5
(C6H6)Ru 7.5 ±0.6 × 10
2 n.d. n.d. 4.0 ±0.6 × 103
(C6H5Me)Ru 1.2 ±0.6 × 10
3 n.d. n.d. 5.4 ±0.5 × 103
(cymene)Ru 2.1 ±0.6 × 103 2.3 ±0.6 × 103 2.4 ±0.6 × 103 5.8 ±1.0 × 104 b
b. 2.0 equiv. of CsOH were employed.
(C6H5CO2Et)Ru 2.8 ±0.6 × 10
1 n.d. n.d. n.d.c
c. The integrals of the free and complexed receptors were not suited to determine a binding constant.
CpRh 2.9 ±0.5 × 102 n.d. n.d. 2.7 ±0.6 × 103
(C5HMe4)Rh 1.3 ±0.2 × 10
4 n.d. n.d. 5.6 ±2.1 × 104 b
Cp*Rh 1.3 ±0.4 × 101 n.d. n.d. n.d.d
d. The complex precipitated before trimerisation was complete.
(C5HMe4)Ir 2.6 ±0.5 × 10
2 n.d. n.d. 1.2 ±0.6 × 103
Cp*Ir 9.0 ±2.0 × 10−2 n.d. n.d. < 5 × 10−2
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IX.IV.3 pKa of Water Soluble 12-Metallarown-3 Complexes
Table IX.6: pka1
a of complexes containing the corresponding metal fragment and ligand.b
a. pH after addition of 0.5 equiv. CsOH.
b. n.d.: not determined.
Metal Fragment L2 L3 L4 L5
— 10.8 n.d. 10.3 9.5
(C6H6)Ru 5.7 n.d. n.d. n.d.
(C6H5Me)Ru 5.4 n.d. n.d. n.d.
(cymene)Ru 5.5 5.4 5.4 6.1
(C6H5CO2Et)Ru 4.4 n.d. n.d. n.d.
CpRh 5.3 n.d. n.d. n.d.
(C5HMe4)Rh 6.9 n.d. n.d. 7.1
Cp*Rh 7.6 n.d. n.d. n.d.
(C5HMe4)Ir 4.9 n.d. n.d. n.d.
Cp*Ir 5.3 5.2 5.3 5.9
Table IX.7: pka2
a of complexes containing the corresponding metal fragment and ligand.b
a. pH after addition of 1.5 equiv. CsOH.
b. n.d.: not determined
Metal Fragment L2 L3 L4 L5
— 11.8 n.d. 11.7 11.6
(C6H6)Ru 9.4 n.d. n.d. n.d.
(C6H5Me)Ru 9.2 n.d. n.d. n.d.
(cymene)Ru 9.1 7.1 9.1 8.1
(C6H5CO2Et)Ru 9.1 n.d. n.d. n.d.
CpRh 9.4 n.d. n.d. n.d.
(C5HMe4)Rh 9.7 n.d. n.d. 8.4
Cp*Rh 9.9 n.d. n.d. n.d.
(C5HMe4)Ir 8.5 n.d. n.d. n.d.
Cp*Ir 8.9 6.6 8.7 7.4
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IX.IV.4 pH of Monomeric and Trimeric Complexes
Table IX.8: pHa of monomeric complexes [(π-ligand)M(H2O)]2+ composed of the
corresponding metal fragment and ligand.b
a. pH before addiotion of  CsOH.
b. n.d.: not determined.
Metal Fragment L2 L3 L4 L5
— 8.6 7.7 8.3 8.5
(C6H6)Ru 4.8 n.d. n.d. n.d.
(C6H5Me)Ru 4.4 n.d. n.d. n.d.
(cymene)Ru 4.2 3.4 3.3 4.7
(C6H5CO2Et)Ru 3.5 n.d. n.d. n.d.
CpRh 4.4 n.d. n.d. n.d.
(C5HMe4)Rh 5.1 n.d. n.d. 5.0
Cp*Rh 5.5 n.d. n.d. n.d.
(C5HMe4)Ir 3.9 n.d. n.d. n.d.
Cp*Ir 4.2 4.1 4.1 4.8
Table IX.9: pHa of trimeric complexes [(π-ligand)M(ligand−H+)]3 composed of the
corresponding metal fragment and ligand.b
a. pH after addition of 1.0 equiv. CsOH.
b. n.d.: not determined
Metal Fragment L2 L3 L4 L5
— 11.4 n.d. 11.2 10.8
(C6H6)Ru 7.9 n.d. n.d. n.d.
(C6H5Me)Ru 6.9 n.d. n.d. n.d.
(cymene)Ru 7.5 6.1 6.7 7.1c
(C6H5CO2Et)Ru 7.3 n.d. n.d. n.d.
CpRh 7.9 n.d. n.d. n.d.
(C5HMe4)Rh 7.8 n.d. n.d. 7.7
c
c. Trimerisation was not complete.
Cp*Rh 8.7 n.d. n.d. n.d.
(C5HMe4)Ir n.d. n.d. n.d. n.d.
Cp*Ir 7.9 6.1 7.1 7.1
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IX.V pH Triggered Assembly
Figure IX.6 The pH of solutions containing the ligand L2 (15.0 mM) and the complexes 1 (?),
2 (?), 3 (Δ) and 4 (?) ([Ru] = 15.0 mM) after addition of increasing amounts of
CsOH (0.0–2.0 equiv. with respect to the ligand).
Figure IX.7 The pH of solutions containing the ligand L2 (15.0 mM) and the complexes 7 (?),
8 (?), 9 (Δ), 10 (?) and 11 (?) ([Rh] = [Ir] = 15.0 mM) after addition of
increasing amounts of CsOH (0.0–2.0 equiv. with respect to the ligand).
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Figure IX.8 The pH of solutions containing the complex 3 ([Ru] = 15.0 mM) and the ligands L2
(Δ), L3 (?),  L4 (?) and L5 (?) (15.0 mM) after addition of increasing amounts
of CsOH (0.0–2.0 equiv. with respect to the ligand).
Figure IX.9 The pH of solutions containing the complex 11 ([Ir] = 15.0 mM) and the ligands L2
(Δ), L3 (?),  L4 (?) and L5 (?) (15.0 mM) after addition of increasing amounts
of CsOH (0.0–2.0 equiv. with respect to the ligand).
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Figure IX.10 The pH of solutions containing the complex 3 ([Ru] = 15.0 mM) and the ligand L2
(15.0 mM) after addition of increasing amounts of CsOH (?), and subsequent
addition of HCl (?) (0.0–1.0 equiv. with respect to the ligand).
Figure IX.11 pH of solutions containing receptor [(cymene)Ru(L2−1 H+)]3 (5.0 mM) after
addition of increasing amounts of HCl (0.0–3.0 equiv. with respect to the receptor).
The titrations were performed in the presence of 20 equiv. LiNO3 (?) and without
LiNO3 (?).
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Figure IX.12 The pH of solutions containing the complex 3 ([Ru] = 15.0 mM) and the ligand L5
(15 mM) after addition of increasing amounts of CsOH (?), and subsequent
addition of HCl (?) (0.0–2.0 equiv. with respect to the ligand).
Figure IX.13 pH of solutions containing receptor [(cymene)Ru(L5−2 H+)]3 (5.0 mM) after
addition of increasing amounts of HCl (0.0–3.0 equiv. with respect to the receptor).
The titrations were performed in the presence of 20 equiv. LiNO3 (?),  1.00 equiv.
LiNO3 (Δ), 0.75 equiv. LiNO3 (?), 0.50 equiv. LiNO3 (?), 0.25 equiv. LiNO3 (?)
and without LiNO3 (?).
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Figure IX.14 The pH of solutions containing the complex 4 ([Ru] = 15.0 mM) and the ligand L2
(15 mM) after addition of increasing amounts of CsOH (?), and subsequent
addition of HCl (?) (0.0–1.0 equiv. with respect to the ligand).
Figure IX.15 The pH of solutions containing the complex 8 ([Rh] = 15.0 mM) and the ligand L2
(15 mM) after addition of increasing amounts of CsOH (?), and subsequent
addition of HCl (?) (0.0–1.0 equiv. with respect to the ligand).
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Figure IX.16 The pH of solutions containing the complex 8 ([Rh] = 15.0 mM) and the ligand L5
(15 mM) after addition of increasing amounts of CsOH (?), and subsequent
addition of HCl (?) (0.0–2.0 equiv. with respect to the ligand).
Figure IX.17 The pH of solutions containing the complex 10 ([Ir] = 15.0 mM) and the ligand L2
(15 mM) after addition of increasing amounts of CsOH (?), and subsequent
addition of HCl (?) (0.0–1.0 equiv. with respect to the ligand).
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Figure IX.18 pH of solutions containing the ligands L2 (Δ), L3 (?), L4 (?) and L5 (?)
(15.0 mM) after addition of increasing amounts of HCl (0.0–3.0 equiv.).
Figure IX.19 pH of solutions containing the ligands L2 (Δ), L4 (?) and L5 (?) (15.0 mM) after
addition of increasing amounts of CsOH (0.0–2.0 equiv.).
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Figure IX.20 The pH of solutions containing the complex 3 ([Ru] = 15.0 mM) and the ligand L2
(15 mM) in the presence of different salts (100 mM): no salt (?), CsCl (?), and
LiNO3 (?) after addition of increasing amounts of CsOH (0.0–2.0 equiv. with
respect to the ligand).
Figure IX.21 The pH of solutions containing the complex 3 ([Ru] = 15.0 mM) and the ligand L5
(15 mM) in the presence of different salts (100 mM): no salt (?), CsCl (?), LiCl
(Δ) and LiNO3 (?) after addition of increasing amounts of CsOH (0.0–2.0 equiv.
with respect to the ligand).
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Figure IX.22 The pH of solutions containing the ligand L2 (15.0 mM) and the complexes 3 (Δ)
and 4 (?) ([Ru] = 15.0 mM) in the presence of LiNO3 (100 mM) after addition of
increasing amounts of CsOH (0.0–2.0 equiv. with respect to the ligand).
Figure IX.23 The pH of solutions containing the ligand L2 (15.0 mM) and the complexes 7 (?),
8 (?), 9 (Δ), and 11 (?) ([Rh] = [Ir] = 15.0 mM) in the presence of LiNO3
(100 mM) after addition of increasing amounts of CsOH (0.0–2.0 equiv. with
respect to the ligand).
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IX.VI Crystallographic Data
Table IX.10: Selected bond lengths (Å) and angles (°)a for 12-metallacrown-3 complexes of
3-hydroxy-2-pyridone ligands with diverse metal fragments.
a. Averaged values are given, except for [Cp*Rh(L5−2 H+)]3, [Cp*Ir(L3−2 H+)]3 and [(C5HMe4)Rh(L5−2 H+)]3 which 
display a C3 axis.
Complex M–N M–O1 M–O2
O1–M–
O2
M–O–
C1–C2
M–N–
C1–C2
O–O’ M–M’
[(C6H6)Ru(L1−2 H+)]3[126] 2.13 2.08 2.07 79.66 8.2 5.2 3.04 5.32
[(C6H6)Ru(L1−2 H+)]3 × LiCl[126] 2.14 2.11 2.05 79.44 8.4 8.1 2.98 5.38
[(C6H6)Ru(L1−2 H+)]3 × NaBr[126] 2.14 2.11 2.06 79.1 10.8 5.7 3.11 5.39
[(C6H5Me)Ru(L1−2 H+)]3 2.14 2.09 2.08 79.5 4.5 7.4 3.04 5.37
[(C6H5Me)Ru(L1−2 H+)]3 × LiCl 2.14 2.12 2.08 79.5 8.7 5.8 2.96 5.40
[(cymene)Ru(L1−2 H+)]3[126] 2.13 2.08 2.05 79.41 11.1 7.6 3.09 5.38
[(cymene)Ru(L1−
2 H+)]3 × LiCl
[126] 2.14 2.10 2.06 79.51 8.8 9.2 2.97 5.36
[(cymene)Ru(L1−
2 H+)] × NaCl[126]
2.14 2.09 2.04 79.29 11.6 7.8 3.11 5.36
[(cymene)Ru(L1−
2 H+)]3 × NaI
[126] 2.15 2.10 2.05 79.2 12.3 8.5 3.14 5.42
[(C6H5CO2Et)Ru(L1−2 H+)]3[165] 2.12 2.06 2.05 80.3 10.5 7.9 3.00 5.28
[(C6H5CO2Et)Ru(L1−
2 H+)]3 × LiCl
[165] 2.13 2.08 2.05 80.0 8.3 6.1 2.93 5.33
[(C6H3
iPr3)Ru(L1−2 H+)]3 2.14 2.09 2.06 79.5 13.5 8.7 3.15 5.39
[(C6H3
iPr3)Ru(L1−2 H+)]3 × LiCl 2.14 212 2.03 79.5 11.7 11.8 3.07 5.48
[(C6Me6)Ru(L1−2 H+)]3[124] 2.14 2.12 2.05 78.6 15.1 9.8 3.21 5.46
[(C5HMe4)Rh(L1−2 H+)]3 2.14 2.11 2.10 80.4 13.9 9.6 3.10 5.33
[(C5HMe4)Rh(L1−2 H+)]3 × LiCl 2.13 2.08 2.13 79.5 11.4 10.9 2.99 5.34
[Cp*Rh(L1−2 H+)]3[124] 2.13 2.09 2.06 80.1 11.2 5.8 3.10 5.35
[Cp*Rh(L1−2 H+)]3 × LiCl[124] 2.12 2.14 2.06 79.2 10.8 9.1 3.07 5.47
[Cp*Ir(L1−2 H+)]3[166] 2.13 2.11 2.07 79.2 10.3 7.7 3.05 5.37
[(C6H6Ru)2(C6Me6Ru)(L1−
2 H+)3]
2.13 2.07 2.07 80.0 11.5 8.6 3.03 5.26
[(C6H6Ru)2(Cp*Rh)(L1−2 H+)3] 2.11 2.08 2.08 79.6 11.9 8.1 3.04 5.26
[(cymene)Ru(L2−2 H+)]3 2.14 2.08 2.07 79.6 11.7 7.0 3.10 5.43
[(cymene)Ru(L3−2 H+)]3 2.14 2.09 2.06 79.1 13.4 9.7 3.13 5.37
[(cymene)Ru(L5−2 H+)]3 2.14 2.08 2.05 79.5 12.8 8.7 3.10 5.34
[(C5HMe4)Rh(L5−2 H+)]3 2.12 2.08 2.09 78.0 9.9 16.2 3.15 5.32
[Cp*Rh(L5−2 H+)]3 2.13 2.09 2.05 80.1 12.4 7.4 3.11 5.35
[Cp*Ir(L3−2 H+)]3 2.13 2.12 2.09 78.6 8.8 5.8 3.04 5.37
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Table IX.11: Selected bond lengths (Å) and angles (°) for monomeric complexes .
Complex M–Cl M–O1 M–O2 O1–M–O2 O1–M–Cl1
M–O1–
C1–C2
N2–Cl2 N1-Cl2
[(C6Me6)Ru(L2)Cl]Cl 2.42 2.15 2.09 78.6 83.3 14.23 3.08 3.14
[(C6Me6)Ru(L3)Cl]Cl 2.43 2.17 2.07 78.4 84.5 11.24 3.07 3.17
[(C6Me6)Ru(L4)Cl]Cl 2.43 2.14 2.08 78.3 85.2 13.79 3.02 3.14
[Cp*Rh(L2−H+)Cl] 2.42 2.14 2.13 78.3 86.9 7.52 — —
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Table IX.12: Crystallographic data of monomeric complexes [(C6Me6)Ru(L2)Cl]Cl and
[(C6Me6)Ru(L3)Cl]Cl.
[(C6Me6)Ru(L2)Cl]Cl 
× 0.5 CH2Cl2
[(C6Me6)Ru(L3)Cl]Cl 
× 0.5 CHCl3
Empirical formula C23.5H35Cl3N2O2Ru C22.5H32.5Cl3.5N2O3Ru
Mol. weight / g mol−1 584.96 604.15
Crystal size / mm3 0.22 × 0.14 x 0.09 0.18 x 0.16 x 0.09
Crystal system monoclinic monoclinic
Space group P21/n P21/c
a / Å 8.7505(8) 9.3253(6)
b / Å 21.6323(15) 16.161(5)
c / Å 13.6254(8) 17.709(6)
α / ° 90 90
β / ° 95.697(6) 94.734(14)
γ / ° 90 90
Volume / Å3 2566.5(3)3 2659.7(12)3
Z 4 4
Density / g cm−3 1.514 1.509
Temperature / K 140(2) 140(2)
Absorption Coeff. / mm−1 0.946 0.967
Θ range / ° 3.00 to 25.03 2.85 to 25.02
Index ranges
−9 → h → 9, −25 → k → 25,
−16 → l → 16
−10 → h → 10, −19 → k → 19,
−21 → l → 21
Reflections collected 14809 16307
Independent reflections 4266 (Rint = 0.0382) 4434 (Rint = 0.0439)
Absorption corrrection semi-empirical semi-empirical 
Max. & min. transmission 0.9486 and 0.7834 0.9471 and 0.8191
Data / restraints / param. 4266 / 0 / 289 4434 / 0 / 308
Goodness-of-fit on F2 1.066 1.188
Final R indices [I > 2 σ (I)] R1 = 0.0422, wR2 = 0.1157 R1 = 0.0527, wR2 = 0.1481
R indices (all data) R1 = 0.0536, wR2 = 0.1223 R1 = 0.0679, wR2 = 0.1659
Larg. diff. peak/hole / eÅ−3 1.653 and −1.261 0.823 and −0.875
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Table IX.13: Crystallographic data of monomeric complexes [(C6Me6)Ru(L4)Cl]Cl and
[Cp*Rh(L3−H+)Cl].
[(C6Me6)Ru(L4)Cl]Cl 
× 0.5 CHCl3
[Cp*Rh(L3−H+)Cl]
Empirical formula C20.5H30.5Cl3.5N2O2Ru C20H28ClN2O3Rh
Mol. weight / g mol−1 562.11 482.8
Crystal size / mm3 0.19 × 0.15 × 0.09 0.23 × 0.12 × 0.07
Crystal system monoclinic monoclinic
Space group P21/c P21/c
a / Å 8.8640(10) 7.4799(5)
b / Å 18.626(6) 22.9529(14)
c / Å 14.885(5) 12.0712(6)
α / ° 90 90
β / ° 100.814(19) 93.000(5)
γ / ° 90 90
Volume / Å3 2413.9(12) 2069.6(2)
Z 4 4
Density / g cm−3 1.547 1.550
Temperature / K 140(2) 140(2)
Absorption Coeff. / mm−1 1.056 0.976
Θ range / ° 2.99 to 25.02 3.15 to 25.02
Index ranges
−9 → h → 10, −22 → k → 22,
−15 → l → 17
−8 → h → 8, −27 → k → 27,
−12 → l → 12
Reflections collected 14850 12027
Independent reflections 4033 (Rint = 0.0434) 3421 (Rint = 0.0325)
Absorption corrrection semi-empirical semi-empirical
Max. & min. transmission 0.8949 and 0.8213 1.0371 and 0.7320
Data / restraints / param. 4033 / 0 / 281 3421 / 0 / 245
Goodness-of-fit on F2 1.213 1.072
Final R indices [I > 2 σ (I)] R1 = 0.0451, wR2 = 0.1221 R1 = 0.0282, wR2 = 0.0676
R indices (all data) R1 = 0.0625, wR2 = 0.1339 R1 = 0.0331, wR2 = 0.0698
Larg. diff. peak/hole / eÅ−3 0.584 and −0.641 0.657 and −0.845
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Table IX.14: Crystallographic data of the trinuclear complexes [(C6H5Me)Ru(L1−2 H+)]3 and
[(C6H5Me)Ru(L1−2 H+)]3 × LiCl.
[C6H5MeRu(L1−2 H+)]3 
× CHCl3 × 2 H2O
[C6H5MeRu(L1−2 H+)]3 × LiCl 
× CHCl3 × H2O
Empirical formula C37H38Cl3N3O8Ru3 C37H36Cl4LiN3O7Ru3
Mol. weight / g mol−1 1062.26 1086.64
Crystal size / mm3 0.52 x 0.27 x 0.19 0.24 x 0.14 x 0.13
Crystal system monoclinic monoclinic
Space group P21/n P21/n
a / Å 15.512(3) 15.580(3)
b / Å 13.6976(10) 14.1083(14)
c / Å 17.9333(18) 17.736(2)
α / ° 90 90
β / ° 102.723(10) 102.820(10)
γ / ° 9 90
Volume / Å3 3717.0(8) 3801.5(9)
Z 4 4
Density / g cm−3 1.898 1.899
Temperature / K 100(2) 100(2)
Absorption Coeff. / mm−1 1.477 1.512
Θ range / ° 3.07 to 25.03 3.04 to 25.03
Index ranges
−18 → h → 18,  −16 → k → 16,
−21 → l → 21
 16 → h → 18,  −16 → k → 16,
−21 → l → 18
Reflections collected 73189 29632
Independent reflections 6563 (Rint = 0.0901) 6591 (Rint = 0.1100)
Absorption corrrection semi-empirical semi-empirical
Max. & min. transmission 1.0000 and 0.6795 1.0000 and 0.7079
Data / restraints / param. 6563 / 6 / 499 6591 / 3 / 502
Goodness-of-fit on F2 1.141 1.127
Final R indices [I > 2 σ (I)] R1 = 0.0392, wR2 = 0.0736 R1 = 0.0567, wR2 = 0.0757
R indices (all data) R1 = 0.0623, wR2 = 0.0838 R1 = 0.1136, wR2 = 0.0919
Larg. diff. peak/hole / eÅ−3 0.790 and −0.649 1.133 and −0.915
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Table IX.15: Crystallographic data of the trinuclear complexes [(C6H3
iPr3)Ru(L1−2 H+)]3 and
[(C6H3
iPr3)Ru(L1−2 H+)]3 × LiCl.
[(C6H3
iPr3)Ru(L1−2 H+)]3 
× 0.5 C6H14 × H2O
[(C6H3
iPr3)Ru(L1−2 H+)]3 × LiCl 
× 2 C6H14
Empirical formula C63H90N3O7Ru3 C72H109ClLiN3O6Ru3
Mol. weight / g mol−1 1304.59 1458.22
Crystal size / mm3 0.50 × 0.36 × 0.26 0.33 x 0.17 x 0.13
Crystal system monoclinic orthorhombic
Space group P21/n P212121
a / Å 13.4120(6) 13.2934(6)
b / Å 24.4988(13) 16.9892(11)
c / Å 18.6820(8) 32.829(2)
α / ° 90 90
β / ° 100.255(4) 90
γ / ° 90 90
Volume / Å3 6040.4(5) 7414.3(7)
Z 4 4
Density / g cm−3 1.435 1.306
Temperature / K 140(2) 140(2)
Absorption Coeff. / mm−1 0.794 0.688
Θ range / ° 3.34 to 25.03 2.70 to 25.03
Index ranges
−15 → h → 15, −29 → k → 29,
−18 → l → 22
−15 → h → 15, −20 → k → 20,
−39 → l → 35
Reflections collected 35584 45721
Independent reflections 10064 (Rint = 0.0439) 13029 (Rint = 0.1970)
Absorption corrrection empirical none
Max. & min. transmission 0.9020 and 0.6630 0
Data / restraints / param. 10064 / 11 / 709 13029 / 607 / 733
Goodness-of-fit on F2 0.961 0.751
Final R indices [I > 2 σ (I)] R1 = 0.0339, wR2 = 0.0674 R1 = 0.0671, wR2 = 0.0984
R indices (all data) R1 = 0.0584, wR2 = 0.0746 R1 = 0.1858, wR2 = 0.1361
Larg. diff. peak/hole / eÅ−3 0.890 and −0.640 0.742 and −0.557
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Table IX.16: Crystallographic data of the trinuclear complexes [(C5HMe4)Rh(L1−2 H+)]3 and
[(C5HMe4)Rh(L1−2 H+)]3 × LiCl.
[(C5HMe4)Rh(L1−2 H+)]3 × Et2O [(C5HMe4)Rh(L1−2 H
+)]3 
× LiCl × 2 H2O
Empirical formula C46H58N3O7Rh3 C42H52ClLiN3O8Rh3
Mol. weight / g mol−1 1073.68 1077.99
Crystal size / mm3 0.23 × 0.12 × 0.09 0.32 x 0.21 x 0.16
Crystal system triclinic monoclinic
Space group Pī P21/c
a / Å 9.2098(15) 17.405(3)
b / Å 11.7685(15) 12.8191(13)
c / Å 23.039(3) 20.414(3)
α / ° 75.250(11) 90
β / ° 85.279(17) 109.714(10)
γ / ° 74.286(12) 90
Volume / Å3 2324.3(6) 4287.8(9)
Z 2 4
Density / g cm−3 1.534 1.670
Temperature / K 140(2) 100(2)
Absorption Coeff. / mm−1 1.103 1.258
Θ range / ° 3.31 to 25.03 3.11 to 25.01
Index ranges
−10 → h → 9, −14 → k → 14,
−27 → l → 27
−20 → h → 20, −15 → k → 15,
−24 → l → 24
Reflections collected 13419 58639
Independent reflections 7120 (Rint = 0.0693) 7519 (Rint = 0.1339)
Absorption corrrection none semi-empirical
Max. & min. transmission 1.0000 and 0.5761
Data / restraints / param. 7120 / 0 / 533 7519 / 6 / 534
Goodness-of-fit on F2 1.205 1.121
Final R indices [I > 2 σ (I)] R1 = 0.0920, wR2 = 0.2593 R1 = 0.0663, wR2 = 0.1161
R indices (all data) R1 = 0.0991, wR2 = 0.2798 R1 = 0.1243, wR2 = 0.1407
Larg. diff. peak/hole / eÅ−3 1.971 and −3.117 2.178 and −1.821
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Table IX.17: Crystallographic data of the mixed trinuclear complexes
[(C6H6Ru)2(C6Me6Ru)(L1−2 H+)3] and [(C6H6Ru)2(Cp*Rh)(L1−2 H+)3].
[(C6H6Ru)2(C6Me6Ru)(L1−
2 H+)3] × 2 CHCl3
[(C6H6Ru)2(Cp*Rh)(L1−2 H+)3] 
× MeOH × C7H8 × H2O
Empirical formula C41H41Cl6N3O6Ru3 C45H50N3O8RhRu2
Mol. weight / g mol−1 1187.68 1065.93
Crystal size / mm3 0.20 × 0.12 × 0.09 0.17 × 0.17 × 0.13
Crystal system triclinic monoclinic
Space group Pī P21/n
a / Å 9.2537(14) 13.273(5)
b / Å 12.040(3) 18.718(5)
c / Å 20.007(5) 18.668(4)
α / ° 85.44(2) 90
β / ° 80.731(16) 110.09(3)
γ / ° 88.110(16) 90
Volume / Å3 2192.5(8) 4356(2)
Z 2 4
Density / g cm−3 1.799 1.625
Temperature / K 140(2) 140(2)
Absorption Coeff. / mm−1 1.436 1.115
Θ range / ° 3.09 to 25.03 2.73 to 25.03
Index ranges
−10 → h → 10, −14 → k → 14,
−23 → l → 23
−15 → h → 15, −22 → k → 22,
−21 → l → 22
Reflections collected 14091 26761
Independent reflections 7271 (Rint = 0.0439) 7694 (Rint = 0.0626)
Absorption corrrection semi-empirical semi-empirical
Max. & min. transmission 0.9528 and 0.7704 0.8564 and 0.7350
Data / restraints / param. 7271 / 0 / 533 7694 / 3 / 492
Goodness-of-fit on F2 1.08 0.998
Final R indices [I > 2 σ (I)] R1 = 0.0638, wR2 = 0.1757 R1 = 0.0688, wR2 = 0.1885
R indices (all data) R1 = 0.0769, wR2 = 0.1941 R1 = 0.1118, wR2 = 0.2197
Larg. diff. peak/hole / eÅ−3 1.152 and −1.076 0.946 and −0.957
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Table IX.18: Crystallographic data of the trinuclear complexes [(cymene)Ru(L3−2 H+)]3 and
[(cymene)Ru(L5−2 H+)]3.
[(cymene)Ru(L3−2 H+)]3 
× 3 H2O
[(cymene)Ru(L5−2 H+)]3 
× 2 C6H6 × H2O
Empirical formula C60H84N6O12Ru3 C75H101N9O7Ru3
Mol. weight / g mol−1 1384.54 1543.86
Crystal size / mm3 0.25 × 0.19 × 0.13 0.16 × 0.15 × 0.15
Crystal system monoclinic triclinic
Space group P21/n Pī
a / Å 13.0075(9) 15.289(3)
b / Å 24.6431(14) 15.347(3)
c / Å 18.6453(9) 16.3869(11)
α / ° 90 103.747(11)
β / ° 90.045(5) 97.591(11)
γ / ° 90 95.256(16)
Volume / Å3 5976.7(6) 3672.0(10)
Z 4 2
Density / g cm−3 1.539 1.396
Temperature / K 140(2) 293(2)
Absorption Coeff. / mm−1 0.815 0.667
Θ range / ° 2.71 to 25.03 2.83 to 25.03
Index ranges
−15 → h → 15, −29 → k → 29,
−21 → l → 18
−18 → h → 18, −18 → k → 17,
−18 → l → 18
Reflections collected 34821 23883
Independent reflections 10178 (Rint = 0.0433) 12170 (Rint = 0.0343)
Absorption corrrection semi-empirical semi-empirical
Max. & min. transmission 0.9680 and 0.8113 0.9480 and 0.8733
Data / restraints / param. 10178 / 0 / 740 12170 / 0 / 848
Goodness-of-fit on F2 1.071 1.104
Final R indices [I > 2 σ (I)] R1 = 0.0479, wR2 = 0.1180 R1 = 0.0655, wR2 = 0.1783
R indices (all data) R1 = 0.0659, wR2 = 0.1276 R1 = 0.0825, wR2 = 0.2039
Larg. diff. peak/hole / eÅ−3 1.650 and −1.391 1.957 and −1.086
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Table IX.19: Crystallographic data of the trinuclear complexes [(C5HMe4)Rh(L5−2 H+)]3 and
[Cp*Rh(L5−2 H+)]3.
[(C5HMe4)Rh(L5−2 H+)]3 
× 12 H2O
[Cp*Rh(L5−2 H+)]3 × 4.5 C6H6
Empirical formula C60H108N9O18Rh3 C90H117N9O6Rh3
Mol. weight / g mol−1 1552.28 1729.66
Crystal size / mm3 0.32 × 0.20 × 0.15 0.26 × 0.26 × 0.26
Crystal system rhombohedral cubic
Space group I23
a / Å 20.5761(11) 26.0844(7)
b / Å 20.5761(11) 26.0844(7)
c / Å 145.280(11) 26.0844(7)
α / ° 90 90
β / ° 90 90
γ / ° 120 90
Volume / Å3 53268(6) 17747.7(8)
Z 24 8
Density / g cm−3 1.161 1.295
Temperature / K 140(2) 140(2)
Absorption Coeff. / mm−1 0.608 0.606
Θ range / ° 2.60 to 25.03 2.92 to 25.02
Index ranges
−24 → h → 24, −24 → k → 24,
−172 → l → 172
−29 → h → 29, −31 → k → 31,
−31 → l → 30
Reflections collected 100131 55759
Independent reflections 10477 (Rint = 0.1864) 5230 (Rint = 0.0526)
Absorption corrrection none none
Max. & min. transmission
Data / restraints / param. 10477 / 0 / 503 5230 / 0 / 325
Goodness-of-fit on F2 1.062 1.11
Final R indices [I > 2 σ (I)] R1 = 0.1104, wR2 = 0.2884 R1 = 0.0265, wR2 = 0.0648
R indices (all data) R1 = 0.1644, wR2 = 0.3183 R1 = 0.0290, wR2 = 0.0656
Larg. diff. peak/hole / eÅ−3 1.420 and −1.083 0.362 and −0.414
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Table IX.20: Crystallographic data of the trinuclear complex [Cp*Ir(L3−2 H+)]3 and the dimeric
halfsandwich complex [(C5HMe4)IrCl2]2 (10).
[Cp*Ir(L3−2 H+)]3 [(C5HMe4)IrCl2]2
Empirical formula C60H81Ir3N6O9 C18H26Cl4Ir2
Mol. weight / g mol−1 1606.91 768.59
Crystal size / mm3 0.19 × 0.19 × 0.14 0.17 × 0.16 × 0.08
Crystal system rhombohedral monoclinic
Space group R3 P21/c
a / Å 18.832(4) 15.6001(11)
b / Å 18.832(4) 8.1663(6)
c / Å 13.812(5) 16.7110(12)
α / ° 90 90
β / ° 90 101.477(6)
γ / ° 120 90
Volume / Å3 4242.3(19) 2086.3(3)
Z 3 4
Density / g cm−3 1.887 2.447
Temperature / K 140(2) 140(2)
Absorption Coeff. / mm−1 7.104 13.255
Θ range / ° 2.90 to 25.02 2.98 to 25.03
Index ranges
−22 → h → 19, −22 → k → 22,
−16 → l → 16
−18 → h → 18, −8 → k → 9,
−19 → l → 19
Reflections collected 8956 11408
Independent reflections 3304 (Rint = 0.0498) 3621 (Rint = 0.0648)
Absorption corrrection semi-empirical semi-empirical
Max. & min. transmission 0.4041 and 0.3390 0.2723 and 0.1103
Data / restraints / param. 3304 / 1 / 235 3621 / 0 / 217
Goodness-of-fit on F2 1.013 0.997
Final R indices [I > 2 σ (I)] R1 = 0.0314, wR2 = 0.0537 R1 = 0.0372, wR2 = 0.0887
R indices (all data) R1 = 0.0388, wR2 = 0.0566 R1 = 0.0478, wR2 = 0.0936
Larg. diff. peak/hole / eÅ−3 3.388 and −1.077 2.089 and −1.835
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Table IX.21: Crystallographic data of the hexanuclear complexes [{(C6H6)Ru}2(L13−4 H+)]3
and [{(C6H5Me)Ru}2(L13−4 H+)]3.
[{(C6H6)Ru}2(L13−4 H+)]3 
× 39.25 H2O
[{(C6H5Me)Ru}2(L13−4 H+)]3 
× 14 H2O
Empirical formula C84H162.50N12O51.25Ru6 C90H124N12O26Ru6
Mol. weight / g mol−1 2767.18 2396.43
Crystal size / mm3 0.34 x 0.30 x 0.26 0.24 × 0.21 × 0.18
Crystal system triclinic orthorhombic
Space group Pī Pna21
a / Å 16.2163(17) 21.3799(7)
b / Å 18.3321(19) 24.3158(14)
c / Å 22.563(5) 18.4091(10)
α / ° 101.528(11) 90
β / ° 93.817(11) 90
γ / ° 115.455(10) 90
Volume / Å3 5845.3(15) 9570.3(8)
Z 2 4
Density / g cm−3 1.572 1.663
Temperature / K 100(2) 140(2)
Absorption Coeff. / mm−1 0.849 1.004
Θ range / ° 2.92 to 25.03 2.91 to 25.03
Index ranges
−19 → h → 19, −21 → k → 21,
−26 → l → 26
−22 → h → 22, −28 → k → 28,
−21 → l → 21
Reflections collected 101158 57579
Independent reflections 20469 (Rint = 0.0694) 16075 (Rint = 0.0778)
Absorption corrrection
Semi-empirical from equivalents 
(SADABS)
none
Max. & min. transmission 1.0000 and 0.6742 0
Data / restraints / param. 20469 / 0 / 1375 16075 / 697 / 1208
Goodness-of-fit on F2 1.063 0.794
Final R indices [I > 2 σ (I)] R1 = 0.0581, wR2 = 0.1358 R1 = 0.0416, wR2 = 0.0683
R indices (all data) R1 = 0.0890, wR2 = 0.1580 R1 = 0.0699, wR2 = 0.0744
Larg. diff. peak/hole / eÅ−3 1.859 and −1.789 1.116 and −0.981
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Table IX.22: Crystallographic data of the hexanuclear complexes [{(C6H5Me)Ru}2(L14−4 H+)]3
and [{(C5HMe4)Rh}2(L15−4 H+)]3.
[{C6H5Me)Ru}2(L14−4 H+)]3 
× 26 H2O
[{(C5HMe4)Rh}2(L15−4 H+)]3 
× 3 NEt3 × 5 H2O
Empirical formula C90H154N12O38Ru6 C147H229N15O17Rh6
Mol. weight / g mol−1 2618.67 3095.91
Crystal size / mm3 0.32 × 0.24 × 0.15 0.26 × 0.26 × 0.26
Crystal system monoclinic cubic
Space group I2/a P213
a / Å 24.471(5) 25.758(2)
b / Å 14.566(3) 25.758(2)
c / Å 31.674(6) 25.758(2)
α / ° 90 90
β / ° 91.08(3) 90
γ / ° 90 90
Volume / Å3 11288(4) 17091(2)
Z 4 4
Density / g cm−3 1.541 1.203
Temperature / K 100(2) 140(2)
Absorption Coeff. / mm−1 0.866 0.623
Θ range / ° 2.93 to 25.03 2.85 to 25.02
Index ranges
−28 → h → 29, −16 → k → 17,
−37 → l → 37
−30 → h → 30, −29 → k → 30,
−30 → l → 30
Reflections collected 41808 107235
Independent reflections 9830 (Rint = 0.0673) 10065 (Rint = 0.1578)
Absorption corrrection semi-empirical none
Max. & min. transmission 1.0000 and 0.8729 0
Data / restraints / param. 9830 / 120 / 727 10065 / 7 / 506
Goodness-of-fit on F2 1.091 1.166
Final R indices [I > 2 σ (I)] R1 = 0.0868, wR2 = 0.1933 R1 = 0.1346, wR2 = 0.3297
R indices (all data) R1 = 0.1567, wR2 = 0.2397 R1 = 0.1697, wR2 = 0.3625
Larg. diff. peak/hole / eÅ−3 1.959 and −1.419 4.403 and −1.350
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